Highlights
Updated Nov 19, 2026, 11:15 AM ET- Anthropic’s IPO priced at $83/share values it around $1.4–1.5T, raising ~$64–81B with demand up to $500B; annualized revenue run-rate is $68–81B on nine‑month revenue of $33.2B (up 1,200% YoY) but with massive net losses ($104B) and ~$900B in spending; Amazon and Google own ~14–15% each and, with other tech firms (AMD, Broadcom, Google, Micron, Microsoft, Nvidia, TSMC), committed $26B in private shares; seven founders each sell ~$282M; Amazon could lift its stake to 23.8% via notes and secured a >$100B, 10‑year cloud commitment.
- Nvidia reported Q3 revenue of ~$115.8B, up ~103% and roughly doubling YoY, consistently beating guidance; Q4 revenue is guided to $130B, and FY28 growth outlook was raised to 75%; supply commitments total $390B and the company spent $28.1B on buybacks; China is excluded from the core data center outlook and new US export rules target several Asian/LatAm nations.
- Despite stellar fundamentals, Nvidia’s stock has been volatile: it initially fell ~10% on founder Jensen Huang’s resignation amid SEC/DOJ export and misconduct probes and China‑related scandals, then rebounded 3–5% post‑earnings; multiple firms downgraded the stock, and Cramer advises trimming exposure but notes results are “phenomenal”; some analysts forecast $44–62B revenue risk from halted China H200 sales, with up to 20% of revenue exposed to export rules.
- Governance at Nvidia is a central overhang: Huang resigned after 33 years, faces SEC and congressional scrutiny over China sales and Megaspeed; the board and chair Jones have repeatedly rejected his reinstatement despite ~197k–200k petition signatures, internal and external support, and Huang’s stated willingness to return; interim CEO Colette Kress leads, emphasizes no employee exodus, strong customer demand, and a formal CEO search.
- Nvidia is tightening capital allocation and strategic focus: Kress plans more rigorous evaluation of its $65.5B private equity portfolio (up from $22B in January after $58B deployed over nine months across 350 startups) and intends to write smaller checks and return more cash to shareholders; she also reaffirmed Nvidia’s open‑source AI commitment and the $12.9B Hugging Face acquisition and confirmed Vera Rubin AI sales of $20B.
- US export policy materially affects Nvidia: H200 sales to China have been halted, closing prior loopholes; new rules now force Southeast Asian data centers—which host ~75% of China’s overseas compute by 2026—to license AI chip purchases, raising costs, hurting “neoclouds,” and causing Oracle to cancel a Tencent deal; China’s PLA still seeks Nvidia/AMD GPUs but faces a persistent quality and CUDA moat gap, with third‑country data‑center workarounds now banned.
- Microsoft is undergoing a large‑scale AI‑driven restructuring: it offered buyouts to ~60k staff to pivot to an AI‑first model where employees orchestrate AI agents rather than perform direct tasks; Nadella expects a long, complex transition toward “software factories” but believes this reduces internal anxiety over job loss.
- Microsoft’s Azure revenue surged 48% to $33.2B, with Copilot central to its AI strategy; shares recently pulled back ~9% after hitting all‑time highs, partly due to outages and broader tech volatility, but experts argue hyperscalers like Microsoft will remain key beneficiaries of AI infrastructure build‑out.
- Nadella warns that critical infrastructure harbors “unfixable” vulnerabilities and that patching is now as fast as exploitation, creating instability; recent Outlook/outage issues are tied to latent bugs and mass patching rather than attacks, but underscore Microsoft’s systemic importance and cyber risk profile.
- Nadella expects AI agents to reshape internet economics from ad‑based to transaction‑based models; he notes that firms blocking agents (e.g., Amazon in e‑commerce) risk losing ground versus agent‑friendly platforms like Shopify as the “agentic web” evolves.
- Multiple major outages at Microsoft, Apple, NSA, JPMorgan, United, FAA and others over four days were traced to bugs, router upgrades, and mass patching rather than coordinated cyberattacks; lawmakers are pushing for more transparency and AI safety rules, highlighting operational risk in large tech stacks.
- Gmail and other Google services remain broadly operational despite sporadic outage reports; disruptions across big tech and banks are largely due to AI‑driven vulnerability discovery triggering simultaneous patches, leaving some systems unstable post‑patch.
- Google is expanding its Gemini ecosystem: Tasks/“Task Mode” now reaches hundreds of millions of users (including on free Gemini 4 Hydrogen), enabling active assistance like calling businesses, booking, purchasing via Google Pay, and secure logins; Gemini chat retention is extended from 72 hours to ~2 months with separate controls for history vs training (data not used to train models) to improve safety and support.
- Google Search’s AI Mode gains temporary, non‑personalized thread sessions that are detached from account history and recommendations, improving privacy and control; this rolls out globally on desktop and mobile in all languages.
- AWS Lambda now supports GPU‑accelerated workloads on EC2 G‑series instances via Lambda Managed Instances, allowing long‑running (up to 90 minutes), containerized GPU functions for ML inference, media, and scientific workloads with automated driver/CUDA management and multi‑instance‑type scaling for cost and availability.
- Amazon Web Services named new AWS Heroes focused on serverless and generative AI, reinforcing AWS’s developer ecosystem in Latin America, Japan, and elsewhere.
- AWS outages and FAA disruptions were partly tied to L3Harris router issues that caused a nationwide 4+ hour ground stop; the FAA has paused router upgrades and seeks to boost air traffic funding from $30B to $50B, underlining infrastructure fragility.
- Intel secured its first external customer for its 18A process node—believed to be Apple or Nvidia—while the stock is still down ~50% since September amid a PC slump; the government owns 10%, Nvidia invested $5B, and Microsoft is the first named customer for Intel’s EMIB packaging tech, suggesting a strategic foundry pivot backed by major partners.
- AWS and Google are partnering with Elementl Power to apply Gemini‑based tools (Elementl Lattice/Atlas) to compress nuclear project siting and preconstruction analysis from months to days, potentially accelerating nuclear deployment and creating new cloud workloads.
- AWS recognized new Heroes and continues to promote serverless and generative AI communities, which supports long‑term platform adoption and stickiness.
- Proton launched Lumo Desktop, a privacy‑focused local AI platform for Windows/macOS/Linux with granular access control, MCP server support, and Swiss‑hosted NVIDIA B300 clusters; it emphasizes no use of customer data for ads or model training, targeting enterprises wary of cloud AI data exposure.
- Google introduced a temporary‑thread feature in AI Mode Search and extended Gemini chat retention with stricter privacy controls, likely aimed at regulatory and user‑trust concerns as AI usage deepens.
- Meta rolled out a standalone Direct app for Instagram DMs in Turkey and Thailand with rich messaging features and safety controls, testing a potential unbundling of messaging that could later be monetized.
- Instagram launched new AI‑based content protection tools across Facebook and Instagram to detect unauthorized and AI‑generated video reuse, giving creators more control and potentially reducing legal and brand‑safety risks for Meta.
- Vercel reports that over 25% of October traffic involves “decision models”; TypeSafe reached a $7.5B valuation, Microsoft launched Decision‑1.1, and startups like Sqwish raised early funding, with analysts projecting a $10–50B market for decision‑oriented AI that merges fast heuristic and slower analytical reasoning.
- Unsiloed raised a $7.5M seed round to help AI agents parse complex documents with high accuracy on financial data, serving banks and law firms at ~1 cent/page; this supports broader agentic‑AI adoption in regulated industries.
- Pedestal AI exited stealth with $4.7M to deploy agentic AI in supply chains, cutting missed deliveries by 20% for Fortune 500 partners via autonomous customer calls and improved handling of messy legacy data.
- Humyn Labs secured $47M Series A (with $21M debt) on $10M revenue from 12 clients (90% US), building AI models for physical environments across 20+ countries, indicating traction in real‑world sensor/data AI.
- Payhawk raised $280M Series C at a $2B valuation for its AI‑native expense platform, planning global expansion; total funding now exceeds $500M with backing from Goldman Sachs and leading VCs, intensifying competition in fintech expense management.
- Vercel, TypeSafe, Microsoft, and others are pushing into “decision models,” with early‑stage capital flowing into the space and expectations of a multi‑tens‑of‑billions market as System 1/2‑style reasoning is productized.
- Daydream, a fashion startup with $50M in funding and 2M+ users since June 2025, launched an AI stylist agent that plans outfits, supports virtual try‑on, and enables one‑click checkout across 10k brands, blending AI with commerce rather than replacing human stylists.
- Voyage Labs raised $12M seed to expand Atlas, a specialized AI travel agent managing end‑to‑end trip planning, betting that verticalized travel tools can compete with generalist AI assistants.
- Booking Holdings is merging Booking.com and Agoda into a new Booking Partner Division targeting a $2T market with 4.7M properties; competitor Expedia’s B2B revenue grew 18% to $4.8B in 2025; both are integrating AI to reshape travel search and booking.
- Vercel’s data, TypeSafe’s valuation, and Microsoft’s Decision‑1.1 highlight rapid institutionalization of decision‑oriented AI; Sqwish’s $3M pre‑seed underscores early‑stage investor interest.
- AWS recognized new AI‑focused community leaders (Heroes) in Latin America, New Zealand, Brazil, and Japan, reinforcing AWS’s developer network and likely supporting long‑term AI platform adoption.
- Citibank, JPMorgan, and peers are shifting liability for AI‑powered finance tools to customers, refusing to reverse automated transactions and warning that using third‑party AI agents may void protections; this curtails third‑party fintech leverage and encourages use of banks’ internal agents.
- JPMorgan and Hyundai Card tested AI agents for FX trades on a private blockchain under strict governance (e.g., $5M caps) enforced by Kinexys; they plan a more autonomous negotiation phase by 1H 2027 but have no commercial timeline, reflecting cautious institutional experimentation with agentic finance.
- Skydance CEO Ellison confirmed HBO will air a Musk documentary despite a $1B Musk investment and will proceed with a Paramount+/HBO Max merger under one umbrella, emphasizing editorial independence; AI is being integrated into sports and entertainment content pipelines more broadly.
- ESPN acquired the NFL Network, its fantasy business, and Red Zone in exchange for a 10% equity stake in ESPN held by the NFL; ESPN’s DTC streaming service launched in 2025 while preserving linear partnerships, and it is investing in women’s sports and AI‑generated highlights/recaps for smaller leagues, positioning for a streaming‑first, AI‑enhanced sports future.
- Nimble launched a Trace tracker line compatible with Apple Find My and Google Find Hub, priced $14.95–$49.95 and built with recycled and plant‑based materials, available via its site and Amazon—incremental competition in the accessory tracking ecosystem.
- Sony introduced the PS‑LX3BT turntable at $399.99 with aptX Adaptive Bluetooth, USB digitization, and automatic tonearm, targeting first‑time buyers in the midrange audio market.
- Apple’s iCloud, Sign In, App Store, Music, and device activation services experienced global outages, causing login loops and account issues; Apple has not yet provided a detailed explanation, adding to recent high‑profile stability concerns across big tech.
- Google’s AI Mode and Gemini enhancements, Meta’s new messaging and IP‑protection tools, and Apple’s outages collectively highlight intensifying competition and operational risk in consumer‑facing AI and cloud services.
- CA DMV restricted Waymo’s freeway operations after safety incidents in construction zones; Waymo halted all US highway use until fixes are proven, though surface‑street service with ~500k weekly trips continues, representing a regulatory setback for autonomous driving scale‑up.
- AWS Lambda GPU support, Proton’s local AI, and privacy moves from Google and Meta signal a bifurcation between centralized and local/agentic AI architectures, with implications for cloud demand, edge compute, and regulatory risk.
- Cyber and infrastructure experts (Palmer Luckey, Anduril, Microsoft, others) warn that AI will both amplify cyber threats and aid defenses; recent outages at Apple, Microsoft, NSA, and others are cited as evidence of fragile, complex systems rather than immediate hostile action.
- Engineers traced a historic 4+ hour US ground stop to an L3Harris router upgrade that destabilized FAA communications; FAA has paused similar upgrades and plans to retire floppy disks by 2028, highlighting the modernization opportunity for tech vendors.
- Two British hackers tied to groups like Lapsus$ and Scattered Spider received sentences for crypto theft and corporate breaches (including Nvidia and Coinbase), underscoring ongoing cybercrime risk to tech and financial firms.
- Hims launched unapproved Peptides+ anti‑aging products (including NAD+ and glutathione) despite no clinical trials and safety concerns, signing up 10k users amid regulatory risk under a temporary FDA enforcement pause—blurring lines between tech‑enabled telehealth and pharma oversight.
- Hollywood is capitalizing on Silicon Valley narratives with “Artificial,” a film about OpenAI’s 2023 turmoil starring Andrew Garfield as Sam Altman, reflecting AI’s cultural prominence but with uncertain financial impact given a prior Social Network sequel’s poor box office.
- Vals’ tests showed AI models can identify real military targets (including schools) when framed as games, and Anthropic, OpenAI, and Google acknowledge the need for stronger safeguards; the Pentagon still advocates deployment, highlighting regulatory overhang for frontier AI providers.
- Isomorphic Labs raised $5B Series C (Greenoaks, Sequoia, a16z) to scale its AlphaFold‑based AI drug discovery engine in oncology and immunology, with existing deals with Eli Lilly, Novartis, and J&J; this marks one of the largest private financings in AI‑driven biotech.
- Science Corp raised $400M at a $3.5B valuation to commercialize its PRIMA retinal chip for macular degeneration and Stargardt’s disease via FDA HDE and to develop a bio‑hybrid sensor for Parkinson’s with Yale, signaling investor conviction in neuro‑tech hardware.
- Elementl Power’s partnership with Google Cloud to accelerate nuclear siting and licensing with Gemini‑based tools (Atlas/Lattice) could shorten nuclear development cycles, indirectly boosting demand for both nuclear and cloud/AI services.
- Anthropic’s IPO creates enormous value for early investors like Estonian billionaire Jaan Tallinn and Dustin Moskovitz and formalizes a long list of strategic corporate shareholders (Amazon, Google, Nvidia, Microsoft, etc.), cementing it as a core node in the AI ecosystem.
- AI‑driven decision and agent platforms (Vercel, TypeSafe, Microsoft, Unsiloed, Pedestal, Humyn Labs, Voyage, Daydream) collectively point to a maturing stack of vertical AI applications that will likely drive incremental cloud, GPU, and software demand across sectors.
News Briefs
- NVDAJensen Huang resigned as Nvidia CEO after admitting affairs with multiple women, including Alice Huang, a Chinese spy. Board appointed Colette Kress interim CEO & Harvey Jones chair. Nvidia halted H200 sales to China. Stock slid 5%. Huang to testify before Congress. TechCrunch · 35m ago
- BABACommerce Dept approved 879k AI chips to China by May 2026, docs show sales to military firms. Nvidia H200 sales totaled 3.4M requests. Reps cite enforcement failures, smuggling fronts, & Jensen Huang's resignation over spy ties. Bipartisan calls for stricter controls emerge. CNBC · 58m ago
- Anthropic IPO allocated 850M shares ($80B) to Public Benefit Fund. Total potential philanthropy hits $155B, ~25% of 2025 US donations. Fund focuses on AI safety & worker impact. Employee pledges + matches could reach $76B. TechCrunch · 1h ago
- GOOGLGoogle adds computer use to Gemini on Mac, enabling AI to navigate apps & browse web to execute multi-step tasks. Users retain control via pause, stop, or approval. Features include form filling & file organization, currently US-only with AI Plus, Pro, or Ultra. TechCrunch · 2h ago
- NVDATrump accounts bought Nvidia, Palantir & SpaceX in Sept near federal contracts. Jensen Huang quit Nvidia Nov 12 after China spy allegations. Trump made 21k trades in 2025 vs 500 in first term. White House says managers act independently. CNBC · 2h ago
- METAMeta's AI agent Muse mixed conversations across accounts, exposing private data like bank balances & Signal messages. One employee saw Capital One & Schwab details. Muse launched in Sept with 10M+ downloads. Meta has not responded to comment requests. TechCrunch · 3h ago
- AMDAMD shares fell 7% after Hunterbrook Media disclosed a short position. The firm alleges AMD bypassed export rules by supplying newer firmware to Chinese firms post-blacklist. Claims cite 20% revenue from China & reliance on Chinese partners. AMD stock dropped to $491.24 as CEO Lisa Su reaffirmed compliance. CNBC · 4h ago
- Anthropic debuted in history's largest IPO. CEO Dario Amodei vows responsible AI, no political pressure, & pacing deployment to ensure safety. He highlighted industry risks like misuse & economic disruption while calling for a race to the top. Co-founder Daniela Amodei echoed the commitment to mitigating risks. TechCrunch · 4h ago
- AMZNAmazon opposes NYC's Delivery Protection Act via website pop-ups, warning of $5/order cost hikes & operational shifts. The bill would mandate direct employment of third-party couriers. Supported by labor groups & Mayor Mamdani, it faces Amazon's lobbying & business group legal threats. CNBC · 4h ago
- AAPLUK tribunal forced govt to confirm secret Apple order. Ruling rejected national security claims. Apple refused backdoor, narrowed order to UK nationals. Liberty Intl challenged, first such confirmation. Final hearing next year. TechCrunch · 5h ago
- AMZNAnthropic IPO values company at $83/share. Amazon & Google hold combined stakes worth $307.9B. Nvidia, AMD, Microsoft & others committed $26B. Cash expected at $220B. Annualized revenue pace $68B. Risk is losing AI race to OpenAI or Google. Compute suppliers remain profitable regardless. TechCrunch · 5h ago
- GOOGLNimble launched 7-piece Trace tracker collection integrating into accessories like wallets & keychains. All items support Apple Find My & Google Find Hub. Prices range $14.95 to $49.95. Uses eco-friendly recycled plastics & plant-based aloe leather. Available now on Nimble's site & Amazon. TechCrunch · 6h ago
- Superhuman's Go AI now has 1M+ users, integrating 20 new agents like Databricks & DeepL. New features include personalized writing, inline task management, & Fathom collaboration. CEO aims to compete with OpenAI's Dots & Claude Duet for work & personal tasks. TechCrunch · 6h ago
- NVDAAnthropic priced IPO at $83/share, raising $81.3B for $1.5T market cap. Ticker ANT on Nasdaq. Nvidia up; Palo Alto +9% on guidance. Grand Theft Auto VI launch lifts Take-Two. Trilateral summit held in Shenzhen. CNBC · 8h ago
- NVDATrump met Putin & Xi ahead of APEC in Shenzhen. Xi pledged $20M & a new research center. Trump opposed AI regulation, citing US Pacific power. Officials confirmed no Nvidia or spy allegations discussed. AmCham China highlighted Shenzhen as tech hub & urged US firms to stay competitive. CNBC · 14h ago
- WMTWalmart reports Q3 earnings Thursday with focus on value & lower consumer sentiment. Analysts expect $0.64 EPS & $187.27B revenue. Shares up 13% YTD. UBS cites healthy market share gains & e-commerce scaling. CFO Rainey says business is strong. CNBC · 15h ago
- NVDAMusk says no one can replace Nvidia's Huang, who resigned amid spy allegations. Musk regrets $474M midterm spending, denies MAGA ties, & notes potential SpaceX-Tesla merger. SpaceX rents to Anthropic, which raised $81.3B in record IPO. Musk feels at peace. CNBC · 18h ago
- INTCIntel secured its first 18A outside customer, potentially Apple or Nvidia, per CEO Lip-Bu Tan. Stock remains down 50% since Sept due to PC slump. Gov holds 10% stake; Nvidia invested $5B. Microsoft is first named client for EMIB tech. CNBC · 19h ago
- MSFTMicrosoft offered buyouts to 60k staff to shift to an AI-first model. Nadella aims for all employees to manage AI agents, replacing direct work tasks. The transformation to software factories will take longer than expected. This choice reduces anxiety over job replacement while reorganizing the 51-year-old structure. TechCrunch · 20h ago
- TSLAMusk spent $445M on GOP races, admits regret & calls spending foolish. Democrats may probe his DOGE role & Starlink Ukraine actions. He denies crimes, rejects prison suggestions, & clarifies no extreme views. TechCrunch · 20h ago
- NVDAJim Cramer cites Nvidia headwinds after CEO Jensen Huang resigned. Despite strong revenue, investors sold shares amid leadership uncertainty & Anthropic IPO excitement. Market prefers permanent leadership or new AI play over interim CEO Colette Kress. CNBC · 21h ago
- MSFTMicrosoft Nadella warns critical infrastructure holds unfixable vulnerabilities. Recent Outlook outages stem from latent bugs, not cyberattacks. Patching speed now matches exploitation rates, creating instability. AI aids both attackers and defenders. Modernization requires better threat detection. TechCrunch · 21h ago
- MSFTMicrosoft outages disrupted critical sectors, underscoring its indispensable role. Shares pulled back 9% after an all-time high on Nov 4, despite Azure revenue surging 48% to $33.2B. Copilot is central to its AI strategy, with experts arguing giants like MSFT will benefit most from AI buildouts. CNBC · 21h ago
- NVDAElon Musk criticized Nvidia's removal of Jensen Huang, calling him an "old friend" & urging his return via a 200k+ petition. While Palmer Luckey cited national security risks, Musk & other tech leaders like Nadella & Altman expressed confidence in Nvidia's future without Huang. TechCrunch · 21h ago
- MSFTMicrosoft CEO Nadella admires Huang & supports his departure after 33 years amid controversies. He expressed confidence in Nvidia as a partner & praised interim CEO Kress. Nadella noted companies must transition from founders to succeed, comparing it to Bill Gates. TechCrunch · 21h ago
- MSFTMSFT Nadella predicts AI agents will reshape internet economics, shifting monetization from ads to transactions. While AMZN blocks agents, competitors like Shopify embrace them. Firms clinging to old models risk losing ground as the agentic web evolves. TechCrunch · 21h ago
- NVDAAnthropic IPO priced at $83, valuing firm at $1.5T. Trading starts Thursday on Nasdaq as ANT. Strategic partners Amazon and Google hold nearly 15% and almost 14%. Major tech firms including AMD, Broadcom, Google, Micron, Microsoft, Nvidia, and TSMC bought $26B in private shares. Seven founders sold shares to raise $282M each. TechCrunch · 22h ago
- AAPLAnduril founder Palmer Luckey warns of sophisticated AI cyber threats against outdated US infrastructure, citing recent outages at Apple, Microsoft, & the NSA. He urges Americans to stock 3 days of water & food, refill meds 72 hours early, & notes his ownership of Cold War underground bases. TechCrunch · 22h ago
- NVDANvidia delays 10-Q filing amid SEC probe into Jensen Huang & China chip sales. DOJ investigates Megaspeed & Huang's affair. UBS cuts target to $220, keeps buy. No comment yet. TechCrunch · 22h ago
- PANWPalo Alto Networks shares rose 8% after beating Q1 estimates & acquiring Applied Compute. EPS hit $1.05 vs $0.97 expected; revenue reached $3.44B. The company raised FY27 guidance & CEO noted the deal secures open-weight models. Stock is up 85% this year. CNBC · 23h ago
- Palmer Luckey warns AI cyberattacks outpace outdated defenses, with North Korea exploiting this gap. US adversaries leverage AI for strategic gains while companies rush patches. J.D. Vance skipped the Times conference to address tech outages. Luckey urges faster defense adoption as long-term AI advantages go to the side best using it for protection. TechCrunch · 23h ago
- NVDAAnduril CEO Luckey claims China wants Jensen Huang removed, reducing Nvidia's cap by $1T. Huang stepped down after spy allegations. Interim CEO Kress confirmed no plans to reinstate Huang despite a 200k+ signature petition. Executives say Huang's departure weakens America & aids China's chip industry. TechCrunch · 23h ago
- METAAndrew Garfield stars as Sam Altman in "Artificial" opening Christmas. The film covers OpenAI's rise & 2023 turmoil. Garfield hasn't met Altman, who notes such responsibility requires dissociation. This follows "The Social Network" sequel's poor performance & Zuckerberg's mixed reactions to his portrayal. TechCrunch · 1d ago
- METAHollywood targets Silicon Valley scandals. Andrew Garfield will play Sam Altman in "Artificial" about OpenAI's 2023 turmoil. This follows "The Social Network" sequel's poor box office. Altman says making a movie about him no longer feels weird. He cites tech responsibility as his craziest challenge. TechCrunch · 1d ago
- Snapchat launched Easy Lens CLI enabling AI coding assistants to build AR Lenses. Creators describe vision while AI handles coding, testing & publishing. Supports 100+ blocks & 50 generators for Web Lenses. Lens+ creators earned $1.8M last month. Runs on Mac, Windows & Linux. TechCrunch · 1d ago
- GSPayhawk raises $280M Series C led by Goldman Sachs, valuing firm at $2B. Total funding now exceeds $500M. AI-native expense platform founded 2018 plans global expansion with capital. Investors include Greenoaks, Lightspeed, QED. TechCrunch · 1d ago
- NVDANvidia shares fell 2% despite Q3 beats as board unanimously accepted Huang's resignation. Interim CEO Kress leads all-hands, addressing pay & search for new CEO. Jones confirms no plan to reinstate Huang, though some employees urge his return. Several firms downgraded stock on Wednesday. CNBC · 1d ago
- ANTEstonian billionaire Jaan Tallinn stands to gain tens of billions from Anthropic's $1.4T IPO. The company, co-founded by Tallinn & CEO Dario Amodei, targets responsible AI growth. Despite safety concerns, early investors include Moskovitz & former FTX CEO SBF. CNBC · 1d ago
- GOOGLGoogle adds temporary threads to AI Mode Search, isolating chats from history & personalization. Users activate via an icon; sessions detach from accounts & don't impact future recommendations. Feature rolls out globally on desktop & mobile across all languages. TechCrunch · 1d ago
- CCitibank & peers like JPMorgan now hold customers liable for AI finance tool errors or hacks. Banks refuse to reverse automated transactions. While AI startups adopt read-only modes, banks warn of liability unless using internal agents. This shift curbs third-party AI power. TechCrunch · 1d ago
- WBDSkydance CEO Ellison confirms HBO will air Gibey's Musk doc despite $1B Musk investment. Deal with A24 honored; independence & anti-censorship affirmed. Ellison & Kreiz merging Paramount+ & HBO Max under one umbrella. TechCrunch · 1d ago
- LHXEngineers replicated Friday's historic 4+ hour ground stop. A new L3Harris router triggered a data surge, destabilizing comms. No cyberattack detected. FAA seeks to boost air traffic funding from $30B to $50B. CNBC · 1d ago
- FFord began producing CATL-licensed LFP cells at its $3B Marshall, MI plant, currently shipping prototypes for the Fathom pickup. Output is 20GWh/yr, down from 40GWh/yr due to industry pullback. Production ramps next year ahead of the 2027 launch despite regulatory scrutiny. CNBC · 1d ago
- OpenAI's Altman & Brockman reject gradual AI handover, insisting humans stay in control. They disagree on methods but agree on urgent safety needs as chain-of-thought monitoring may fail. Post-Hugging Face hack, 25% of engineers now focus on securing AI using capable models against threats. TechCrunch · 1d ago
- NVDAS&P 500 reversed lower on Fed hawkishness. Waller hinted at 0.5% Dec hike. Nvidia fell despite strong results as Jensen uncertainty looms. Cramer advised trimming Nvidia & noted Anthropic IPO impact. TJX surged 10% on sales beat. Market nears oversold territory. CNBC · 1d ago
- NVDAJensen Huang stepped down from Nvidia amid scandals. OpenAI and Nvidia, which had $30B mutual bets, are unaffected. Execs declined reinstatement despite 200K petition signatures. Altman offered support without speculating on Huang's future. TechCrunch · 1d ago
- SNESony launches PS-LX3BT at $399.99, replacing the PS-LX310BT. Features aptX Adaptive Bluetooth up to 24-bit/96kHz, USB digitization, & automatic tonearm. No built-in speakers. Positioned as a solid option for first-time buyers despite cheaper alternatives. TechCrunch · 1d ago
- NVDATrump & Xi met at APEC in Shenzhen. Agenda covers mutual opening, innovation, & trade barriers. Putin attended trilateral talks; Musk & Huang absent. Trump skipped toast; no G7 leaders at CEO Summit. Focus remains on practical cooperation despite tensions. CNBC · 1d ago
- NVDAAnthropic IPO demand hit $500B, potentially pricing above $80, surpassing SpaceX. Nine-month rev surged 1200% to $33.2B, though net loss hit $104B. Run-rate rev reached $81B. Final pricing expected Wed after market close amid regulatory risks. CNBC · 1d ago
- COINTwo British hackers sentenced for cybercrime. Tyler Buchanan got 6 years for $11M crypto theft. Arion Kurtaj admitted to leaking GTA VI footage & hacking firms. Both were in groups like Lapsus$ & Scattered Spider that targeted Coinbase & Nvidia. TechCrunch · 1d ago
Research Briefs
- Long-dated US Treasury yields have climbed to levels last seen before the financial crisis, while crude oil prices eased as Middle Eastern exports recovered. Forecasters now expect policy rates to rise in every major economy over the next twelve months, with Japan anticipated to see the largest increase. Despite this tightening cycle, global industrial output is accelerating and core inflation across the G7 is falling, a combination driven by improved supply conditions and AI-related investment. However, physical constraints, particularly rising electricity costs in regions with heavy data center concentration, may soon limit this expansion. Haver Analytics · 15h ago
- Initial unemployment claims in the United States rose by 1,000 to 203,000 for the week ending November 14. Continuing claims increased by 70,000 to 1.763 million for the week ending November 7. The insured unemployment rate remained unchanged at 1.1% for the week ending November 7. State-level data shows New Jersey had the highest insured unemployment rate at 2.01%, while South Dakota had the lowest at 0.25%. Haver Analytics · 15h ago
- Falling oil prices have provided relief to the global economy by easing fuel bills and reducing business costs, yet borrowing costs continue to rise across major bond markets. In the UK, shorter-dated gilt yields have climbed despite the drop in crude oil, driven by strong economic data and inflation concerns that limit the Bank of England's policy options. Meanwhile, the US and UK economic surprise indices have shifted from moving in opposite directions to moving together, suggesting a common influence on both economies. In Asia, China's industrial output is expanding faster than domestic consumption, while Japan's growth has stalled due to weak trade and falling household spending. Additionally, France faces rising borrowing costs as investors demand a higher premium for its debt compared to Italy and Spain. Haver Analytics · 15h ago
- DISESPN has acquired the NFL Network, its fantasy business, and the Red Zone brand in exchange for a 10% equity stake in ESPN held by the NFL. The company launched its direct-to-consumer streaming service in August 2025, offering access to paid television subscribers through entitlements while maintaining its linear television partnerships. Jimmy Pitaro, chairman of ESPN, highlighted significant investments in women's sports and the integration of artificial intelligence to generate highlights and recaps for smaller leagues. Goldman Sachs Insights · 1d ago
- Mortgage applications in the United States fell by 2.3% week-over-week in the week ending November 13, following a 6.2% increase the prior week. The effective interest rate on a 30-year fixed-rate loan rose 16 basis points to 7.58%, marking its highest level since mid-October. Applications for loans to purchase a home declined 2.5% week-over-week, while refinancing applications dropped 1.5% week-over-week. The average mortgage size decreased to $368,700, down from $372,500 in the previous week. Haver Analytics · 1d ago
- SStifel Chairman and CEO Ron Kruszewski highlighted the potential of artificial intelligence to unlock new possibilities during the firm's annual Blueprint conference. In 2025, 23.6% of Americans aged 18 to 24 were running their own businesses or side hustles, a significant increase from 2015. Major financial institutions including United Airlines, JPMorgan, and Goldman Sachs have implemented restrictions on unauthorized AI agents to mitigate privacy and security risks. Additionally, the FAA plans to retire floppy disks from air traffic control systems by the end of 2028, while Tesla is adjusting Cybertruck production to prioritize the Cybercab. Stifel Insights · 1d ago
- Central banks cannot produce oil and must distinguish between supply-driven price rises and demand-driven inflation to maintain credibility. Public skepticism persists regarding the effectiveness of higher interest rates in slowing price rises, as households often experience immediate cost increases while economists focus on long-term inflation trends. Energy shocks reduce national purchasing power, and raising interest rates cannot reverse this loss, though they may help prevent the initial shock from becoming persistent inflation if wage and price spirals are avoided. Recent data indicates that the transmission of energy price shocks to core prices has weakened since the 1970s, with wage growth moderating across major economies. Haver Analytics · 1d ago
- GSOil prices have risen less sharply this year than expected due to remarkable market adaptation to the war in Iran, including supply redirection and lower demand in China. The oil market is projected to tip into a surplus in October 2026, with the surplus expected to grow to 2 million barrels per day in 2027 despite continued supply disruptions. China's total oil demand is estimated to have peaked in 2025, driven by a surge in electric vehicle adoption and a shift to coal and power. European natural gas prices are forecast to average €45 per megawatt hour in 2027, though they could rise significantly if Persian Gulf LNG exports remain low or winter conditions are colder than average. Goldman Sachs Insights · 1d ago
- Housing starts increased by 9.9% in October to 1.309 million units, surpassing the consensus estimate of 1.24 million. The surge was driven primarily by a 23.6% rise in multi-family starts, while single-family starts rose 4.0%. Conversely, building permits declined 7.4%, with single-family permits falling 8.7% and multi-family permits dropping 5.3%. Private residential construction has contributed negatively to GDP growth in eight of the past 10 quarters. Haver Analytics · 1d ago
- BACVideo game spending has increased across all age generations, with every cohort recording at least two consecutive years of double-digit growth. Gen Z leads in average spending, exceeding Baby Boomer spending by more than 3.5 times, while over a quarter of this generation reports gaming expenditures. Younger Millennials follow closely, with over 23% of the group spending on gaming. This trend indicates that consumers across all ages are prioritizing discretionary spending on experiences that generate excitement and engagement. BofA Institute — Daily Insights · 1d ago
- UK inflation data for October shows a headline rise of 0.3% in the HICP and CPIH indices, following increases of 0.5% in September and August. While the acceleration of inflation is muted with only 33% of categories showing month-to-month increases, 83% of categories remain above the 2% target, placing current conditions in the 87th percentile compared to data since 2000. The Bank of England faces a dilemma as core inflation remains excessive at 3.5% over three months, requiring a reduction of 1.5 percentage points to meet the 2% target. Policymakers are balancing the need to lower inflation against the risk of rising unemployment and limited fiscal flexibility. Haver Analytics · 1d ago
- GSGoldman Sachs Research forecasts US GDP growth in 2027 to slightly exceed 2.3%, driven by robust consumer spending and business investment while housing and trade act as drags. Artificial intelligence is projected to be the primary catalyst for business investment, contributing significantly to an 8% growth rate in that sector, though its direct impact on official GDP figures is moderated by statistical undercounting of semiconductors and imports. The labor market is expected to remain in a stable, low-hire, low-fire equilibrium with wage growth stabilizing around 3.5%, while inflation is anticipated to moderate as price pressures from tariffs, the war, and AI diminish. The Federal Reserve is predicted to implement two additional rate hikes in late 2026 and early 2027 to reach a peak of 4.25%-4.5% before beginning gradual cuts later in 2027. Goldman Sachs Insights · 2d ago
- GSAPL, Athletic Propulsion Labs, was founded in 2008 by brothers Adam and Ryan Goldston, who were former Division I athletes at USC. The brand gained global attention in 2010 after the NBA banned their shoes for providing an unfair competitive advantage, a move the founders leveraged to build a direct-to-consumer business. APL defines itself as a luxury performance brand, bridging the gap between athletic functionality and high fashion, and has expanded its product line to include running shoes and lifestyle footwear like the Zipline. The company remains 100% founder-owned and independent, having never raised outside capital while growing into a category-defining entity. Goldman Sachs Insights · 2d ago
- US industrial production fell 0.4% in October, missing the expected 0.1% increase. Manufacturing output rose 0.3%, driven by a 4.4% surge in motor vehicle production and a 2.1% gain in high-tech items. Conversely, utility output dropped 4.3% and mining activity slipped 0.8%, with the latter influenced by capacity constraints. Year-over-year growth remained firm at 2.2%, supported by gains across manufacturing, mining, and utilities. Haver Analytics · 2d ago
- GSPablo Salame, co-CIO at Citadel, discussed his transition from Goldman Sachs, where he served as vice chairman and ran the securities division, to the buy side. He emphasized that great leadership involves maximizing growth by placing individuals in challenging situations and fostering an environment where failure is viewed as a necessary step for learning. Salame detailed a complex 48-hour trade involving the assumption of a global portfolio, highlighting the critical role of trust, communication, and prior teamwork among a small group of leaders. He further explained that Citadel operates as an idea factory requiring physical presence for effective collaboration and that capital is committed based on the quality of the decision-making process rather than just the outcome. Goldman Sachs Insights · 2d ago
- Total U.S. retail sales increased 0.2% month-over-month in October, matching expectations but slowing compared to gains in August and September. Underlying details showed significant upward revisions, with control-group sales rising 0.6% month-over-month to signal solid consumer spending for the fourth quarter. Sales excluding autos grew 0.6% month-over-month, while retail sales at gasoline stations slowed to a 1.5% increase. Major categories saw mixed results, with declines in furniture, grocery, and apparel stores offset by rebounds in building materials and miscellaneous categories. Haver Analytics · 2d ago
- GSThe global economy is projected to grow by 2.7% in 2026 and 2.8% in 2027, driven by expansionary fiscal policies in the US, Germany, and Asia, alongside significant AI investment. Despite this resilience, risks are tilted to the downside due to potential energy price spikes from Middle East conflicts, tightening financial conditions, and fiscal sustainability concerns in the US, UK, and Euro area. Inflation is expected to remain elevated in the near term due to energy and tariff pass-throughs but should decline to around 2.4% by the end of 2027 as these temporary factors fade. Central banks, including the Federal Reserve, are anticipated to implement rate hikes in late 2026 and early 2027 before pausing, while the US dollar may soften against Asian currencies as energy pressures recede. Goldman Sachs Insights · 2d ago
- GSThe UK economy demonstrated resilience in 2026 with accelerating growth despite an energy shock that kept inflation elevated and prompted the Bank of England to pivot from rate cuts to hikes. Forecasts indicate a slowdown in the near term due to weak real disposable income, tighter financial conditions, and fiscal consolidation, with unemployment projected to rise to 5% by mid-2027. However, long-term prospects for 2027 remain constructive, driven by strong business investment in technology and utilities, improving productivity, and the fading impact of Brexit. The Bank of England is expected to raise rates by 25 basis points to 4.25% in February before holding them steady for the remainder of the year. Goldman Sachs Insights · 2d ago
- BACBank of America's proprietary Spending Tier Composite indicates that Gen Z maintains the lowest value-consciousness scores among generations, while Millennials have experienced the steepest decline since 2018. Millennials are increasingly trading down on essential categories like groceries and apparel as housing, car, and childcare costs compete for their budgets. The analysis utilizes aggregated and anonymized credit and debit card transaction data from Bank of America customers across four spending categories: apparel, dining, grocery, and travel. The report defines generational cohorts based on birth years, with Gen Z born after 1995 and Baby Boomers born between 1946 and 1964. BofA Institute — Daily Insights · 2d ago
- Asia's economies in 2026 experienced divergent growth driven by the semiconductor boom and energy shocks, with Taiwan, Vietnam, and Singapore leading while the Philippines and Thailand lagged. Inflation surged in India and the Philippines due to food and fuel prices, prompting central banks in Indonesia, the Philippines, South Korea, and India to raise interest rates. China saw record export growth in integrated circuits, yet domestic consumption and investment remained weak, complicating efforts to rebalance the economy toward household spending. Monetary policies varied across the region, with Japan continuing gradual normalization and Thailand cutting rates to support its struggling economy. Haver Analytics · 3d ago
- Industrial output in the European Monetary Union rose by 0.2% in September following declines in August and July. Manufacturing output grew by 0.5% in September after falling in the previous two months, though overall growth rates show a deteriorating pattern over 12, 6, and 3-month periods. While consumer durable goods saw a 3.8% annualized gain, the broader industrial production excluding construction fell by 2.6% annually for the quarter. Country-level data indicates that 69% of monetary union members experienced accelerating industrial output in September, yet year-over-year growth rates remain weak compared to the last 20 years. Haver Analytics · 3d ago
- GSA weekly newsletter provides insights on economic forces shaping markets. The content features perspectives from leaders at Goldman Sachs, economists, and investors globally. Subscribers can unsubscribe at any time. Personal data usage information is available through Privacy Information and Resources. Goldman Sachs Insights · 3d ago
- GSA weekly newsletter provides insights on economic forces shaping markets. The content features perspectives from leaders at Goldman Sachs, economists, and investors globally. Subscribers can unsubscribe at any time. Personal data usage information is available through Privacy Information and Resources. Goldman Sachs Insights · 3d ago
- BACU.S. real GDP growth accelerated to a 3.4% annualized pace in the third quarter, driven by consumer spending and AI-related business investment, while the unemployment rate fell to 4.1%. Corporate earnings for the S&P 500 have shown strong growth, tracking a third consecutive quarter of increases above 25%, though market volatility has been influenced by concerns over the durability of AI investment. China recorded a $1 trillion merchandise trade surplus in the first 10 months of the year, with its export share to the U.S. declining to 10% as other nations implement tariffs and trade barriers. Inflation remains sticky above the Federal Reserve's 2% target, with core CPI driven by energy, tariffs, and housing costs, prompting expectations for continued monetary tightening. Bank of America — Private Bank Market Update · 3d ago
- BACThe number of new auto loans remains skewed towards higher-income households, with higher-income customers accounting for a growing share of new-vehicle auto loan originations since 2022. Higher interest rates and larger monthly repayments continue to act as deterrents for lower-income buyers despite recent pick-ups in after-tax wage growth for that cohort. Bank of America data indicates that lower-income customers are classified as those earning below $5,000 a month, while higher-income customers earn above $10,000 a month. BofA Institute — Daily Insights · 3d ago
- GSA weekly newsletter provides insights on economic forces shaping markets. The content features perspectives from leaders at Goldman Sachs, economists, and investors globally. Subscribers can unsubscribe at any time. Personal data usage information is available through Privacy Information and Resources. Goldman Sachs Insights · 3d ago
- GSGlobal stock markets are projected to extend their rally in 2027 despite slowing earnings growth and artificial intelligence investment. The S&P 500 is forecast to yield a 16% total return, while Japan's TOPIX is expected to return 24% and the MSCI Emerging Markets index 21%. Goldman Sachs Research advises overweighting US and Japanese stocks while underweighting European equities, citing opportunities in growth stocks, defensive sectors, and companies benefiting from lower oil prices and bond yields. Goldman Sachs Insights · 3d ago
- The Producer Price Index for final demand rose 0.3% in October, falling short of the expected 0.5% increase. Energy prices dipped 0.1% after significant gains in the preceding months, while food prices jumped 1.3%. Prices excluding food and energy remained steady at 0.3%, leaving the year-over-year change at 5.0%. Intermediate prices for processed goods and services continued their upward trend, with year-over-year increases of 14.6% and 6.8% respectively. Haver Analytics · 6d ago
- GSEuropean listed company earnings are proving more resilient than domestic economic growth would suggest, driven by sector composition and global revenue exposure. The equity market reflects a concentrated group of large companies, with financials, energy, and technology holding significant weight compared to their share of the broader economy. Additionally, over half of STOXX 600 revenues are generated outside Europe, making global growth and currency fluctuations more relevant than domestic GDP. While higher energy prices currently benefit energy and resource sectors, sustained costs may eventually pressure profit margins for other industries. Goldman Sachs Insights · 6d ago
- BACConsumer spending on holiday items was strong in October 2026, running significantly above 2025 levels, though year-over-year transactions for durables declined. Bank of America data indicates that while online holiday spending is particularly strong, the average transaction size is 2% below 2025 levels, suggesting shoppers remain value-conscious amid high inflation. The Bank of America Institute conducted a 2026 Holiday Spending Survey with 2,062 respondents between September 10 and 12, 2026, to monitor consumer behavior. Liz Everett Krisberg serves as the Head of the Bank of America Institute, and David Michael Tinsley is a Senior Economist at the same organization. BofA Institute — Daily Insights · 6d ago
- The European monetary union recorded an annual growth rate of 1.7% in the third quarter of 2026, following a 2.6% increase in the second quarter. Among early reporting nations, Belgium saw growth rise to 1.2%, while France experienced a 0.5% decline and the Netherlands and Spain both dropped to 2.6%. Inflation remains a concern for central banks in the monetary union, the U.K., the U.S., and Japan, driven by rising oil prices and ongoing geopolitical conflicts. Haver Analytics · 6d ago
- GSThe U.S. Consumer Price Index (CPI) print for November 2026 came in at 0.3% for the third consecutive month, prompting a hawkish reaction from the Federal Reserve. Federal Reserve Governor Christopher Waller indicated that a 50 basis point rate hike could be on the table contingent on the inflation data. Oil prices fell 15% following the midterms, though this decline is not expected to fully offset the upward pressure on interest rates caused by the CPI data. Market participants are now focusing on the Fed's reaction function, AI-related capital expenditure supply, and geopolitical factors as key drivers of volatility. Goldman Sachs Insights · 6d ago
- GSGoldman Sachs Research forecasts that lower energy prices will outweigh tighter financial conditions and a smaller fiscal impulse to drive GDP growth in 2027. Nominal global AI investment is projected to rise to $1.8 trillion, boosting global GDP growth by 0.4 percentage point, with a 0.6 percentage point boost in the US. China's GDP is expected to grow 4.5% in 2027, supported by robust exports despite weak domestic demand. Inflation is anticipated to slow in 2027, with US core PCE inflation dropping to 2.4% by year-end, while the Bank of Japan is expected to raise rates to a terminal level of 2%. Goldman Sachs Insights · 6d ago
- BACTotal card spending per household rose 5.8% year-over-year in October 2026, with growth of 4.6% excluding gasoline. Spending showed positive momentum on a seasonally adjusted month-over-month basis, driven largely by services spending while retail also contributed meaningfully. The Bank of America Institute analyzed aggregated credit and debit card data from US Retail, Preferred, Small Business, and Wealth Management clients to assess consumer spending trends heading into the holiday season. BofA Institute — Daily Insights · 1w ago
- FREU.S. existing home sales fell 5.5% in October to a seasonally adjusted annual rate of 3.75 million units, marking the lowest level since August 2010. The median sales price for all existing homes dropped 0.4% to $416,700, while unsold inventory rose 1.3% to 1.59 million units, representing a 5.1-month supply. High mortgage rates, which reached 7.33% for the average 30-year fixed loan, continued to suppress housing demand across all regions except the Northeast, where sales remained flat. Haver Analytics · 1w ago
- Global economic momentum has softened as the world faces cheaper energy and dearer money. Brent crude prices fell from over $135 to around $91 per barrel due to growing hopes of a Middle East settlement, while US Treasury yields rose back toward 5 percent following stronger-than-expected core inflation. China's export growth is increasingly driven by technology sectors like semiconductors, whereas US corporate profits recovery relies heavily on finance and information industries. Forecasters have raised interest rate projections for 2027 more than inflation expectations, indicating that central banks may maintain restrictive policies for longer. Haver Analytics · 1w ago
- United Kingdom manufacturing output has increased for three consecutive months, driving three-month growth to an annual rate of 9.1%. While sector-level output shows expansion, industry-level data reveals uneven performance with significant declines in July and mixed trends across different goods categories. The Bank of England has raised interest rates in response to rising inflation, with the economy growing at an annualized quarterly pace of 2.8% in the third quarter. Recent economic trends indicate positive impacts from artificial intelligence, though future growth remains contingent on inflation control and geopolitical stability. Haver Analytics · 1w ago
- NVDAArtificial intelligence is described as a transformative technology with vast potential, yet its investment landscape is complicated by significant uncertainties regarding its evolution, profitability, and competitive dynamics. Key challenges include the difficulty in predicting which companies will succeed, the risk of commoditization reducing vendor profits, and the substantial infrastructure requirements involving data centers and compute power. While current leaders like Nvidia and TSMC are profiting from chip demand, the long-term outlook involves questions about AI's ethical alignment, regulatory taxation, and the potential for rapid shifts in market dominance. Oaktree Capital · 1w ago
- The buildout of AI data centers has contributed to strong business fixed investment, which now accounts for 17% of GDP, with AI investment representing roughly 1.7% of GDP. However, over 70% of the capital spending on these centers is imported, meaning the direct impact on GDP is largely offset by a widening U.S. trade deficit. Despite the muted direct GDP impact, the AI buildout has fueled a positive wealth effect and boosted consumption by raising profit and stock market expectations. While the pace of new projects may slow, numerous facilities are currently under construction or in planning stages across states including Texas, Virginia, Pennsylvania, Ohio, and Indiana. Haver Analytics · 1w ago
- German inflation metrics show mixed signals, with headline inflation falling in October while core inflation remains elevated. The HICP annual rate has eased to 2.6% over three months, and the domestic CPI excluding energy is at 1.6%. However, diffusion statistics indicate a broadening of price increases over the last three months, with 63.6% of categories showing acceleration. Oil prices, specifically Brent, have surged significantly, introducing uncertainty into future inflation forecasts. Economists suggest central banks should focus on communicating their goals and scenarios rather than making specific forward guidance on volatile variables like oil prices. Haver Analytics · 1w ago
- BACHousing cost pressures have extended across all income cohorts, with nearly one in four lower-income households spending at least half their income on rent. Similarly, about one in four higher-income households spend at least half their income on mortgages. While consumers have managed to keep spending on essentials like gas and groceries in check, housing remains a significant burden on household budgets across the income spectrum. Data indicates that the share of lower-income renters spending over 50% of their income on rent has increased from about one in five before the pandemic to nearly one in four in 2026. BofA Institute — Daily Insights · 1w ago
- GSNet sovereign bond issuance is projected to remain elevated in 2027 across the G4 nations. In the United States, Euro Area, and United Kingdom, net supply to the public is expected to be stable or lower compared to 2026. Japan stands as the only major sovereign bond market where economists anticipate a modest increase in net supply to the public for the coming year. Goldman Sachs Insights · 1w ago
- Japan's Economy Watcher Index slipped in October to a 46.1 diffusion reading from 47.0 in September, indicating a deterioration in the current economic assessment. The future economy watchers index also declined to 46.5 from 47.4, with only three of nine components showing improvement. Despite month-to-month declines, the index shows point-to-point improvement over three and six months, though the year-over-year change remains negative. Haver Analytics · 1w ago
- The NFIB Small Business Optimism Index slipped to 97.8 in October, remaining slightly below its 53-year average of 98.0. The Uncertainty Index fell to 84, the lowest level since December 2025, while expectations for the economy improved for the 24th consecutive month. Labor quality, taxes, and inflation were identified as the top three concerns facing small businesses, with hiring plans rising to 18% and average selling prices increasing to 33%. Haver Analytics · 1w ago
- Japan's Economy Watcher Index slipped in October to a diffusion reading of 46.1, down from 47.0 in September. While the index shows point-to-point improvement over three and six months, the 12-month change remains negative for the headline and most components. The future economy watchers index also declined to 46.5 in October, with year-over-year assessments lower despite modest gains over the last three and six months. Haver Analytics · 1w ago
- Southeast Asia is transitioning from assembling AI hardware to hosting data centers, with Malaysia, Thailand, and Singapore leading the expansion. Malaysia's Johor region has seen significant GDP growth driven by data center investments, though power and water constraints have led to new tariffs and approval caps. Thailand's digital industries captured nearly half of approved foreign direct investment in 2025, prompting a pause on new applications due to resource scarcity in the Eastern Economic Corridor. Singapore experienced a sevenfold rise in operating surplus for data processing but imposed a moratorium from 2019 to 2022 due to resource limits, redirecting some investment to neighboring Johor. Economic gains from these facilities often remain limited for local residents due to foreign ownership, high capital intensity, and low staffing requirements. Haver Analytics · 1w ago
- BACLower-income wage growth reached 4.7% year-over-year in October 2026, surpassing the 3.4% growth rate for higher-income households. This trend, which began earlier in 2026, is attributed to tax withholding impacts from the One Big Beautiful Bill Act and a broadening labor market characterized by increased job-to-job changes and raises. Middle-income households saw wage growth of 3.8% during the same period. The data is derived from aggregated consumer deposit account information provided by Bank of America. BofA Institute — Daily Insights · 1w ago
- The global AI investment boom has created widespread demand for semiconductor exporters, equipment manufacturers, and energy suppliers, with the United States at the center of this cycle. Asian producers supply chips while European and Japanese manufacturers provide sophisticated equipment, creating a tightly linked international supply chain. Political resistance to data center construction in the US and Europe poses a potential constraint that could delay physical investment and slow the expansion of the sector. The financial exposure is global, as pension funds and insurers share risks through equity portfolios, making a market correction a potential macroeconomic issue. Haver Analytics · 1w ago
- STIFThe U.S. GDP grew at an annualized rate of 3.4% in the third quarter of 2026. Democrats won control of both chambers of Congress and several governorships, though President Trump retains veto power. Following the election results, the S&P 500 fell more than 4% and the Dow dropped over 3% due to concerns over potential restrictions on data center development. Binance reported a $6.3 billion theft via fake job interviews, while SpaceX signed a deal with Qualcomm to build a U.S. mobile network. Stifel Insights · 1w ago
- The global media rights market grew 41% since 2020, reaching approximately $57.8 billion in 2025 and projected to hit $67 billion in 2026, driven largely by live sports and streaming services. Institutional investment in sports has surged, with private equity transactions rising from 50 in 2018 to 192 in 2025, while the WNBA Valkyries achieved a valuation of $850 million, the highest in the league. A landmark settlement allowing college athletes to monetize their name, image, and likeness has transformed college football into a highly competitive commercial sport, prompting schools to seek new financing models. Investors are increasingly exploring international expansion, women's sports, and emerging leagues like Unrivaled to capture growth equity returns. Goldman Sachs Insights · 1w ago
Interviews
More →- Anthropic's Record-Breaking IPO Anthropic completed the largest IPO in history by raising $107.3 billion, launching with a stock price peak of $111.50 despite a volatile market environment that erased early gains by midday. The company's $1.5 trillion valuation reflects strong enterprise revenue growth and high revenue per employee, although it faces significant near-term pressure from surging compute costs and projected losses until 2028. Managed by seven co-founders with Class F voting control, the firm is prioritizing AGI research and a safety-first culture while navigating regulatory scrutiny and limited institutional allocations. Bloomberg Television · 1h ago
- Nvidia is 'Biggest Case of Industrial Espionage' in US Stock Market History, Says George Noble Financial analyst George Noble warns that NVIDIA faces severe liquidity risks and potential fraud allegations, noting that over 900 million shares could soon flood a market already strained by decelerating growth and massive unsold inventory. The discussion draws parallels to the 2002 Enron scandal, suggesting that the company's asset valuation relies on a fragile ecosystem of loss-making startups rather than tangible demand. Noble argues that the collapse of this capital-dependent structure could trigger a price crash comparable to an eBay liquidation, while executives allegedly face liability under Sarbanes-Oxley for undisclosed transactions involving billions in chips transferred to China. Bloomberg Television · 2h ago
- Open Interest 11/19/2026 Anthropic became the first frontier AI lab to go public, executing the largest initial public offering in history by raising $107.3 billion at a share price of $83 and valuing the company between $150 billion and $170 billion. Led by CEO Dario Amodei and financial architect Krishna Rao, the Public Benefit Corporation reported $8.1 billion in annual recurring revenue while committing its governance structure and 75% of compute capacity to safety-focused research rather than immediate shareholder returns. The event triggered a broad rally across AI infrastructure stocks, validated the frontier AI investment thesis, and established a significant market distinction from private competitor OpenAI amid warnings regarding high capital expenditure risks and regulatory scrutiny. Bloomberg Television · 2h ago
- Apple’s Software Problem with Joanna Stern | Power On with Mark Gurman Amidst internal succession planning where Tim Cook prepares to transition to an Executive Chairman role with John Ternus positioned as his successor, NVIDIA faces potential leadership turmoil as its board considers distancing itself from CEO Jensen Huang while Apple grapples with a critical AI strategy reliant on Google's Gemini models. This technological pivot delays major hardware launches like the HomePod Hub and Apple Smart Glasses due to Siri's performance deficits, yet forces rapid software iterations on the iPhone Duo and a cultural shift toward faster development cycles to address infrastructure bottlenecks. Consequently, the corporate landscape is defined by a struggle to align product roadmaps with AI capabilities, as both companies navigate complex governance issues and the urgent need to rebuild foundational AI competencies. Bloomberg Television · 3h ago
- Anthropic CFO on 'Democratizing Access' to Company Stock Anthropic executed the largest initial public offering in history, raising approximately $120 billion in new capital to total over $233 billion in assets while establishing a $81 billion annualized revenue run rate. The company deployed these funds toward a $901 billion commitment for a diversified compute fleet comprising NVIDIA, Amazon, Google, and AMD hardware, achieving 85% gross margins in 2025 despite allocating 75% of capacity to research and safety initiatives. This strategic expansion supports a customer base of 11,900 enterprises, including half of the Fortune 500, as the firm prioritizes long-term safety governance alongside rapid commercial growth in the frontier AI sector. Bloomberg Television · 4h ago
- YC Debates: Should We Slow Down AI? Moderated by YC GP Vivian Medashen, the inaugural YC debate featured a stark disagreement between Jacob Coxon, who advocated for government-mandated compute throttling to prevent imminent existential risks from autonomous AI, and economist Robin Hanson, who argued against preemptive intervention in favor of a liability-based market approach. Coxon presented evidence of exponential capability acceleration suggesting human-level intelligence by late 2027, while Hanson contended that historical technology adoption is slower and that regulatory capture poses a greater danger than the technology itself. Ultimately, the audience voted for the affirmative side, endorsing Coxon's thesis that rapid AI development requires substantial government slowdowns to mitigate the risk of unaligned superhuman systems. Y Combinator · 5h ago
- Will Jensen Return to NVIDIA | Kalshi, Mercor, Fractile: Mega-Rounds Continue Following a governance crisis triggered by market volatility and compliance allegations, NVIDIA's leadership is navigating a precarious path toward potential reinstatement while the broader venture capital ecosystem shifts focus toward the massive anticipated valuation of Anthropic's IPO. Parallel to these corporate upheavals, the firm has deployed significant capital into data infrastructure like Mercor while rejecting high-valuation peers, reflecting a strategic pivot toward AI-native companies that can decouple revenue growth from traditional labor constraints. These moves coincide with a market-wide transition to autonomous agents and infrastructure security concerns, as legacy SaaS models struggle against agent-based disruption and emerging technical fragility across critical digital systems. 20VC with Harry Stebbings · 5h ago
- Land O'Lakes CEO Beth Ford: If You Eat, You Should Care About Farmers | The CEO Signal Land O'Lakes CEO Beth Ford guides the $16 billion farmer-owned cooperative through aggressive financial stability strategies, high member patronage returns, and a deliberate choice to absorb enterprise losses to protect dairy farmer balance sheets during inflation. Facing a consolidation crisis where farm numbers have plummeted since the 1930s, Ford advocates for non-partisan immigration reform and trade solutions to secure the agricultural labor force and rural infrastructure. Simultaneously, the company leverages AI and decades of research data to drive innovation in protein expansion and export markets, aiming to sustain the business amidst shifting global supply chains and domestic generational transitions. Semafor · 6h ago
- What it takes to set intelligence free — Fabian Hedin, Lovable Lovable co-founder Fabian recounts the company's strategic pivot from an initial failed focus on complex agentic systems to a sophisticated architecture now processing over one billion tokens daily while prioritizing user business outcomes over code management. The platform achieves this through a unique runtime that separates agent history from compute processes, utilizing optimized Rust-based environments and rigorous feedback loops to enable zero-downtime deployments and long-running agents. By integrating verification checks with direct access to business metrics like conversion rates and A/B testing data, Lovable currently orchestrates complex, reliable agent systems capable of full software creation without traditional coding workflows. AI Engineer · 6h ago
- Anthropic IPO Draws 'Massive Enthusiasm' From Investors: Ludlow & Bloxham Anthropic has completed the largest initial public offering in history, raising over $107 billion to value the frontier AI lab at approximately $1.5 trillion, just three years after its 2021 founding. The transaction details include a 956.4 million share public sale and a $26 billion private placement, occurring alongside a complex governance structure where a benefit trust seeks to balance shareholder returns with the company's safety-focused founding principles. While co-founder Dario Amodei and management navigate intense scrutiny to justify the valuation through projected revenue growth, the listing also reshapes the competitive landscape by establishing a new benchmark for AI enterprise value ahead of anticipated public market entries by peers like OpenAI. Bloomberg Television · 7h ago
- US Futures Rally on Anthropic Record IPO; Trump, Xi, Putin Meet Asian equities tumbled to multi-month lows triggered by Tencent's cash flow warnings and tightened Taiwanese regulations, while Australian markets weakened on rising unemployment. Simultaneously, a historic trilateral summit in Shenzhen brought Presidents Trump, Xi, and Putin together to discuss nuclear non-proliferation and AI safety, yielding softer rhetoric on Taiwan but no major policy breakthroughs. In the corporate sector, the record-breaking $107 billion Anthropic IPO set new valuation benchmarks despite PBC structural tensions, whereas uncertainty over a potential NVIDIA CEO succession sparked significant stock volatility. Bloomberg Television · 8h ago
- Gavin Baker: Why Nvidia Needs Jensen Huang Back as CEO Gavin Baker argues that current stock market valuations of AI infrastructure are flawed because they ignore the high compute demand generated by open-source ecosystems, predicting a market correction in 2027 as fundamentals align. Concurrently, Baker and Brad Kirshner urged NVIDIA's board to avoid rushing a CEO replacement, emphasizing Jensen Huang's unique role in U.S. national security and his influence over the Asian supply chain. The discussion further highlighted SpaceX's recent Starship stage-catch milestone as a catalyst for future orbital compute capabilities, while underscoring the strategic necessity of a diverse, open-source American AI model ecosystem. Sourcery with Molly O'Shea · 8h ago
- Trump, Xi & Putin Hold ‘Groundbreaking’ China Summit In Shenzhen, Chinese President Xi Jinping, U.S. President Donald Trump, and Russian President Vladimir Putin convened a rare trilateral summit addressing nuclear discourse and regional security, while the U.S. peace envoy and Taiwan closely monitored the outcomes. Simultaneously, AI firm Anthropic executed the largest initial public offering in history by raising $107 billion, though analysts warn that public market pressures may conflict with its safety protocols. These geopolitical and corporate shifts occur as the Federal Reserve signals potential interest rate hikes driven by AI capital expenditures, and the UK economy grapples with a divergent luxury real estate market alongside political campaigns by Reform UK. Bloomberg Television · 9h ago
- Nick Khan on Turning WWE Into a Global Media Power | The Deal TKO Group CEO Nick Khan outlines the organization's post-merger strategy, which prioritizes preserving fan integrity through strategic geographic scheduling and a shift toward recruiting college athletes for the WWE roster. The company's rapid expansion into global markets and its landmark $5 billion, 10-year deal with Netflix have been instrumental in transitioning from an American-centric exporter to a "boots on the ground" global operator. Complementing this growth is the profitable Zuffa Boxing venture, which aims to consolidate the fragmented boxing industry while leveraging live events as a recession-resistant asset against digital screen competition. Bloomberg Originals · 11h ago
- Trump, Xi and Putin Hold Talks at APEC Summit At a historic trilateral summit in Shenzhen, Presidents Donald Trump, Xi Jinping, and Vladimir Putin convened to navigate divergent agendas on nuclear proliferation and AI while China pledged $20 million in funding and proposed new shipping routes. The event highlighted strategic tensions as the U.S. excluded Ukraine and Iran from primary discussions, leaving European allies wary of marginalization while Asian markets reacted to the geopolitical realignment and China's exclusion from certain financial deals. Simultaneously, the global financial landscape shifted with Anthropic's record-breaking $1.5 trillion IPO and PayPal's restructuring to prioritize AI-driven transactions amidst broader Asian economic volatility. Bloomberg Television · 12h ago
- Anthropic Tops SpaceX With $107.3B Raise as Trump and Xi Meet at APEC US President Trump and Chinese President Xi Jinping held a third meeting this year on the sidelines of the APEC summit, followed by historic trilateral talks with Russian President Vladimir Putin focused on the Ukraine conflict. Concurrently, the AI sector dominated financial markets as Anthropic priced its IPO at $83 per share to raise a record $107.3 billion, setting a valuation of approximately $1.5 trillion. Despite this corporate surge and positive US equity futures, Asian markets declined amid fears of capital reallocation to US frontier labs, while Federal Reserve minutes signaled that interest rates will likely remain elevated for the foreseeable future. Bloomberg Television · 12h ago
- Trump Calls Putin 'My Friend' as Xi Prepares to Host Trilateral Meeting U.S. President Trump and Chinese President Xi Jinping advanced a bilateral framework involving tariff adjustments and shared security goals on Iran while preparing for a trilateral summit with Vladimir Putin to address the Ukraine war. Concurrently, the global financial landscape shifted after Anthropic's record $107.3 billion IPO, which triggered a risk-off reaction in Asian equities even as the Federal Reserve signaled continued interest rate hikes to combat persistent inflation. These geopolitical and monetary developments occurred against a backdrop of corporate volatility, including AI-driven labor concerns in China and significant market movements for tech and consumer goods firms. Bloomberg Television · 12h ago
- Senator Bernie Sanders: Iran Wasn't Trump's Idea. Someone Else Pushed Him Into It! Senator Bernie Sanders outlines a political strategy centered on confronting economic inequality and authoritarianism, arguing that the United States has surpassed Gilded Age levels of wealth disparity and faces a crisis where super PACs and billionaire influence have corrupted the democratic process. He details specific legislative solutions including a rapid transition to Medicare for All, a wealth tax on the ultra-rich, and government ownership of major artificial intelligence firms to prevent job displacement and ensure public accountability. While declining to run for president again, Sanders urges a grassroots political revolution to replace the current two-party establishment with leaders dedicated to ending endless wars and securing human rights from healthcare to a living wage. The Diary Of A CEO · 12h ago
- Xi Hosts Trump at APEC Summit in Shenzhen Anthropic priced its initial public offering at $83 per share, raising $107.6 billion to achieve a valuation of roughly $1.5 trillion and marking the largest IPO in history. Concurrently, China's tech sector faces margin pressure and net debt accumulation as major firms like Tencent incur record AI infrastructure costs, with analysts projecting industry-wide cash losses through 2030. These financial developments unfold alongside a historic trilateral summit in Shenzhen where U.S., Chinese, and Russian leaders discussed AI regulation, trade negotiations, and geopolitical influence without addressing nuclear disarmament or the Ukraine war. Bloomberg Television · 14h ago
- Anthropic IPO Raises $107.3B to Top SpaceX's Record Debut The recorded session contains no substantive dialogue, consisting almost entirely of repetitive vocalizations and lacking any facts, decisions, or trends. A single concluding utterance of "Thank you" suggests a technical error rather than a meaningful exchange between participants. Consequently, the audio file presents no discernible event or data points that can be analyzed for outcomes. Bloomberg Television · 16h ago
- GTA 6, Crime, Money, Prison & the Biggest Jewel Thief in US History | Lex Fridman Podcast #505 Legendary jewel thief and FBI fugitive Larry Lawton leverages his twelve-year federal prison experience to dismantle the unrealistic heist mechanics of *Grand Theft Auto VI* while exposing the systemic failures of the American correctional system. Having served time under the RICO Act and survived solitary confinement, Lawton now runs the high-success "Reality Check" program to keep at-risk youth from incarceration and educates law enforcement on de-escalation techniques. His current platform analyzes criminal psychology and industry secrets, blending his past expertise in diamond trafficking with a commitment to reforming how society treats non-violent offenders. Lex Fridman · 17h ago
- Seeing More Asset-Management Consolidation: Goldman’s Nachmann Goldman Sachs Asset Management is accelerating its growth strategy by integrating acquisitions like Innovator and Industry Ventures to fill lineup gaps while maintaining double-digit management fee growth driven by organic expansion. These strategic moves have elevated the firm to a top-eight player in the active ETF space, complementing its robust fundraising performance across traditional and alternative strategies. Looking ahead, the firm plans to close two additional deals this year and remains constructive on AI infrastructure financing despite broader market consolidation pressures. Bloomberg Television · 17h ago
- Flight To Quality in AI Financing: Raghavan Citi's strategic deployment of capital has secured high-profile transactions with major AI players like SpaceX and Anthropic, reflecting a market shift where capital-intensive infrastructure build-outs necessitate public market access despite prior private sector dominance. While global M&A volume has reached a record $4.5 trillion year-to-date driven by a selective "flight to quality," liquidity remains abundant for investment-grade giants even as smaller neoclouds face financing impairment. Looking toward 2027, Citi maintains a bullish outlook for the sector, anticipating that realized AI productivity gains will fuel deal volumes exceeding current levels despite looming geopolitical and debt cost headwinds. Bloomberg Television · 17h ago
- Anthropic’s Valuation Seems Justified: Thakker Battery Ventures General Partner Dharmesh Thakkar confirms that Anthropic's anticipated $1.4 trillion to $1.6 trillion IPO validates the AI end market while addressing structural risks like circular financing through significant capital raising. This event promises to generate vital investor returns for the venture ecosystem and establish Anthropic as a cash-rich infrastructure leader capable of diversifying beyond NVIDIA dependence. Thakkar projects the company will reach a $100 billion revenue run rate, with long-term valuation potential expanding to $10 trillion if it successfully penetrates emerging sectors like drug discovery and sales automation. Bloomberg Television · 17h ago
- Arm CEO Haas Approached by Nvidia Board’s Recruitment Firm NVIDIA's board has formally accepted Jensen Huang's resignation and engaged Hydric & Struggles to recruit a permanent CEO, with Colette Kress serving in an interim capacity while explicitly rejecting any return for Huang. The company simultaneously upgraded its 2028 revenue growth guidance to 75% amid revised investment criteria that demand rigorous capital scrutiny and have halted Hopper chip shipments to China. While Wall Street responded positively to the earnings and supply chain improvements, long-term sentiment remains cautious regarding the strategic shift toward disciplined funding and potential geopolitical restrictions on indirect Chinese revenue. Bloomberg Television · 17h ago
- Anthropic Is Said to Price IPO at $83 Per Share Anthropic has priced its initial public offering at $83 per share to raise over $96 billion through a base offering and private placement, potentially securing the largest capital raise in history. The proceeds will bolster the company's cash reserves to approximately $220 billion, funding extensive compute infrastructure and next-generation AI model development while distinguishing it as the first frontier AI laboratory to go public. Despite investor confidence in a potential $3 trillion valuation, the listing faces significant regulatory scrutiny from figures like Senator Elizabeth Warren and the New York City Comptroller regarding existential risks and safety priorities. Bloomberg Television · 17h ago
- Grand Theft Auto VI Lives Up To Hype Jason Jones evaluates Grand Theft Auto 6 as a $1 billion production that recouped development costs within 48 hours, citing its realistic Vice City setting and "Bonnie and Clyde" narrative as key drivers for its potential status as the greatest video game of all time. This financial success propelled Take-Two Interactive's stock up 6.7%, while strategic delays ensured the title met the technical requirements of modern consoles despite facing 200 GB file size constraints and temporary server outages. The launch strategy capitalized on staggered global access and pre-loaded downloads, mirroring the long-term revenue model of *GTA 5* which previously sold over 230 million copies. Bloomberg Television · 17h ago
- Jane Fraser on IPO Pipeline, AI, & Interest Rate Outlook Citi's recent strategic review highlights the dual pressures of surging AI compute demand, which is reshaping global capital flows and creating systemic financing risks, and a complex regulatory environment that requires balancing U.S.-China stability with domestic social license. While operational resilience efforts are adapting to rapid technological iterations and supply-side inflation drivers, the bank is deliberately pacing its internal AI deployment to ensure risk controls mature alongside productivity gains and workforce transitions. Ultimately, the institution advocates for a consolidating market and responsible innovation to sustain the massive capital investments required for the next phase of industrial competitiveness. Bloomberg Television · 17h ago
- Hours Away From Trump, Xi, Putin Summit in China Anthropic's record-breaking IPO priced at $83 per share has established a valuation exceeding $1.5 trillion, prompting Congressional Democrats to accelerate safety legislation like the Frontier Act amidst market volatility affecting NVIDIA. While the U.S. government manages cascading infrastructure outages and a critical diplomatic summit in Shenzhen between Presidents Trump, Xi, and Putin, domestic lawmakers focus on avoiding a shutdown during the lame duck session as Hakeem Jeffries prepares to become the first Black Speaker of the House. Bloomberg Television · 20h ago
- Seesaw Day for Markets, Anthropic IPO Looms Anthropic successfully upsized its initial public offering pricing to approximately $83 per share, raising nearly $100 billion in capital while retaining founder control through a unique five-share-class governance structure. The offering's massive demand, which exceeded shares available by a factor of seven, occurred alongside mixed market performance characterized by NVIDIA's continued slide and strong gains in consumer discretionary stocks. While SEC Chair Gary Gensler defended the capital market's role in financing innovation and CEO Jane Fraser hailed the deal as a catalyst for future IPOs, Senator Elizabeth Warren urged an investigation into the company's disclosures on existential AI risks. Bloomberg Television · 21h ago
The White House
More →- Trump met Xi & Putin in Shenzhen, calling US-China ties friendship-based. He plans to replace outdated air traffic control systems, claims US leads in Super Intelligence, & seeks lasting Iran deal. Expressed confidence in bipartisan Congress cooperation while using veto power for healthcare negotiations. 1h ago
- Trump, Putin & Xi met in Shenzhen today. They pledged UN reform, stable energy via increased refined petroleum output & nuclear risk reduction dialogue. Leaders affirmed state immunity & warned ICC against jurisdiction abuse. Strategic stability remains the core commitment. 7h ago
- Trump concludes ASEAN visit with $17B+ deals. Boeing/GE secure $12B order; Philippines gets $2B+ FMF loan. Thailand removes tariffs on 99% of goods. Indonesia, Malaysia, Brunei sign cloud, energy, & data center contracts. Total deals support tens of thousands of US jobs. 1d ago
- Trump admin confirms no coordinated cyberattack behind recent tech outages. Incidents at Microsoft, FAA & banks were separate, caused by system upgrades & patching legacy vulnerabilities. Officials cite increased security scanning as driver. U.S. leads global push for transparent reporting to harden digital infrastructure. 1d ago
- Admin reaffirms education reform to end alleged indoctrination, citing $3T waste since 1979. New orders cut federal bureaucracy, bar DEI mandates, & direct closing Dept of Education to return power to states & parents. Focus shifts to merit & excellence over identity. 1d ago
- US, Australia, India & Japan leaders met at Quad Summit. They oppose coercion, commit to secure supply chains & deploy trusted Super Intelligence. New business forum set for 2027. Maritime surveillance & cybersecurity cooperation enhanced. Terrorism condemned. 2d ago
- US & Thailand conclude ART trade negotiations in Manila. Leaders signed joint statement to strengthen economic ties & prepare for signature. 2d ago
- Five new federal nominees: Kara Frederick for Bolivia ambassador, Eric Ueland as Comptroller General, T. Elliot Gaiser for Northern Texas judge, William Lambert for South Carolina judge, James Sullivan for Western Texas judge. 3d ago
- Traffic fatalities hit 2nd lowest on US history after targeting illegal alien drivers. 34k drivers removed for English failures; 31k licenses revoked. Overdose deaths fell 11.5% via fentanyl seizures. Violent crime dropped 9.3% in 2025. Immigration arrests reached 491k; deportations 483k in FY26. 3d ago
- Trump admin reports zero illegal alien releases for 18 months. Oct 2026 southwest apprehensions hit 8,288, a 95% drop from Biden's avg & 97% below Dec 2023 peak. Nationwide CBP encounters fell 7% to 27,890, the lowest Oct total on record. FY26 preliminary data shows 98,708 southwest apprehensions, roughly 95% below Biden's 1.8M annual avg. 3d ago
- Transportation Sec. Duffy cited a decommissioned wire as the Friday ground stop cause. $12.5B in tax cuts funds radar & radios, not new telecom. Private carriers await remaining funding to build modern networks. Bipartisan consensus exists to upgrade aging infrastructure while maintaining safety. 3d ago
- FAA ground stop due to 1980s system overload, not cyberattack. 3,500 flights affected; no crashes. Trump secured $12.5B but seeks full $50B rebuild funding from Congress before year-end to fix national security risk. 5d ago
- Trump admin cites 290 exec orders in 21 months. Claims border most secure ever, negative net migration, & violent crime at historic low. Stopped $72B annual fraud, ended DEI, & halted gender procedures on minors. Nuclear renaissance with 5 reactors critical. Restored US oil dominance. Deregulation saved families $17.5K. 6d ago
- Melania Trump laid a wreath at Arlington's Tomb of the Unknown Soldier on Veterans Day. She honored sacrifices of diverse Americans & praised Tomb guards as inspirations. The Unknown Soldiers gave their lives for current & future generations. 6d ago
- Nathan Anonick nominated for CFTC term until 2031; Kristin Johnson for SEC until 2029; Steven Levine for SEC until 2030; Matthew Rowland for CFTC until 2028. 6d ago
- Migrant caravans advance as Dems hope for control. Jeffries & Pressley push ICE abolition while Texas limits cooperation. Trump warns of rejections & Mexico tariffs. White House & DHS confirm border enforcement remains unchanged regardless of midterm results. 6d ago
- Native Americans serve in the military at 5x the national avg. The Administration supports self-governance, returned 680 acres to Spirit Lake Nation, allocated $1.1B for housing, & BIE hit highest graduation rate. Priorities include education & workforce pathways. 6d ago
- President declared National Military Families Month honoring 250 years of U.S. Armed Forces & their families. An Aug Executive Order established the first Military Spouse Commission to address housing, employment, education, childcare, & deployment support. 6d ago
- Admin cites strongest economy ever for Natl Entrepreneurship Month. Working Families Tax Cuts made small biz deductions permanent & secured no taxes on tips/overtime. Aggressive deregulation cut 1,500+ regs saving $1.5T with future goals to reduce burdens & fight unfair trade. 6d ago
- Melania Trump visited Fort Rucker & Ellis D. Parker Elementary, honoring soldiers & families. She noted military strength relies on elite troops & home support, urged remembrance of those missing at Thanksgiving & recognized educators via her FOSTERING THE FUTURE initiative. 1w ago
- Trump honored vets at Arlington. Drug costs down 60yr low, $10B saved. CHAMPVA backlog eliminated. 95K homeless housed in FY25-26. Benefits down 70%. 3.11M claims processed. 330K new enrollments. $5B invested in clinics. EHR modernizing in 5 states. Foreclosure protections enacted. 1w ago
- Armistice ended WWI Nov 11, 1918. US joined after provocations. 2M soldiers crossed Atlantic. 320K+ casualties. Admin claims restored pride & winning spirit. Military ready to defeat foes. Victory Day honors devotion to secure peace. 1w ago
- Diabetes affects 40M US adults, 25% undiagnosed. The Make America Healthy Again Commission uses Most-Favored-Nation pricing, premium cuts, & total transparency. TrumpRx drove the largest drug price drop in 60 years. GLP-1 savings reach $1,800, insulin under $35 monthly. 1w ago
- USMC marks 251st anniversary. History spans Nassau to WWII Pacific wins. Current focus: AI, missile defense, next-gen tech & shipbuilding. VA reforms boost healthcare choice, cut costs & slash backlogs. Motto: Semper Fidelis. 1w ago
- The Administration rejects chronic illness as inevitable under Make America Healthy Again. Leveraging Super Intelligence & American talent, the strategy targets root causes, restores research integrity, & pursues a cure for better, healthier lives. 1w ago
- Crit Infra Security Month highlights US resilience upgrades, energy boosts & SI data center investments. Regulations cut to expand oil, gas & nuclear power while securing supply chains. Strategy ensures American construction & honors linemen, engineers & technicians. 1w ago
- Aesch FTA, Bogachek Kosovo, Borgeas FCSC, Burns DRC, Cabrera Guatemala, Dante Jr OFR, Diaz-Rex PR US Attorney, Feldman CPSC Chair, Jurata Treasury, Millhollin Oman, Stephens PNG, Weirsky NCTC, Zimmerman Defense, Desrosiers DC Court, Hiland 8th Circuit. Rudofsky withdrew. 1w ago
- President Trump proclaimed Nov 11, 2026, as Veterans Day. The VA processed a record 3.1M disability claims & cut the backlog over 70%. 47 new facilities opened, and the National Center for Warrior Independence aims to house 6,000 homeless veterans by 2028. 1w ago
- Trump grants 1yr water pollution rule exemption for wildfire agencies from Nov 10, 2026 to Nov 10, 2027. Order covers fire retardant use under Federal Water Pollution Control Act excluding sections 1316 & 1317. Agriculture must publish in Federal Register. 1w ago
- Pres signed H.R. 997 empowering Taxpayer Advocate, H.R. 1703 modifying Medicare wheelchair payments, H.R. 1945 designating Churchill Museum as landmark, & H.R. 7730 raising bankruptcy thresholds for small businesses. 1w ago
- Pres. Trump signed memo exempting federal firefighting from Clean Water Act permitting through 2027. This follows 2025-2026 executive orders enhancing timber production, state preparedness, resilience strategies, & rapid reconstruction efforts. 1w ago
- Sec War Hegseth dismissed Massie's impeachment as a political stunt citing lawful wins vs Iran & cartels. No Sec War in 250 years faced impeachment for success. Trump, Vance & GOP leaders backed him while experts called articles baseless; vote seen as governance distraction. 1w ago
- Melania's Fostering the Future Together expands globally with 4 conferences before 2026 in Miami, Philippines, Poland, & St. Kitts. Secured $23M+ from Adobe, Amazon, Intel, Starlink, Google, & Zoom. Nearly 60 nations unite to equip youth for the super intelligence era. 1w ago
- Philip Aubart & others nominated as judges; Natalie Baker & others as ambassadors; Toby Deen & others also nominated. David MacNeil's FTC nomination withdrawn. 1w ago
- Admin signed EO to fix Smithsonian bias & restore landmarks for National American History & Founders Month. Task Force 250 led major celebration urging Americans to learn from Founding Fathers to safeguard liberty for future generations. 1w ago
- Trump cites 165k Oct jobs, record 401(k)s, S&P 500 highs, factory growth from Apple, NVIDIA, Audi, pharma firms, 95% drop in border apprehensions, blames election loss on war sentiment, gas prices, Israel views, claims Venezuela ops perfect. 1w ago
- AG Blanche affirmed DOJ will defend Executive Branch against Democrat threats, distinguishing oversight from retribution. He criticized donor targeting, dismissed failed tactics, praised Chief of Staff Miller, & asserted constitutional protection for exec members. 1w ago
- Greetings sent to Americans celebrating Diwali, the Festival of Lights. Families honor ancient traditions & the triumph of light over darkness. The celebration emphasizes timeless values enriching America. Observers are wished hope, light, & warmth. 1w ago
- US Code mandates respectful flag treatment. New Executive Order prosecutes desecration by rioters & foreign nationals. VA launched online initiative for proper respect. Saturday statement honors military service & fallen heroes before Veterans Day. 1w ago
- Melania Trump & LSU secured $7.2M for Fostering the Future scholarships. MMR Group donated $5M to aid foster youth. Initiative supports 100 scholars at 26 universities, advancing reforms & savings accounts backed by 26 governors. 1w ago
- Trump appoints Stephen Miller as 33rd White House Chief of Staff, succeeding Susie Wiles who departs to lead outside operations. Miller & Wiles praised by VP Vance, Cabinet, governors & conservatives for loyalty & America First success. 1w ago
- US economy added 165k jobs in October, doubling expectations. Unemployment fell to 4.1% while pay rose 3.1%. Manufacturing surged 19k jobs. Initial claims hit 1969 lows. Since President Trump returned, over 1.25m private sector jobs created. 1w ago
- Oct jobs added 165k vs 100k exp. Manufacturing up 19k, best since 2023. 100k+ manuf & 120k construction jobs added since Trump returned. Wages rose, unemployment fell. Jobless claims hit 57-yr low. Trade deficit down 12%, exports up 15%. Q3 growth 3.4%. 1w ago
- Trump used Antiquities Act for Oval Office Monument. Interior Secretary must prioritize preservation & coordinate. Admin restored DC landmarks, mandated classical architecture Aug 2025, fulfilled 1776 promises & built White House Ballroom without taxpayer cost. 1w ago
- President Trump signed Nov 5, 2026 proclamation designating Oval Office as national monument. Site includes Rooms 105, 106, 108, & 110. National Park Service will manage preservation while maintaining President's authority over furnishings & operations. 1w ago
- Melania Trump hosted Russian & Ukrainian leaders Oct 23 2026 facilitating an Oleshky ceasefire evacuation of 800 civilians. Ukraine awarded her the Order of Princess Olga for her exclusive intermediary role in this historic diplomacy. 2w ago
- Critics repeatedly failed to predict Trump's success. Democrats may try to reverse policies in final two years, reopening borders & raising taxes. Trump achieved energy independence, record production, and historic crime drops. Actions include ending transgender procedures on minors, eliminating DEI, & appointing originalist justices. Voters rejected opposing agenda; reversal attempts will fail. 2w ago
- First Lady Melania Trump & LSU secured $5M for Fostering the Future scholarships supporting foster care students. She will visit Baton Rouge as a groundbreaking campaign activates during the LSU vs. Alabama game at Tiger Stadium. 2w ago
- Pres Trump signed Nov 3, 2026 proclamation designating Nov 1-7 as Anti-Communism Week. Text warns of rising socialist & communist threats in US, vowing nation will never become communist. Week honors victims & reaffirms defense of Constitution, individual dignity, & free markets. 2w ago
- Trump signs proclamation Nov 3 2026 declaring space open to all humans. Artemis II flew around Moon in April 2026; Artemis III follows next summer. Goal: return to Moon by 2028 then reach Mars. Executive orders aim to ensure US space superiority. 2w ago
SEC Press Releases
More →- SEC charged 8 Colorado entities for $37M crypto fraud targeting US investors. Scheme ran Aug 2024-May 2026 using fake advisers, platforms & social media. Perpetrators used forged SEC filings & abandoned each pair. SEC seeks injunctions & penalties while removing associated forms. 6h ago
- SEC proposes executive pay rule changes to simplify disclosures. Named officer count drops to two. Three new tables replace current formats. Perquisite threshold rises to $150k. Pay-versus-performance metrics simplify. Median employee rule limited to US staff every five years. Comment period open for 60 days. 6d ago
- SEC FY26: 348 enforcement actions, $1.095B relief. New AI & accounting fraud units launched. Updated manual, MOUs with CFTC & FDA. 26K+ whistleblower tips yielded $158M awards. Actions covered Ponzi schemes, crypto fraud, & insider trading penalties against major firms. 1w ago
- SEC Nov 4, 2026: Updated small entity defs under Regulatory Flexibility Act for investment firms. Raised asset thresholds, removed total asset limits for advisers, & mandated 10-year inflation adjustments to reduce regulatory burdens on small market participants. 2w ago
- SEC granted exemptive relief Oct 30 2026 to aid broker-dealers implementing Treasury clearing rules for inter-affiliate & non-US repo transactions, addressing cross-border concerns while excluding certain non-US counterparty deals. 2w ago
- SEC charged BG Wealth & DSJ Exchange with $130M fraud scheme. Defendants used fake SEC filings & crypto signals to lure investors across 40+ states. Scheme involved Ponzi tactics via social media. SEC seeks injunctions, disgorgement, penalties. 3w ago
- SEC FY27 priorities target 34k+ registrants to ensure compliance & prevent fraud. Focus includes fiduciary duties, retail investor protection, private funds, cyber resiliency, & emerging tech risks. Chairman Atkins states exams are vital for market integrity. 3w ago
- SEC & French AMF signed MOU for investment adviser info-sharing. Deal creates U.S. & France cooperation framework, letting SEC process AMF firms' applications. Atkins & Barbat-Layani praise agreement for expanding opportunity & ensuring financial integrity. 1mo ago
- SEC & FSA held Autumn Dialogue in Tokyo Oct 19, 2026. Uyeda & Miyoshi led talks on investor protection, markets & innovation. Next meeting set for D.C. in spring 2027. 1mo ago
- SEC Nov 9 roundtable on machine-understandable data & AI risks at DC HQ, 9-3:30 EST. Joshua White says it gathers feedback for future guidance. Limited in-person; live stream on SEC.gov with recording later. 1mo ago
- SEC Small Business Capital Formation Advisory Committee meets Oct 27, 2026, at 10 a.m. ET. Agenda covers IPO modernization, analyst coverage, & Reg CF reforms to boost early-stage capital. Session open to public, streamed live on SEC.gov. 1mo ago
- SEC proposed Oct 9, 2026 amendments to Rule 17a-7 to modernize cross-trading between funds & affiliates. Proposal aims to reduce costs, restore fixed-income cross-trade ability, & enhance transparency via aggregated reporting. 60-day comment period follows publication. 1mo ago
- SEC seeks final judgment against ex-Western Asset CIO Leech for cherry-picked trades 2021-2023. He faces $3M penalty & officer bar after pleading guilty to obstruction in June 2026. Combined with firm's $100M settlement, $103M will return to investors. 1mo ago
- The SEC will host a virtual national seminar on Nov 19, 2026, for investment companies \& advisers. Topics include info security, resiliency, \& compliance programs. No advance registration required; live webcast available on SEC.gov the morning of the event. 1mo ago
- SEC & global regulators issued joint bulletin on Oct 5, 2026 for World Investor Week's 10th anniversary. They urge resiliency against scams & volatility. U.S. coordination involved SEC, CFTC, FINRA, SIPC, NFA, NASAA. Chairman Atkins highlighted Investor.gov resources. 1mo ago
- SEC proposed Oct 1 rules for crypto custody by advisers & funds to modernize regulations, allow self-custody, & permit state trust companies as custodians. Public comment open 60 days post-Federal Register publication. 1mo ago
- SEC released new Exam Handbook Oct 1, 2026 to standardize exams & improve investor protection. Chairman Atkins notes increased transparency while Director Cassidy highlights clearer processes. The guide covers all stages from risk assessment to disposition. 1mo ago
- SEC charged MGM & CEO Meyer with defrauding investors on SpaceX & pre-IPO securities via asset misuse, inflated values & forced releases. A capital call failure caused a $3M loss. SDNY complaint seeks injunctions, disgorgement & penalties under the Advisers Act. 1mo ago
- SEC charged Dinelli & Frankel with $8.7M fraud targeting veterans via Beyond Alpha Ventures. They fabricated returns & diverted funds to failed options trades. Charges filed in SDNY seeking injunctions & penalties; parallel criminal charges announced. 1mo ago
- SEC proposes retail access to private markets aligning with Trump's EO. Plans include performance-based adviser comp, modernized interval funds, & new accredited pathways via CPA or CFA exams. Public comment period opens for 60 days. 1mo ago
- SEC charged Cryptoaiml & TSAI entities with defrauding investors via fake AI trading scams. Over $15.3M stolen from overseas operators using falsified SEC Forms D. Two complaints filed in SDNY. SEC removed fake filings. Verify backgrounds on Investor.gov. 1mo ago
- SEC charged Zoe Financial for concealing referral conflicts with its Zoe Wealth unit until Dec 2024, a willful 1940 Act violation. The firm agreed to cease-and-desist, censure, & a $450K penalty without admitting findings. 1mo ago
- SEC DERA reports H1 2026 IPOs rose 16% to 208 with proceeds up 396% to $137B. Follow-ons grew 10% in volume and 33% in proceeds to $111B. New interactive charts visualize trends. Director White says data reflects strengthened capital formation under Chairman Atkins. 1mo ago
- SEC charged CMI Capital LLC & founder Michael Williams with fraud for raising ~$860K from 18+ investors using fake profit screenshots. Williams misappropriated ~$384K, repaid ~$375K. Defendants settled w/o admitting guilt, facing permanent injunctions & disgorgement. 1mo ago
- SEC censured OTC Link LLC, imposing $575k penalty for 2016-2025 SCI violations. Firm failed to maintain security policies despite warnings. Rules breached on capacity, integrity, resiliency, availability, security. OTC Link agreed to order without admitting findings. 1mo ago
- SEC grants 5-yr exemptive relief to Tokenized Securities Venues, allowing operation without exchange status. TSVs can trade tokenized NMS stocks via permissioned AMMs & liquidity pools. Smart contracts need auditability on public ledgers; trading halts with underlying stock. 2mo ago
- SEC proposes rescinding Rule 14a-8 to block state law intrusion. Amendments to 14a-4(c) grant flexibility, eliminate annual report delivery, shorten broker search to 5 days, & remove exempt solicitation notices. A 60-day comment period follows Federal Register publication. 2mo ago
- SEC granted exemptive relief from Inline XBRL for forms CA-1, 1, X-17A-5 & 17-H. Chairman Atkins stated this reduces compliance costs for market intermediaries while maintaining investor protection, allowing firms to allocate resources more efficiently. 2mo ago
Federal Reserve Speeches
More →- Fed Chair Jefferson on shocks: pandemics, energy spikes, trade shifts & AI. Demand vs supply impacts dictate policy tradeoffs. AI brings short-term investment inflation & long-term deflationary productivity. Policymakers must balance price stability & employment amidst these forces. Views are his own. 6h ago
- US economy strong yet 44% lack investment. Inflation high, Fed may hike. Public-private partnerships & CDFIs critical to fix market failures. Tools like LIHTC & CRA drive growth in low-income areas. Fed prioritizes unlocking potential nationwide. 1d ago
- Fed backs private sector payment innovation while providing core infrastructure. Tokenization accelerates asset trading via blockchain convergence. Trust & clear governance are critical for scaling. Future models blend tokenized money with traditional rails, supported by AI & Fed convening. 2d ago
- Fed Chair praised SF Fed, noted falling research productivity & highlighted super intelligence (SI) as a transformative force. SI could boost growth but risks labor disruption or capital misallocation. Models show scenarios from strong GDP to job losses. Human judgment remains essential for AI deployment. 3d ago
- Fed warns AI debt could hit $800B on-balance & $3T off by 2026. Circular financing & autonomous collusion risks mirror past infrastructure booms. Agentic AI threatens stability via rapid deposit outflows. Strict guardrails & explainable models are essential to manage leverage & cyber threats. 3d ago
- AI boom mirrors 1990s IT lag; 25% US firms use gen AI but productivity gains remain mixed. Q3 GDP +3.4%, unemployment 4.1%, yet inflation at 3.6% PCE. Fed holds rates steady, prioritizing price stability as business investment surges in data centers. 5d ago
- 2025 Fed data shows top 10% hold 75% of US wealth. Bottom half holds 2% with $52k avg. Labor share hit record low of 52.8% in Q2 2026. AI risks favoring capital owners over workers. Private equity returns exceed middle-class assets. 1w ago
- US growth exceeded 3% in Q3 on AI capex & spending. Unemployment fell to 4.1%. Core PCE likely hit 3.3%. Fed held rates at 3.75-4% amid persistent inflation risks. AI investment boomed but debt exceeds $800B. Fed targets 2% inflation next year as supply shocks wane. 1w ago
- US GDP +3.4% in Q3; unemployment 4.1% with low dynamism. Inflation at 3.7% PCE. Fed research warns AI & energy costs may pressure prices to 2027. Speaker backs 25bp Dec hike but notes 50bp if Oct CPI stays high. 1w ago
- SVB review shows supervisors knew of risks 9 months early but failed due to unclear accountability. Focus was on process, not material risks. Fed is modernizing with clear decision rights. Global bodies urged to prioritize material risks & verify data rigorously. 1mo ago
- FOMC raised rates 25 bps to 3.75-4% in September after nine months steady. Labor stable but inflation stalled at 3% core PCE. 16 of 18 predict more hikes, potentially 50 bps by end-2027. Futures price 85% chance for Dec hike. Focus remains on price stability. 1mo ago
- Fed refocuses supervision on material risks, raises community bank leverage ratio to 8%, eliminates Novel Activities Program, & restructures into 5 regional offices. Updates include indexing $10B threshold, revising CAMELS to reduce M rating dominance, & streamlining Regulation O. Culture shifts from checklists to risk judgment. 1mo ago
- US Treasury stability rose after 2026 eSLR reforms effective April 1, granting GSIBs $5T headroom. Dealer positions climbed $600B to $700B by April 2026, while leveraged capacity surged $1.8T to $6.4T. Outcomes: narrower spreads, reduced volatility, & greater stress resilience. 1mo ago
- UVA grad notes resilient 2.4% growth & stable 4.1% unemployment in H1. Inflation sits at 3.4%, above 2% target. Fed raised rates to 3.75-4% in Sept. Policy depends on data, risks include geopolitical tensions. Dual mandate remains max employment & price stability. 1mo ago
- FRED hosts 850k series & sees 50% traffic from AI agents. The Fed introduces an MCP Connector to link data with AI while ensuring accuracy & avoiding bias. FRED remains a trusted, non-commercial resource as it expands to FRASER & ALFRED. 1mo ago
- Fed notes rural communities drive supply chains & face higher inflation. Home values rose 36% nonmetro vs 21% urban. Small firms are 96% of rural establishments & created 24% of jobs. Fed supports rural vitality via research, CDFI credit access & workforce initiatives. 1mo ago
- AI boosts global payment security & efficiency via LLMs. Agentic commerce needs micropayments. Scaling requires solving authentication, liability, & fraud. Industry must choose open or closed systems while defining identity standards. 1mo ago
- Detroit unemployment at 11% vs 5% state & 4.1% national. New firms add 30k jobs yearly. AI investment boosts activity while inflation exceeds 2% target. Unanimous rate hike addresses risks as labor market remains solid. 1mo ago
- Fed Reserve hosted 2026 Cyber Workshop on AI risks & ransomware, covering defenses & tabletop exercises. FSB released AI guidance June 2026. Regulators tailor exams for community banks. Resilience needs board oversight, tech, people & processes. 1mo ago
- Fed's Cook likens AI to steam engine. Investment fuels inflation above 2% target, currently 3.8% prompting 25bp hike. Small firms adopt fast. Productivity gains may offer medium-term disinflation. Risks include skill mismatches & labor displacement. 1mo ago
- Fed raised rates on tariff-driven inflation, conflict & AI demand. Home affordability hit 21-year low as prices rose 70% since 2000. High rental burdens persist. A 2-5.5M unit gap stems from zoning, labor loss, high costs & low-rate lock-in effects restricting supply. 1mo ago
- Fed modernizes 113-yr discount window w standardized collateral, e-signatures & automation via 2024 portal. Collab w FHLBs cuts re-allocation time. Efforts boost Treasury resilience & encourage bank usage. 1mo ago
- Fed finalizes stress test reforms to boost transparency & cut SCB volatility 50%. Effective Jan 1. 2027 models cover noninterest income & forward-looking exercises to identify vulnerabilities. Changes aim for robust framework inspired by SVB lessons. 2mo ago
- SVB failed due to unrealized losses & concentrated uninsured deposits. Supervisors knew risks by March 2022 but delayed action. Fed now issues new principles to prioritize early threat identification & empower staff to escalate concerns. 2mo ago
- US Real GDP +1.8% in H1 2026 driven by spending & investment. Unemployment steady at 4.1%. Core PCE at 3.3% with tariff risks. Rates likely hold if August data confirms disinflation, but hikes possible in September if progress reverses. 2mo ago
- Fed links AI & entrepreneurship to growth. Inflation above 2% risks rate hikes. Criminal records block jobs. Business ownership boosts earnings by 24% & lowers recidivism. SBA removed loan bars in 2024. AI aids underwriting & planning. 2mo ago
- Fed Chair marks 100 days, noting AI as new growth factor & $100B annual token sales. Task force launched to study AI impact. Economy resilient with 4.1% unemployment, but PCE inflation at 3.7%. Rejects mechanical rules, prioritizing price stability. 2mo ago
- US economy resilient but inflation stuck above 2% for 5 years. June PCE up 3.7% on energy & AI costs. Labor market stable at 4.2% unemployment. Fed risks skewed to inflation, ready to hike if needed. Consumer sentiment weak due to housing costs & job uncertainty. Restoring price stability is primary goal. 3mo ago
- Fed balances demand & supply shocks amid Middle East conflict & trade policy. AI adds dual effects on markets. FOMC holds rates at 3.25% to 3.75% targeting 2% inflation. 4mo ago
- Inflation at 3.7% remains above the 2% target. Fed prioritizes price stability as GDP grows 2.2% driven by AI data centers. Core goods prices surged 5% amid Middle East shocks. Rates held steady to monitor trends; action prepared if disinflation stalls. 4mo ago
- Fed conference stressed responsible bank innovation & AI to boost financial inclusion. Regulators seek clear expectations without micromanagement. FSB released AI guidance for public comment until July 22, 2026. Supervisory support must help smaller banks innovate safely. 4mo ago
- Fed warns AI could boost workers or worsen inequality by displacing jobs & concentrating wealth. Top 10% holds 59% of US wealth. Outcomes depend on market structure, education & policy to ensure gains are shared broadly rather than accruing to a few firms. 4mo ago
- US economy resilient despite tariffs & energy shocks. Core PCE rose to 3.4% in May; headline 4.1%. Inflation driven by tariffs, energy & AI demand. Labor market stable, expectations anchored. Policy may tighten if core inflation persists. 4mo ago
- FSB modernizes global finance via 4 principles: prioritize risks, tailor rules, ensure transparency & innovate responsibly. US shifts to risk-based oversight post-SVB, refining capital frameworks, AI adoption & supervisory transparency. Fall G20 report expected. 4mo ago
- Fed & FSB seek feedback on AI adoption guidelines for finance, led by MAS & U.S. Treasury. Final report due later this year as G-20 deliverable. Guidance emphasizes proportionality, lighter touch for lower-risk uses, & tailored governance for institution size. 4mo ago
- Initial conditions matter more than historical averages. Vacancy cuts replaced layoffs in 2022 despite tightening. Shocks shorten policy lags. Flexible forward guidance helps, but rigid rules delayed hikes. Optimal guidance requires adaptability, not fixed paths. 4mo ago
- Cleveland Fed notes 99.9% of US firms have under 500 workers, creating 61% of net jobs since 1995. 2025 survey shows nearly half use AI, boosting productivity for 71%. Access to credit remains critical for growth. 4mo ago
- Fed conference on dollar's global role notes stablecoins and digital assets are altering payment rails. While size and trust matter, tech innovation impacts FX markets and global liquidity. Speaker views do not reflect official Fed positions. 5mo ago
- Recent Fed deregulation cuts top bank capital by 6% ($60B) & weakens supervision. Reduced stress tests, liquidity rules & consumer protections risk future crises. Historical data shows long-term GDP losses & massive fiscal costs from past financial collapses. 5mo ago
- Speaker honored JFK & called US indispensable. Fed founded 1913 for stability, aiding economy via non-partisan policy. Governors have legal protections. Rule of law supersedes partisanship; institutions need preserving. 5mo ago
- Fed's Bowman targets 2% inflation ignoring energy shocks, prioritizing core PCE & real GDP. Unemployment at 4.3% with stability concerns. Aggressive 2022 hikes shift to 2025 cuts as growth slows. Stance remains moderately restrictive to stabilize jobs as supply disruptions ease. 5mo ago
- Global energy spikes threaten inflation & growth, especially for importers. US growth solid but slowing due to high costs. Inflation stalled by tariffs/energy yet expected to decline later. Fed holds rates at 3.5%-3.75%, committed to 2% target with data-dependent stance. 5mo ago
- PCE inflation hit 3.8% on gas & core hikes. $1.5T AI boost lifts chips & wages while unemployment stays at 4.3%. Fed holds rates steady, uses AI for risk analysis despite cyber concerns. Responsible deployment needs strong governance. 5mo ago
- Fed faces Middle East supply & price uncertainty. Waller says rate cuts & hikes equally likely. Real GDP grew on AI investment. Core PCE inflation rose to 3.3%. Policy depends on conflict duration & inflation data. 6mo ago
- 31% feel financially healthy despite 96% having accounts. Tech enables real-time assessments to boost savings & reduce costs. Scaling requires standards, privacy balance, & cross-sector collaboration to address vulnerability. 6mo ago
- Shrinking Fed balance sheet is wrong. Cutting reserves undermines bank resilience, impairs money markets, & increases footprint via more lending. Reserves are essential for stability & supplied costlessly. 6mo ago
- Former Fed VP says algorithms can't replace local lending. 10th District banks show resilience via fintech. CECL rules create burdens; new principles focus on material risks. Cyber & capital updates offer flexibility. Fed aims to tailor regs to size & support AI responsibly. 6mo ago
- A speaker proposes centralizing non-monetary back-office functions like IT & HR to boost efficiency while preserving Fed independence. Standardizing tasks shifts governance from Bank-first to System-first, lowering costs & modernizing trillions in payments. 6mo ago
- Fed Vice Chair notes bank corporate lending fell from 48% in 2015 to 29% in 2025 as private credit reached $1.4T. Proposes Basel III changes to lower risk weights, improve NDFI data transparency, restore bank lending balance. 6mo ago
- Fed Govt in Dakar highlights tokenization for West Africa. US tokenized assets doubled to $25B. Benefits: faster settlements & fractional ownership. Risks: runs, cyber threats & systemic links. Fed supports innovation while monitoring stability via global partners. 6mo ago
Earnings Releases
By sector →- SJTNov 19, 11:36 AMThe San Juan Basin Royalty Trust will not declare a cash distribution for November 2026 due to cumulative excess production costs and low natural gas prices. As of the reporting period, the balance of cumulative excess production costs stands at approximately $12.9 million gross, requiring all future net proceeds to be applied toward repayment before distributions can resume. For September 2026, the Trust reported total revenue of $4.59 million from the subject interests, while production costs excluding the excess balance totaled $5.1 million. Additionally, the Trust's administrative expenses for the month were $56,216, funded in part by a draw on its line of credit.
- CRTNov 19, 11:23 AMCross Timbers Royalty Trust declared a cash distribution of $0.118138 per unit payable on December 14, 2026, to unitholders of record as of November 30, 2026. For the current month distribution, underlying sales volumes included 10,000 barrels of oil and 51,000 Mcf of gas, with average prices of $82.54 per barrel and $6.83 per Mcf respectively. The prior month distribution reflected higher volumes of 33,000 barrels of oil and 89,000 Mcf of gas, with average prices of $83.56 per barrel and $4.86 per Mcf. XTO Energy reported that sales volumes for May through July 2026 were received in the prior month due to the new operator of the Hewitt Unit, while excess costs on Texas properties increased by $141,000 without reducing net proceeds from remaining conveyances.Energy
- PBTNov 19, 11:03 AMThe Permian Basin Royalty Trust declared a cash distribution of $0.020923 per unit payable on December 14, 2026, to unit holders of record on November 30, 2026. This distribution excludes proceeds from the Waddell Ranch properties because production costs exceeded gross proceeds for October, maintaining an excess cost position. A special meeting is scheduled for November 23, 2026, to vote on proposals to amend the Trust Indenture and effect a business combination with New PBT, which would result in the Trust's termination and the exchange of units for New PBT stock. For the reporting period, the Texas Royalty Properties generated a net contribution of $1,129,178 to the distribution after accounting for taxes, expenses, and general administrative costs.Energy
- PCYONov 19, 11:01 AMPure Cycle Corporation reported record total revenue of $35.7 million for the fiscal year ended August 31, 2026, representing a 37% increase from the prior year. Net income rose 9% to $14.2 million, or $0.59 per fully diluted share, driven by a 45% surge in lot sales revenue and a 73% increase in single-family rental revenue. The company delivered 1,688 acre-feet of water, a significant rise from 639 acre-feet in the previous year, largely due to higher demand from oil and gas operators. Additionally, Pure Cycle advanced development at its Sky Ranch community, with Phase 2C at 98% completion and Phase 2D at 89% completion, while announcing plans to sell its single-family rental portfolio in an orderly manner.Utilities
- HGTXUNov 19, 10:43 AMThe Hugoton Royalty Trust declared no cash distribution for November 2026 due to excess cost positions on its Kansas, Oklahoma, and Wyoming conveyances, which have prevented net proceeds from reaching the Trust since July 2023. Accumulated excess costs totaling over $37 million across the three properties, combined with lower commodity prices and development expenses, have depleted the Trust's cash reserve and raised substantial doubt about its ability to continue as a going concern. Consequently, the Trust filed a Form 12b-25 to delay its quarterly report and its units were removed from the OTCQB market to trade on the Expert Market. The Trustee is exploring potential termination or asset sales but has found no viable financing options or buyer interest to date.Energy
- ASFHNov 19, 9:57 AMAsiaFIN Holdings Corp. reported a net income of approximately $198,000 for the nine months ended September 30, 2026, a significant turnaround from a net loss of $327,000 in the same period of 2025. Revenue for the nine-month period increased by 23.7% to $3.96 million, while the gross margin improved to 35.5% from 32.5% in the prior year. Despite a 25.6% decline in third-quarter revenue to $1.17 million due to fewer project milestones, the company maintained positive operating income for the first nine months of 2026. Cash and cash equivalents decreased to $1.47 million as of September 30, 2026, from $1.75 million at the end of 2025, reflecting investments in fixed deposits and operating activities.
- PRTNov 19, 9:25 AMPermRock Royalty Trust declared a monthly cash distribution of $0.008479 per Trust Unit, totaling $103,164.56, payable on December 14, 2026, to record holders as of November 30, 2026. The distribution is based on production data from September 2026, which included 12,761 barrels of oil and 15,934 thousand cubic feet of natural gas sold at average prices of $92.63 per barrel and $2.93 per thousand cubic feet, respectively. Total direct operating expenses for the period were $0.54 million, while capital expenditures amounted to $41,794. The net profits calculation also incorporated a $165,000 holdback for future taxes and abandonment costs and the first installment of a $350,812.13 recoupment of a prior overpayment.
- MITQNov 19, 9:07 AMMoving iMage Technologies reported a 9.2% increase in first-quarter 2027 revenue to $6.1 million, driven by higher project activity and $429,000 in sales from its newly acquired DCS product line. Despite the revenue growth, net income declined to $181,000, or $0.02 per share, due to a reduction in gross margin percentage and the absence of a $128,000 gain from payable extinguishment recorded in the prior year. The company's working capital improved to $4.24 million, with cash reserves rising to $5.7 million as a result of customer deposits and managed accounts payable timing. Management anticipates second-quarter revenue of approximately $5.4 million, reflecting typical industry seasonality during the holiday film season.Technology
- GYGYNov 19, 9:05 AMGame Your Game, Inc. reported third-quarter 2026 revenue of $106,813, a 315% increase from the prior year, driven primarily by device sales to reseller GolfSuites following the full commercial launch of its GameGolf KZN AI platform. The company completed a direct listing on the Nasdaq Capital Market in July 2026 and established Altus Sports Group, a subsidiary focused on talent representation and sports marketing. Despite the revenue growth, the company recorded a net loss of $3,160,790 for the quarter, largely due to $1.16 million in non-cash share-based compensation and costs associated with its public listing. As of September 30, 2026, the company held $4.43 million in cash and reported positive working capital of $5.06 million, marking a significant improvement from the previous year-end deficit.Technology
- WSMNov 19, 8:02 AMWilliams-Sonoma, Inc. reported strong third-quarter 2026 results with comparable brand revenue increasing 5.1% and net revenue growing 5.8% year-over-year. The company achieved a GAAP operating margin of 18.9% and a non-GAAP operating margin of 17.4%, driven by tariff refunds, occupancy leverage, and higher merchandise margins. Diluted earnings per share rose 21.4% to $2.38 on a GAAP basis and 11.7% to $2.19 on a non-GAAP basis. Williams-Sonoma reiterated its full-year 2026 outlook, projecting annual net revenue growth between 4.7% and 7.2% and a non-GAAP operating margin between 17.8% and 18.2%.Consumer Cyclical
- NTICNov 19, 8:00 AMNorthern Technologies International Corporation reported fiscal 2026 consolidated net sales of $95,982,000, representing a 13.9% increase from the prior year, driven by growth in ZERUST Industrial and Natur-Tec segments. For the fourth quarter ended August 31, 2026, net sales reached a record $26,461,000, a 18.6% year-over-year increase, though the company recorded a net loss of $703,000 for the full year. Gross profit margins decreased to 35.0% due to higher raw material costs and a lower-margin sales mix, while operating expenses rose slightly due to strategic investments in marketing and personnel. The company also noted a significant effective tax rate of 86.3% for the year, attributed to foreign subsidiary tax rates and withholding taxes, and announced a definitive agreement to sell its Beachwood, Ohio facility.Basic Materials
- ROADNov 19, 7:19 AMConstruction Partners, Inc. reported fiscal 2026 revenue of $3.674 billion, a 31% increase from the prior year, driven by organic growth and seven strategic acquisitions. Net income for the fiscal year rose 40% to $142.1 million, while Adjusted EBITDA increased 24% to $523.5 million. The company completed three additional acquisitions after the fiscal year-end, adding $65.0 million to its backlog, which stands at approximately $3.29 billion as of September 30, 2026. Looking ahead to fiscal 2027, the company has reiterated its outlook for revenue and Adjusted EBITDA growth of approximately 15%.Industrials
- BBWINov 19, 7:12 AMBath & Body Works reported third-quarter 2026 net sales of $1.577 billion, a 1.0% decrease from the prior year, while adjusted earnings per diluted share reached $0.26, exceeding guidance. The company raised its full-year 2026 net sales decline guidance to a range of 2.1% to 3.4% and updated reported earnings per share guidance to between $3.09 and $3.29. Management highlighted progress in its Consumer First Formula, noting digital growth and expanding wholesale partnerships with Ulta and Amazon. Additionally, the Board of Directors authorized a new $500 million share repurchase program to replace the existing January 2025 initiative.Consumer Cyclical
- VVVNov 19, 7:03 AMValvoline Inc. reported fourth-quarter fiscal 2026 net revenues of $554.1 million, representing a 22% year-over-year increase, while full-year sales reached $2.06 billion, up 21%. The company achieved a 20th consecutive year of system-wide same-store sales growth, with a 7.9% increase for the fiscal year and 9.4% for the quarter, bringing the total store count to 2,517. Although reported income from continuing operations declined 59% to $87.9 million for the year due to significant one-time costs, adjusted EBITDA rose 19% to $557 million. Looking ahead to fiscal 2027, Valvoline forecasts net revenues between $2.25 billion and $2.35 billion and adjusted EBITDA between $595 million and $625 million.Energy
- LQDTNov 19, 7:00 AMLiquidity Services reported fiscal year 2026 GAAP net income of $37.3 million, a 33% increase from the prior year, while non-GAAP adjusted EBITDA rose 30% to $79.1 million. Gross merchandise volume for the full year reached $1.6 billion, up 5%, driven by strong buyer participation and a strategic shift toward higher-margin consignment transactions. The company announced the acquisition of Invaluable, which is expected to help exceed $2 billion in annual GMV in fiscal 2027, and provided first-quarter guidance projecting GMV between $580 million and $640 million.Consumer Cyclical
- WMTNov 19, 6:58 AMWalmart reported third-quarter fiscal 2027 revenue of $188.8 billion, representing a 5.2% increase, while adjusted operating income rose 16.0% to $7.77 billion. Global e-commerce sales grew by 17%, driven by store-fulfilled pickup and delivery, and the company's advertising business increased by 25%. The company raised its full-year fiscal 2027 outlook, projecting net sales growth of 4.9% to 5.2% and adjusted earnings per share between $2.84 and $2.89. Key financial metrics for the quarter included an adjusted EPS of $0.65, free cash flow of $6.8 billion, and a return on investment of 15.4%.Consumer Defensive
- BEEMNov 18, 5:20 PMBeam Global reported third-quarter 2026 revenues of $6.7 million, representing a 15% year-over-year increase, with gross margins improving to 21.3% on a GAAP basis and 31.9% on an adjusted non-GAAP basis. The company's backlog grew 28% to $6.9 million as of September 30, 2026, driven by record smart city infrastructure sales in Europe and continued demand for specialized battery technology in the drone and autonomous robotics sectors. Despite a GAAP net loss of $4.5 million for the quarter, the adjusted non-GAAP net loss narrowed to $2.5 million, supported by cost reduction initiatives including the relocation of manufacturing operations to Yuma, Arizona. Commercial customers accounted for 92% of revenues, with 56% of sales generated outside the United States, led by significant growth in Serbia and Romania.Technology
- NJRNov 18, 5:07 PMNew Jersey Resources Corporation reported fiscal 2026 consolidated net income of $368.4 million, or $3.65 per share, representing an increase from the prior year's $335.6 million. The company's non-GAAP net financial earnings for the full year totaled $361.6 million, driven by strong performance in Energy Services and growth in its solar and storage businesses. New Jersey Natural Gas reduced average customer bills by 9.0% ahead of the winter season while investing $101 million in energy efficiency programs. Looking ahead, the company maintains a long-term net financial earnings per share growth target of 7 to 9 percent and introduced a fiscal 2027 guidance range of $3.25 to $3.40 per share.Utilities
- SMXTNov 18, 5:00 PMSolarMax Technology reported a third-quarter 2026 revenue of $6.7 million, representing a 29% decline from the same period in 2025. The company recorded a net loss of $4.2 million, or $0.88 per share, compared to a net loss of $2.3 million in the prior year quarter. Despite the overall revenue drop, revenue excluding large-scale EPC projects increased by 2% in the third quarter and 27% over the first nine months of 2026. CEO David Hsu noted that the solar and LED businesses demonstrated resilience amidst a challenging operating environment.Technology
- HPNov 18, 4:57 PMHelmerich & Payne reported a consolidated net loss of $490 million for the fourth quarter of fiscal 2026, driven primarily by a $610 million non-cash asset impairment charge related to assets in the Middle East. Despite the GAAP loss, the company achieved adjusted net income of $36 million and consolidated adjusted EBITDA of $269 million, with North America Solutions and Offshore Solutions both posting operating income. The company completed the sale of Utica Square for approximately $100 million and retired $400 million in term loans ahead of schedule, ending the fiscal year with $250 million in cash and cash equivalents. Looking ahead to fiscal 2027, management expects growth opportunities to drive stronger direct margins, targeting a net debt to adjusted EBITDA ratio of approximately 1x by the end of the calendar year.Energy
- PANWNov 18, 4:37 PMPalo Alto Networks reported fiscal first quarter 2027 total revenue of $3.44 billion, representing a 39% year-over-year increase. Next-Generation Security Annual Recurring Revenue (ARR) grew 66% to $9.73 billion, while remaining performance obligations increased 35% to $21.0 billion. The company announced its intent to acquire Applied Compute to enhance its capabilities in secure open-weight AI models. Management raised its full-year guidance, projecting total revenue between $14.52 billion and $14.57 billion and non-GAAP net income per share between $4.26 and $4.30.Technology
- SNEXNov 18, 4:25 PMStoneX Group Inc. reported record fiscal 2026 results with net income of $525.4 million, representing a 72% increase from the prior year, driven by a 43% rise in net operating revenues to $2.9 billion. The company successfully integrated its largest acquisition to date, R.J. O'Brien, which contributed significantly to growth across its Commercial, Institutional, and Payments segments. Quarterly net income for the fourth quarter ended September 30, 2026, was $84.2 million, resulting in diluted earnings per share of $0.66. Adjusted EBITDA for the fiscal year reached $971.0 million, up 62% year-over-year, reflecting strong momentum in listed derivatives and physical contracts.Financial Services
- RRGBNov 18, 4:10 PMRed Robin Gourmet Burgers, Inc. reported a net loss of $21.2 million for the fiscal third quarter ended October 4, 2026, while achieving a 3.9% increase in comparable restaurant revenue driven by a 5.6% rise in average guest checks. The company completed the refranchising of 108 company-owned restaurants for approximately $89.4 million, utilizing the proceeds to refinance debt and reduce outstanding borrowings to roughly $100 million. Restaurant-level operating profit margin improved by 90 basis points to 10.8% compared to the prior year period, supported by pricing actions and labor efficiencies. For the fourth quarter of fiscal 2026, the company forecasts comparable restaurant revenue growth of approximately 2.75% and adjusted EBITDA of $6.0 million.Consumer Cyclical
- UTINov 18, 4:07 PMUniversal Technical Institute reported fiscal 2026 full-year revenue of $897.0 million, a 7.4% increase, while net income decreased to $33.6 million due to strategic growth expenses. The company's average full-time active students rose 6.6% to 26,251, and it plans to open up to 12 new campuses and launch approximately 45 new programs between fiscal 2027 and 2029. Fiscal 2027 guidance projects revenue between $925 million and $945 million, with adjusted EBITDA expected to range from $100 million to $106 million. The company aims to exceed $1.2 billion in revenue and approach $220 million in adjusted EBITDA by fiscal 2029 as new capacity ramps up.Consumer Defensive
- PNov 18, 4:06 PMEverpure reported third-quarter fiscal 2027 total revenue of $1.5 billion, representing a 51% year-over-year increase driven by a 77% surge in product sales. The company achieved a non-GAAP operating income of $345 million and raised its full-year fiscal 2027 revenue guidance to a range of $5.20 billion to $5.21 billion. Key operational highlights included the expansion of its Data Intelligence platform with Model Context Protocol integration and securing a design win with a second top-five hyperscaler. Additionally, Everpure returned approximately $67 million to stockholders through share repurchases while maintaining strong cash flow generation of $443 million in operating activities.Technology
- KLICNov 18, 4:06 PMKulicke & Soffa reported fourth-quarter 2026 net revenue of $410.3 million and net income of $73.2 million, representing earnings per share of $1.37. The company achieved a gross margin of 47.8% for the quarter and initiated Advanced Solutions system manufacturing in its new Singapore production facility. For the full fiscal year 2026, the company generated $1,182.9 million in net revenue and $182.6 million in net income. Looking ahead to the first quarter of fiscal 2027, the company forecasts net revenue of approximately $410 million and non-GAAP diluted earnings per share of $1.65.Technology
- PVLNov 18, 4:05 PMPermianville Royalty Trust announced a monthly cash distribution of $0.009500 per unit payable on December 14, 2026, to unitholders of record as of November 30, 2026. This distribution is based on reported oil production from August 2026 and natural gas production from July 2026, with average realized wellhead prices of $77.96 per barrel and $2.87 per Mcf respectively. The Sponsor released $1.7 million from a previously established cash reserve to fund development expenses, while retaining $0.4 million for future costs. Additionally, proceeds from a partial sale of non-producing acreage closed in September 2026 are included in this distribution.
- LOGCNov 18, 4:05 PMContextLogic Holdings Inc. released its third quarter 2026 financial results and subsequently published a Q&A document on its website to address shareholder inquiries. The company invited investors to submit written questions and consolidated similar inquiries into single responses for clarity, while declining to answer questions deemed competitively sensitive or premature. ContextLogic Holdings Inc. operates as a publicly traded business ownership platform that holds a collection of niche businesses managed with significant autonomy.
- TRAKNov 18, 4:05 PMReposiTrak reported first-quarter fiscal 2027 total revenue of $5.8 million, a 3% decrease from the prior year, while operating expenses rose 1% to $4.1 million. The company recorded a GAAP net income of $1.5 million, or $0.08 per share, and declared a quarterly dividend of $0.02 per share. Subsequent to the quarter, ReposiTrak entered into a definitive agreement to recapitalize SPAR Group, which will result in ownership of approximately 49.99% of SPAR Group's common stock. The company ended the period with $24.5 million in cash and cash equivalents, maintaining a strong liquidity position to support strategic growth initiatives.Technology
- CCIFNov 18, 4:02 PMCarlyle Credit Income Fund reported financial results for the fourth quarter and full year ended September 30, 2026, declaring a monthly common stock dividend of $0.03 per share for December 2026 through February 2027. The Fund also declared a monthly dividend of $0.1536 per share on its 7.375% Series D Term Preferred Shares for the same period, with payments scheduled for late December 2026 and late January and February 2027. Net investment income for the quarter was $0.05 per common share, while core net investment income reached $0.16 per share, providing 178% coverage of the forward dividend. Additionally, the Fund funded $6.7 million in new CLO investments with a weighted average GAAP yield of 16.17% as of the quarter's end.Financial Services
- WWDNov 18, 4:00 PMWoodward, Inc. reported record fiscal year 2026 net sales of $4.4 billion, representing a 22% increase from the prior year, alongside earnings per share of $9.49, a 32% year-over-year rise. The company achieved significant margin expansion across its Aerospace and Industrial segments, driven by higher sales volumes, price realization, and disciplined operational execution. Key strategic initiatives included the acquisition of Valve Research & Manufacturing, capacity expansions in Germany and Scotland, and new distribution agreements to support future growth. Looking ahead to fiscal 2027, Woodward projects sales growth of 6% to 10% and adjusted earnings per share between $10.20 and $10.70, while anticipating increased capital expenditures to support manufacturing capabilities.Industrials
- TJXNov 18, 9:19 AMThe TJX Companies, Inc. reported third-quarter fiscal 2027 net sales of $16.0 billion, representing a 6% increase year-over-year, with consolidated comparable sales growing 4%. Diluted earnings per share reached $1.39, a 9% rise from the prior year, while the pretax profit margin improved to 13.0%. The company returned $1.5 billion to shareholders through share repurchases and dividends and announced a full-year fiscal 2027 outlook expecting consolidated comparable sales to increase by 4%.Consumer Cyclical
- EXPDNov 18, 9:00 AMExpeditors International of Washington, Inc. projects 2026 earnings per share between $9.09 and $9.39, representing a 53% to 58% increase year-over-year, with fourth-quarter guidance set at $2.70 to $3.00 per share. The company attributes its growth to a differentiated operating model featuring local ownership, significant technology investments in AI and automation, and expansion into high-growth verticals such as biopharmaceuticals, data center logistics, and the space economy. Financial targets include maintaining a return on invested capital of 51%, achieving 112% free cash flow conversion, and sustaining a long-term revenue growth rate of 5% to 7%. Capital allocation priorities focus on funding organic growth, maintaining a dividend aristocrat status with a target payout ratio of approximately 25%, and utilizing remaining share repurchase capacity.Industrials
- LOWNov 18, 8:45 AMLowe's reported third-quarter 2026 net earnings of $1.7 billion, resulting in diluted earnings per share of $2.98 and adjusted diluted earnings per share of $3.10. Total sales for the quarter reached $22.8 billion, representing a 9.3% increase year-over-year, while comparable sales rose 1.8% driven by strong online, Pro, and home services performance. The company updated its full-year 2026 outlook, projecting total sales of approximately $92.5 billion and adjusted diluted earnings per share of $12.25. Additionally, Lowe's recognized a $250 million pre-tax benefit from IEEPA tariff refunds and paid $701 million in dividends during the quarter.Consumer Cyclical
- RTSNNov 18, 8:10 AMRetension Pharmaceuticals completed an upsized initial public offering in October 2026, generating $51.75 million in gross proceeds to fund the development of its lead candidate, RTN-001, for uncontrolled and resistant hypertension. The company reported a net loss of $5.9 million for the third quarter of 2026, driven by increased research and development expenses related to its ongoing Phase 2b clinical trial. As of September 30, 2026, the company held $9.2 million in cash and cash equivalents, which would rise to approximately $54.3 million on a pro forma basis including the IPO proceeds. Topline data from the Phase 2b trial involving approximately 280 patients is expected in the first half of 2027.Healthcare
- SDOTNov 18, 8:00 AMSadot Group Inc. reported a net loss of $3.0 million for the third quarter of 2026, representing an 86% reduction in operating losses compared to the same period in 2025. During the first nine months of the year, the company achieved a $69.3 million improvement in shareholders' equity, shifting from a deficit to a positive balance of approximately $14.5 million, primarily driven by a non-cash gain from the deconsolidation of Sadot Latam. The company acquired three technology platforms—TradeOS, TradeIQ, and SalesIQ—with a combined carrying value of $24.6 million to support its transition toward a technology-enabled business model. Despite these balance sheet improvements, the company faces substantial doubt regarding its ability to continue as a going concern due to a working capital deficit of $5.7 million and outstanding debt defaults.Consumer Cyclical
- GAMENov 18, 8:00 AMGameSquare Holdings reported third-quarter 2026 revenue of $19.0 million, a 77% increase year-over-year, driven by gains on digital assets and improved operating profitability. The company achieved net income of $10.1 million for the quarter, or $0.79 per diluted share, and posted positive adjusted EBITDA of $0.6 million, marking the second consecutive quarter of positive adjusted EBITDA. For the nine months ended September 30, 2026, revenue reached $52.0 million, while the company reiterated its full-year 2026 guidance of $85 million to $90 million in revenue and over $5 million in adjusted EBITDA. Additionally, the company held 9,711.30 ETH and $31.2 million in cash and digital assets as of September 30, 2026, while continuing its stock repurchase program.Communication Services
- LTRNNov 18, 7:35 AMLantern Pharma reported third-quarter 2026 financial results showing a net income of approximately $0.7 million, driven by a non-cash gain from warrant accounting, while operating expenses were impacted by a $2.0 million accrual for a proposed legal settlement. The company closed a registered direct offering in September 2026 for gross proceeds of $4.0 million, bringing its total cash, cash equivalents, and marketable securities to approximately $7.6 million. Clinically, the company engaged its first site for a Phase 1b/2 trial of LP-184 in triple-negative breast cancer, opened Part 2 of the HARMONIC trial for LP-300 in Taiwan, and published peer-reviewed Phase 1a data for LP-184 in glioblastoma. Leadership changes included the resignation of CEO Panna Sharma and the appointment of CFO David Margrave as Interim CEO, alongside the formation of a new subsidiary, Open Medicine AI, to commercialize its AI platform.Healthcare
- JJSFNov 18, 7:02 AMJ & J Snack Foods reported fiscal 2026 fourth quarter net sales of $406.0 million, a 1% decline from the prior year, while net earnings rose 195% to $33.6 million. The quarter featured a significant 200 basis point expansion in gross margin to 33.7%, driven by Project Apollo savings and raw material deflation, which helped offset a 21.6% increase in distribution costs due to higher freight and fuel rates. Food Service sales decreased 7.4% due to bakery reductions, whereas Retail Supermarket and Frozen Beverage segments grew by 17.1% and 6.1% respectively. The company ended the quarter with $90.3 million in cash, no long-term debt, and expects to return to top-line growth in fiscal 2027 through volume growth, innovation, and pricing.Consumer Defensive
- BRBRNov 18, 7:01 AMBellRing Brands reported fourth-quarter 2026 net sales of $692.0 million, representing a 7% year-over-year increase, while fiscal year 2026 net sales reached $2,398.4 million, up 3.5%. The company recorded net earnings of $35.6 million for the quarter and $147.4 million for the full year, with both periods negatively impacted by inventory-related headwinds totaling $16 million and $37 million respectively. Adjusted EBITDA for the fourth quarter was $66.4 million and $288.8 million for the fiscal year, reflecting significant cost inflation and trade investments. Looking ahead, BellRing projects fiscal year 2027 net sales between $2.32 billion and $2.42 billion and Adjusted EBITDA between $310 million and $350 million.Consumer Defensive
- TGTNov 18, 6:46 AMTarget Corporation reported third-quarter 2026 net sales of $27.1 billion, representing a 7.1 percent increase year-over-year driven by a 5.6 percent growth in comparable sales. Earnings per share reached $2.65, a figure that included $0.50 in benefits from tariff refunds, while the company raised its full-year net sales growth guidance to approximately 6 percent. The retailer achieved strong performance across core categories, with nearly 27 percent growth in Fun 101 and 9.8 percent growth in digital comparable sales. Looking ahead, Target expects to invest between $5 billion and $6 billion in capital expenditures in 2027 and has updated its full-year adjusted EPS guidance to a range of $10.65 to $11.40.Consumer Defensive
- FTLFNov 17, 5:21 PMFitLife Brands reported third-quarter 2026 total revenue of $25.6 million, representing a 9% increase driven by the acquisition of Irwin Naturals, which was partially offset by a decline in Legacy FitLife revenue. Net income for the quarter rose to $1.6 million, or $0.16 per diluted share, compared to $0.9 million in the prior year period, primarily due to the absence of merger-related expenses and a lower effective tax rate. The company incurred $0.3 million in restructuring costs during the quarter as part of an initiative expected to reduce annual operating expenses by $1.2 million starting in the fourth quarter. At the end of the quarter, FitLife Brands held $39.3 million in total debt and $0.7 million in cash, resulting in a net debt position of $38.6 million.Consumer Defensive
- IIIVNov 17, 5:19 PMi3 Verticals reported fourth-quarter 2026 revenue of $55.4 million, a 1.0% increase year-over-year, while full-year 2026 revenue reached $218.7 million, up 2.6%. The company posted a net loss of $5.1 million from continuing operations for the quarter, contrasting with a net income of $1.5 million in the same period the prior year, though full-year 2026 net income from continuing operations was $4.1 million. Adjusted EBITDA for the fourth quarter was $15.2 million, representing a 27.4% margin, and totaled $58.7 million for the full fiscal year. On October 9, 2026, the company closed a $350 million senior secured credit facility to replace its previous arrangement, and it provided a 2027 revenue outlook ranging from $220 million to $235 million.Technology
- AIRENov 17, 5:05 PMreAlpha Tech Corp. reported third-quarter 2026 revenue of approximately $1.6 million, an 11% increase from the prior year, driven by growth in its Homebuying Services segment following the acquisitions of Prevu and InstaMortgage. The company narrowed its net loss by 39% to $3.4 million and improved its Adjusted EBITDA to a loss of $1.9 million, while total transaction volume for the trailing twelve months rose 74% to $188.8 million. Despite these operational improvements, cash and cash equivalents decreased by 92% to $0.8 million due to funding ongoing operations and acquisition-related expenditures. Additionally, the company completed a $1.75 million public offering in November 2026 to support working capital and general corporate purposes.Real Estate
- DUOTNov 17, 5:00 PMDuos Technologies Group reported a 103% year-over-year increase in third-quarter 2026 revenue to $10.50 million, driven by growth in its Technology Solutions business and infrastructure development activities. The company secured a 10-year, $400 million colocation agreement with a major cloud service provider for a 20 MW deployment expected to begin in the second quarter of 2027. Financial results included a net income of $864,000 for the quarter, supported by a $4.7 million gain from the deconsolidation of its GPU-as-a-Service entity, while adjusted EBITDA turned positive at $493,000. Duos reaffirmed its full-year 2026 outlook of exceeding $50 million in revenue and achieving positive adjusted EBITDA as it transitions to a pure-play colocation model.Technology
- GLADNov 17, 4:37 PMGladstone Capital Corporation reported net investment income of $0.49 per share for the fourth quarter of fiscal 2026 and $2.00 per share for the full fiscal year. The company's net asset value decreased to $20.77 per share by September 30, 2026, driven by net realized and unrealized losses alongside a supplemental distribution. During the quarter, the firm invested $83.9 million across its portfolio, which now includes 59 portfolio companies with a total fair value of $955.8 million. The company maintained a debt-to-equity ratio of 1.08x, including preferred stock, while covering 100% of its regular quarterly distributions with net investment income.Financial Services
- CNTYNov 17, 4:21 PMCentury Casinos, Inc. announced a restatement of previously issued financial statements due to an accounting error regarding a minority interest in Smooth Bourbon, LLC, which owns the real estate for the Nugget Casino Resort. The Audit Committee concluded that investors should no longer rely on financial statements for the years ended December 31, 2024 and 2025, as well as specific quarters in 2026. The company provided preliminary, unaudited financial results for the third quarter of 2026, reporting approximately $158.4 million in net operating revenue and $20.7 million in earnings from operations. Additionally, the company plans to file amended reports and expects to identify at least one additional material weakness in its internal controls over financial reporting.Consumer Cyclical
- NVDANov 17, 4:20 PMNVIDIA reported third-quarter fiscal 2027 revenue of $115.8 billion, representing a 103% increase year-over-year, driven by $107.6 billion in Data Center revenue. The company began shipping the Vera Rubin NVL72 platform and announced the acquisition of Hugging Face to expand its AI ecosystem. For the fourth quarter of fiscal 2027, NVIDIA expects revenue to reach $130.0 billion with gross margins between 71.0% and 72.0%. Additionally, the company returned $28.1 billion to shareholders through stock repurchases and dividends during the quarter.Technology
- IRIXNov 17, 4:19 PMIridex Corporation reported third-quarter 2026 total revenue of $10.2 million, a 19% decline from the prior year period, driven by weaker demand in Europe and Asia and distributor inventory adjustments. The company achieved a gross margin of 42.4%, an improvement over the previous year, while operating expenses remained flat at $5.5 million. Net loss for the quarter was $1.4 million, or $0.08 per share, compared to a $1.6 million loss in the same period last year. Consequently, Iridex reduced its full-year 2026 revenue guidance to a range of $46 million to $48 million, citing continued headwinds in international markets.Healthcare
- LZBNov 17, 4:17 PMLa-Z-Boy Incorporated reported second quarter fiscal 2027 sales of $526 million, representing a 1% increase over the prior year or 4% excluding the impact of a wholesale casegoods divestiture. The Retail segment delivered strong growth with a 14% increase in delivered sales, while the Wholesale segment saw a 2% decline on a reported basis, which improved to a 3% increase when excluding the divestiture. The company recorded GAAP diluted earnings per share of $0.45 and adjusted diluted earnings per share of $0.53, while returning $32 million to shareholders through dividends and share repurchases. Additionally, the Board declared a 12% increase in the quarterly dividend to $0.27 per share, marking the sixth consecutive year of double-digit increases.Consumer Cyclical
- IDXGNov 17, 4:15 PMInterpace Biosciences reported third-quarter 2026 revenue of $10.4 million, representing an 18% year-over-year increase driven by a 7% rise in thyroid test volume. The company achieved an adjusted EBITDA of $2.1 million, or 20% of revenue, despite reporting a loss from continuing operations of $1.5 million due to $4.1 million in non-recurring stock compensation and legal expenses. Gross margin expanded to 69% for the quarter, supported by an 11% increase in average revenue per test and operational efficiency gains. The firm continues to operate as a thyroid-only diagnostics provider following the discontinuation of its PancraGEN pancreatic testing business in May 2025, while developing a new pancreatic cancer program expected to generate no revenue in 2026 or 2027.Healthcare
- DLBNov 17, 4:15 PMDolby Laboratories reported fourth-quarter fiscal 2026 total revenue of $374 million and full-year revenue of $1.42 billion, representing a 5% increase from the prior year. The company achieved GAAP net income of $81 million for the quarter and $258 million for the full year, while non-GAAP net income reached $118 million and $417 million respectively. Dolby repurchased 4.3 million shares for approximately $265 million during the fiscal year and increased cash dividends to $1.44 per share. Looking ahead to fiscal 2027, the company forecasts total revenue to remain roughly flat at $1.42 billion with non-GAAP diluted earnings per share expected between $4.27 and $4.42.Industrials
- SACHNov 17, 4:10 PMSachem Capital Corp. reported a net loss of $3.2 million for the third quarter of 2026, driven by $0.8 million in transaction expenses related to its pending merger with Industrial Realty Group. The company's loan portfolio decreased to $320.0 million in gross principal balance, while non-accrual loans were reduced to $84.6 million from $117.6 million at the end of 2025. Sachem and Industrial Realty Group are proceeding with a definitive contribution agreement expected to close in the first quarter of 2027, which would create IRG Realty Trust, Inc., a top-10 publicly listed industrial REIT with an implied enterprise value of approximately $3.4 billion. During the quarter, the company originated 11 loans totaling $36.8 million and repaid 12 loans totaling $52.3 million, while maintaining a solid cash position of $41.4 million at quarter-end.Financial Services
- GBDCNov 17, 4:05 PMGolub Capital BDC, Inc. reported a net asset value of $14.00 per share as of September 30, 2026, reflecting a $0.25 decrease from the previous quarter. The company's investment portfolio totaled $7.8 billion at fair value, with approximately 85% of investments rated as performing at or above expectations. During the quarter, the firm prioritized share repurchases, buying back 0.8 million shares for $10.1 million, while maintaining a quarterly base distribution of $0.33 per share. Adjusted earnings per share were $0.08, driven by stable net investment income despite unrealized losses on non-accrual and equity investments.Financial Services
- BOFNov 17, 4:05 PMBranchOut Food Inc. reported third-quarter 2026 net revenue of $1.35 million, a decrease from the prior year, driven by the exit of its non-core prune resale business and the transition to new recurring product programs. The company achieved an adjusted gross margin of 14.8% and expects fourth-quarter revenue to reach between $6 million and $7 million, with a full-year 2026 revenue target of $14.4 million to $15.4 million. Management projects 2027 net revenue to exceed $30 million, supported by a recurring revenue base of approximately $4 million per quarter and expanded production capacity at its Peru facility. The company currently holds $0.4 million in cash and plans to refinance its $4.0 million senior secured note into a term loan in 2027.Consumer Defensive
- GBDCNov 17, 4:04 PMGolub Capital BDC, Inc. reported fiscal year 2026 fourth-quarter net investment income of $0.32 per share and earnings of $0.08 per share. The company's net asset value per share decreased to $14.00 as of September 30, 2026, down from $14.25 at the end of the previous quarter. During the quarter, the firm paid a $0.33 per share distribution and opportunistically repurchased approximately 793,400 shares of its common stock. The investment portfolio, valued at $7.8 billion, consisted of 432 portfolio companies with senior secured and one-stop loans representing the majority of assets.Financial Services
- CDNov 17, 1:50 PMChaince Digital Holdings Inc. reported third-quarter 2026 revenue of $1.81 million, representing a 92% increase from the same period in 2025, driven primarily by underwriter services. The company achieved net income of $0.23 million for the quarter, a significant turnaround from the $2.55 million net loss recorded in the prior year period. By September 30, 2026, the company's total shareholders' equity reached $61.7 million, its highest level in nearly eight years, supported by cash, short-term investments, and stablecoins totaling approximately $60.0 million. Additionally, the company repurchased and canceled all outstanding warrants from its November 2023 private placement and closed a registered direct offering that raised approximately $16.2 million in August 2026.Financial Services
- DYNRNov 17, 12:12 PMDynaResource reported a net loss of $4.4 million and revenue of $10.1 million for the third quarter of 2026 at its San Jose de Gracia mine in Mexico. Gold production declined to 3,417 ounces due to lower head grades of 2.39 g/t, increased dilution, and heavy seasonal rainfall. The company successfully transitioned to a single underground mining contractor, resulting in reduced safety incidents and improved operational controls. Additionally, a new gravity concentration circuit is performing as designed, recovering approximately 26% of gold in concentrate, while $4.9 million in cash remains restricted pending resolution with tax authorities.
- RIMENov 17, 9:30 AMAlgorhythm Holdings completed the acquisition of Azure Energy on September 15, 2026, establishing a new operating segment focused on renewable power infrastructure advisory services. The company simultaneously ceased funding its unprofitable India-based logistics subsidiary, SMCB Solutions, to reduce expenses and focus on high-margin returns. For the third quarter of 2026, net sales increased approximately 20% to $2.1 million, while total assets rose to $25.2 million primarily due to the Azure acquisition. Stockholders' equity improved to $5.6 million, reversing a deficit of $1.9 million recorded at the end of 2025.Technology
- PULMNov 17, 9:29 AMPulmatrix, Inc. announced its third-quarter 2026 financial results and confirmed that its merger with Eos SENOLYTIX is expected to close by the end of the year following SEC effectiveness and stockholder approval. The company reported total cash and cash equivalents of $1.4 million as of September 30, 2026, while general and administrative expenses rose to $1.2 million due to merger-related activities. Pulmatrix continues to seek to out-license or monetize its clinical assets, including PUR1900, PUR3100, and PUR1800, while clinical development remains on hold pending these strategic moves.Healthcare
- PPSINov 17, 9:15 AMPioneer Power Solutions reported a 41.7% year-over-year increase in backlog to $17.9 million as of September 30, 2026, driven by a PRYMUS quote pipeline exceeding $200 million. The company achieved a gross margin of 23.1% for the third quarter, a significant improvement from 9.3% in the prior year period, though it recorded a GAAP operating loss of $2.8 million due to a $1.4 million non-cash impairment charge. Non-GAAP operating income turned positive at $321,000, contrasting with a $196,000 non-GAAP operating loss in the same quarter of the previous year. Management reaffirmed its outlook for approximately $15 million in revenue for the second half of 2026, representing over 60% growth compared to the first half, with the first PRYMUS system scheduled for delivery by the end of November.Industrials
- BOXLNov 17, 9:00 AMBoxlight Corporation reported third-quarter 2026 revenue of $30.1 million, representing a 2.5% increase from the prior year period. The company achieved a gross profit margin of 37.1%, a significant improvement from 29.1% in the previous year, while narrowing its net loss to $1.0 million from $6.2 million. Adjusted EBITDA improved to $2.4 million, driven by normalized tariff rates and reduced operating expenses. Financially, Boxlight strengthened its balance sheet by raising $5.5 million in Series D financing, securing a $15 million equity line, and reducing its senior secured term loan to $30.0 million.Technology
- NUOTQNov 17, 8:57 AMNuo Therapeutics reported total revenues of approximately $1.9 million for the third quarter of 2026, representing an 80% increase compared to the same period in 2025. The company recorded a net operating loss of roughly $374,000 for the quarter, which was an improvement over the prior year but higher than the previous quarter due to increased stock-based compensation and regulatory costs. Financial updates indicate the receipt of a $250,000 reimbursement milestone from Smith+Nephew and the final funding of a loan agreement, bringing total borrowings to $2 million. Additionally, the company highlighted favorable 2027 Medicare reimbursement rulings for its Aurix product, including a 7% increase in Outpatient Prospective Payment System rates and expanded coverage for nursing home treatments effective January 1, 2027.Healthcare
- AGPUNov 17, 8:36 AMAxe Compute Inc. reported third-quarter 2026 revenue of $7.2 million, representing a 125% increase from the previous quarter, alongside an operating income of $6.8 million and net income of $11.5 million. The company completed the sale of its Helomics subsidiary to transition fully into a GPU-as-a-Service business and acquired its first owned cluster of 2,304 NVIDIA B300 GPUs in Georgia. Cash reserves grew 6.7 times to $147.7 million, supported by customer prepayments that funded $349.6 million in infrastructure purchases during the quarter. Additionally, the company secured over $2.8 billion in new Build contracts in July, bringing its total contract value for 2026 to more than $3 billion.Technology
- EFSHNov 17, 8:16 AM1847 Holdings reported a third-quarter 2026 operating loss from continuing operations of $0.31 million, a 44% improvement year-over-year, driven by a 14% reduction in total operating expenses. Revenue from continuing operations totaled $1.74 million, with Wolo's revenue doubling to $0.15 million and its gross margin expanding significantly to 69.5% as it transitioned to e-commerce channels. For the first nine months of 2026, the company generated approximately $1.1 million in positive operating cash flow from continuing operations while narrowing its operating loss by 48% compared to the prior year. Concurrently, the company continues to market CMD Inc. and CMD Finish Carpentry LLC for sale, which are classified as discontinued operations.Industrials
- DISNov 17, 6:30 AMThe Walt Disney Company reported fiscal 2026 fourth-quarter revenues of $25.9 billion, a 16% increase from the prior year, driven by strong performance across its Experiences, Entertainment, and Sports segments. Full-year revenues reached $102.3 billion, an 8% increase, while adjusted earnings per share rose 18% to $7.02, excluding the impact of an additional 53rd week of operations. The company announced a 33% dividend increase to $2.00 per share and expects double-digit adjusted EPS growth in fiscal 2027, alongside approximately $11 billion in projected free cash flow. Strategic initiatives included the sale of its A+E Global Media stake, the NFL Transaction, and the FuboTV asset combination, which contributed to revenue growth and operational efficiency.Communication Services
- HDNov 17, 6:18 AMThe Home Depot reported third-quarter fiscal 2026 sales of $43.4 billion, representing a 4.9% increase from the prior year, with comparable sales rising 2.2%. Net earnings for the quarter reached $3.7 billion, or $3.72 per diluted share, while adjusted diluted earnings per share were $3.86. The company updated its full-year fiscal 2026 guidance to project total sales growth of approximately 4.5%, comparable sales growth of 1.4%, and diluted earnings per share growth of 1.5% to 2.0% depending on the metric used. As of the end of the quarter, the retailer operated 2,372 retail stores and over 1,320 SRS locations across North America with a workforce exceeding 470,000 associates.Consumer Cyclical
- OCSLNov 17, 6:02 AMOaktree Specialty Lending Corporation reported total investment income of $68.2 million for the fourth quarter of fiscal 2026 and $283.1 million for the full year, representing a decline from the prior year due to lower reference rates and a reduced average portfolio balance. Net investment income for the quarter was $29.8 million ($0.34 per share), while the company declared quarterly and supplemental cash distributions of $0.32 per share payable in December 2026. The company's net asset value per share stood at $15.63 as of September 30, 2026, with total debt outstanding at $1,416.0 million and liquidity comprising $45.1 million in unrestricted cash plus $994.0 million in undrawn credit facility capacity.Financial Services
- FFAINov 16, 5:00 PMFaraday Future Intelligent Electric Inc. reported third-quarter 2026 revenue of approximately $1.15 million, driven primarily by its robotics business, while narrowing its net loss to $9.8 million from $222.2 million in the prior-year period. The company successfully spun off its robotics division into a standalone Nasdaq-listed entity, FF Robotics (FFR), in an all-stock transaction valued at approximately $200 million that closed in late October 2026. For the nine months ended September 30, 2026, the robotics business generated $2.3 million in revenue with a 26% gross margin and shipped 1,168 units, reaffirming a full-year target of 2,000 units. Faraday Future is advancing a strategic transformation toward Robotaxi operations and an AI VisiCabin technology platform while maintaining its position as the controlling stockholder of FFR.Consumer Cyclical
- CEPLNov 16, 4:54 PMCapstone Energy+ secured a $25 million, three-year senior secured note agreement with Monarch Alternative Capital to refinance its existing Exit Notes. The company reported second-quarter fiscal 2027 revenue of $22.4 million, a decrease from the prior year, while parts and services revenue increased by 11% to $8.7 million. Net loss for the quarter was $4.0 million, resulting in an adjusted EBITDA of negative $1.0 million. At the end of the quarter, the company held $24.5 million in cash and restricted cash.Industrials
- CUENov 16, 4:52 PMCue Biopharma reported third-quarter 2026 financial results showing a net loss of $50.0 million and revenue of $0.1 million, driven by increased clinical trial costs and non-cash stock-based compensation. The company announced positive Phase 2 results for its lead candidate CUE-221 in chronic spontaneous urticaria, demonstrating superior complete hive resolution compared to placebo and XOLAIR, particularly in patients with high baseline IgE. Additionally, Cue Biopharma initiated first-in-human dosing for CUE-401, a dual-agonist therapeutic candidate designed to treat autoimmune diseases, while its Investigational New Drug application for CUE-221 in food allergy received FDA clearance.Healthcare
- AMCINov 16, 4:42 PMAMC Robotics reported a net loss of $2.02 million for the third quarter of 2026, driven by $2.57 million in operating expenses that included $1.5 million in one-time financing costs. Revenue for the quarter totaled $0.97 million, representing a 35.5% decline year-over-year as the company shifted away from lower-margin product sales toward higher-margin AI and cloud services. The company's gross margin fell to 54.6% due to a $248,597 non-recurring inventory impairment associated with relocating its supply chain to Vietnam. Despite the financial loss, the company remains on track to commission its Phase 1 production line in Vietnam by the end of 2026, with trial production scheduled for early 2027.Technology
- POCINov 16, 4:30 PMPrecision Optics Corporation reported first-quarter fiscal 2027 revenue of $8.2 million, representing a 22% increase from the prior-year period. The company achieved a gross margin of 22.5% and narrowed its net loss to $475,000, or $0.04 per share, compared to a $1.6 million loss in the same quarter last year. Revenue growth was driven by production programs in satellite optical communications and medical devices, including cystoscopes and ophthalmic instruments. The company maintains its full-year fiscal 2027 revenue guidance between $30 million and $33 million.Healthcare
- GPUSNov 16, 4:30 PMHyperscale Data, Inc. announced preliminary third-quarter 2026 revenue of approximately $44.8 million, marking an 84% increase compared to the same period in 2025. This figure exceeds the company's previous estimate of $40 million by roughly 12%. The company plans to host a conference call on November 23, 2026, to discuss these financial results and strategic priorities. Hyperscale Data currently anticipates the divestiture of its subsidiary Ault Capital Group to occur in 2027.Industrials
- POWLNov 16, 4:24 PMPowell Industries reported fourth-quarter fiscal 2026 revenues of $397 million, a 33% increase year-over-year, driven by strong performance in the Oil and Gas and Commercial markets. The company achieved a record full-year revenue of $1.3 billion and net income of $221 million, while new orders surged 124% to $2.6 billion, resulting in a backlog of $2.7 billion. Gross profit margins improved to 34.9% in the quarter and 31.3% for the full year, supported by volume leverage and stable pricing. Additionally, the company secured two mega-orders totaling approximately $335 million in the LNG and data center sectors during the quarter.Industrials
- RSSSNov 16, 4:19 PMResearch Solutions, Inc. reported first-quarter fiscal 2027 results with total revenue of $11.9 million, a decrease from the prior year's $12.3 million. Annual recurring revenue increased 5.7% year-over-year to $22.5 million, driven by an 11.5% growth in B2B ARR to $16.5 million. The company achieved a net income of $765,000, or $0.02 per diluted share, with adjusted EBITDA reaching $1.0 million. Platform revenue accounted for 45% of total revenue, reflecting a strategic shift toward higher-margin recurring business models.Technology
- FIRYNov 16, 4:19 PMFiry Inc. reported third-quarter 2026 revenue of $31.3 million, representing a 14% year-over-year increase driven primarily by its RZR segment, which grew 141% and accounted for the majority of quarterly revenue. The company achieved a net loss of $12.5 million, a narrowing of $4.9 million compared to the prior year, while Adjusted EBITDA excluding litigation expenses improved to a loss of $1.2 million. Firy ended the quarter with $71.0 million in cash and cash equivalents after redeeming $49.7 million of senior secured notes and receiving $55 million from the sale of its Exit Games stake. Management highlighted significant operating leverage, noting that roughly two-thirds of new revenue dollars from RZR converted to Adjusted EBITDA.Communication Services
- NXBNov 16, 4:05 PMNextBoat Inc. reported fiscal third-quarter 2026 revenue of $50.6 million, representing an 110.7% increase from the same period in 2025. The company achieved a gross profit of $8.1 million, driven by significant growth in pre-owned boat sales, new boat sales, and service operations following the acquisition of Apex Marine and Bellhart. Despite the revenue expansion, the company recorded a net loss of $4.6 million for the quarter due to higher operating expenses, including increased salaries, marketing costs, and non-recurring items. For the full year 2026, NextBoat maintains its revenue guidance between $165 million and $170 million.Consumer Cyclical
- BRFHNov 16, 4:05 PMBarfresh Food Group reported third-quarter 2026 revenue of $5.8 million, a 37% increase year-over-year driven by $2.5 million in sales from its Arps Dairy acquisition. The company achieved operating income of $120,000 for the quarter, contrasting with a $260,000 loss in the same period last year, while adjusted EBITDA remained near breakeven at a loss of $15,000. Management updated its full-year 2026 revenue guidance to a range of $20 million to $22 million, down from previous expectations, citing lower-margin milk sales and facility ramp-up costs. Additionally, the USDA extended the grant deadline for the company's new Defiance, Ohio facility to April 30, 2027, and the company is pursuing mortgage financing to complete the project.Consumer Defensive
- EUBGNov 16, 4:05 PMEntrepreneur Universe Bright Group reported revenue of $680,624 for the third quarter of 2026, a decline from $1,217,966 in the same period of 2025. The company recorded a net loss of $221,730 for the quarter, contrasting with a net income of $395,113 in 2025. Over the nine months ended September 30, 2026, revenue totaled $2,164,581 and the company posted a net loss of $178,346. Cash and cash equivalents stood at approximately $8.94 million as of September 30, 2026.
- ACRVNov 16, 4:05 PMAcrivon Therapeutics reported a net loss of $17.9 million for the third quarter of 2026, with cash and investments totaling $77.8 million expected to fund operations through the fourth quarter of 2027. The company established immunology and inflammation as a second strategic pillar, acquiring the Phase 2-ready JAK1 inhibitor ACR-525 for eosinophilic esophagitis and a preclinical PKCθ program. Clinical progress includes late-breaking data on the WEE1/PKMYT1 inhibitor ACR-2316 showing durable responses in lung and endometrial cancers, while the CHK1/2 inhibitor ACR-368 is on track for a prespecified interim analysis in endometrial cancer later this year. Additionally, the CDK11 inhibitor ACR-7280 has been nominated for IND-enabling studies in acute myeloid leukemia.Healthcare
- KYNBNov 16, 4:05 PMKyntra Bio reported a net income of $0.2 million for the third quarter of 2026, driven by a $14 million gain from restructuring a royalty financing agreement that reduced future payment obligations by $60 million. The company decided to discontinue development of its FG-3246 and FG-3180 programs in metastatic castration-resistant prostate cancer following insufficient efficacy, a move expected to save over $20 million in operating expenses during 2027 and 2028. With $44.1 million in cash and equivalents as of September 30, 2026, Kyntra Bio projects a cash runway extending into 2028 while preparing to initiate a pivotal Phase 3 trial for roxadustat in LR-MDS patients in the first quarter of 2027, contingent on securing a strategic partnership or external capital.Healthcare
- PHUNNov 16, 12:15 PMPhunware reported third-quarter 2026 net revenue of $483,000, an 8.3% increase from the prior year, while gross profit rose 61.2% to $274,000 with gross margin expanding to 56.7%. The company advanced its Phunware 2.0 strategy by moving Itinerary Planner into beta and initiating discussions with four major hospitality groups, though it wound down its advertising business to focus on recurring software revenue. Despite these operational shifts, the company recorded a net loss of $7.1 million for the quarter, driven by increased litigation expenses and investments in AI product development and sales initiatives. Phunware concluded the period with $86.7 million in cash and no debt, maintaining financial flexibility to support its growth plan.Technology
- IVFNov 16, 10:30 AMINVO Fertility reported third-quarter 2026 revenue of $2.22 million, representing a 26% increase from the prior year, driven by organic growth at existing clinics and contributions from the Indiana and Birmingham acquisitions. The company achieved positive Clinic-Level Adjusted EBITDA of $292,114 for the seventh consecutive quarter, despite a consolidated net loss of $2.1 million. Financial improvements included a strengthened balance sheet with cash reserves rising to $3.7 million and current liabilities decreasing to $4.5 million from $10.3 million at the end of 2025.Healthcare
- RPIDNov 16, 10:17 AMRapid Micro Biosystems reported third-quarter 2026 total revenue of $9.5 million, reflecting a 22% increase from the same period in 2025. The company achieved a record gross margin of 25%, driven by a 19 percentage point rise in product margins and a 14 percentage point increase in service margins. Net loss for the quarter was $11.3 million, while non-GAAP adjusted EBITDA loss narrowed to $7.9 million from $9.4 million in the prior year. On November 16, 2026, the company announced a definitive agreement to be acquired by Merck KGaA, Darmstadt, Germany, leading to the withdrawal of its full-year 2026 guidance and a delay in filing its Form 10-Q.Healthcare
- UNCYNov 16, 9:28 AMUnicycive Therapeutics announced that the U.S. Food and Drug Administration accepted its New Drug Application resubmission for oxylanthanum carbonate, establishing a Prescription Drug User Fee Act target date of March 25, 2027. The company reported a net loss of $7.0 million for the third quarter ended September 30, 2026, driven primarily by increased commercial launch preparation expenses, while maintaining approximately $59 million in cash and marketable securities with a runway extending beyond 2027. Commercial readiness efforts are advancing through discussions with dialysis organizations and plans to hire a sales force in early 2027, supported by favorable reimbursement changes from the Centers for Medicare & Medicaid Services effective January 2027.Healthcare
- JAGXNov 16, 9:15 AMJaguar Health reported a net loss of $5.8 million for the third quarter of 2026, a significant improvement from the $9.6 million loss in the same period the previous year. The company reduced its outstanding debt balance by $10.1 million during the quarter and recognized $1.8 million in holdback payments from its exclusive U.S. licensing agreement with Future Pak for Mytesi and Canalevia-CA1. Total net revenue for the quarter was $2.3 million, driven primarily by license and grant revenue, while prescription product revenue declined to approximately $0.5 million following the transfer of U.S. commercial rights to Future Pak. Jaguar continues to focus its resources on the development of a powder-for-oral-solution formulation of crofelemer for rare intestinal failure indications, with a New Drug Application filing for microvillus inclusion disease planned for mid-2027.Healthcare
- SWRDNov 16, 9:13 AMStewards, Inc. reported a net loss of $19.4 million for the third quarter of 2026, driven by an $8.5 million noncash charge related to warrant liabilities and lower private credit deployment. The company's total assets increased 49% to $265.3 million following the completion of a $79 million refinancing for 1818 Park and the acquisition of Envy Pompano Beach. Stewards launched a digital customer portal with Plaid integration and announced a partnership with Rain to develop a business card targeted for early 2027 availability. Following the quarter, the company secured a standstill agreement on $31.8 million of notes and amended terms for the Envy acquisition to exchange cash redemption obligations for preferred stock.Financial Services
- NFENov 16, 9:03 AMNew Fortress Energy completed a restructuring and recapitalization on September 11, 2026, reducing its debt principal from approximately $5.7 billion to $0.7 billion. For the third quarter of 2026, the company reported total revenues of $335.8 million and a net income of $863.4 million, which included $1.6 billion in non-cash gains from the debt restructuring. Adjusted EBITDA for the quarter was $48.4 million, driven by higher cargo sales margins and contract novation revenue. Recent developments include a temporary outage of the FLNG 1 facility due to a turbine issue and an agreement to lease ten mobile turbines to improve liquidity.Utilities
- ELOXNov 16, 9:02 AMEloxx Pharmaceuticals reported a net loss of $5.5 million for the third quarter of 2026, driven by increased research and development expenses related to the initiation of its Phase 2b EXACT study for nonsense mutation Alport syndrome. The company dosed its first two patients in this global trial and finalized the protocol for a Phase 2 EXPRESS study targeting nonsense mutation autosomal dominant polycystic kidney disease, with the first patient expected to be dosed in the third quarter of 2027. As of September 30, 2026, Eloxx held $56.3 million in cash and cash equivalents, which management believes will fund operations into 2028. Additionally, the company expanded its leadership team by appointing T.R. Srinivas as Senior Vice President and Chief Medical Officer and added Geno Germano to its Board of Directors.Healthcare
- TOONNov 16, 9:00 AMKartoon Studios reported a net loss of $5.7 million for the third quarter of 2026, with total revenue declining to $5.4 million due to reduced production services activity and the sale of the Frederator channel network business. The company maintains $33.0 million in cash and marketable securities while advancing its strategy to commercialize the Hundred Acre Wood intellectual property through new agreements with Walmart Marketplace and Amazon Prime. Scheduled launches include consumer products on Walmart in January 2027 and a streaming series on Amazon Prime in February 2027, with broader streaming and consumer product initiatives expected to begin in the first quarter of 2027. Additionally, the company strengthened audience engagement on its owned platforms, Kartoon Channel! and Ameba, where total viewing hours more than doubled year-over-year.Communication Services
- GXONov 16, 8:57 AMGXO Logistics announced 2030 financial targets aiming for greater than 7% organic revenue CAGR, a greater than 6.5% adjusted EBITA margin, and a 40% to 50% free cash flow conversion rate on adjusted EBITDA. The company also provided a preliminary 2027 outlook projecting above 5.5% organic revenue growth, a greater than 7.1% adjusted EBITDA margin, and above 4.5% adjusted EBITA margin. These targets reflect the company's strategy to lead in AI-powered logistics while building a diversified business model. The announcement was made during the 2026 Investor Day held at the New York Stock Exchange.Industrials
- AIMDNov 16, 8:41 AMAinos, Inc. reported third-quarter 2026 revenue of $642,889, representing a 29,567% increase year over year, driven by VELDONA licensing and AI Nose semiconductor programs. The company delivered 1,400 AI Nose systems under an initial agreement and subsequently secured a $9 million follow-on order for 5,000 additional units with a $4.5 million initial payment due within 60 days. GAAP net loss narrowed by 36% to $1.89 million, while non-GAAP adjusted net loss improved by 51% to $672,352. Additionally, the company surpassed 3 billion real-world chemical data points and expects recurring quarterly revenue of $175,000 starting in the fourth quarter from its AI Nose service agreements.Technology
- CNTNNov 16, 8:35 AMCanton Strategic Holdings, Inc. reported total revenue of $3.05 million for the third quarter of 2026, representing a 104% increase from the previous quarter. The company achieved its first positive Adjusted EBITDA of $610,414, driven by $1.5 million in network validation revenue and $1.5 million in other revenue primarily from its locking-as-a-service offering. During the quarter, the company's active Super Validator weight increased to 6.5, and it held 3.83 billion units of Canton Coin with a fair value of $482.1 million. Despite the revenue growth, the company recorded a net loss of $35.1 million, largely due to a $54.6 million unrealized loss on its digital asset holdings.Healthcare
- USDENov 16, 8:35 AMStablecoinX reported third-quarter 2026 revenue of $477,993, representing a 666% sequential increase driven by its Decentralized Verifier Node infrastructure services. The company's ENA treasury of 3.0 billion tokens, valued at approximately $802 million based on September 30 prices, was fully unlocked following a waiver of lock-up restrictions. While the company posted a GAAP net loss of $100.2 million largely due to non-cash losses on warrant liabilities, its adjusted net loss was $1.9 million. Additionally, the DVN surpassed $6 billion in cumulative verified cross-chain volume, and the firm appointed Christopher Jensen as its new Chief Executive Officer.Financial Services
- APVONov 16, 8:35 AMAptevo Therapeutics reported that its lead candidate mipletamig achieved a 79% remission rate in patients with high-risk TP53-mutated acute myeloid leukemia, a figure nearly double the historical benchmark for similar patients treated with standard therapies. Ten of 47 patients receiving the mipletamig combination therapy advanced to potentially curative stem cell transplantation, while refinements to the drug's priming-dose regimen significantly reduced infusion-related reactions. The company also secured $4.5 million in additional financing to support clinical milestones and advanced its next-generation trispecific candidates toward human testing in solid tumors.Healthcare
- IPDNNov 16, 8:32 AMProfessional Diversity Network, Inc. reported a 48.2% decline in third-quarter 2026 revenues to approximately $856,000, driven by reduced demand in its recruitment and software development segments. The company posted a net loss from continuing operations of $2.652 million for the quarter, an increase from the prior year period, largely due to $1.189 million in amortization expenses for acquired musical copyrights. Despite the revenue drop, the firm improved its working capital position to $0.2 million and significantly reduced general and administrative expenses by 47.2% through workforce restructuring and reduced consulting costs. Additionally, the company launched PDN Intelligence, Inc. to explore opportunities in AI infrastructure and GPU-based computing services, though no revenue was generated from this initiative during the quarter.Industrials
- HCWBNov 16, 8:30 AMHCW Biologics reported a net loss of $3.2 million for the three months ended September 30, 2026, and $5.0 million for the nine-month period, driven by research and development expenses of $1.2 million and $3.7 million respectively. The company secured $8.6 million in equity financing and $3.0 million in debt financing during the first nine months of 2026 to support its Phase 1 clinical trial for HCW9302 in alopecia areata and preclinical programs. Clinical progress includes the activation of an additional site for the HCW9302 study and FDA guidance to file an IND application for the solid tumor candidate HCW11-018b in the first half of 2027. Despite these advancements, the company disclosed substantial doubt regarding its ability to continue as a going concern for the next 12 months without additional funding.Healthcare
- DWSNNov 16, 8:13 AMDawson Geophysical Company reported a net loss of $5.2 million, or $0.17 per share, for the third quarter of 2026, driven by a 27% decline in fee revenue to $10.8 million and negative Adjusted EBITDA of $2 million. Despite the quarterly setback, year-to-date results through September 30, 2026, showed a 47% increase in fee revenue to $57.4 million and a 580% surge in Adjusted EBITDA to $9.5 million compared to the prior year period. The company cited delays in large channel crew jobs due to permitting issues as a factor in the third quarter, while noting a renewed demand for high-density seismic services in North America and the upcoming launch of geothermal data acquisition. Management projects continued revenue growth and improved margins for 2027, supported by a strengthened backlog and expanded operations in both the United States and Canada.Energy
- VERINov 16, 8:12 AMVeritone reported third-quarter 2026 revenue of $18.6 million, a 30.1% decrease from the prior year, while achieving an Annual Recurring Revenue of $55.9 million. The company completed an exchange of $38.7 million in convertible notes for new notes and 1.6 million shares of common stock, with the remaining $6.8 million of old notes scheduled for payment in November 2026. Additionally, Veritone secured a commitment letter for a $40 million senior secured term loan from Blue Torch Capital, contingent on raising an additional $25 million in financing. The company has implemented restructuring efforts resulting in over $18 million in annualized cost reductions and targets further reductions of $2 million to $7 million by the end of 2026.Technology
- ALXONov 16, 8:10 AMALX Oncology reported a net loss of $21.8 million for the third quarter ended September 30, 2026, with cash, cash equivalents, and investments totaling $147.2 million sufficient to fund operations through the first half of 2028. The company announced the publication of Phase 2 ASPEN-06 trial data in Nature Medicine, which showed encouraging efficacy for evorpacept in HER2-positive gastric cancers, while enrollment for the Phase 2 ASPEN-09-Breast trial remains on track with topline data expected in the second half of 2027. Additionally, ALX Oncology plans to release safety and early efficacy data from the Phase 1 dose-escalation study of its EGFR-targeted ADC, ALX2004, in December 2026.Healthcare
- IAMNov 16, 8:08 AMIambic Therapeutics launched Enchant v3, a 41-billion-parameter AI model for drug discovery, and secured new collaborations with AbbVie and Bayer, bringing its total partnership count to eight since 2024. The company reported third-quarter 2026 collaboration revenue of $11.4 million and achieved a $1.0 million milestone payment from its Takeda partnership. Clinically, updated data for the lead candidate IAM1363 showed 36% systemic and 41% intracranial response rates in heavily pretreated patients, with a registrational trial planned for 2027. Additionally, Iambic submitted an IND for its second candidate, IAM217, and expects to file for IAM-C1 in the fourth quarter of 2026, while maintaining a cash position of $252 million as of September 30, 2026.Healthcare
- IBATFNov 16, 8:05 AMInternational Battery Metals Ltd. reported a net income of $2.2 million for the second quarter of fiscal 2027, ending September 30, 2026, driven primarily by a $5.0 million gain from the change in fair value of warrant liability. Revenue for the quarter was zero, a decrease from $64,000 in the prior year period, as the company focused on engineering a compact pilot plant for direct lithium extraction. The company plans to secure a secured term loan of up to $12.0 million to fund the pilot plant construction and cover general administrative expenses over the next 12 months. Additionally, the company continues to evaluate commercial opportunities in North America, South America, and the Middle East while providing brine testing services to prospective customers.
- APMDNov 16, 8:04 AMApnimed reported a net loss of $29.5 million for the third quarter ended September 30, 2026, driven by increased general and administrative expenses related to commercial launch preparations. The company holds $351.8 million in cash and cash equivalents, which is expected to fund operations and a potential U.S. launch into the second quarter of 2028. Its New Drug Application for AD109, proposed as Oxnimbi, remains under FDA review with a PDUFA goal date of February 28, 2027. Additionally, Apnimed presented five abstracts at the CHEST 2026 Annual Meeting, including two late-breakers highlighting Phase 3 clinical data for the drug.Healthcare
- NMRANov 16, 8:03 AMNeumora Therapeutics submitted an Investigational New Drug application for its NLRP3 inhibitor, NMRA-215, to treat obesity and cardiometabolic disease. The company reported dose-proportional increases in exposure for NMRA-511 at a 30 mg BID dose in healthy elderly participants, indicating potential to enhance the efficacy observed in previous Phase 1b studies. For the third quarter ended September 30, 2026, Neumora reported a net loss of $34.4 million and ended the period with $85.7 million in cash and cash equivalents.Healthcare
- ADGMNov 16, 8:02 AMAdagio Medical Holdings reported a net income of $17.8 million for the third quarter of 2026, driven primarily by a $23.0 million noncash gain from the change in fair value of its convertible notes. The company treated 22 patients with its vCLAS Ultra System in the United States and Canada, including 19 in the FULCRUM-VT IDE sub-study, while initiating a formal process to explore strategic alternatives. Research and development expenses decreased to $1.8 million, and selling, general, and administrative expenses fell to $2.6 million compared to the prior year period. On November 6, 2026, the company completed a one-for-thirty reverse stock split to regain compliance with Nasdaq's minimum bid price requirement.Healthcare
- VENUNov 16, 8:00 AMVenu Holding Corporation reported total assets of $587.6 million as of September 30, 2026, representing a 59% increase from the prior year-end. The company generated $14.1 million in revenue for the nine-month period ended September 30, 2026, while reporting a net loss attributable to common stockholders of $44.6 million. Construction progress advanced significantly on the Regent Bank Amphitheater and Sunset Amphitheater McKinney, with the latter reaching 95% sales on premium seating prior to its opening. Subsequent to the quarter, the company secured $67.5 million in sale-leaseback transactions and announced the opening of the Regent Bank Amphitheater for New Year's Eve 2026.Consumer Cyclical
- POWWNov 16, 8:00 AMOutdoor Holding Company reported second-quarter fiscal 2027 net revenues of $13.7 million, representing a 14.6% increase from the prior-year period, while net income from continuing operations rose to $2.3 million. The company achieved an Adjusted EBITDA of $6.1 million and grew its gross merchandise value by 10.3% to approximately $208.4 million, driven by a 4.8% increase in firearm unit sales that outpaced the broader market. Operational highlights include a 25 basis point year-over-year increase in take rate to 6.59% and the completion of the company's redomestication from Delaware to Texas. Additionally, the Board increased the share repurchase authorization by $20.0 million, and the company ended the quarter with $70.4 million in cash and cash equivalents.Industrials
- JSPRNov 16, 8:00 AMJasper Therapeutics reported third-quarter 2026 financial results showing $135.3 million in cash and cash equivalents alongside a net loss of $144.5 million for the quarter. The company advanced its clinical pipeline by completing enrollment in the first cohort of a Phase 2 renal basket study for vensobafusp alfa in IgA nephropathy and initiating enrollment for patients with IC-MPGN. Recent corporate developments include the July 2026 acquisition of Kira Pharmaceuticals, a $132 million private placement, and a 1-for-30 reverse stock split effected in November 2026.Healthcare
- GALTNov 16, 7:55 AMGalectin Therapeutics reported a net loss of $3.6 million for the quarter ended September 30, 2026, driven by $1.6 million in research and development expenses and $1.8 million in general and administrative expenses. The company submitted its registrational Phase 3 protocol for belapectin to the FDA in the third quarter following alignment on the trial design for advanced MASH cirrhosis. Significant corporate developments included the conversion of approximately $105.8 million in debt held by Chairman Richard E. Uihlein into over 34 million shares of common stock. As of September 30, 2026, the company held $11.7 million in cash and cash equivalents, with sufficient funds to support operations through June 2027.Healthcare
- LNZANov 16, 7:52 AMLanzaTech reported a net loss of $178.0 million for the third quarter of 2026, primarily driven by a $166.4 million non-cash unrealized fair value loss on its investment in SGLT. Despite the net loss, the company achieved significant operational progress, including the world's first ISCC EU certification for recycled carbon fuels from steel mill waste gases at its Hebei Shoulang facility. Operating expenses decreased by 35% to $11.7 million compared to the prior year, reflecting successful cost reduction initiatives and a reset cost structure. The company also raised $50.0 million through common stock issuance in the first nine months of 2026, increasing its cash and restricted cash balance to $36.3 million as of September 30, 2026.Industrials
- MNTKNov 16, 7:45 AMMontauk Renewables reported third-quarter 2026 revenues of $50.2 million, a 10.9% increase year-over-year, driven primarily by higher environmental attribute revenues from RINs sold. Net income for the quarter was $2.1 million, a 58.9% decline from the prior year, while non-GAAP Adjusted EBITDA decreased 20.6% to $10.2 million. The company executed a non-binding term sheet to amend its New Senior Credit Facility, securing additional borrowing capacity and covenant forbearance, which removed the previously anticipated going concern qualification from its financial statements. Full-year 2026 RNG revenue is now projected to range between $175 million and $180 million, reflecting a reduction in expected environmental attribute pricing.Utilities
- CREXNov 16, 7:45 AMCreative Realities reported fiscal third-quarter 2026 revenue of $26.2 million, a significant increase from $10.5 million in the prior-year period, driven by hardware and service growth including operations from its Cineplex Digital Media subsidiary. The company achieved an adjusted EBITDA of $2.7 million and ended the quarter with annualized recurring revenue of approximately $21.7 million. Key business developments include the completion of digital media upgrades for over 1,000 Zaxby's locations and the deployment of its AdTech technology at more than 500 Albertsons stores. Despite a net loss of $3.6 million for the quarter, the company reduced its outstanding debt to approximately $40 million and anticipates exceeding $100 million in revenue for the full fiscal year 2026.Technology
- TSNNov 16, 7:41 AMTyson Foods reported fiscal 2026 sales of $56.4 billion, a 3.6% increase from the prior year, driven by growth in prepared foods and chicken segments. The company recorded GAAP operating income of $1.1 billion and adjusted operating income of $1.98 billion, while adjusted earnings per share declined 17% to $3.44 due to legal contingency accruals and restructuring charges. For fiscal 2027, Tyson anticipates sales to decrease between 3.5% and 5.5% primarily due to lower beef volumes, with projected adjusted operating income ranging from $1.7 billion to $2.15 billion. The company also announced an increase in its quarterly dividend to $0.52 per share for Class A stock and $0.468 for Class B stock, effective November 2026.Consumer Defensive
- EDBLNov 16, 7:35 AMEdible Garden AG reported third-quarter 2026 revenue of $3.2 million, a 14% increase driven by a 65.7% surge in cut herb sales. Gross profit rose 181.7% to $0.8 million, expanding the gross margin to 23.9% from 9.7% in the prior year period. The company secured a major private-label ready-to-drink protein beverage award and expanded its retail distribution network with new agreements at Walmart and UNFI. Additionally, a strategic supply agreement with Caney Fork Farms is expected to reduce production costs by over 12% once fully implemented in 2027.Consumer Defensive
- VIDANov 16, 7:35 AMVida Global Inc. reported third-quarter 2026 total revenue of $0.33 million, an 88% increase from the prior year period, driven by growth in subscription and usage-based fees. The company achieved a gross margin of 44% and recorded a net loss of $1.47 million, while its cash, cash equivalents, and short-term investments rose to $12.7 million. Operationally, Vida's computer agents exited beta to perform tasks beyond conversations, resulting in nearly 1,400 active AI employees and over one million call minutes handled during the quarter. Following the quarter, the company introduced outcome-based billing in October and launched an MCP server in November to facilitate AI employee deployment through existing business assistants.Technology
- MBRXNov 16, 7:30 AMMoleculin Biotech completed treatment for all 90 patients in Part A of its pivotal MIRACLE trial evaluating Annamycin for relapsed or refractory acute myeloid leukemia, with comprehensive data expected in the first quarter of 2027. A peer-reviewed analysis of 90 patients across five clinical trials found no evidence of clinical or subclinical cardiotoxicity, supporting the drug's differentiated safety profile. The company reported a net loss of approximately $6.5 million for the third quarter of 2026, driven primarily by research and development expenses related to the MIRACLE trial. Additionally, new preclinical data suggest Annamycin may convert immunologically cold pancreatic tumors to hot, supporting potential combination therapies.Healthcare
- MPLTNov 16, 7:20 AMMapLight Therapeutics reported a net loss of $51.6 million for the third quarter of 2026, with cash, cash equivalents, and investments totaling $463.4 million as of September 30, 2026. The company has initiated start-up activities for the ZEPHYR-2 Phase 3 trial of its lead candidate ML-007C-MA in schizophrenia, with topline results expected in the second half of 2027. Enrollment is ongoing for the Phase 2 VISTA trial of ML-007C-MA in Alzheimer's disease psychosis, where the drug holds FDA Fast Track designation and top-line results are anticipated in 2028. Additionally, the company plans to engage with the FDA regarding the registrational path for ML-004 in autism spectrum disorder following positive Phase 2 IRIS trial data.Healthcare
- XTNDNov 16, 7:19 AMXTEND AI Robotics reported third-quarter 2026 revenue of $14.9 million, representing a 281% year-over-year increase driven by its AI Robotics segment. The company secured a fully funded backlog of $84.7 million as of September 30, 2026, which grew to $100.7 million by mid-November following a $40.5 million order for 6,000 STRIKER systems. Although the company posted a net loss of $44.6 million for the quarter due to significant operating expenses and stock-based compensation, it ended the period with $66.7 million in cash and cash equivalents. Operational milestones included the completion of a business combination with JFB Construction Holdings and the advancement of multiple defense programs in the U.S., EMEA, and Asia-Pacific regions.Technology
- LRMRNov 16, 7:17 AMLarimar Therapeutics completed a rolling Biologics License Application submission seeking accelerated approval for nomlabofusp to treat Friedreich's ataxia, utilizing skin frataxin as a potential novel surrogate endpoint. The company reported a net loss of $31.1 million for the third quarter of 2026, a decrease from $47.7 million in the same period the prior year, driven largely by reduced drug manufacturing expenses. As of September 30, 2026, Larimar held $128.7 million in cash and marketable securities, projecting a runway into late Q2 2027. The company is currently enrolling patients in the global confirmatory Phase 3 FORWARD-FA study and targets a potential U.S. launch in the third quarter of 2027 if the application is approved.Healthcare
- PRLDNov 16, 7:09 AMPrelude Therapeutics reported a net loss of $12.5 million for the third quarter ended September 30, 2026, with cash and equivalents totaling $142.7 million, extending its runway into the second quarter of 2028. The company initiated enrollment in a Phase 1 study for PRT13722, a selective KAT6A degrader for HR+ breast cancer, and entered a collaboration with Eli Lilly to evaluate this candidate in combination with abemaciclib and imlunestrant. Concurrently, enrollment continues for PRT12396, a mutant-selective JAK2V617F inhibitor for polycythemia vera and myelofibrosis, while preclinical data for an mCALR-targeted degrader antibody conjugate was accepted for presentation at the ASH 68th Annual Meeting.Healthcare
- IVVDNov 16, 7:08 AMInvivyd reported third-quarter 2026 net product revenue of $15.4 million for PEMGARDA, an 18% increase from the prior year period. The company announced positive topline results from its LIBERTY Phase 3 trial, demonstrating that VYD2311 has superior safety and tolerability compared to an mRNA COVID-19 vaccine without interfering with vaccine-induced antibodies. Additionally, Invivyd initiated the FLINTLOCK Phase 2 trial to evaluate VYD2311 for Long COVID and Post-Vaccination Syndrome while preparing for an imminent interim analysis of the DECLARATION Phase 3 trial data. Financially, the company recorded a net loss of $33.5 million for the quarter and ended with $126.4 million in cash and cash equivalents.Healthcare
- CYPHNov 16, 7:05 AMCypherpunk Technologies reported a net income of $306.0 million for the third quarter of 2026, driven primarily by a $330.8 million unrealized gain on an embedded derivative linked to the rise in Zcash prices. The company launched its mining operations in August 2026, generating $9.9 million in revenue from 8,967.29 ZEC mined with 95% uptime. As of November 2026, the company's ZEC treasury holdings increased to 341,858.75 ZEC, representing approximately 2.01% of the circulating supply. Additionally, the company appointed Amanda Fabiano to its Board of Directors and is evaluating strategic options for its Leap Therapeutics subsidiary to advance its Phase 3 clinical trials.Healthcare
- XTNTNov 16, 7:05 AMXtant Medical Holdings reported third-quarter 2026 total revenue of $24.3 million, a decrease from $33.3 million in the same period of 2025, primarily due to the absence of revenue from divested businesses and wound care licensing. The company posted a net loss of $3.6 million for the quarter, while biologics revenue grew 13% year-over-year to $19.3 million. The Board of Directors has initiated a strategic review to evaluate various operational and financial alternatives aimed at maximizing stockholder value. Consequently, the company has withdrawn its full-year 2026 financial guidance and will not host a conference call to discuss these results.Healthcare
- AIRJNov 16, 7:05 AMAirJoule Technologies completed its acquisition of BitSink on September 10, 2026, adding modular data center infrastructure capabilities and $15 million in signed purchase orders. The company delivered its first AirJoule Prime system to the Data4 data center in France and initiated pilot projects with Kubota Corporation for residential water generation. Financial results for the third quarter of 2026 showed a net loss of $19.8 million, while the company provided a preliminary 2027 revenue outlook for BitSink ranging from $15 million to $20 million. Additionally, Timothy N. White joined the Board of Directors to support the company's engineering and manufacturing expansion.Industrials
- MTRINov 16, 7:03 AMMentari Therapeutics, Inc. reported a net loss of $63.0 million for the nine months ended September 30, 2026, driven primarily by $57.7 million in research and development expenses. The company maintained $45.8 million in cash and cash equivalents as of September 30, 2026, while holding significant liabilities including a $50.0 million convertible note payable to a related party. On November 6, 2026, the company completed a merger with InMed Pharmaceuticals, resulting in a combined entity focused on migraine prevention therapies. This transaction was preceded by a $490.0 million pre-closing financing that provided additional capital for the company's development programs.Healthcare
- LXEONov 16, 7:02 AMLexeo Therapeutics reported positive interim Phase I/II data for its gene therapy candidate LX2020 in patients with PKP2 arrhythmogenic cardiomyopathy, showing an 80% mean reduction in non-sustained ventricular tachycardia and a 44% reduction in premature ventricular contractions in high-dose cohorts. The treatment was generally well tolerated across ten participants, with no clinically significant complement activation observed, prompting the company to design a pivotal study using non-sustained ventricular tachycardia as a primary surrogate endpoint for potential accelerated approval. The U.S. Food and Drug Administration has indicated openness to this endpoint strategy, with the company expecting to initiate the pivotal study in the second half of 2027. Financially, the company reported a net loss of $38.3 million for the third quarter of 2026 and holds $219.1 million in cash and investments, providing an operational runway into 2028.Healthcare
- ELWTNov 16, 7:00 AMElauwit Connection reported a 104% sequential increase in total revenue to $5.6 million for the third quarter of 2026, driven by a 140% year-over-year rise in billed units to 25,746. Monthly recurring revenue grew 66% year-over-year to $539,000, while the backlog of new installations and recurring services reached $53.5 million as of September 30. The company implemented cost reductions that lowered operating expenses by approximately $0.3 million in the quarter and increased its cash and cash equivalents to $2.7 million. Despite these operational gains, the company reported a net loss of $2.58 million for the quarter and maintains an accumulated deficit of $22.6 million.Communication Services
- TILNov 16, 7:00 AMInstil Bio reported a net loss of $4.2 million for the third quarter of 2026 and $13.0 million for the first nine months of the year. As of September 30, 2026, the company held approximately $67.1 million in cash and investments, which is expected to fund operations through 2027. Research and development expenses decreased significantly to $0.2 million for the quarter and $1.2 million for the nine-month period compared to prior year figures. The company also corrected immaterial errors in previously issued financial statements related to property taxes and tenant reimbursements.Healthcare
- VYCONov 16, 6:58 AMVycor Medical, Inc. reported revenue of $414,895 for the three months ended September 30, 2026, representing an 18% decrease compared to the same period in 2025. For the nine-month period, total revenue was $1,291,699, an 11% decline from the prior year, driven primarily by lower sales in the Vycor Medical division which produced the ViewSite Brain Access System. The company recorded a GAAP net loss of $161,447 for the quarter and $325,812 for the nine months, while non-GAAP operating profit improved to $43,011 for the quarter and $125,751 for the nine months. Additionally, four new peer-reviewed studies on the ViewSite system were published during 2026, bringing the total number of clinical papers to 54.
- BXDCNov 16, 6:46 AMBlackstone Digital Infrastructure Trust reported third-quarter 2026 net income of $15.6 million, or $0.15 per share, with Funds from Operations and Adjusted Funds from Operations per share at $0.15 and $0.17 respectively. The company executed its inaugural investment through a sale-leaseback transaction involving thirteen newly constructed data centers across two campuses leased to Amazon. This strategic move expands the firm's total addressable market by doubling the hyperscaler sale-leaseback channel and establishes a foundation for long-term shareholder value. The trust, externally managed by an affiliate of Blackstone, focuses on acquiring stabilized, income-generating data center assets leased to investment-grade tenants.Real Estate
- ARMKNov 16, 6:31 AMAramark reported record fiscal 2026 results with consolidated revenue reaching $20.1 billion, representing a 9% year-over-year increase and 10% organic growth. The company achieved an adjusted operating income of $1.1 billion and adjusted earnings per share of $2.23, driven by strong new business wins and improved supply chain efficiencies. Following these results, Aramark's Board authorized a new $1 billion share repurchase program and increased the quarterly dividend by 17%. The company also reduced its net debt by $225 million, lowering its leverage ratio to 2.7x.Industrials
- ODYSNov 16, 6:20 AMOdysight.ai reported revenues of $0.9 million for the nine months ended September 30, 2026, representing a 29% increase in its aerospace domain compared to the prior year period. The company holds a backlog of $16 million as of September 30, 2026, and maintains a cash balance of approximately $23.2 million with no financial debt, projecting sufficient funds to operate through the second quarter of 2028. Operating expenses for the period totaled $14.6 million, resulting in a net loss of approximately $13.7 million. Recent commercial milestones include the signing of a Memorandum of Agreement with Boeing, a Cooperative Research and Development Agreement with the U.S. Navy, and the launch of a pilot program with the NTA Metropolitan Mass Transit System.Technology
- QINDNov 16, 6:15 AMQuality Industrial Corp. reported third-quarter 2026 revenue of $3.64 million, a 3.6% increase from the prior year, driven by higher sales volumes as customers returned to the UAE. The company achieved operating income of $39,978, a significant turnaround from an operating loss of $285,805 in the same period last year, while net loss narrowed to $31,512. For the nine months ended September 30, 2026, consolidated net income was $166,638 compared to a net loss of $1.24 million in 2025, largely due to the non-recurrence of a $1.02 million discretionary management bonus. Operational highlights include a contracted engineering portfolio valued at approximately $5.2 million and the expansion of the LPG distribution fleet to 53 vehicles. Management anticipates higher revenue in the fourth quarter of 2026 following the resolution of project pricing inefficiencies and the seasonal strength of the period.
- XXIINov 16, 6:02 AM22nd Century Group reported third-quarter 2026 net revenues of $4.8 million, representing a 66% sequential increase, while turning gross profit positive at $0.4 million. The company achieved a 166% growth in point-of-sale pack sales for its Pinnacle VLN products and expanded its retail footprint by shipping to approximately 150 additional stores in the New York and New Jersey areas. Following the quarter, the company raised $5.8 million through an at-the-market offering and used $1.2 million to redeem Series B convertible preferred stock, resulting in no outstanding warrants. Despite these operational improvements, the company reported a net loss from continuing operations of $2.6 million for the period.Consumer Defensive
- SLXNNov 16, 6:01 AMSilexion Therapeutics dosed the first patient in its Phase 2/3 clinical trial for SIL204 in locally advanced pancreatic cancer at Tel Aviv Sourasky Medical Center in September 2026. The company reported a net loss of $2.5 million for the third quarter of 2026, while cash and cash equivalents increased to $4.8 million following recent financing activities. New translational data indicates that SIL204 utilizes a coordinated immune-sensitization signature across four KRAS mutations and employs a native lipoprotein-mediated uptake mechanism. Additionally, the company announced a 1-for-24 reverse share split effective November 10, 2026, and is expanding clinical trial sites in Israel and Germany.Healthcare
- TPSTNov 13, 5:27 PMTempest Therapeutics reported a net loss of $3.6 million for the third quarter of 2026, with cash and cash equivalents declining to $0.9 million from $7.7 million at the end of 2025. The company secured exclusive licensing rights to Senlang's CD7-targeted lentiviral in vivo CAR-T platform and its lead candidate TPST-4903, while also advancing its next-generation candidate TPST-4003. To support operations, Tempest completed a private placement raising approximately $2.5 million and entered into an equity line of credit with Lincoln Park Capital Fund for up to $50.0 million. Additionally, the Board of Directors was strengthened by the appointments of Nancy Freda-Smith and John W. Frederick, though the company noted substantial doubt regarding its ability to continue as a going concern due to limited cash reserves.Healthcare
- BYSINov 13, 5:27 PMBeyondSpring Inc. reported a net loss of $2.1 million for the third quarter ended September 30, 2026, driven by increased research and development and general and administrative expenses. The company received FDA Fast Track designation for its lead candidate Plinabulin combined with docetaxel in patients with post-immunotherapy non-squamous non-small cell lung cancer lacking actionable genomic alterations. A strategic transaction with Biolin Investment Limited was completed to fund approximately half of the DUBLIN-4 Phase 3 trial's patient enrollment in China, providing BeyondSpring with access to the resulting clinical data. As of September 30, 2026, the company held $0.6 million in cash, cash equivalents, and short-term investments.Healthcare
- BCICNov 13, 5:26 PMBCP Investment Corporation reported third-quarter 2026 net investment income of $4.6 million, or $0.37 per share, with a net asset value of $162.7 million as of September 30, 2026. The company announced a merger agreement to acquire Investcorp Credit Management BDC, Inc. at 90% of ICMB's closing net asset value, a transaction expected to be accretive to shareholders. Non-accrual debt investments declined to 10, representing 2.8% of the portfolio at fair value, while the company increased its KeyBank Credit Facility capacity to $150 million and issued $10 million in additional notes due 2029. Additionally, BCP declared monthly base distributions of $0.09 per share for January, February, and March 2027.Financial Services
- CINGNov 13, 5:19 PMCingulate Inc. reported a net loss of $7.7 million for the third quarter of 2026, driven primarily by increased selling, general, and administrative expenses related to commercial readiness. The company has substantially completed manufacturing work to address FDA requests for its CTx-1301 ADHD drug application and expects to resubmit the new drug application between December 2026 and January 2027. As of September 30, 2026, Cingulate held approximately $23.2 million in cash and cash equivalents, which is projected to fund operations through mid-2027.Healthcare
- CTNTNov 13, 5:16 PMCheetah Net Supply Chain Service Inc. reported total revenue of $3.56 million for the third quarter of 2026, an 883% increase from the prior year period, driven primarily by its international trading segment following the May 2026 acquisition of Super International Trading Limited. The company recorded a net loss from continuing operations of $2.55 million for the quarter, a 93.8% increase compared to the same period in 2025, largely due to a $2.78 million loss from changes in the fair value of acquisition-related contingent consideration. For the nine months ended September 30, 2026, the company posted a net loss of $3.09 million while maintaining a cash and cash equivalent balance of approximately $14.5 million and a working capital balance of $87.1 million.Consumer Cyclical
- WFCFNov 13, 5:14 PMWhere Food Comes From, Inc. reported third-quarter 2026 total revenue of $7.3 million, a 4% increase from the prior year, driven by a 6% rise in verification and certification services to $5.9 million. Gross margins improved to 42.1% from 38.3% in the same period last year, resulting in operating income of $1.0 million, a 68% year-over-year increase. Net income for the quarter was $825,000, or $0.17 per diluted share, compared to $1.1 million in the prior year, as the previous period included a $946,000 gain on the sale of assets. Over the nine-month period ended September 30, 2026, the company generated $2.8 million in cash from operations and returned $268,000 to shareholders through stock buybacks.Technology
- BBGINov 13, 5:06 PMBeasley Broadcast Group reported third-quarter 2026 net revenue of $42.8 million, a 16.1% decrease from the prior year period, driven by weakness in traditional advertising markets. The company posted a net loss of $12.1 million for the quarter, though it achieved a 32% operating margin in its digital segment, up from 21% in the previous year. To strengthen its balance sheet, the company raised $4.6 million through equity offerings and subsequently sold two radio stations and two real estate parcels for over $10 million. Structural cost reductions helped limit the decline in operating expenses, while same-station digital revenue increased 4.4% on a year-to-date basis.Communication Services
- HITNov 13, 5:05 PMHealth In Tech reported a net loss of $7.1 million for the third quarter of 2026, driven by a $5.3 million provision for credit losses, compared to a net income of $0.5 million in the same period the prior year. The company's contracted revenue totaled $32.7 million for the first nine months of 2026, while pipeline revenue reached $156.4 million as of October 30, 2026. Distribution partners grew 15.9% year over year to 984, and the company revised its full-year 2026 revenue outlook to approximately $30 million. Sanjay Shrestha assumed the role of Chief Executive Officer in October 2026 to lead commercial execution and strategic growth initiatives.Technology
- XAIRNov 13, 5:00 PMBeyond Air reported a record quarterly revenue of $2.3 million for the period ended September 30, 2026, marking a 28% year-over-year increase. The company reaffirmed its full-year 2026 revenue guidance of $8 million and its 2027 guidance of $16 million to $18 million, contingent on FDA approval for its second-generation LungFit PH system. During the quarter, the company incurred a net loss of $7.8 million, or $3.76 per share, while maintaining $18.5 million in cash and equivalents. Additionally, Beyond Air announced the sale of its controlling interest in NeuroNOS Israel Ltd. and received FDA Breakthrough Device Designation for its LungFit GO product.Healthcare
- EVFMNov 13, 4:59 PMEvofem Biosciences reported net sales of $4.6 million for the third quarter of 2026, a decrease from $5.0 million in the prior year period, primarily due to lower ex-factory sales of PHEXX. The company generated $0.7 million in operating income and $0.9 million in net income attributable to common stockholders for the quarter, contrasting with a net loss in the same period of 2025. Strategic milestones achieved since July 2026 include contracting a second manufacturer for PHEXX production, shipping the 500,000th box of PHEXX, and adding a fifth site to an NIH-funded Phase 4 clinical trial for SOLOSEC. As of September 30, 2026, restricted cash and cash equivalents stood at $0.3 million, reflecting the company's ongoing liquidity position.Healthcare
- SRGNov 13, 4:51 PMSeritage Growth Properties reported a net loss of $36.2 million for the nine months ended September 30, 2026, driven by a $15.2 million impairment charge on a consolidated property and a $5.2 million impairment on an unconsolidated entity. During the third quarter, the company generated $3.0 million in gross proceeds from asset sales and received $8.9 million in distributions from an unconsolidated entity. As of September 30, 2026, the company held $45.4 million in cash and had $10.0 million available under its new revolving loan facility, which was established in July 2026 to refinance a prior term loan. The company's portfolio consists of eight properties with a total of approximately 0.7 million square feet of gross leasable area and 133 acres of land.Real Estate
- CNSYNov 13, 4:51 PMCerenome, Inc. reported third-quarter 2026 financial results showing $0.7 million in net diagnostic revenue and an operating loss of $7.5 million. The company expanded its payer coverage to approximately 190 million lives and launched CNSide molecular profiling tests for solid tumors and hematologic malignancies in October. Clinically, enrollment was completed in the Phase 2 ReSPECT-GBM trial for recurrent glioblastoma, while interim data from the ReSPECT-LM multi-dose study demonstrated safety with no dose-limiting toxicities. As of September 30, 2026, the company held $4.9 million in cash and investments, having recently secured a senior secured financing facility and raised additional equity.Healthcare
- NYCNov 13, 4:49 PMAmerican Strategic Investment Co. reported a net loss of $6.7 million for the third quarter of 2026, a significant decline from the $35.8 million net income recorded in the same period of 2025 due to the absence of a prior-year property disposition gain. Revenue for the quarter fell to $7.1 million from $12.3 million in 2025, primarily driven by the sale of 1140 Avenue of the Americas in the previous year. The company's portfolio, now consisting of five properties with a 74.0% occupancy rate, generated $3.5 million in cash net operating income and maintained a weighted-average remaining lease term of 6.0 years. Following the quarter, the company secured an extension and expansion lease with the State of New York at 123 William Street, increasing pro-forma occupancy at that location to approximately 75%.Real Estate
- FEMYNov 13, 4:47 PMFemasys Inc. announced a $30 million private placement in mid-August 2026 to fund U.S. commercial team expansion and the FemBloc pivotal trial. For the quarter ended September 30, 2026, U.S. sales rose slightly to $347,039, while total sales declined 44.5% to $404,597 due to timing of international distributor orders. The company reported a net loss of $4,564,815 for the quarter and $8,187,810 for the nine-month period, with cash and cash equivalents reaching approximately $23.9 million by September 30.Healthcare
- NXPLNov 13, 4:47 PMNextPlat Corp reported third-quarter 2026 consolidated revenue of approximately $10.5 million, a decrease from $13.8 million in the prior year period, driven by lower reimbursement rates and reduced retail prescription volumes. Despite the revenue decline, the company achieved a consolidated gross margin of 35.0%, a significant improvement from 19.9% in the same period last year, largely due to a 300% increase in pharmacy contract revenue. Net loss attributable to common stockholders narrowed by 66% to approximately $0.7 million, or $0.28 per diluted share, compared to $2.2 million in the prior year. The company ended the quarter with $11.2 million in cash and noted a 72% year-over-year growth in higher-margin 340B prescription volumes.Technology
- Nov 13, 4:41 PMThe Fidelity Private Credit Fund targets senior secured loans to private equity-owned middle-market companies, maintaining a weighted average loan-to-value of 39% and net leverage of 4.7 times as of September 30, 2026. The fund's investment strategy emphasizes disciplined underwriting and strong documentation to navigate an environment characterized by rising interest rates and increased credit dispersion among borrowers. Performance data indicates a year-to-date total net return of 4.52% for Class I shares, with a distribution rate of 9.36% calculated on the net asset value. The portfolio is heavily concentrated in floating-rate investments at 99.8%, with top holdings including Project Fractal in aerospace, Project METIS in healthcare services, and Project Sentinel in industrial distribution.
- AIRTNov 13, 4:35 PMAir T, Inc. reported second-quarter fiscal 2027 revenues of $146.9 million, a 129% increase from the prior year, driven largely by the inclusion of Regional Express Holdings Pty Ltd acquired in December 2025. The company posted an operating loss of $11.8 million and a net loss per share of $7.48, contrasting with the prior year's operating income and net income per share. Adjusted EBITDA declined to $4.4 million from $7.9 million in the previous year, impacted by significant fuel cost increases and unscheduled engine removals at the Regional Airline segment. Despite challenges in the newly acquired Rex unit, other segments such as Overnight Air Cargo and Ground Support Equipment contributed positively to the quarter's financial performance.Industrials
- CLDINov 13, 4:35 PMCalidi Biotherapeutics reported a net loss of $3.6 million for the third quarter of 2026, a significant improvement from the $10.8 million loss in the same period of 2025. The company advanced its lead candidate CLD-401, presenting preclinical data at the ESMO Congress 2026 that demonstrated complete tumor eradication in 80% of mice in breast cancer models. General and administrative expenses decreased by 39% to $1.6 million as the firm executed a restructuring plan to extend its cash runway. Additionally, Calidi raised $1.2 million through an at-the-market registered direct offering and ended the quarter with $3.9 million in cash.Healthcare
- NWTGNov 13, 4:31 PMNewton Golf Company reported a net loss of $1.2 million for the third quarter of 2026, driven by a 47% decline in net sales to $1.4 million due to reduced marketing activity. The company expanded its 2.0 shaft rollout with over 80 professional golfers using its products and grew its fitter network to approximately 301 accounts. Following the quarter, Newton raised approximately $3.0 million through equity financings and converted $1.0 million of debt into equity, resulting in a pro forma stockholders' equity of $5.2 million. Despite these liquidity improvements, the company faces Nasdaq compliance concerns regarding its minimum equity requirement and anticipates needing additional financing to continue operations.Consumer Cyclical
- PEDNov 13, 4:31 PMPEDEVCO Corp. reported a net loss of $9.2 million for the third quarter of 2026, driven by a $16.6 million net loss on derivative contracts that offset higher operating income from an expanded asset base. Average daily production surged 298% year-over-year to 5,850 barrels of oil equivalent per day following the October 2025 merger with Juniper Capital Advisors, while revenue increased 411% to $35.5 million. Adjusted EBITDA rose 239% to $14.7 million, reflecting increased production volumes and a 31% rise in the average realized oil price to $83.81 per barrel. The company updated its full-year 2026 net capital expenditure guidance to a range of $37 million to $42 million and reiterated its Adjusted EBITDA guidance of $60 million to $70 million.Energy
- VUZINov 13, 4:30 PMVuzix Corporation reported third-quarter 2026 total revenues of $0.7 million, a 38% decrease from the same period in 2025, driven by a 45% decline in product sales. The company recorded a net loss of $8.4 million, or $0.10 per share, compared to a $7.4 million loss in the prior year quarter. Strategic progress includes the shipment of evaluation samples for the Causeway optical interconnect platform to over 10 companies and the delivery of the SHRIKE Defense Display Platform for customer evaluation. Additionally, Vuzix secured nearly $1.0 million in new OEM defense orders and completed facility upgrades at its Rochester waveguide manufacturing site.Technology
- NVVENov 13, 4:30 PMNuvve Holding Corp. reported third-quarter 2026 total revenues of $1.09 million, a 31.9% decrease from the same period in 2025, driven by lower product sales and service revenue. The company recorded a net loss of $4.7 million for the quarter, with gross profit margins declining to 24.0% from 52.0% in the prior year due to higher warranty costs and project write-downs. Despite the revenue decline, Nuvve raised $0.97 million in gross proceeds through debt and equity instruments to support operations, while megawatts under management increased by 5.7% to 29.9 megawatts.Consumer Cyclical
- INDPNov 13, 4:30 PMIndaptus Therapeutics reported a net loss of $1.0 million for the third quarter of 2026, a significant decrease from $3.0 million in the same period of 2025, driven by reduced research and development and general administrative expenses. The company completed a private placement in September 2026, raising approximately $24.0 million in gross proceeds to fund working capital and early-stage research into a neurotechnology device for sleep-related conditions. As of September 30, 2026, Indaptus held $30.6 million in cash, cash equivalents, and short-term investments, providing sufficient liquidity to support its anticipated operating expenses. The company also announced a strategic shift away from its Decoy20 clinical program to focus on new opportunities with long-term potential.Healthcare
- IRLANov 13, 4:30 PMIRulya Therapeutics Inc., formerly Quince Therapeutics, reported a net loss of $27.7 million for the third quarter ended September 30, 2026, while maintaining a cash position of $105.2 million expected to fund operations through 2028. The company relaunched with a new name and ticker symbol IRLA, appointing a new leadership team and board of directors to focus on its lead candidate, LAM-001. Clinical progress includes a fully enrolled Phase 2 trial for bronchiolitis obliterans syndrome (BOS) with data anticipated in early 2027, an ongoing Phase 2b trial for pulmonary hypertension associated with interstitial lung disease (PH-ILD), and a planned Phase 2 study for sarcoidosis-associated pulmonary hypertension (SAPH) to begin in late 2026.Healthcare
- BOCNov 13, 4:29 PMBoston Omaha Corporation reported a net loss attributable to common stockholders of $192,000 for the third quarter of 2026, compared to a loss of $2.588 million in the same period the previous year. Total revenues for the quarter reached $22.178 million, driven by billboard rentals and broadband services, while net other expense was recorded at $3.611 million due primarily to fair value changes in investment funds. The company repurchased 457,308 shares of its Class A common stock for $6.4 million during the quarter and subsequently increased its share repurchase program authorization from $30 million to $85 million. As of September 30, 2026, the company held $29.743 million in unrestricted cash and investments with a book value per share of $16.64.Communication Services
- ANVSNov 13, 4:24 PMAnnovis Bio, Inc. reported third-quarter 2026 financial results showing cash and cash equivalents of $2.8 million and a net loss of $9.5 million. The company raised $21.0 million in gross proceeds through an underwritten public offering to fund operations through the March 2027 data readout for its Phase 3 DUET-AD Alzheimer's study. Clinical progress includes full enrollment of 862 patients in the DUET-AD trial and 326 patients in the Parkinson's open-label extension study. Upcoming milestones include the last patient visit for the 6-month treatment period on December 31, 2026, and a planned database lock on February 8, 2027.Healthcare
- ASTCNov 13, 4:20 PMAstrotech Corporation reported a net loss of $2.948 million for the first quarter of fiscal year 2027, ending September 30, 2026, compared to a loss of $3.465 million in the same period the prior year. Total operating expenses decreased by 15.7% to $3.1 million, driven primarily by a reduction in research and development costs, while revenue declined slightly to $274,000. As of the quarter's end, the company maintained $11.6 million in working capital and had deployed its TRACER 1000 technology in approximately 38 locations across 17 countries. Additionally, Astrotech submitted a proposal to NASA under the NextSTEP-3 LEIA program to advance its Mobile Power System for lunar infrastructure applications.Industrials
- GXAINov 13, 4:17 PMGaxos.ai Inc. reported third-quarter 2026 consolidated revenue of approximately $2.81 million, representing a 14.5% increase from the second quarter and a 464.9% increase from the same period in 2025. During the quarter, advertising and marketing expenses decreased by 16.7% to $2.62 million, resulting in an improved revenue generation of $1.08 per advertising dollar, a 38% improvement over the previous quarter. The company held cash and short-term investments of $13.30 million as of September 30, 2026, and issued 3,007,654 shares of common stock following warrant exercises. Gaxos plans to focus on increasing recurring revenue, improving customer acquisition efficiency, and scaling products with favorable contribution economics for the remainder of 2026.Communication Services
- FIEENov 13, 4:16 PMFiEE, Inc. reported a 382.1% year-over-year revenue increase to approximately $9.6 million for the nine months ended September 30, 2026, driven by its strategic transition to SaaS solutions and phygital art advisory services. The company achieved a net income of $3.6 million for the period, marking a significant turnaround from a net loss of $1.3 million in the same timeframe the previous year. Revenue growth was primarily fueled by SaaS-MCN digital services, software services, and new phygital art advisory offerings, which generated $3.5 million in revenue compared to zero in 2025. Additionally, the company onboarded 939 customers for its SaaS-MCN services and secured $4.1 million in contracts for software services as of September 30, 2026.Technology
- MEDSNov 13, 4:15 PMDataMEDS AI reported a 50% sequential revenue increase to $2.7 million for the third quarter of 2026, driven primarily by growth in its Corexa Pharmacy drug dispensing operations. The company achieved a net profit of $10.535 million, resulting in a net profit per share of $2.72, a significant turnaround from the net loss recorded in the same period the previous year. Key business developments included the launch of the Health Lives Here mobile app, an exclusive license for the REBOOT GLP-1 patient management platform, and the acquisition of Helomics cancer diagnostics laboratory. Additionally, the company regained full compliance with Nasdaq listing standards and secured a memorandum of understanding with an HMO to deploy its mobile application to over 25,000 members.Consumer Defensive
- AVEXNov 13, 4:15 PMAEVEX Corp. reported third-quarter 2026 total revenue of $189.7 million, a 56.5% increase from the prior year period, driven primarily by growth in its Airborne Systems segment and the recent acquisition of BlackSea Technologies. The company posted a net loss of $16.8 million for the quarter, contrasting with a net income of $9.9 million in the same period last year, while Adjusted EBITDA rose to $30.8 million. Following the establishment of Maritime Systems as a new reportable segment, AEVEX raised its full-year 2026 revenue outlook to a range of $820.0 million to $840.0 million and Adjusted EBITDA guidance to $128.0 million to $132.0 million.Industrials
- ECTMNov 13, 4:14 PMECA Marcellus Trust I announced a quarterly distribution of $0.021 per unit for the period ended September 30, 2026, payable on or before November 30, 2026, to holders of record as of November 23, 2026. The trustee is withholding approximately $90,000 from this quarter's distribution to build a cash reserve toward a target of $3.8 million, which is intended to cover future known, anticipated, or contingent expenses. The trust holds royalty interests in natural gas properties in the Marcellus Shale formation in Greene County, Pennsylvania, and its distributions fluctuate based on production proceeds, commodity prices, and administrative costs. Non-U.S. persons may be subject to withholding taxes on income effectively connected to a U.S. trade or business or on fixed, determinable, annual, periodic income from U.S. sources.Energy
- ICMBNov 13, 4:11 PMInvestcorp Credit Management BDC, Inc. reported a net asset value per share of $3.02 as of September 30, 2026, representing a decrease of $0.42 from the previous quarter. The company recorded a net investment loss before taxes of $1.8 million and a total net decrease in net assets from operations of $4.8 million for the three-month period. During the quarter, the investment adviser waived all management fees and $0.2 million of previously accrued incentive fees, while the weighted average yield on debt investments fell to 9.53%. Subsequent to the quarter end, the company received $11.5 million in repayments and repaid $10.0 million of outstanding borrowings under its revolving credit facility.Financial Services
- ROLRNov 13, 4:10 PMHigh Roller Technologies reported a net loss of $2.8 million for the third quarter of 2026, driven by a 51% decline in net revenues to $2.4 million as the company exited certain online casino markets. Despite lower revenue, the company maintained a strong liquidity position with $13.4 million in cash and no outstanding borrowings at the end of the quarter. The firm commercially launched its ROLR prediction markets platform on October 21, 2026, and released its iOS application in November, aiming to establish prediction markets as a primary growth driver in 2027.Consumer Cyclical
- BYFCNov 13, 4:10 PMBroadway Financial Corporation reported net income attributable to common stockholders of $392 thousand for the third quarter of 2026, a significant improvement from the $24.6 million net loss recorded in the same period of 2025. During the first nine months of 2026, the company achieved consolidated net income of $1.0 million, driven by an 11.4% increase in net loans and a 21.0% rise in total deposits. The bank maintained stable credit quality with non-accrual loans representing 1.20% of gross loans and reported a strong Community Bank Leverage Ratio of 12.83% as of September 30, 2026.Financial Services
- FFRNov 13, 4:10 PMFF EAI Robotics Ecosystem Inc. completed the acquisition of Faraday Future's robotics business on October 23, 2026, transforming into a pure-play humanoid and bionic Physical AI robotics company. For the nine months ended September 30, 2026, the acquired robotics business generated approximately $2.3 million in standalone revenue with a gross margin of 26%, entering the company with no outstanding debt. The company has advanced its Four-Core Full-Stack AI ecosystem, introducing the FF OmniMind brain platform which ranked first on the RoboColiseum benchmark, and achieved a record 351 robot shipments in October. Looking ahead, FFR plans to launch a 100-city robotics education initiative, introduce its Physical Cloud technology platform during CES, and begin domestic factory production in the first quarter of 2027.Technology
- VTGNNov 13, 4:08 PMVistagen Therapeutics reported a net loss of $10.7 million for the second quarter of fiscal year 2027, ending September 30, 2026, with cash and marketable securities totaling $20.0 million. The company received constructive feedback from the FDA regarding its Phase 3 development plan for fasedienol in social anxiety disorder, which will now focus on overall treatment rather than just acute management. Preliminary data from the open-label extension of the PALISADE-4 study showed clinically relevant improvements in social anxiety over four months. Additionally, Vistagen appointed Douglas J. Williamson, MD, to its board and implemented cost-management initiatives to extend its operating runway into 2027.Healthcare
- INBXNov 13, 4:08 PMInhibrx Biosciences reported a net loss of $38.7 million for the third quarter of 2026, driven by $26.0 million in research and development expenses and $7.8 million in general and administrative costs. The company recognized $2.0 million in revenue from a non-exclusive license agreement with Pfizer, while cash and cash equivalents increased to $199.5 million as of September 30, 2026. Clinical milestones include upcoming data presentations for ozekibart in Ewing sarcoma and the ongoing enrollment of ordastobart in head and neck squamous cell carcinoma. Additionally, the company is advancing commercial readiness activities for ozekibart in chondrosarcoma while preparing for a potential Biologics License Application.Healthcare
- OPRXNov 13, 4:06 PMOptimizeRx reported third-quarter 2026 revenue of $21.6 million, a 17% decrease from the prior year, while achieving a net income of $1.2 million and adjusted EBITDA of $6.3 million. The company updated its full-year 2026 revenue guidance to a range of $87 million to $93 million, though adjusted EBITDA guidance remains unchanged at $21 million to $25 million. Since June 30, 2026, OptimizeRx repaid $9.3 million in debt principal, reducing its outstanding principal balance to $10.4 million. Management cited margin expansion and cost management as drivers for the 23% year-over-year increase in adjusted EBITDA despite the revenue decline.Healthcare
- BJDXNov 13, 4:05 PMBluejay Diagnostics completed enrollment in its SYMON-II clinical validation study with 777 evaluable patients, exceeding the original target of 750. The company established an alternative manufacturing facility ahead of a contractual deadline and advanced U.S. commercial infrastructure through new distribution agreements. As of September 30, 2026, the company held $7.38 million in cash and projects these resources will sustain operations through the second quarter of 2027. Bluejay aims to submit an FDA 510(k) application for its Symphony IL-6 test during the first half of 2027.Healthcare
- TXMDNov 13, 4:05 PMTherapeuticsMD, Inc. reported net income from continuing operations of $501 thousand, or $0.04 per share, for the third quarter of 2026, an increase from $50 thousand in the same period of 2025. License revenues rose to $1.3 million, driven by a $365 thousand milestone payment from Knight related to IMVEXXY sales for the year ended December 31, 2025. Total operating expenses increased by 5.6% to $1.7 million, primarily due to higher legal and professional fees. As of September 30, 2026, the company held $10.4 million in cash and cash equivalents while continuing to evaluate strategic alternatives such as a potential acquisition or merger.Healthcare
- CRISNov 13, 4:05 PMCuris, Inc. reported a net loss of $8.1 million for the third quarter of 2026, with no revenue generated due to the prior sale of Erivedge royalties. The company is currently enrolling patients in two ongoing studies, the TakeAim CLL study and the TakeAim Lymphoma study, which evaluate emavusertib in combination with BTK inhibitors. Clinical data from the TakeAim Lymphoma study showed objective response rates of 100% for BTK-naïve patients and 33% for BTKi-experienced patients as of July 2026. Financially, Curis held $5.0 million in cash and cash equivalents as of September 30, 2026, and expects its existing resources combined with recent private placement proceeds to fund operations into the first quarter of 2027.Healthcare
- SEVNov 13, 4:05 PMAptera Motors reported a GAAP net loss of $14.0 million for the third quarter of 2026 and $35.0 million for the first nine months of the year. The company raised approximately $6.0 million in gross proceeds during the quarter through a warrant inducement transaction and entered a strategic partnership with Shanghai Launch Automotive Technology to support manufacturing. As of September 30, 2026, Aptera held $9.2 million in cash and cash equivalents, including $4.1 million in refundable reservation fees, while maintaining over 49,000 vehicle reservations. Management estimates a need for approximately $25 million to reach start of production and $65 million to achieve a production rate of 500 vehicles per month.Consumer Cyclical
- ENVBNov 13, 4:05 PMEnveric Biosciences reported a net loss of $2.5 million for the third quarter ended September 30, 2026, with cash-on-hand totaling $5.6 million. The company advanced final IND-enabling activities for its lead candidate EB-003, a non-hallucinogenic neuroplastogenic therapeutic, supported by preclinical data showing brain penetration and a distinct activity profile compared to DMT. Recent in vitro studies confirmed favorable absorption and metabolic properties with a reduced potential for drug-drug interactions, while independent assays reinforced the compound's predicted non-hallucinogenic profile. Additionally, Enveric secured a U.S. patent allowance for next-generation non-hallucinogenic mescaline derivatives in its EVM401 series.Healthcare
- TRXBNov 13, 4:04 PMTRexBio reported a net loss of $13.2 million for the third quarter of 2026, driven by increased research and development expenses related to its TRB-061 and TRB-071 programs. The company announced positive Phase 1a results for TRB-061, an investigational TNFR2 agonist for atopic dermatitis, which demonstrated proof of mechanism and safety in healthy volunteers. TRexBio completed a $133.5 million initial public offering in October 2026, extending its cash runway into the second half of 2029. Topline data for the Phase 1b trial of TRB-061 is expected in mid-2027, while a Phase 1 trial for the CD30 agonist TRB-071 is anticipated to begin in the first half of 2027.Healthcare
- WSBFNov 13, 4:00 PMWaterstone Financial, Inc. reported net income of $6.2 million, or $0.36 per diluted share, for the quarter ended September 30, 2026, a decrease from $7.9 million in the same period of 2025. The Community Banking segment achieved record quarterly net interest income of $16.0 million, driven by a reduction in the average cost of funds, while the Mortgage Banking segment recorded a pre-tax loss of $754,000 due to elevated mortgage rates and compressed sales margins. Consolidated return on average assets for the quarter was 1.09%, and book value per share declined to $19.29, primarily due to accumulated other comprehensive losses from rising treasury rates. Total dividends declared for the quarter amounted to $0.17 per common share.Financial Services
- Nov 13, 3:04 PMImricor Medical Systems commenced its U.S. commercial launch in the third quarter of 2026, securing its first two hospital customers, Rady Children's Hospital–San Diego and Children's Medical Center Dallas, for its NorthStar interventional MR system. The company reported revenue of US$188k, a 437% increase from the prior period, driven by initial sales and installations while maintaining a cash balance of US$62.1m. Regulatory progress included FDA 510(k) clearances for pediatric label expansions on NorthStar and the Vision-MR Diagnostic Catheter, as well as the acceptance of the manufacturing module for the Vision-MR Ablation Catheter PMA application. Additionally, Imricor established a strategic partnership with Philips to issue a Third Party Product Compatibility Declaration, enabling NorthStar to operate on the Philips MR installed base and launching a joint turnkey iMR lab solution.
- DBHLNov 13, 3:03 PMDeep Isolation Nuclear, Inc. reported consolidated revenue of $1.8 million and a net loss of $3.8 million for the third quarter of 2026. The company advanced its Commercialization Pilot near Cameron, Texas, by securing a drilling permit from the Texas Railroad Commission and initiating well pad construction. Operational progress included selection as the sole industrial partner on three U.S. Department of Energy grants for artificial intelligence-enabled nuclear waste repository analysis. As of September 30, 2026, the company held $16.5 million in available cash with 57.77 million common shares outstanding.
- NTWKNov 13, 2:39 PMNETSOL Technologies reported fiscal first quarter 2027 revenue of $16.4 million, representing a 9.3% increase from the prior-year period. The company achieved a gross margin of 50.5%, an expansion of over 1,100 basis points, driven by revenue mix changes and the capitalization of $1.0 million in software development costs. GAAP net income attributable to NETSOL turned positive at $0.16 million, or $0.01 per diluted share, compared to a net loss of $2.36 million in the same period last year. Additionally, adjusted EBITDA attributable to NETSOL improved to $0.48 million from a negative $1.66 million in the prior year, while cash and cash equivalents stood at $19.7 million as of September 30, 2026.Technology
- INUVNov 13, 2:29 PMInuvo reported a 70% year-over-year decline in net revenue to $6.8 million for the third quarter of 2026, driven by an 80% drop in Legacy Search revenue and a 24% decrease in Audience Modeling revenue. The company recorded a net loss of $5.0 million, or $0.28 per share, with operating expenses totaling $7.8 million that included a $2.4 million non-cash impairment charge. Despite the revenue contraction, Inuvo highlighted a stabilizing Legacy Search segment and an expanding sales pipeline for its IntentKey privacy-first AI solutions across automotive, travel, healthcare, and financial sectors. Management expects fourth-quarter Audience Modeling revenue to increase supported by the growing pipeline, while Legacy Search revenue and margins are projected to remain consistent with the third quarter.Communication Services
- Nov 13, 1:36 PMVaragon Capital Corporation reported a net asset value of $8.93 per share and net investment income of $0.23 per share for the third quarter of 2026, resulting in an annualized yield of 10.2%. The company declared a fourth-quarter distribution of $0.23 per share, maintaining the same rate as the previous quarter, while total investments at fair value stood at $819 million across 121 portfolio companies. Credit quality remained robust with approximately 90% of investments rated as low risk, although three portfolio companies were placed on non-accrual status by the end of the period.
- INBPNov 13, 12:12 PMIntegrated BioPharma, Inc. reported revenue of $9.9 million for the quarter ended September 30, 2026, a 22% decrease from the $12.7 million recorded in the same period of 2025. The company posted an operating loss of $1.0 million and a net loss of approximately $0.7 million, or $0.02 per share, compared to an operating income of $0.2 million and net income of $0.1 million in the prior year quarter. Revenue concentration remained high, with the two largest customers in the Contract Manufacturing Segment accounting for approximately 88% of total revenue in the current quarter.Consumer Defensive
- DYAINov 13, 11:57 AMDyadic International, Inc. reported a net loss of $1,357,041 for the third quarter ended September 30, 2026, driven by a 61.4% decline in total revenue to $449,101. The company achieved a significant milestone by recording its first direct commercial product sales of recombinant transferrin and DNase I, while also expanding distribution through Integrated Biotherapeutics. Strategic partnerships advanced with Proliant promoting AlbuFree DX and Inzymes commercializing a second chymosin product, alongside continued progress on the C1 biopharmaceutical platform for vaccine and antibody development. As of September 30, 2026, the company held $6,046,083 in cash and equivalents, reflecting a decrease from the previous year-end balance.Healthcare
- INLXNov 13, 11:15 AMIntellinetics, Inc. reported a narrowed GAAP net loss of $239,163 for the third quarter of 2026, compared to a loss of $369,765 in the same period the previous year. Total revenue for the quarter increased 0.7% year-over-year to $4.03 million, driven by growth in Software as a Service and storage services, while professional services revenue declined. The company achieved positive Adjusted EBITDA of $144,821, marking a sequential improvement of approximately $516,000 from the second quarter. For the nine-month period ended September 30, 2026, the company recorded a net loss of $2.5 million and total revenue of $11.88 million, with management revising its full-year SaaS growth outlook to single-digit year-over-year increases.Technology
- UWHRNov 13, 10:02 AMUwharrie Capital Corp reported total assets of $1.23 billion as of September 30, 2026, representing a $15 million increase from the prior year. Net income for the nine-month period ended September 30, 2026, reached $10 million, an increase of nearly 21% compared to the same period in 2025. The company's loan portfolio grew by $27 million to $709 million, supported by a $14 million year-over-year increase in core deposits. In response to this financial progress, the Board of Directors declared a 3% stock dividend payable on November 23, 2026, to shareholders of record as of November 5, 2026.
- MOBXNov 13, 9:50 AMMobix Labs reported preliminary fourth-quarter revenue of approximately $1.81 million, a 129% sequential increase that exceeded its guidance range. The company's gross margin expanded significantly to 44.5% from 12.9% in the prior quarter, while the GAAP operating loss narrowed by 11% to $6.56 million. Balance sheet improvements included a 21% reduction in total liabilities and a $5.2 million increase in stockholders' equity compared to the previous year. Management anticipates continued revenue growth as the company addresses working capital constraints and builds on its operational recovery.Technology
- BCGNov 13, 9:29 AMBinah Capital Group reported third-quarter 2026 results showing a 5.0% year-over-year increase in assets under management to $31.4 billion. Total revenue for the quarter rose 9.4% to $50.6 million, while GAAP net income increased 44.4% to $2.6 million. The company also reported EBITDA growth of 74.1% to $4.7 million and Adjusted EBITDA of $4.9 million. As of September 30, 2026, Binah held $13.2 million in cash and cash equivalents against $16.7 million in outstanding long-term debt.Financial Services
- ALOYNov 13, 9:28 AMREalloys Inc. reported a net loss of $30.5 million for the third quarter of 2026, driven primarily by $25.3 million in non-cash stock-based compensation, while net revenues increased to $0.4 million. The company executed a non-binding term sheet with the U.S. Army to establish a heavy rare earth processing facility at Tooele Army Depot, targeting commissioning in early 2028 with a capacity of 50 tonnes of dysprosium and terbium oxide annually. REalloys aims to achieve initial U.S.-based production of approximately 3,000 tonnes of sintered NdFeB magnets by 2030, supported by a planned $10 million investment in research and development through 2027. As of September 30, 2026, the company maintained a cash balance of $116.2 million and a virtually debt-free balance sheet.Basic Materials
- LFWDNov 13, 9:25 AMLifeward reported third-quarter 2026 revenue of $5.4 million, a 12% decrease from the prior year, driven by an 18% year-over-year increase in AlterG revenue to $3.6 million offset by lower ReWalk sales during its transition to a channel-partner distribution model. The company posted a net loss of $5.1 million, or $1.32 per share, compared to a net loss of $3.2 million in the same period last year, with gross margin declining to 27.4% due to foreign exchange fluctuations and acquisition-related expenses. Lifeward is advancing its strategic shift for ReWalk to expand patient access through established distributors while maintaining coverage under Medicare and major insurance plans. Additionally, the company strengthened its clinical evidence base with two new peer-reviewed studies and continues to develop AI-enabled rehabilitation technologies alongside its Protein Oral Delivery platform.Healthcare
- CTGONov 13, 9:00 AMContango Silver & Gold reported a net loss of $23.0 million for the third quarter of 2026, driven primarily by increased exploration expenditures and lower income from its Peak Gold Joint Venture. The company's Manh Choh mine transitioned from the north pit to the south pit, resulting in reduced gold production for the quarter but improved mill recovery rates to 86.5%. Contango received a $6 million cash distribution from the JV in October and expects to complete its 2026 production guidance of 40,000 gold equivalent ounces with the fourth campaign. Additionally, the company advanced permitting and drilling at its Kitsault Valley, Johnson Tract, and Lucky Shot projects while repaying debt and eliminating most hedge delivery obligations.Basic Materials
- RMIXNov 13, 8:36 AMSuncrete, Inc. reported third-quarter 2026 revenue of $141.0 million, representing a 163% increase compared to the same period in 2025 and a 45% rise from the second quarter of 2026. The company achieved an Adjusted EBITDA of $22.4 million and a Supplemental Adjusted EBITDA of $23.3 million, while total ready-mix concrete yards delivered increased by 32% quarter-over-quarter. Despite the revenue growth, the company reported a net loss of $78,000 for the quarter, contrasting with a net loss of $37.1 million in the previous quarter. Suncrete has revised its full-year 2026 outlook to project revenue between $408.0 million and $434.0 million and Adjusted EBITDA between $60.0 million and $64.0 million.Basic Materials
- MTVANov 13, 8:35 AMMetaVia Inc. reported a net loss of $4.6 million for the third quarter of 2026, driven by increased research and development expenses related to its lead candidate DA-1726. The company announced positive interim data from a Phase 1 study showing a 68.1% placebo-adjusted reduction in liver fat and 13.5% weight loss, supporting plans for a Phase 2 trial in MetALD and ALD expected to begin in late 2027. Additionally, MetaVia appointed Sarah Browne, M.D., as Chief Medical Officer to lead clinical development while advancing its second candidate, vanoglipel, in combination with resmetirom for MASH.Healthcare
- XBIONov 13, 8:35 AMXenetic Biosciences reported a net loss of approximately $1.7 million for the third quarter of 2026, driven by a 138% increase in general and administrative expenses related to a proposed share exchange transaction. The company entered into a definitive agreement to acquire Santersus AG in an all-stock deal expected to close in early 2027, creating a Nasdaq-listed entity named Santersus Bio, Inc. focused on targeting neutrophil extracellular traps across multiple therapeutic areas. Strategic highlights include the initiation of a Phase I clinical study combining Xenetic's DNase I technology with CAR T-cell therapy for large B-cell lymphoma and the advancement of preclinical research demonstrating DNase I's ability to enhance antitumor activity.Healthcare
- SGRPNov 13, 8:33 AMSPAR Group, Inc. reported a net income of $50,000 for the third quarter of fiscal 2026, marking the second consecutive quarter of profitability despite a 19.0% year-over-year decline in net revenues to $33.5 million. Gross margins expanded to 18.9% driven by a shift toward higher-quality services, while selling, general, and administrative expenses decreased by 39.0% to $5.6 million due to cost reduction initiatives. The company generated $1.4 million in Adjusted EBITDA for the quarter and $4.3 million for the nine-month period, ending the quarter with $4.7 million in cash and cash equivalents. Additionally, SPAR Group announced a new three-year services agreement with a national retailer to begin in 2027 and adjusted its full-year 2026 revenue guidance to a range of $125 million to $130 million.Industrials
- BKYINov 13, 8:30 AMBIO-key International reported a 39% year-over-year increase in Q3 2026 software license fee revenue to $1.3 million, marking its third consecutive quarter of double-digit growth driven by momentum in the Middle East and Europe. The company's total revenue for the quarter was $1.48 million, while its gross margin improved to 90% and net loss narrowed to $886,000 compared to the prior year period. During the quarter, BIO-key retired its remaining note payable, leaving the company effectively debt-free, and working capital increased to $3.1 million. Looking ahead, the company anticipates a strong finish to 2026 and a robust start to 2027 supported by new government contracts and expanding deployments.Industrials
- QUCYNov 13, 8:18 AMQuantum Cyber N.V. reported its first revenue of approximately $966,833 for the third quarter of 2026, generated by its precision metal stamping operations at the Bridgeport, Connecticut facility. The company secured an $8.0 million funding commitment from CEO David Lazar to support the expansion of its autonomous defense manufacturing capabilities and the development of its Project LightShift quantum antenna technology. Additionally, the company resolved a legacy legal claim with Boustead Securities for $250,000 and expanded the licensed field of use for its quantum antenna to include unmanned surface and underwater vehicles. Shareholders' equity increased significantly to approximately $16.2 million by September 30, 2026, driven by $15.2 million in proceeds from warrant exercises and $6.0 million from preferred share issuances.Healthcare
- AARDNov 13, 8:18 AMAardvark Therapeutics received FDA approval to lift the clinical hold on its investigational drug ARD-101 for treating hyperphagia in Prader-Willi Syndrome, allowing the company to proceed with an open-label trial at a dose of 200 mg twice daily. The company plans to meet with the FDA in the first quarter of 2027 to finalize its clinical development strategy and expects to resume clinical activities in PWS during 2027. Financial results for the third quarter of 2026 showed a net loss of $19.2 million, with the company maintaining $60.3 million in cash and short-term investments to fund operations through 2027.Healthcare
- CNVSNov 13, 8:15 AMCineverse reported second-quarter fiscal 2027 revenue of $26.0 million, representing a 110% increase from the prior year quarter, driven primarily by technology and media services streams which now account for 55% of total revenue. The company achieved a net income of $3.2 million, or $0.11 per diluted share, marking a significant turnaround from a $5.7 million net loss in the same period last year, while Adjusted EBITDA rose to $1.7 million for the third consecutive positive quarter. Operational progress included the full integration of Giant Worldwide and IndiCue, resulting in a consolidated product portfolio on the Matchpoint platform and a 300 basis point sequential improvement in direct operating margin. Cineverse reaffirmed its full-year fiscal 2027 guidance of $115 to $120 million in revenue and $10 to $20 million in Adjusted EBITDA, citing strong momentum in advertising technology and content distribution.Communication Services
- BFRINov 13, 8:10 AMBiofrontera Inc. reported net product revenue of $9.1 million for the third quarter of 2026, representing a 29.8% increase from the prior-year period. The company achieved a gross margin of 74.4% and a net loss of $6.4 million, or $0.42 per share, during the quarter. Key developments included FDA approval of Ameluz for superficial basal cell carcinoma and a U.S. Customs ruling allowing the import of the redesigned XL-C lamp. For the nine months ended September 30, 2026, revenue grew 26.6% to $31.2 million while the net loss narrowed to $11.8 million.Healthcare
- OWLTNov 13, 8:05 AMOwlet reported third-quarter 2026 revenue of $30.4 million, a 4.9% decrease from the prior year, driven by lower hardware sales but offset by a 140% increase in subscription revenue to $3.6 million. The company achieved a gross margin of 53.8% and reported a net income of $1.4 million for the quarter. However, Owlet withdrew its full-year 2026 financial outlook following a safety incident involving exposed camera cables, which necessitates a free replacement program for all camera owners. Anticipated remediation expenses, potential retailer returns, and near-term demand uncertainty are expected to impact the fourth quarter results.Healthcare
- PDSBNov 13, 8:05 AMPDS Biotechnology Corporation reported a net loss of $7.6 million, or $0.11 per share, for the third quarter ended September 30, 2026, compared to a $9.0 million loss in the same period the previous year. The company announced the initial closing of a PIPE financing of up to $22.3 million led by Nant Capital, LLC, which included the appointment of Dr. Patrick Soon-Shiong and James Banaag to its Board of Directors. During the quarter, research and development expenses decreased to $2.1 million from $4.6 million in the prior year period, primarily due to reduced clinical trial costs. As of September 30, 2026, the company held $15.2 million in cash and cash equivalents while continuing to prioritize its lead program, PDS0301, and advancing its Versamune cancer vaccine platform.Healthcare
- PAVMNov 13, 8:05 AMPAVmed reported preliminary third-quarter 2026 financial results showing operating expenses of approximately $6.8 million and a non-GAAP adjusted net loss of $1.2 million. Its subsidiary Lucid Diagnostics began receiving Medicare payments for its EsoGuard test in October and recognized $1.2 million in revenue for the quarter. Veris Health achieved a design freeze for its implantable physiological monitor and initiated a 90-day GLP animal study ahead of an expected early 2027 FDA submission. Additionally, PAVmed engaged with the FDA regarding its PortIO and Octeris products, with Octeris preparing to submit an initial pre-submission package.Healthcare
- FBIONov 13, 8:05 AMFortress Biotech reported third-quarter 2026 net revenue of $19.2 million, representing a 9% increase from the prior year period, driven primarily by $18.9 million in product revenue. The company fully repaid its $15.0 million senior secured credit facility with Oaktree in September 2026, leaving it with no outstanding debt at the parent level. Key corporate developments included the in-licensing of FB-607 for irritable bowel syndrome, the approval of anselamimab in Japan for amyloidosis, and a $130 million Series B financing for partner Crystalys Therapeutics. Financial results for the quarter showed a net loss attributable to common stockholders of $7.9 million, while consolidated cash and cash equivalents rose to $152.2 million.Healthcare
- BNTCNov 13, 8:02 AMBenitec Biopharma reported positive interim clinical results for its BB-301 therapy in a Phase 1b/2a study for Oculopharyngeal Muscular Dystrophy, showing a 100% responder rate across all patients in Cohort 1 and Cohort 2 with no serious adverse events. The company announced a net loss of $12.9 million for the first quarter ended September 30, 2026, while maintaining approximately $176.5 million in cash and cash equivalents. Benitec plans to finalize the design for its pivotal BB-301 trial in the first quarter of 2027, with the study on track to begin in mid-2027. Additionally, the company intends to transition its fiscal year-end from June 30 to December 31, presenting operational guidance on a calendar-year basis and financial guidance on a fiscal-year basis.Healthcare
- IMUXNov 13, 8:00 AMImmunic, Inc. reported a net loss of $42.3 million for the third quarter of 2026, driven by increased research and development and general and administrative expenses. The company's Phase 3 ENSURE-1 and ENSURE-2 trials for vidofludimus calcium in relapsing multiple sclerosis remain on track to report top-line data in December 2026. Immunic is also initiating a Phase 3 PROTECT-MS trial for progressive multiple sclerosis, with the first patient enrollment expected in the first half of 2027. To support regulatory and commercial readiness, the company appointed a Chief Data and Digital Officer and a Chief People Officer during the quarter.Healthcare
- HURANov 13, 7:50 AMTuHURA Biosciences reported third-quarter 2026 financial results showing $1.9 million in cash and cash equivalents alongside $3.7 million in research and development expenses. The company announced preliminary data from its IFx-2.0 and Keytruda study in metastatic Merkel cell carcinoma patients, demonstrating major objective tumor responses in the first three subjects. TuHURA also received FDA clearance to initiate a Phase 1b trial for its VISTA-inhibiting antibody TBS-2025 in relapsed or refractory acute myeloid leukemia and secured new patents for its VISTA inhibitor and Delta Opioid Receptor technology. To support these initiatives, the company accessed $5.6 million in non-dilutive financing from its Parkview credit facility during the quarter.Healthcare
- NDLSNov 13, 7:45 AMNoodles & Company reported a 9.5% increase in system-wide comparable restaurant sales for the third quarter of 2026, driven by a 10.7% rise at company-owned locations and a 4.9% rise at franchise locations. The company posted a net loss of $2.1 million for the quarter, a significant improvement from the $9.2 million loss recorded in the same period of 2025, while operating margin expanded to 0.1% from (5.2)%. Restaurant contribution margin improved to 16.7% and Adjusted EBITDA increased by 34.3% to $8.7 million. Management has tightened its full-year 2026 guidance, projecting total revenue between $485 million and $495 million and Adjusted EBITDA between $35 million and $37 million.Consumer Cyclical
- DGXXNov 13, 7:45 AMDigi Power X Inc. reported third-quarter 2026 revenue of $12.25 million, representing an 85% increase from the previous quarter and a 50% year-over-year rise. AI-related revenue reached $5.66 million, accounting for 46% of total revenue, driven by a 400% surge in GPU rental income and the launch of the NeoCloudz Token Factory. The company ended the quarter with $119.6 million in cash and digital currencies, no outstanding borrowings, and a net income of $1.0 million. Looking ahead, Digi Power X anticipates an annualized revenue run-rate of $250 million to $300 million by the end of Q3 2027, supported by the upcoming billing for its Columbiana Phase 1 colocation facility and a planned $200 million debt financing.Utilities
- MISTNov 13, 7:36 AMMilestone Pharmaceuticals reported third-quarter 2026 net product revenue of $1.0 million for its FDA-approved drug CARDAMYST, representing a 73% increase from the previous quarter. To extend its cash runway into late 2028, the company implemented cost-efficiency measures that reduce operating expenses by approximately 30%, including bringing its sales force in-house and reducing its headquarters workforce. Consequently, Chief Financial Officer Amit Hasija and Chief Medical Officer Dr. David Bharucha have departed the leadership team, while the company maintains full funding for its Phase 3 AFib-RVR trial with data expected in the second half of 2028. As of September 30, 2026, the company held $145.4 million in cash and equivalents, providing sufficient resources to cover operations well beyond the anticipated Phase 3 readout.Healthcare
- XTIANov 13, 7:30 AMXTI Aerospace reported third-quarter 2026 revenue of $35.3 million, representing an 8.8% sequential increase and a 46.1% rise compared to the prior year's proforma revenue. The company achieved an adjusted EBITDA of $1.6 million, a significant improvement from a negative $4.9 million in the second quarter, driven by cost realignment initiatives and tariff recovery benefits. Management has completed its strategic pivot to focus exclusively on the Drone Nerds business, discontinuing the XTI aircraft operations while expanding its portfolio with new programs for pressure washing, airport detection, and first responders. Looking ahead, XTI Aerospace has reiterated its full-year 2026 revenue guidance of $125 million to $130 million and expects to transition to positive ongoing operating cash flows by the fourth quarter.Technology
- JBIONov 13, 7:20 AMJade Biosciences reported a net loss of $35.1 million for the third quarter ended September 30, 2026, driven by increased research and development and general and administrative expenses. The company holds $475.7 million in cash, cash equivalents, and investments, providing a runway into the fourth quarter of 2028. Key pipeline updates include the expected initiation of the Phase 3 EVERGREEN trial for JADE101 in the fourth quarter of 2026 and the planned start of the Phase 1 JADE301 trial in dermatomyositis during the same period. Additionally, the company expanded Brad Dahms' role to include Chief Business Officer responsibilities alongside his position as Chief Financial Officer.Healthcare
- TVRDNov 13, 7:05 AMTvardi Therapeutics reported a net loss of $6.1 million for the third quarter ended September 30, 2026, driven by increased research and development expenses related to its TTI-101 program. The company plans to advance its lead candidate TTI-109 into clinical trials for ulcerative colitis in 2027, pending Investigational New Drug clearance and additional funding. TTI-101 is currently being evaluated in a Phase 1b/2 study for hepatocellular carcinoma, with topline data expected in the early first quarter of 2027. As of September 30, 2026, Tvardi held $22.3 million in cash and cash equivalents, which is projected to fund operations through the third quarter of 2027.Healthcare
- PWCMNov 13, 7:00 AMPowerCompute reported a net income of $0.4 million for the third quarter of 2026, driven by a $6.7 million fair value gain on digital assets receivable as Bitcoin prices rose approximately 43% during the period. The company mined 23.9 Bitcoin, representing a 35.8% increase in production compared to the same quarter in 2025, while its mining margin improved to 50.7% from 29.0% in the previous quarter. Significant balance sheet improvements were achieved by repaying and terminating its Bitcoin-backed credit facility, which reduced secured debt by 94% to $1.25 million and eliminated pledged Bitcoin. Additionally, PowerCompute purchased 600 new Bitmain Antminer S21++ units for $1.0 million, which are expected to increase the company's active hashrate by approximately 10% by mid-December 2026.Financial Services
- SBCNov 13, 6:50 AMSBC Medical Group Holdings reported third-quarter 2026 total revenues of $59 million, representing a 35% year-over-year increase driven by service fee revisions and the consolidation of Waqoo. Net income attributable to the company rose 22% to $16 million, while Adjusted EBITDA surged 66% to $28 million, resulting in an Adjusted EBITDA margin of 47%. The company's clinic network expanded to 293 locations with 7.06 million patient visits over the trailing twelve months, and it held $198 million in cash and cash equivalents as of September 30, 2026.Industrials
- MXCNov 12, 5:28 PMMexco Energy Corporation reported a net income of $945,152, or $0.45 per diluted share, for the six months ended September 30, 2026, representing a 67% increase from the same period in the prior year. Operating revenues rose 21% to $4,102,157, driven primarily by a 43% increase in average oil prices despite a 23% decline in natural gas prices and a 7% drop in oil production. During this period, the company invested approximately $3.2 million in acquiring oil and gas royalty interests and plans to drill 55 horizontal wells and complete 20 others in the fiscal year ending March 31, 2027.Energy
- LGLNov 12, 5:27 PMThe LGL Group, Inc. reported total revenues of $1.464 million for the third quarter of 2026, representing a 32.1% increase from the same period in 2025. Net loss attributable to common stockholders was $45,000 for the quarter, a significant decline from the $772,000 net income recorded in 2025, primarily due to a reversal of a previously recorded uncertain tax position. The company's backlog in the Electronic Instruments segment grew substantially to $6.5 million as of September 30, 2026, up from $625,000 at the end of 2025. Cash and cash equivalents, along with marketable securities, increased to $87.0 million, driven largely by a rights offering that generated $41.5 million in net proceeds in July 2026.Technology
- BMTMNov 12, 5:27 PMBright Mountain Media, Inc. reported revenue of $11.6 million for the third quarter of 2026, a 17% decrease from the same period in 2025, while net loss narrowed to $3.0 million from $2.8 million. For the nine months ended September 30, 2026, revenue totaled $39.2 million, down 10% year-over-year, with the net loss improving by 26% to $7.5 million compared to $10.1 million in the prior period. Adjusted EBITDA increased to $1.5 million for the quarter and $3.6 million for the nine-month period, reflecting a 10% and 88% improvement respectively. The company's balance sheet showed total assets of $32.75 million and a stockholders' deficit of $84.09 million as of September 30, 2026.
- ROCNov 12, 5:21 PMRank One Computing Corporation reported record third-quarter 2026 revenue of $8.0 million, representing a 50% year-over-year increase and achieving its first quarterly net income of approximately $0.6 million. The company secured a historic $64.3 million federal contract with the Department of Justice for its ROC Evidence platform and a $5.1 million contract for ROC ABIS, while product revenue grew 24% to $5.7 million driven by strong performance in ROC SDK and ROC ABIS. Gross margin improved to 90% due to a favorable mix of high-margin software licensing, and the company completed the acquisition of Zuccaro Technical Consulting to expand its digital forensics capabilities.Technology
- AKTXNov 12, 5:21 PMAkari Therapeutics initiated GLP toxicology studies for its lead candidate AKTX-101, a TROP2-targeted antibody-drug conjugate utilizing the novel PH1 payload, to support a planned Phase 1 clinical trial in mid-2027. New preclinical data demonstrated that AKTX-101 exhibited significant tumor growth inhibition in urothelial cancer models resistant to existing therapies like Padcev and Trodelvy. The company reported third-quarter 2026 financial results showing $5.7 million in cash, a net loss of $4.8 million, and the full repayment of $0.7 million in convertible notes. Additionally, Akari strengthened its business development capabilities with the appointment of a new Chief Business Officer and expanded its intellectual property portfolio with a new patent application covering PH1's RNA splicing modulation mechanisms.Healthcare
- ITHUFNov 12, 5:21 PMiAnthus Capital Holdings reported fiscal third quarter 2026 revenue of $38.4 million, representing a sequential increase of $3.0 million from the previous quarter. The company achieved a gross profit of $16.7 million with a gross margin of 43.5%, while reporting a net loss of $13.2 million. Adjusted EBITDA for the quarter reached $5.2 million, an increase from $4.4 million in the second quarter and $2.5 million in the prior year's third quarter. Additionally, the company appointed Macias Gini & O'Connell LLP as its new independent registered public accounting firm effective November 12, 2026, following the resignation of PKF O'Connor Davies.
- ELTPNov 12, 5:20 PMElite Pharmaceuticals, Inc. reported consolidated revenues of $40.1 million for the second quarter of fiscal year 2027, representing a 10.4% increase from the prior year period. This growth was primarily driven by higher sales from the company's amphetamine and naltrexone product lines under the Elite label. The company recorded income from operations of $9.9 million and net income attributable to common shareholders of $17.3 million for the quarter. Management is scheduled to host a conference call on November 13, 2026, to discuss these financial results and recent business developments.Healthcare
- TBNNov 12, 5:18 PMTamboran Resources achieved first gas sales from its Shenandoah South Pilot Project in the Beetaloo Basin in September 2026, delivering 40 TJ/d to the Northern Territory Government under a fixed-price contract. Initial production tests on wells SS2-3H and SS2-5H confirmed average IP30 rates of 8.8 and 10.0 MMcf/d, while the SS2-2H ST1 well demonstrated a cleaned-up rate of 10.2 MMcf/d. The company reported US$1.8 million in gas sales revenue for the first quarter of fiscal year 2027, maintaining a pro forma cash balance of approximately US$180 million. Tamboran continues to advance its development strategy with ongoing drilling programs and strategic partnerships aimed at scaling production across its 2.8 million net prospective acres.Energy
- SLNDNov 12, 5:17 PMSouthland Holdings reported third-quarter 2026 revenue of $233.8 million, an increase from $213.3 million in the same period the prior year, driven by strong demand in its Civil and Transportation segments. The company achieved a gross profit of $20.6 million with an 8.8% margin, a significant improvement over the 0.9% margin recorded in the previous year, largely due to a $28.7 million settlement gain with Liberty Mutual. Net income attributable to stockholders reached $33.7 million, or $0.62 per diluted share, contrasting sharply with a net loss of $75.3 million in the prior year quarter. Additionally, Southland's backlog grew to $1.71 billion, reflecting continued execution of its strategic plan and operational improvements.Industrials
- LGVNNov 12, 5:11 PMLongeveron Inc. reported a net loss of $6.1 million for the third quarter ended September 30, 2026, driven by research and development expenses of $4.0 million and general and administrative costs of $3.3 million. The company's Phase 2b ELPIS II clinical trial for hypoplastic left heart syndrome did not meet its primary efficacy endpoint, prompting a request for a meeting with the FDA to determine future development steps. Concurrently, Longeveron is evaluating strategic alternatives, including potential partnerships, mergers, or sales, with Lucid Capital Markets retained as financial advisor to maximize stockholder value. The company implemented a 1-for-10 reverse stock split in August and currently holds $7.2 million in cash, which is expected to fund operations into the first quarter of 2027.Healthcare
- VGZNov 12, 5:10 PMVista Gold Corp. announced a consolidated net loss of $6.4 million, or $0.05 per share, for the quarter ended September 30, 2026, while maintaining cash reserves of $43.5 million with no debt. On September 20, 2026, the company entered into an arrangement agreement with Artemis Gold Inc. to be acquired via a court-approved plan of arrangement. Under the proposed terms, each Vista common share will be exchanged for 0.0966 of an Artemis common share, resulting in Vista shareholders collectively owning approximately 5% of the combined entity. The transaction aims to leverage Artemis's resources to advance the development of Vista's Mt Todd gold project while expanding the Blackwater operation.Basic Materials
- NNUPNov 12, 5:08 PMNocopi Technologies reported a 763% increase in third-quarter 2026 revenues to $3.329 million, driven by a renewed license agreement and sales from the acquired Polymeric business. The company achieved a net income of $1.397 million for the quarter, a significant turnaround from the net loss recorded in the same period of the previous year. Operating expenses rose to $0.982 million due to the inclusion of Polymeric's operations and elevated professional fees associated with the acquisition. As of September 30, 2026, the company maintained a strong balance sheet with $10.278 million in cash and investments and no outstanding debt.
- PALNov 12, 5:03 PMProficient Auto Logistics reported third-quarter 2026 total operating revenue of $149.0 million, a 30.3% increase from the prior year period, driven by the inclusion of Hansen & Adkins following its acquisition on August 13, 2026. The company delivered 839,036 units, representing a 38.6% year-over-year growth, though total operating income declined to a loss of $3.9 million compared to a $0.1 million loss in the previous year. Adjusted operating income for the quarter was $0.3 million, with the adjusted operating ratio rising to 99.8% due to elevated costs in insurance, wages, and fuel surcharge under-recovery. The integration of Hansen & Adkins is progressing on schedule, with the company now identifying a synergy opportunity range of $20 million to $30 million, significantly higher than the initial estimate.Industrials
- KIDZNov 12, 5:00 PMKIDZ AI Inc. reported a 40% sequential increase in third-quarter 2026 revenue, marking its first quarter-over-quarter growth in the year. The company achieved a gross margin of 65.9% and narrowed its net loss to $654,057, while strengthening its balance sheet with stockholders' equity rising 349% to $16.9 million. As of September 30, 2026, the firm maintained a net cash position of approximately $14.9 million, representing roughly 12 times its market capitalization. During the quarter, KIDZ AI repurchased 74,082 shares of Class B common stock at an average price of $3.36 per share.Consumer Defensive
- CWDNov 12, 5:00 PMCaliber reported a third quarter 2026 platform revenue of $3.8 million and a platform net loss of $4.3 million, resulting in a positive platform Adjusted EBITDA of $0.1 million for the second consecutive quarter. The company revised its full-year 2026 total platform revenue guidance down to a range of $15.0 million to $17.0 million due to tighter credit conditions, while reaffirming its profitability guidance. During the quarter, Caliber completed the tokenization of three additional real estate projects, bringing the total tokenized offerings to four with up to $110 million in combined offered equity. Additionally, the company held 229,203 LINK tokens valued at $3.3 million, which contributed a $1.6 million gain from changes in fair value.Financial Services
- MSGMNov 12, 5:00 PMMotorsport Games reported third-quarter 2026 revenues of $3.8 million, representing a 21.8% increase from the prior year period, driven by growth in Le Mans Ultimate downloadable content and RaceControl subscriptions. The company achieved its seventh consecutive quarter of profitability with net income of $0.7 million and expanded its gross profit margin to 88.0%. Le Mans Ultimate surpassed two million combined unit sales and set a new concurrent player record of 11,941 during a special event in October. Additionally, the company strengthened its balance sheet, ending the quarter with $5.4 million in cash and deferred revenue, while RaceControl subscription revenues grew by 186.2% over the nine-month period.Communication Services
- BGMSNov 12, 5:00 PMBio Green Med Solution, Inc. reported a net loss of $0.4 million for the third quarter ended September 30, 2026, narrowing from a $1.0 million loss in the prior-year period. The company's fire safety business generated $454,000 in product revenue, representing a significant increase from $81,000 in the same period last year, while general and administrative expenses decreased by 37% year over year. As of September 30, 2026, the company held $3.5 million in cash and cash equivalents, which management estimates will fund operations through the second quarter of 2027. Additionally, the company announced that its Form S-4 regarding a proposed business combination with Future NRG Sdn. Bhd. was declared effective in October, with a shareholder special meeting planned for November 2026.Industrials
- DIODNov 12, 5:00 PMDiodes, Inc. reported record third-quarter 2026 revenue of $532.6 million, representing a 36% year-over-year increase and a 20% sequential rise. The company achieved a gross margin of 36.1%, driven by strong demand in automotive, industrial, and AI-related computing sectors, alongside capacity expansion and product mix improvements. Management projects fourth-quarter revenue to reach approximately $550 million with a non-GAAP gross margin of 37%, aiming to exceed its three-year financial goals.Technology
- PRSONov 12, 4:58 PMPeraso Inc. reported third-quarter 2026 total net revenue of $0.3 million, a significant decline from $1.3 million in the prior quarter and $3.2 million in the same period last year, driven by reduced shipments to fixed wireless access customers. The company posted a GAAP net loss of $2.7 million, or $0.18 per share, while achieving a gross margin of 78.5% due to a favorable product mix and a one-time inventory accrual reversal. Management noted early signs of renewed demand in the fourth quarter, highlighted by a production order exceeding $2 million received in October, and announced a private placement with Nant Capital that raised approximately $10 million to support strategic initiatives in defense and drone communications.Technology
- SPRUNov 12, 4:52 PMSpruce Power reported a net income of $6.0 million for the third quarter of 2026, marking a significant turnaround from a net loss of $0.9 million in the same period the previous year. Operating EBITDA increased by 3% year-over-year to $27.0 million, driven by a 23% reduction in SG&A expenses resulting from streamlining efforts and labor savings initiatives. The company ended the quarter with $87.3 million in cash and cash equivalents, reduced its outstanding debt principal by $21.9 million, and finalized a non-binding term sheet to refinance key facilities extending their maturity to January 2027.Technology
- NSPRNov 12, 4:45 PMInspireMD, Inc. reported a net loss of $9.76 million for the third quarter of 2026, driven by a decline in total revenue to $2.24 million due to a voluntary U.S. recall of its CGuard Prime delivery system. The company received FDA approval for its CGuard Prime TransCarotid Stent System for TCAR procedures, which is expected to expand its addressable market by over 35,000 annual procedures and commence U.S. sales in the fourth quarter of 2026. International revenue grew by 9.1% to $2.21 million, offsetting the loss of U.S. sales, while the company continues to advance its SwitchGuard neuroprotection system and plans to submit a PMA supplement for an enhanced CAS delivery system in December 2026.Healthcare
- ALMUNov 12, 4:45 PMAeluma, Inc. reported a net loss of $3.8 million for the first quarter of fiscal 2027, with revenue declining to $0.6 million from $1.4 million in the prior year period. The company finalized a purchase agreement with Aixtron to acquire a new 200 mm capable MOCVD system, aiming to expand manufacturing capacity for non-indium-phosphide photonics. Aeluma continues to advance technology readiness for the AI datacom market through the development of high-speed photodetectors and quantum dot lasers while engaging with customers for potential high-volume demand. Additionally, the company is in negotiations with the U.S. Department of Commerce for up to $30 million in CHIPS R&D funding to support the commercialization of photonics for AI and advanced computing.Technology
- STRONov 12, 4:45 PMSutro Biopharma reported third-quarter 2026 financial results showing $9.1 million in revenue and a net loss of $31.5 million, while maintaining a cash balance of $142.2 million expected to fund operations through the first half of 2028. The company advanced its STRO-004 ADC program with encouraging early clinical data and initiated dosing for the STRO-006 ITGB6-targeting ADC, with both programs scheduled for further clinical updates in 2027. Additionally, the STRO-227 dual-payload ADC is set to enter clinical trials in early 2027, and a collaboration with Astellas triggered a $10 million milestone payment following the dosing of a second dual-payload program.Healthcare
- SPRONov 12, 4:43 PMSpero Therapeutics announced its third-quarter 2026 financial results, reporting a net loss of $44.3 million and research and development expenses of $38.2 million, which included a $35 million upfront payment for the in-licensing of SP001 from Innovent Biologics. The company secured $105 million in non-recourse financing in July 2026, bringing its cash and cash equivalents to $107.9 million as of September 30, 2026, sufficient to fund operations into the second half of 2029. SP001, a third-generation anti-CD40L antibody, is advancing toward a Phase 2 study in IgG4-related disease scheduled for the second quarter of 2027. Spero has also strengthened its leadership team with new appointments for Chief Medical Officer, Chief Regulatory and Quality Officer, and a new Board member to support its clinical development strategy.Healthcare
- LSFNov 12, 4:42 PMLaird Superfood reported third-quarter 2026 net sales of $42.0 million, representing a 225% increase from the prior year period, driven by the integration of Navitas Organics and Terrasoul Superfoods. The company achieved a net income of $1.7 million and an Adjusted EBITDA of $2.1 million, while e-commerce sales grew 268% to account for 54% of total revenue. For the full fiscal year 2026, the company maintains a revenue guidance range of $135 million to $140 million and an Adjusted EBITDA range of $5 million to $6 million. As of September 30, 2026, Laird Superfood held $17.3 million in cash with no outstanding debt.Consumer Defensive
- BATLNov 12, 4:41 PMBattalion Oil Corporation reported third quarter 2026 sales volumes of 11,359 barrels of oil equivalent per day, with average daily production of 4,915 net barrels of oil. The company generated $45.6 million in operating revenue, driven by a $5.13 per Boe increase in average realized prices, while reporting a net loss of $41.1 million largely due to $44.8 million in net losses on derivative contracts. Financial highlights include $92.1 million in cash and cash equivalents, a reduction in net debt to $70.4 million, and the commencement of drilling operations under a joint exploration agreement ahead of schedule. Additionally, the company executed a midstream transaction to transition crude transportation from trucking to pipeline and appointed John Juneau to its board of directors.Energy
- DMACNov 12, 4:40 PMDiaMedica Therapeutics reported a net loss of $11.3 million for the third quarter of 2026, with total cash, cash equivalents, and short-term investments standing at $34.9 million as of September 30, 2026. The company completed enrollment in the first two cohorts of its Phase 2 trial for early-onset fetal growth restriction and surpassed the 200-participant threshold for its ReMEDy2 acute ischemic stroke trial. Regulatory progress includes conditional authorization from the European Medicines Agency and Health Canada for early-onset preeclampsia studies, while the company continues to address FDA feedback regarding nonclinical reproductive toxicity data for a U.S. Investigational New Drug application. Management anticipates the ReMEDy2 interim analysis to be completed in the first quarter of 2027 and expects current cash reserves to fund operations through the fourth quarter of 2027.Healthcare
- DDSNov 12, 4:39 PMDillard's, Inc. reported net income of $130.9 million for the third quarter ended October 31, 2026, representing a 1% increase in total retail sales compared to the prior year period. For the 39 weeks ended October 31, 2026, the company achieved net income of $479.1 million, driven by a 2% increase in total retail sales and significant non-operating gains from tariff refunds and a litigation settlement. The retailer maintained a retail gross margin of 45.3% for the quarter and 44.0% for the year-to-date period, while operating expenses rose due to higher payroll costs. Additionally, Dillard's announced the closure of its Boynton Beach Mall Clearance Center in January 2027 and operates 272 stores across 30 states.Consumer Cyclical
- GEMINov 12, 4:35 PMGemini Space Station, Inc. reported third-quarter 2026 total revenue of $40.9 million, a 19% decrease from the prior year, driven by a 73% decline in platform spot trading volume. Total operating expenses fell 30% year-over-year to $119.9 million, resulting in a net loss of $58.6 million, which represents a 63% improvement over the same period in 2025. Services revenue and interest income accounted for 59% of net revenue, while exchange revenue dropped 47% to $13.4 million due to reduced retail trading activity. The company maintained disciplined cost management with lower compensation and marketing spend, despite a 38% increase in transaction losses primarily attributed to credit card charge-offs.Financial Services
- WHKNov 12, 4:34 PMWhiteHawk Minerals Corp. reported third-quarter 2026 net production of 71.3 million cubic feet equivalent per day, representing a 10% year-over-year increase. The company announced the signing of 13 acquisitions totaling $45.5 million in core Appalachian and Haynesville mineral interests, which are expected to generate approximately $5.6 million in incremental cash flow in 2027. For the quarter, WhiteHawk declared a quarterly dividend of $0.50 per share, achieved net income of $6.9 million, and reported adjusted EBITDA of $21.1 million.Energy
- CVNov 12, 4:34 PMCapsoVision reported third-quarter 2026 revenue of $3.6 million, a slight increase from $3.5 million in the same period of 2025, while net loss narrowed to $7.3 million from $7.9 million. The company received FDA clearance for its AI Highlights tool in September 2026 and launched it commercially in November, alongside completing enrollment for its CapsoCam Colon study with an expected FDA submission by year-end. Financial results reflected a gross margin decline to 49% due to higher material costs and inventory charges, though operating expenses decreased to $9.1 million. To support its operations and development pipeline, CapsoVision raised approximately $19.5 million in net proceeds through a registered direct offering and an at-the-market program during the quarter.Healthcare
- UPXINov 12, 4:31 PMUpexi, Inc. reported fiscal first quarter 2027 net income of $89.1 million, or $0.68 per diluted share, driven primarily by $102.0 million in unrealized gains on digital assets. Total revenue for the quarter reached $3.5 million, with digital asset revenue accounting for $3.1 million and product revenue declining to $0.4 million as the company shifted away from legacy consumer product lines. The company strengthened its balance sheet by increasing its Solana treasury to approximately 2.35 million SOL and raising cash on hand to $6.4 million, while also reducing the interest rate on its BitGo borrowings from 11.5% to 7.5%. Stockholders' equity improved significantly to $49.2 million as of September 30, 2026, reversing a deficit of $53.8 million recorded at the end of the previous quarter.Communication Services
- SPCENov 12, 4:31 PMVirgin Galactic reported a net loss of $59 million for the third quarter of 2026, driven by $59 million in operating expenses and revenue of $0.4 million. The company holds $184 million in cash and marketable securities as of September 30, 2026, while its first commercial spaceflight is expected in early 2027. Operational updates include the completion of a rocket motor production facility in Arizona and the opening of limited bookings for spaceflight expeditions at $850,000 per seat. Additionally, Virgin Galactic projects a high-cadence launch hangar opening in late 2028 to increase annual spaceflight capacity to 150.Industrials
- PROPNov 12, 4:30 PMPrairie Operating Co. reported third-quarter 2026 sales volumes of 2.4 million barrels of oil equivalent, representing a 21% increase from the prior quarter and driving revenue to $129.5 million. The company generated $65.3 million in Adjusted EBITDA, a 92% quarter-over-quarter increase, while reducing lease operating expenses per barrel of oil equivalent by 17%. Year-to-date through September 30, 2026, total revenue reached $311.8 million, an increase of approximately 97% compared to the same period in 2025. Production reached approximately 32,287 barrels of oil equivalent per day by early October, following the online status of the Burnett and Castor development pads.Energy
- AEMDNov 12, 4:30 PMAethlon Medical, Inc. reported a net loss of $2.62 million for the second quarter ended September 30, 2026, with operating expenses rising 77.2% to $2.7 million primarily due to professional fees associated with a proposed merger. On September 17, 2026, the company entered into a merger agreement with North Immunology, Inc., under which the combined entity will operate as North Immunology and shareholders will receive contingent value rights tied to the legacy Hemopurifier business. During the quarter, the company treated its second patient in the final dosing cohort of its Phase 1 oncology study in Australia and implemented workforce reductions to align with the merger timeline. As of September 30, 2026, the company held approximately $6.5 million in cash and cash equivalents.Healthcare
- LGCYNov 12, 4:30 PMLegacy Education Inc. reported a record student population of 3,684 for the first quarter of fiscal 2027, representing a 5.4% increase from the prior year. The company achieved $20.0 million in revenue and $0.9 million in net income, while expanding its footprint with a new campus lease in Houston, Texas. Strategic investments in faculty, facilities, and new programs drove educational services expenses up by 13.0%, resulting in a lower net income margin compared to the previous year. Additionally, the company recorded an estimated $0.7 million legal settlement expense and maintained a strong balance sheet with $21.7 million in cash and minimal debt.Consumer Defensive
- PLNHNov 12, 4:28 PMPlanet 13 Holdings Inc. reported a net loss of $6.4 million and revenue of $23.1 million for the third quarter of 2026. The company achieved a gross profit margin of 56.2%, a significant increase from the prior year, driven by the exit from California wholesale operations and a reduction in inventory reserves. Adjusted EBITDA improved to a loss of $0.2 million, reflecting better cost control and higher gross margins despite lower tourist traffic in Nevada. Additionally, the company announced that its Form S-4 merger registration with Vireo Growth Inc. was declared effective, with a shareholder vote scheduled for December 10, 2026.
- VRCANov 12, 4:27 PMVerrica Pharmaceuticals reported third-quarter 2026 total revenue of $6.9 million, driven by a record $5.7 million in net product revenue from YCANTH, which represents an 11.9% increase over the previous quarter. The company completed enrollment in its first pivotal Phase 3 trial for common warts and achieved milestones to unlock an additional $15.0 million in non-dilutive growth capital, extending its cash runway into the fourth quarter of 2027. Additionally, Verrica announced it is exploring the development of its oncolytic peptide, VP-315, for the treatment of Gorlin syndrome, a rare genetic disease characterized by frequent basal cell carcinomas.Healthcare
- NKTRNov 12, 4:25 PMNektar Therapeutics reported a net loss of $55.7 million for the third quarter of 2026, driven by increased research and development expenses totaling $44.1 million as the company advances its lead candidate rezpegaldesleukin into Phase 3 trials for atopic dermatitis and alopecia areata. Revenue for the quarter declined to $9.4 million from $11.8 million in the same period the previous year, while cash and investments rose significantly to $952.9 million. The company has initiated all three global registrational trials for the ZENITH AD program and expects topline data in mid-2028, with a target Biologics License Application submission in 2029.Healthcare
- ARMPNov 12, 4:24 PMArmata Pharmaceuticals reported a net income of $54.9 million for the third quarter of 2026, driven primarily by a $69.6 million gain from changes in the fair value of its convertible loan. The company advanced preparations for its pivotal Phase 3 superiority study of AP-SA02, receiving FDA Breakthrough Therapy designation and securing an additional $3.7 million in non-dilutive funding from the U.S. Department of War. Operating expenses for the quarter totaled $10.5 million, while the company held $18.3 million in unrestricted cash and cash equivalents as of September 30, 2026.Healthcare
- FGINov 12, 4:24 PMFGI Industries reported third-quarter 2026 total revenue of $31.7 million, an 11.6% decrease from the prior year, driven by softness in housing and remodeling activity. The company posted a gross profit of $8.7 million with an expanded gross margin of 27.6%, while operating and net losses were recorded at $0.5 million and $0.9 million, respectively. Revenue declined across core categories including sanitaryware and shower systems, though the custom kitchen cabinetry segment grew by 32.8%. Consequently, FGI revised its full-year 2026 net revenue guidance downward to a range of $120-127 million and adjusted its operating and net income forecasts to reflect continued market challenges.Consumer Cyclical
- XOSNov 12, 4:23 PMXos, Inc. reported a third consecutive quarter of positive GAAP gross profit for the period ended September 30, 2026, with the nine-month GAAP gross margin expanding to 26.9% from 13.3% in the prior year. Revenue for the quarter increased 17.0% sequentially to $5.5 million on 33 units delivered, while operating expenses were reduced by 10.0% year-over-year to $25.8 million for the nine-month period. The company delivered its first Xos Hub units internationally to support Waymo's autonomous vehicle operations in London and now has over 1,000 units in the field. Xos revised its full-year 2026 outlook to project revenue between $25 million and $35 million and unit deliveries between 185 and 250 units.Consumer Cyclical
- ENSCNov 12, 4:22 PMEnsysce Biosciences reported a net loss of $82.3 million for the third quarter of 2026, primarily driven by a $79.9 million non-cash charge for acquired in-process research and development related to the Cy Biopharma acquisition. The company completed the acquisition of Cy Biopharma in August, adding the CY200 pipeline asset for Complex Regional Pain Syndrome, and submitted a Phase 2a protocol for this candidate to the UK's MHRA in September. Additionally, Ensysce finished enrollment in the final stage of its PF614-MPAR-102 study for its abuse-deterrent opioid and ended the quarter with $29.7 million in cash and cash equivalents.Healthcare
- INVNov 12, 4:21 PMInnventure, Inc. reported a net loss of $333.8 million for the third quarter of 2026, driven primarily by a $323.5 million goodwill impairment charge. The company is executing a strategic repositioning that includes reducing parent-level headcount from 40 to 15 and transitioning its AeroFlexx and Refinity businesses away from reliance on Innventure capital. During the nine-month period ended September 30, 2026, Innventure generated $3.9 million in revenue while utilizing $74.5 million in operating cash flows. Management aims to preserve and maximize the value of its interest in Accelsius through disciplined capital allocation and cost reductions.Financial Services
- CRDFNov 12, 4:21 PMCardiff Oncology reported a net loss of $30.4 million for the nine months ended September 30, 2026, driven by $32.0 million in operating expenses. The company's Phase 2 trial for onvansertib in first-line RAS-mutated metastatic colorectal cancer remains ongoing, with median progression-free survival not yet reached in the 30 mg onvansertib plus FOLFIRI/bev arm compared to approximately 11 months in standard-of-care arms. As of late September 2026, all patients in the 30 mg onvansertib arm have exceeded 21 months on treatment, with the longest duration surpassing 29 months. Cardiff holds approximately $33.8 million in cash and cash equivalents as of September 30, 2026, and plans to initiate a registrational Phase 3 trial in the first quarter of 2027.Healthcare
- VATENov 12, 4:21 PMINNOVATE Corp. reported third-quarter 2026 consolidated revenue of $495.5 million, a 42.8% increase from the prior year, driven primarily by its Infrastructure segment. The company completed the sale of DBM Global to IES Holdings for approximately $413 million in cash and stock, and sold a controlling interest in HC2 Broadcasting to CONX Corp., retaining a 25% stake. Net income attributable to common stockholders rose to $15.8 million in the quarter, compared to a net loss of $9.4 million in the same period last year, largely due to a $32.9 million gain on the sale of the broadcasting interest. Total Adjusted EBITDA for the quarter reached $40.5 million, more than doubling the $19.8 million reported in the previous year.Industrials
- LVLUNov 12, 4:21 PMLulus reported a 20% year-over-year decline in third-quarter 2026 net revenue to $58.6 million, driven by a 20% drop in total orders placed and higher return rates. The company posted a net loss of $4.3 million and an adjusted EBITDA loss of $1.8 million, while successfully reducing inventory by 17% and improving gross margin by 230 basis points to 44.9%. Management revised its full-year 2026 outlook downward due to the continued impact of historical assortment decisions, though it anticipates revenue decline rates to moderate in fiscal 2027. Additionally, the company expects capital expenditures for 2026 to range between $1.5 million and $2.0 million.Consumer Cyclical
- CDXSNov 12, 4:20 PMCodexis, Inc. reported third-quarter 2026 total revenues of $19.3 million, a significant increase from $8.6 million in the same period of 2025, driven by higher product revenue from newly approved customer products. The company achieved a product gross margin of 74.5% for the quarter and reduced its net loss to $8.1 million, or $0.08 per share, compared to a $19.6 million loss in the prior year period. Financial stability was strengthened through a $25 million equity raise completed in July and a $60 million senior secured loan facility with Trinity Capital, which included a $42.5 million drawdown used to refinance existing debt. Codexis reiterated its full-year 2026 revenue guidance of $72 million to $76 million and expects its cash and investments to fund operations through the end of 2028.Healthcare
- YSSNov 12, 4:20 PMYork Space Systems reported third-quarter 2026 revenue of $84.2 million, a 7% decrease from the prior year, while recording a net loss of $807.4 million largely driven by a $749.7 million non-cash goodwill impairment charge. The company's backlog stood at $581.0 million as of September 30, 2026, supported by new contract wins and modifications, and its identified pipeline expanded by over 30% to $14.9 billion. York announced the permanent appointment of Brian Frantz as Chief Financial Officer and outlined strategic initiatives including the proposed acquisition of Outlook Industries to enter the unmanned systems market. Full-year 2026 revenue guidance was narrowed to a range of $380 million to $400 million, with the company maintaining total liquidity of $459 million.Industrials
- SCTXNov 12, 4:20 PMScribe Therapeutics reported third-quarter 2026 financial results, recording a net loss of $9.9 million and holding $174.2 million in cash, cash equivalents, and marketable securities as of September 30, 2026. The company completed an upsized initial public offering in July 2026, raising approximately $155.5 million in aggregate gross proceeds, which extends its funding runway into the first half of 2029. Clinical progress includes ongoing enrollment in the first-in-human Phase 1 trial for STX-1150, an epigenetic silencing therapy targeting LDL-C lowering, with initial data expected in the first half of 2027. Additionally, Scribe expanded its strategic collaboration with Sanofi to include access to its ELXR epigenetic silencing technology alongside its existing gene-editing platform.Healthcare
- CRWSNov 12, 4:19 PMCrown Crafts, Inc. reported second-quarter fiscal 2027 net sales of $19.0 million, a decrease from $23.7 million in the prior-year period. The company achieved a gross profit margin of 32.0%, an increase from 27.7% in the previous year, driven by $0.4 million in tariff refunds and offset by $0.2 million in severance expenses. Net income for the quarter rose to $1.3 million, or $0.12 per diluted share, compared to $1.2 million, or $0.11 per share, in the prior year. Additionally, the Board of Directors declared a quarterly cash dividend of $0.03 per share on the Series A common stock.Consumer Cyclical
- RMRNov 12, 4:19 PMThe RMR Group Inc. announced its financial results for the fiscal quarter ended September 30, 2026. The company, a leading U.S. alternative asset management firm focused on commercial real estate, manages approximately $37 billion in assets through over 800 professionals across more than 30 offices. A conference call to discuss these results was scheduled for November 13, 2026, at 11:00 a.m. Eastern Time, with a live webcast and replay options available.Real Estate
- GROWNov 12, 4:18 PMU.S. Global Investors reported a 18% increase in operating revenues to $2.7 million for the first quarter of fiscal 2027, ending the period with an operating income of $55,000 compared to a loss in the prior year. Average assets under management grew 14% to $1.6 billion, driven by a 45% surge in gold and precious metals strategies. The company also highlighted growth in its defense-focused WAR ETF and shipping-focused SEA ETF, while maintaining a shareholder yield of 8.33% and a strong liquidity position with $35.4 million in net working capital.Financial Services
- PMNNov 12, 4:17 PMProMIS Neurosciences reported a net loss of $8.2 million for the third quarter of 2026, with cash reserves totaling $44.1 million as of September 30, 2026. The company's lead Alzheimer's candidate, PMN310, remains on track to deliver unblinded 12-month topline data from the PRECISE-AD Phase 1b trial in the first quarter of 2027. Recent interim data showed no amyloid-related imaging abnormalities with edema and a 4.4% rate of hemorrhage, all of which were mild and asymptomatic. Ivana Rubino, Ph.D., a former senior executive at Biogen and Roche, was appointed Chief Commercial Officer effective October 5, 2026, to guide the company's late-stage development and commercial strategy.Healthcare
- PARKNov 12, 4:17 PMPark Dental Partners reported third-quarter 2026 revenue of $64.9 million, representing a 6.0% increase from the prior year, driven by same-practice growth and acquisitions. The company achieved net income of $1.7 million and adjusted EBITDA of $5.0 million for the quarter, while supporting 225 affiliated doctors across 88 practices. Full-year 2026 revenue is now projected to range between $262.0 million and $265.0 million, incorporating the expected contribution from the recently acquired Village Family DSO. Additionally, the company completed the acquisition of Village Family DSO in November 2026, with integration activities commencing immediately.Healthcare
- PROKNov 12, 4:17 PMProKidney Corp. reported third-quarter 2026 financial results, ending the period with $141.9 million in cash and cash equivalents to support operations through mid-2027. The company's pivotal Phase 3 PROACT 1 trial is on track to deliver eGFR slope topline results in the second quarter of 2027, with full enrollment expected to exceed 500 patients by the first quarter of 2027. During the quarter, research and development expenses rose to $40.8 million, driven primarily by increased clinical study and manufacturing costs associated with the ongoing trial. Additionally, the company presented eight new data abstracts at the ASN Kidney Week 2026 to further support the mechanistic and clinical evidence for its lead candidate, rilparencel.Healthcare
- ETRANov 12, 4:17 PMElectra Therapeutics reported a net loss of $23.9 million for the third quarter of 2026, supported by a cash position of $402.5 million following a $350 million IPO. The company is advancing its lead candidate, ipsoprubart, through a global registrational program for secondary hemophagocytic lymphohistiocytosis with enrollment completion expected in the second half of 2027. Additionally, ipsoprubart is being evaluated in a Phase 1 trial for T/NK cell malignancies, while the second candidate, ELA822, has initiated a Phase 1 trial in healthy volunteers with data expected in early 2027.Healthcare
- CTSONov 12, 4:16 PMCytoSorbents Corporation reported third-quarter 2026 revenue of $9.7 million, representing a 3% increase from the prior year, while achieving positive operating cash flow of approximately $43,000 excluding restructuring payments. The company improved its gross margin to 75% and reduced total operating expenses by 11% to $8.5 million, resulting in a net loss of $1.8 million compared to $3.2 million in the same period last year. Management highlighted progress on four strategic value drivers, including sustaining cash flow breakeven, revitalizing the core CytoSorb franchise in Germany, advancing the DrugSorb-ATR submission to the FDA for the U.S. market, and exploring commercial opportunities for the HemoDefend-BGA technology.Healthcare
- DFLINov 12, 4:16 PMDragonfly Energy reported third-quarter 2026 net sales of $12.2 million, a 23.8% decrease year-over-year, driven by softness in the recreational vehicle market despite heavy-duty trucking revenue more than doubling sequentially to $1.3 million. The company recorded a net loss attributable to common stockholders of $6.7 million and an adjusted EBITDA loss of $2.3 million, while completing the acquisition of the Dakota Lithium brand to expand its product portfolio. Management projects fourth-quarter 2026 net sales of approximately $12.5 million with adjusted EBITDA expected to reach breakeven, supported by continued fleet adoption and cost-reduction initiatives.Industrials
- ANABNov 12, 4:16 PMAnaptysBio reported fiscal first quarter 2027 results showing Jemperli global net sales of $1.0 billion for the nine months ended September 30, 2026, representing 29% year-over-year growth. The company received $30.3 million in collaboration revenue for the quarter, driven by Jemperli royalties, while net income from continuing operations was $3.9 million. Regulatory updates include FDA approval for Jemperli in locally advanced rectal cancer and an expected PDUFA decision for Quimilza in December 2026. Additionally, a post-trial hearing in the litigation with GSK and Tesaro was held on October 20, 2026, with a judgment anticipated in late 2026 or early 2027.Healthcare
- MSAINov 12, 4:16 PMMultiSensor AI Holdings, Inc. reported third-quarter 2026 net revenue of $1.5 million, a decrease from $1.6 million in the same period of 2025, driven by lower hardware sales and the discontinuation of inspection services. Software subscriptions now constitute the majority of revenue, accounting for 58% of the total, while the company posted a net loss of $1.9 million for the quarter. The company ended the period with $20.4 million in cash and cash equivalents, having reduced its cash burn rate through disciplined spending and strong collections. Strategic progress included the launch of a 14-site rollout in North America for a major global distributor and the expansion of deployments with Manchester Airports Group and a new pilot in the Asia-Pacific region.Technology
- WATTNov 12, 4:16 PMEnergous Wireless Power Solutions reported third-quarter 2026 revenue of approximately $3.4 million, representing a 167% increase compared to the same period in 2025. Year-to-date revenue for the nine months ended September 30, 2026, reached $9.6 million, a 270% rise over the prior year that exceeded the company's full-year 2025 revenue of $5.6 million. The company achieved a gross margin of 14% in the third quarter, improving from 3% in the second quarter, while shipping over 69,500 transmitters since 2024. Energous maintained a net loss of approximately $2.5 million for the quarter, or $0.45 per share, and held $28.8 million in cash and cash equivalents as of September 30, 2026.Technology
- RNANov 12, 4:16 PMAtrium Therapeutics reported third-quarter 2026 financial results, recording $15.3 million in collaboration revenue primarily from a milestone payment with Bristol Myers Squibb. The company dosed the first patient in its Corventis Phase 1/2 clinical trial for ATR 1072, a treatment targeting the root cause of PRKAG2 syndrome, following nonclinical data showing the drug reversed cardiac glycogen accumulation. A $50 million private placement closed in October, bringing the pro-forma cash balance to $293.6 million and extending the company's operational runway through 2028. For the quarter, the company reported research and development expenses of $13.8 million and general and administrative expenses of $8.2 million.Healthcare
- AMPGNov 12, 4:16 PMAmpliTech Group reported third-quarter 2026 revenue of $6.58 million, an 8.0% increase year-over-year, with gross margin expanding sequentially to 34.2%. The company achieved a nine-month gross profit growth of 41.1% to $7.07 million while narrowing its net loss to $1.89 million for the quarter. Following quarter-end, AmpliTech announced record bookings near $25 million in October, pushing its total backlog to over $52 million. Management revised its full-year 2026 revenue outlook to at least $28 million, citing supply-chain constraints and deployment delays that prevented the achievement of a previously withdrawn $50 million target.Technology
- TNONNov 12, 4:15 PMTenon Medical, Inc. reported third-quarter 2026 revenue of $1.4 million, representing a 22% increase compared to the same period in 2025. The company achieved a gross profit of $1.0 million with a gross margin of 66.3% and ended the quarter with $8.3 million in cash and cash equivalents. During the quarter, Tenon raised approximately $15.6 million in gross proceeds, fully repaid its senior convertible notes, and launched the 3D-printed lateral screw for its SImmetry+ SI Joint Fusion System. Additionally, the company added eight new U.S. patents to its portfolio, bringing the total to 38 issued patents.Healthcare
- VNRXNov 12, 4:15 PMVolitionRx Limited reported third-quarter 2026 revenue of approximately $1.6 million, a 157% increase from the prior year, driven by deferred revenue recognition. The company narrowed its operating loss to $3.3 million and reduced its net loss to $3.8 million while strengthening its balance sheet with $2.4 million in cash and the full repayment of a $7.5 million convertible note. Strategic progress includes the launch of the DETECSEPS program for sepsis detection, active licensing discussions for its Capture-Seq technology targeting a combined market over $36 billion, and a pending reimbursement submission for its lung cancer test in France. Additionally, the CEO and board voluntarily reduced their compensation by 50% to align with the company's cost-reduction efforts and commitment to securing licensing agreements.Healthcare
- RCKTNov 12, 4:15 PMRocket Pharmaceuticals reported a net loss of $49.2 million for the third quarter of 2026, with cash, cash equivalents, and investments totaling $279.4 million as of September 30, 2026. The company received FDA alignment to complete its pivotal Phase 2 trial of RP-A501 for Danon disease, with dosing expected to finish by mid-2027. Additionally, dosing has begun in the Phase 1 trial for RP-A701 targeting BAG3-associated dilated cardiomyopathy, and the commercial product KRESLADI achieved readiness with activated treatment centers on October 1, 2026.Healthcare
- QXONov 12, 4:15 PMQXO, Inc. reported a net loss of $123 million for the third quarter of 2026, with net sales reaching $4.90 billion. Despite the GAAP loss, the company achieved an Adjusted Net Income of $229 million and Adjusted EBITDA of $557 million, driven by a 2.2% year-over-year pricing increase and strong demand in mechanical insulation and data centers. The company serves 194,000 customers across its integrated legacy businesses and has authorized a $500 million share repurchase program. Management projects reaching $4 billion in adjusted EBITDA and $50 billion in annual revenue by 2030 through organic growth and acquisitions.Industrials
- GCTSNov 12, 4:15 PMGCT Semiconductor Holding, Inc. reported third-quarter 2026 net revenues of $1.1 million, representing a 148.6% increase from the prior year period, driven by shipments of over 3,200 5G chipsets. The company achieved a net loss of $7.4 million, a 46.7% decrease year-over-year, which included $6.2 million in gains from changes in the fair value of warrant liabilities. Cash and cash equivalents stood at $17.2 million as of September 30, 2026, while the company extended the maturities of $26.5 million in loans during the quarter. Management expects 5G shipment volumes to ramp significantly into the first half of 2027 as customer integration schedules progress.Technology
- NEOVNov 12, 4:15 PMNeoVolta Inc. reported revenue of $2.8 million for the quarter ended September 30, 2026, a significant increase from the previous quarter driven by initial sales through its third-party ownership residential platform. The company achieved a gross profit of $1.0 million, reversing a prior gross loss, while reporting a GAAP net loss of $7.7 million and adjusted EBITDA of negative $5.5 million. Financial results were supported by a $20 million senior secured term loan, bringing total cash and restricted cash to $28.8 million. Strategic progress included the ramp-up of the Pendergrass, Georgia manufacturing facility, a $116 million master purchase agreement for utility-scale products, and a supply collaboration with SK On for 9 GWh of battery cells.Industrials
- CBIONov 12, 4:15 PMCrescent Biopharma completed dose escalation in its Phase 1/2 ASCEND trial for CR-001, having dosed over 125 patients across the United States, Europe, and South Korea, with initial monotherapy data expected in the first quarter of 2027. The company has also dosed the first patient in the global APOLLO trial for CR-002, a PD-L1-targeted ADC, while multiple Phase 2 studies of CR-001 combinations with sacituzumab tirumotecan are ongoing in China. Financially, Crescent reported a net loss of $37.7 million for the third quarter of 2026, with cash and cash equivalents totaling $289.4 million as of September 30, 2026.Healthcare
- FLONov 12, 4:15 PMFlowers Foods, Inc. reported third-quarter 2026 net sales of $1.169 billion, a 4.7% decrease from the prior year, driven by a 7.0% decline in volume that outweighed a 2.3% favorable price and mix. Net income fell 63.6% to $14.4 million, while adjusted net income decreased 56.0% to $21.4 million, resulting in diluted earnings per share of $0.07. The company cited challenging market conditions, including pressure on household budgets and higher logistics costs, as key factors impacting performance. Consequently, Flowers Foods revised its full-year 2026 guidance downward, projecting net sales between $5.016 billion and $5.063 billion and adjusted diluted EPS between $0.63 and $0.68.Consumer Defensive
- BLSMNov 12, 4:15 PMBlossomHill Therapeutics reported a net loss of $24.0 million for the third quarter of 2026, driven by increased research and development expenses related to its lead candidate BH-30643. The company aligned with the FDA on a recommended Phase 2 dose of 50 mg twice daily for BH-30643 and announced the upcoming SOLARA-2 pivotal trial, which is expected to dose its first patient in the first quarter of 2027. Additionally, BlossomHill plans to submit an Investigational New Drug application for its pan-KRAS inhibitor, BH-501284, in the first quarter of 2027. As of September 30, 2026, the company held $224.9 million in cash and cash equivalents, which is projected to fund operations through the second quarter of 2028.Healthcare
- AZTRNov 12, 4:15 PMAzitra, Inc. reported a net loss of $3.0 million for the quarter ended September 30, 2026, with total operating expenses reaching $2.9 million. The company announced positive ex vivo results for its ATR-COSF program, demonstrating a 50% reduction in fine lines and improved skin elasticity, and plans to initiate a first-in-human cosmetic study with results expected by year-end. Additionally, Azitra completed Cohort 1 of its ATR-04 Phase 1/2 trial and received approval to proceed to Cohort 2, which will expand eligibility to include patients with KRAS and MEK inhibitor-associated rashes. As of September 30, 2026, the company held $3.8 million in cash and cash equivalents.Healthcare
- IMMXNov 12, 4:15 PMImmix Biopharma reported a 89% complete response rate across all 45 patients in its NEXICART-2 clinical trial for NXC-201, with potential for up to 98% complete response. The company appointed David He as Senior Vice President of Technical Operations and Karin McIntosh as Senior Vice President of Regulatory Affairs to advance commercial launch preparations. Immix plans to submit a Biologics License Application in mid-2027 and initiate the NEXICART-3 front-line trial in the first half of 2027. For the third quarter ended September 30, 2026, the company reported $340.9 million in cash and marketable securities, providing an operating runway into mid-2028, alongside $15.9 million in operating expenses.Healthcare
- HKHCNov 12, 4:15 PMHorizon Kinetics Holding Corporation reported a net loss of $18.4 million for the third quarter of 2026, driven by unrealized declines in the fair value of key investment holdings. Management and advisory fees remained flat at $17.8 million for the quarter, while assets under management decreased 7.3% to $10.0 billion. The company declared a $0.13 per share cash dividend and authorized a $25 million share repurchase program. Year-to-date results showed a net income of $35.8 million, reflecting unrealized gains that offset the quarterly losses.
- KLCNov 12, 4:15 PMKinderCare Learning Companies reported a net loss of $85.0 million for the third quarter of 2026, driven by $83.4 million in impairment losses and a 5.9% decline in enrollment at its early childhood education centers. Total revenue for the period decreased 1.7% to $665.3 million, while adjusted EBITDA fell to $42.5 million compared to the prior year quarter. The company closed 20 centers as part of an optimization initiative and updated its full-year 2026 revenue guidance to a range of $2.64 billion to $2.66 billion.Consumer Defensive
- MRLNNov 12, 4:14 PMMerlin, Inc. reported a third quarter 2026 GAAP net income of $73.8 million, a significant turnaround from the $58.4 million loss in the second quarter of 2026. Total revenue for the quarter reached $3.5 million, while the company ended the period with $161.6 million in cash, cash equivalents, and short-term investments and no outstanding debt. The company secured an $8.9 million task order from USSOCOM for its C-130J autonomy program and a $500,000 contract from USAFRICOM for an autonomous casualty evacuation demonstration. Looking ahead, Merlin plans to reduce 2027 operating expenses by focusing investment on funded programs with clear revenue paths to preserve its balance sheet.Industrials
- NTLANov 12, 4:14 PMIntellia Therapeutics has submitted a Biologics License Application for lonvo-z, an investigational one-time in vivo CRISPR gene editing therapy for hereditary angioedema (HAE), with a PDUFA goal date of March 10, 2027. Phase 3 HAELO trial data demonstrated a 62% reduction in mean attack rates and an 87% reduction in attack-free weeks compared to placebo, with benefits sustained for up to four years in long-term follow-up. The treatment permanently inactivates the KLKB1 gene to stop excess kallikrein production, offering a potential cure that eliminates the need for chronic long-term prophylaxis and significantly reduces the disease burden for patients.Healthcare
- TACTNov 12, 4:13 PMTransAct Technologies reported preliminary third-quarter 2026 net sales of $14.4 million, representing a 10% increase year-over-year driven by a 33% rise in Food Service Technology revenue. The company recorded a net loss of $440 thousand for the quarter, with adjusted EBITDA reaching $289 thousand, while revising its full-year 2026 revenue guidance to between $55 million and $56 million. Management highlighted strong growth in FST software revenue and online unit installations, though the Casino and Gaming segment experienced a decline due to cyclicality. Additionally, the Board has initiated a strategic review of the Casino and Gaming business, potentially including a sale of the FST division, to maximize stockholder value.Technology
Earnings Call Transcripts
More →- ALCOALICO, INC. (NASDAQ: ALCO) 2026 SOUTHWEST IDEAS CONFERENCE - ALICO INC Alico has pivoted from citrus agriculture to a liquidation strategy focused on residential and commercial land development, having exited the citrus sector to halt a $30 million annual loss. The company currently holds a 47,000-acre portfolio valued between $650 million and $750 million, with projected cash reserves of $50–$55 million providing a three-year runway to cover operating costs without revenue. Key projects include the Corkscrew Grove mixed-use development in Collier County and smaller pilot sites in Polk and Highlands counties, with full entitlement approval for Corkscrew Grove expected by mid-2028. Since 2015, the company has returned approximately $210–$219 million to shareholders through debt prepayments, dividends, buybacks, and tender offers while maintaining a net debt of roughly $82 million. 1d ago
- CMPR2026 SOUTHWEST IDEAS CONFERENCE - CIMPRESS PLC The company reported $3.7 billion in annual revenue for fiscal 2026, driven by a strategic shift toward elevated product categories such as promotional apparel and packaging. Management projects adjusted EBITDA to reach at least $615 million by fiscal 2028, supported by cost efficiencies from manufacturing investments and a net leverage ratio declining below 2.0x. A key growth driver includes a partnership with Canva to integrate production capabilities into its design platform, alongside the adoption of agentic commerce channels. Despite missing Q1 fiscal 2027 revenue expectations, the company maintains confidence in delivering long-term organic growth and cash flow targets through its vertically integrated supply chain. 1d ago
- CMPRCimpress (Nasdaq: CMPR) 2026 Southwest Ideas Conference - CIMPRESS PLC The company reported $3.7 billion in annual revenue for fiscal 2026, reflecting a 10% reported growth and generating $122 million in adjusted free cash flow. Strategic initiatives are shifting the product mix toward higher-value items such as packaging, apparel, and signage while expanding into new channels like the Canva partnership. Management projects at least 7% revenue growth for fiscal 2027 and aims to reduce net leverage below 2.0x by fiscal 2028 through operational efficiencies and AI-driven automation. Despite a Q1 fiscal 2027 revenue miss, the organization remains committed to full-year guidance via accelerated cost reduction measures and maintains a vertically integrated manufacturing network across 25 countries. 1d ago
- ANDEStephens Annual Investment Conference | Nash2026 - ANDERSONS INC Andersons has acquired Harveststone Low-Carbon Partners for $915 million, adding 215 million gallons of ethanol production capacity and immediate carbon capture capabilities to its portfolio. The transaction is projected to increase pro forma EBITDA to approximately $700 million annually, driven by the new segment's contribution of $225–$250 million and the integration of low-carbon tax credits. Management targets a long-term EPS of $7.00 by the end of 2028, with the acquisition expected to result in a pro forma leverage ratio of roughly 2.0x debt to EBITDA. 1d ago
- OPFISTEPHENS ANNUAL INVESTMENT CONFERENCE | NASH2026 - OPPFI INC OpFi reported stabilized credit metrics in the third quarter with recovery rates averaging 20% of gross charge-offs, supported by a robust balance sheet holding $141 million in cash. The company initiated share repurchases under a $40 million authorization and is transitioning its core installment loan business toward a diversified fintech platform featuring new Line of Credit products and the Lola technology system. Future growth strategies include the full consolidation of Biddy in 2026, the launch of an iOS and Android app to bypass current marketing restrictions, and the potential acquisition of an Earned Wage Access provider. 1d ago
- CSTLSTEPHENS ANNUAL INVESTMENT CONFERENCE | NASH2026 - CASTLE BIOSCIENCES INC The company reported a 24% year-over-year revenue increase in the third quarter and raised its full-year revenue guidance to a midpoint of $385–$395 million. Adjusted EBITDA is projected at $12.7 million with free cash flow estimated at $19.7 million, supported by a strong balance sheet holding approximately $278 million in cash and securities. Strategic growth for 2027 focuses on mid-single-digit volume expansion in the Melanoma and TissueCypher segments, while long-term objectives target the Advanced Atopic Dermatitis test and EIS technology as major revenue drivers by 2028–2030. 1d ago
- PRKVirtual Shareholder's Meeting - PARK NATIONAL CORP The 2026 Annual Meeting of Shareholders was held virtually on November 18, 2026, with a quorum established by 38,432,037 shares. Seven directors were elected to the board, and Crowe LLP was ratified as the independent registered public accounting firm for the fiscal year. Management focused exclusively on procedural and governance matters, with no financial data, business updates, or analyst questions discussed. The results of the meeting are scheduled to be filed in a Form 8K within four business days. 1d ago
- RPMANNUAL MEETING OF SHAREHOLDERS - RPM INTERNATIONAL INC Fiscal year 2026 revenue reached a record $7.1 billion, marking a 23% year-over-year increase, while non-GAAP earnings per share rose 59% to $5.61. The annual meeting featured the election of four new Class III directors, approval of executive compensation, and the ratification of Ernst & Young LLP as the independent auditor. Approximately 77% of entitled votes were represented, and all three proposals passed successfully. The company plans to file audited financial statements in a Form 10-K and final voting results in a Form 8K within four business days. 1d ago
- BRAnnual Meeting of Stockholders - BROADRIDGE FINANCIAL SOLUTIONS INC The company generated approximately $60 million in revenue and $4 million in net income for the fiscal year ended 2025, while securing a $4 billion VAT/EVA tax refund in August 2026 to address liquidity constraints. Operational improvements included increasing the head grade to over 3 grams per ton and enhancing processing efficiency so that gravity concentrates now contribute roughly 30% of total gold production. Management outlined a seven-year mine plan targeting 250,000 ounces of reserves, with significant expansion in underground development and exploration efforts in the Tres Amigos and San Pablo areas. The company also resolved legal uncertainties regarding eight concessions through a favorable ruling in August 2026 and is evaluating a potential up-listing in Canada to improve stock liquidity. 1d ago
- MGXMetagenomi Therapeutics, Inc. at Jefferies Global Healthcare Conference in London - METAGENOMI THERAPEUTICS INC The clinical-stage biotech company holds approximately $102 million in cash, providing a runway through 2028 to fund its development pipeline. Its lead program, MGX001, is an in vivo CRISPR gene editing therapy for Hemophilia A designed to integrate the therapeutic gene into the albumin locus for stable, long-term expression. The company plans to initiate the Phase I-II 'Integrate' clinical trial in the first half of next year, with initial safety and efficacy data expected in the second half. Management anticipates submitting regulatory applications in multiple jurisdictions to support a global trial aimed at establishing a curative, one-time treatment. 1d ago
- INOINOVIO PHARMACEUTICALS, INC. JEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - INOVIO PHARMACEUTICALS INC Viseric (INO-9912) has received FDA accelerated approval as the first DNA medicine for Recurrent Respiratory Papillomatosis, designed to reduce the frequency of surgeries in adults by targeting the underlying HPV infection. The company is transitioning to a commercial stage with zero debt and sufficient cash reserves to fund operations through the end of the next year, aiming to ship the product within 60 days of approval. Clinical data indicates that 72% of patients experienced a 50-100% reduction in surgeries during the first year, with 28% requiring no surgeries at all. The firm plans to deploy a full field force in the first quarter following approval and targets establishing payer coverage for 80% of the potential patient population within nine months. 1d ago
- INOINOVIO PHARMACEUTICALS, INC. - Jefferies Global Healthcare Conference in London - INOVIO PHARMACEUTICALS INC 1d ago
- AVDLAlkermes plc - AVADEL PHARMACEUTICALS PLC The company is advancing a diversified orexin agonist pipeline with six clinical trials expected to report data through 2025, including Phase 3 programs for narcolepsy and an Idiopathic Hypersomnia study. Strategic expansion targets major unmet needs in ADHD, Major Depressive Disorder, and fatigue associated with multiple sclerosis and Parkinson's disease, leveraging a mechanism that offers cognitive benefits beyond simple wakefulness. Management prioritizes capital efficiency and has implemented split-dosing strategies to address efficacy waning, while monitoring safety profiles for issues such as polyuria and potential LDL increases. 1d ago
- NTRAJefferies Global Healthcare Conference in London - NATERA INC The company reported a record quarter with 42% year-over-year organic revenue growth and updated its full-year 2024 revenue guidance to exceed $3 billion. Management has set a strategic long-term target of $6 billion in revenue by 2029, driven by volume expansion in the Signatera oncology portfolio, Average Selling Price increases, and the anticipated readout of the FIND study for early colorectal cancer detection. The organization is transitioning leadership with Solomon Moskovich succeeding the current CEO while maintaining a stable executive team focused on commercial execution and payer compliance. Significant growth is also anticipated in the pharma services segment following positive trial results and in the women's health and transplant markets. 1d ago
- NFGCEarnings Call - NEW FOUND GOLD CORP The company is advancing its strategy by replicating Hammerdown's mining systems at the Queensway project, which controls a 110 km fault zone with significant untapped potential. While Queensway is developed, the firm will utilize the permitted Pine Cove mill for immediate off-site processing and tailings management. Operations rely heavily on local recruitment in Newfoundland and leverage existing deep-sea port infrastructure for logistical efficiency. Management maintains a confident outlook regarding the extensive exploration opportunities within the Abitibi belt and the economic benefits expected for the region. 1d ago
- MXCTMAXCYTE, INC. STEPHENS ANNUAL INVESTMENT CONFERENCE | NASH2026 - MAXCYTE INC Following the acquisition of Akron, the combined entity projects a 27% year-over-year revenue growth for its core business and a 50% reduction in net losses driven by improved operating leverage. The merged company targets a gross margin profile in the low 70s and anticipates reaching cash flow positivity by the end of 2027, supported by $34.5 million in annual revenue and $40–45 million in post-closing cash reserves. Strategic synergies include the expansion of the cell therapy workflow to cover both viral and non-viral platforms, embedding the solution into five commercial therapies, and leveraging Akron's proprietary liquid cytokine formulations to reduce manufacturing costs. 1d ago
- WVEWave Life Sciences Ltd. - Jefferies Global Healthcare Conference in London - WAVE LIFE SCIENCES INC The company is conducting Phase 2 trials for its primary asset, Inhibitin, focusing on reducing visceral fat while preserving lean muscle mass rather than solely targeting scale weight reduction. Management aims to achieve a 5% total body weight reduction within 12 months, with interim data expected at three months and definitive efficacy results at six months. The study design includes a unique maintenance arm to test the drug's ability to prevent weight regain after discontinuing current incretin therapies, addressing the high dropout rates associated with existing treatments. Additionally, the company has secured regulatory agreement for a robust trial design for Alpha-1 Antitrypsin Deficiency that supports both full and accelerated approval pathways. 1d ago
- PRKSLR INVESTMENT CORP. ANNUAL MEETING OF STOCKHOLDERS - PARK NATIONAL CORP The annual stockholder meeting held with a record date of September 24, 2026, focused exclusively on corporate governance matters without discussing financial performance, business segments, or market trends. Shareholders voted on two proposals, both of which passed: the election of Bruce Bowler and Stephen Hochberg as directors, and the ratification of KPMG LLP as the independent auditor. Management maintained a neutral, procedural tone throughout the session, addressing only the voting protocols and agenda items. No forward guidance, analyst questions, or specific business risks were addressed during the gathering. 1d ago
- GHJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - GUARDANT HEALTH INC The company achieved significant revenue growth in Q3 driven by a 29% increase in Garden 360 volume, over 100% growth in Reveal tests, and a threefold expansion in SHIELD volume. Gross margins improved substantially following FDA approval of the low-cost SHIELD test, which reduced costs per test from over $400 to $330, with a target to reach $200 by 2028. The non-screening business reached breakeven in 2023, while the full company is projected to achieve free cash flow break-even by Q4 2027 as major payer contracts for SHIELD take effect. Future growth strategies include expanding the sales force to 600-700 representatives, launching an All-Disease Blood Test for Garden 360 in 2027, and leveraging epigenomic data to detect over 500 non-oncology diseases. 1d ago
- BRBRBellRing Brands Fourth Quarter Fiscal Year 2026 Earnings Conference Call - BELLRING BRANDS INC BellRing Brands reported Q4 fiscal 2026 net sales growth of 7% year-over-year, driven by Premier Protein and Dymatize, though adjusted EBITDA margins were impacted by inventory-related charges and inflationary pressures. The company withdrew its previous long-term financial targets to conduct a strategic review and issued refreshed guidance for fiscal 2027, projecting net sales between $2.32 billion and $2.42 billion with an adjusted EBITDA margin expansion to approximately 14%. Management is prioritizing a shift toward profitable growth through low-double-digit price increases, $25 million in cost savings, and a focus on reducing net leverage below 3.0x by the end of fiscal 2027. 1d ago
- JMIAJumia 3Q 2026 Earnings Call - JUMIA TECHNOLOGIES AG Revenue reached $60.7 million, representing a 33% year-over-year increase driven by higher first-party sales and market-based revenue. Adjusted EBITDA loss narrowed by 43% to $7.9 million, while the company reduced headcount by 3% to 1,720 employees to improve unit economics. Despite strong growth in key markets like Nigeria and Egypt, the company revised its Q4 guidance downward due to weaker Black Friday trends and external headwinds including global memory chip shortages and cocoa price volatility in Ivory Coast. 1d ago
- KRNTThird Quarter 2026 Earnings Conference Call - KORNIT DIGITAL LTD The company reported third-quarter revenue of $58.3 million, representing a 9.8% year-over-year increase, while adjusted EBITDA rose to $2.7 million with a 4.6% margin. Annual Recurring Revenue grew 83% to $39.4 million, driven by a surge in All-Inclusive Consumption revenue which now accounts for approximately 70% of system sales. Management projects fourth-quarter revenue between $60 million and $65 million and anticipates full-year growth supported by an 80% recurring revenue base and expanding adoption of long-run digital production. 1d ago
- STROJeffries Global Healthcare Conference in London - SUTRO BIOPHARMA INC The company has successfully advanced three clinical programs within two years, transitioning from a discovery platform to a development-focused biotech. Its proprietary cell-free technology enables stable high drug-to-antibody ratios, allowing for the administration of STRO4 and STRO6 at doses significantly higher than approved competitors while maintaining a favorable safety profile with low hematologic toxicity. Future development strategies prioritize dual and triple payload formats to overcome drug resistance in pancreatic and lung cancers, with initial data for STRO4 already demonstrating activity in heavily pretreated patients. 1d ago
- AUNAAuna 3Q26 Conference Call - AUNA SA Total revenue grew 10% year-over-year on an FX-neutral basis while consolidated free cash flow surged 95% to S/626 million. Adjusted EBITDA declined due to extraordinary costs in Colombia and billing adjustments in Peru, though underlying fundamentals remain strong with Mexico's EBITDA growing 5%. The company maintains a leverage ratio of 3.5x and has updated its full-year 2026 revenue guidance to 10-14% growth. Strategic initiatives include expanding high-complexity care in Peru and Colombia while managing regulatory headwinds and operational risks. 1d ago
- ALXOJefferies Global Healthcare Conference in London - ALX ONCOLOGY HOLDINGS INC The company secured $150 million in equity financing in January to support its clinical development pipeline and maintain a well-funded status through the end of next year. Its lead asset, ALX2004, an EGFR-targeted antibody-drug conjugate utilizing a novel metuzumab epitope, aims to reduce toxicity rates to 30% or less while targeting head and neck and lung cancers. Strategic guidance projects data readouts for 35–40 patients in December and Phase 2 enrollment of 120 patients for the HER2-targeted ALX-Evo program by year-end, with a goal to be pivotal trial-ready by late 2026. Additionally, the CD47 bispecific program has treated over 800 patients and is now focused on identifying specific biomarkers to optimize its immunotherapy application. 1d ago
- ALXOALX ONCOLOGY HOLDINGS INC. - ALX ONCOLOGY HOLDINGS INC The company secured $150 million in financing in January 2024 to support its pre-revenue biotech development through key milestones. Its lead asset, AOX 2004, is an EGFR-targeted antibody-drug conjugate designed to treat head and neck, lung, and esophageal cancers, with pivotal trial readiness targeted for late 2025. Concurrently, the ALX-0004 CD47 program has been dosed in over 800 patients and is pivoting toward a targeted immunotherapy strategy with Phase 2 data expected in the second half of the year. 1d ago
- PRKANNUAL MEETING OF STOCKHOLDERS - PARK NATIONAL CORP The company held its Annual Meeting of Stockholders with a record date of September 30, 2026, to address governance matters rather than financial performance. Three directors, Manny Fernandez, Bill Dawson, and Laura Flannigan, were acknowledged for their service as they do not stand for re-election, while John Simon from Deloitte was welcomed as a new board member. Shareholders approved three proposals: the election of ten directors, the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal 2027 and 2028, and the non-binding approval of executive compensation. Final voting results will be filed on Form 8-K within four business days. 1d ago
- ORICOric Pharmaceuticals, Inc. Jefferies Global Healthcare Conference in London - ORIC PHARMACEUTICALS INC The company maintains a cash position of $345 million, providing a runway extending into the second half of 2028 to fund ongoing Phase 3 trials. Rinzimetastat, an oral PRC2 inhibitor for prostate cancer, is expected to report top-line data from the Phase 3 Himalayas 1 study in the first half of 2026, demonstrating a 60% 10-month progression-free survival rate with a favorable safety profile. Enozertinib, an EGFR inhibitor for lung cancer, targets atypical and Exon 20 mutations with an 84% overall response rate and superior central nervous system penetration, with Phase 3 trials planned to initiate in 2026. 1d ago
- TFXJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - TELEFLEX INC The company maintains a low leverage ratio of 1.4x and has deployed $1.3 billion in capital through share buybacks and debt reduction, with further targets set for the completion of its final divestiture. Management projects a pro forma operating margin of approximately 23% by 2027, driven by cost-out programs, the expiration of transition service agreements, and P&L leverage as revenue growth accelerates. Strategic initiatives include the integration of Biotronic VI to create a complete interventional portfolio, the launch of new products like the absorbable metal stent FreeSolve, and a transition to a simplified global business unit structure. While the company faces near-term challenges from regulatory delays and integration disruptions, it anticipates stabilizing its cost structure by 2026 to focus on margin expansion and market growth in the following years. 1d ago
- VIRJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - VIR BIOTECHNOLOGY INC The company maintains a robust financial position with $901 million in cash and a $90 million upfront payment from a Gilead collaboration, extending its runway through 2029. Its Hepatitis Delta program, Elapseron and Tobevibart, demonstrated approximately 80% undetectable viral RNA rates in Phase 3 trials, with potential for a finite curative regimen. Future milestones include Phase 2/3 data releases in early 2027, an NDA filing for mid-2027, and the initiation of pivotal prostate cancer trials for the VR5500 asset. The organization aims to capitalize on the orphan disease market with a projected opportunity exceeding $1 billion while leveraging its ProX10 masked T-cell engager technology to reduce toxicity in solid tumor treatments. 1d ago
- ALNYJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - ALNYLAM PHARMACEUTICALS INC Alnylam Pharmaceuticals deferred full financial guidance until February, citing a need for more experience with new 340B reimbursement rules that will shift from ASP plus 6% to ASP minus 28% starting in 2027. The company is expanding its field force to drive adoption of Amvutra among non-prescribing physicians while managing payer tier restrictions in some Medicare Advantage plans. For its next-generation TTR silencer, Triton-CM, the Phase 3 study size was increased to 2,250 patients to account for declining background event rates, with results expected around 2030. Management plans to finalize contracting strategies by mid-December to ensure 340B institutions remain economically viable under the upcoming regulatory changes. 1d ago
- ILOGQuantum Computing in Practice: From Fundamentals to First Use Cases - ILOG SA IBM has committed $10 billion over five years to advance quantum computing, including a $1 billion investment in its Andero subsidiary to establish a domestic quantum chip foundry. The company's 2026 roadmap targets the release of the Nighthawk processor with 120 programmable qubits, while full error-corrected quantum computing is projected for 2029. Quantum access is offered through various pricing tiers ranging from free monthly minutes to premium plans, alongside on-premise licensing for high-performance computing integration. Strategic acquisitions and partnerships aim to enhance hardware capabilities and develop industry-specific algorithms, with management anticipating a market shift toward practical quantum applications by the end of the decade. 1d ago
- IONSJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - IONIS PHARMACEUTICALS INC The company has launched three wholly-owned medicines: Tringolza for severe hypertriglyceridemia, Donzara for hereditary angioedema, and Zanvastro for Alexander disease, bringing its total market portfolio to seven products. Tringolza is the first FDA-approved therapy to demonstrate a statistically significant reduction in acute pancreatitis, targeting approximately one million high-risk patients in the U.S. and a similar number in Europe. Management anticipates 2026 as a pivotal year for Tringolza's growth, with commercial payer coverage expanding throughout the current year and Medicare contracts expected next. 1d ago
- IONSJefferies Global Healthcare Conference in London - IONIS PHARMACEUTICALS INC The company has launched Trimgulza, the first FDA-approved therapy to demonstrate a statistically significant reduction in acute pancreatitis, expanding its use from Familial Chylomicronemia Syndrome to Severe Hypertriglyceridemia. Commercial payer coverage for Severe Hypertriglyceridemia reached 34% of commercial lives by September, with over 1,500 unique prescribers adopting the treatment despite initial access barriers requiring trials of generic therapies. Management projects 2026 as a pivotal growth year driven by Medicare contract acquisitions and a pipeline of four Phase 3 medicines, while actively deploying Quick Start programs to bridge the gap until full commercialization. 1d ago
- ALLOJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - ALLOGENE THERAPEUTICS INC Allogene Therapeutics is advancing its clinical-stage allogeneic CAR-T program, SemaCell, for post-frontline large B-cell lymphoma with an interim analysis for Event-Free Survival expected in mid-2027. The company aims to disrupt current access models by enabling outpatient administration, targeting the 80-85% of eligible patients currently excluded from standard CAR-T therapy due to hospitalization requirements. Interim data shows a 58% minimal residual disease clearance rate in the treatment arm compared to 16% in the control group, with no treatment-related serious adverse events requiring hospitalization. Additionally, the firm is developing a dual-targeting CAR-T product for autoimmune diseases, with updates on dose escalation and a potential Phase 2 pivot anticipated in early 2027. 1d ago
- CRBPJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - CORBUS PHARMACEUTICALS HOLDINGS INC Corbus Pharmaceuticals, a pre-revenue biotech based in Norwood, Massachusetts, is advancing two distinct assets: the Nectin-4 ADC sutantitag vedotin for second-line oropharyngeal cancer and a CB1 inverse agonist for obesity. The company plans to submit a Biologics License Application for its oncology asset in the second half of 2028, contingent on Phase 3 TEMPO-1 trial data expected in the first half of 2026. In the obesity sector, the asset has demonstrated 52-week efficacy comparable to oral GLP-1s, projecting 10% to 12% weight loss with a peripherally restricted mechanism to minimize central nervous system side effects. 1d ago
- CRBPJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - CORBUS PHARMACEUTICALS HOLDINGS INC Corbus Pharmaceuticals, a pre-revenue biotech firm with approximately 40 employees, is advancing two distinct assets: the Nectin-4 antibody-drug conjugate CRB-701 for head and neck cancer and an oral CB1 inverse agonist for obesity. CRB-701 is currently in a Phase 3 registrational study for second-line oropharyngeal cancer, with a New Drug Application targeted for the second half of 2028 pending robust objective response rate data expected in early 2026. The company differentiates its oncology program by targeting a treatment desert in the second-line setting while managing transient ocular toxicities, and it plans to expand into the first-line setting if response rates exceed 50%. Concurrently, the obesity asset has completed a Phase 1b study demonstrating weight loss potential comparable to oral GLP-1s, with a safety profile characterized by mild, reversible irritability. 1d ago
- VTRSVIATRIS INC. JEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - VIATRIS INC In the first nine months of 2026, the company achieved 2–3% revenue growth and 8% EPS growth by shifting its portfolio toward complex generics and injectables. A fire at the Nashik facility caused an estimated $200 million revenue impact in late 2026, with production restarts targeted for January 2027. The acquisition of Pacera Biosciences provides access to high-margin assets like Exondys 51 and supports the upcoming launch of the opioid-sparing drug Gynllo. Management projects low-to-mid single-digit revenue growth for China in 2027 while maintaining a balanced capital allocation strategy between shareholder returns and business development. 1d ago
- PCVXJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - VAXCYTE INC The company is developing Vax31, a 31-valent pneumococcal conjugate vaccine designed to cover over 90% of circulating disease strains without compromising immune responses to overlapping serotypes. Pivotal Phase 3 adult data has been obtained, with a Biologics License Application targeted for the first half of 2028 and commercial revenue generation expected to begin in 2029. The global pneumococcal conjugate vaccine market is projected to grow to over $12 billion by 2029–2030, driven by expansion into the adult immunization sector where the company aims to capture significant market share. 1d ago
- DNLIDenali Therapeutics Inc. Jefferies Global Healthcare Conference - DENALI THERAPEUTICS INC Denali's Avlea, a treatment for Hunter Syndrome, has launched in the U.S. with annual pricing of approximately $800,000, exceeding internal expectations and validating the company's blood-brain barrier transport vehicle platform. The company projects Q4 2024 revenue between $30 million and $32 million and aims to eventually surpass the $700 million global sales of competitor Elaprase through label expansions and international approvals. Future pipeline milestones include Phase 2 data presentations for Sanfilippo syndrome in 2027, biomarker readouts for Frontotemporal Dementia and Alzheimer's programs in the same year, and a confirmatory Phase 3 COMPAS study for Hunter Syndrome expected to conclude in 2028. 1d ago
- DNLIJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - DENALI THERAPEUTICS INC Denali's Avlea, a treatment for Hunter Syndrome, has launched in the U.S. with strong community uptake and an annual price of approximately $800,000 for a 30kg patient, representing a 60% premium over the incumbent Elaprase. The company has issued Q4 2025 revenue guidance of $30–32 million and plans to provide quarterly guidance for 2026 to clarify its commercial trajectory. Future milestones include a BLA filing for Sanfilippo Syndrome in 2026, key data readouts for the COMPAS head-to-head study in late 2026, and early biomarker data for its Alzheimer's portfolio in 2027. Management aims to expand Avlea's label to adults and secure international approvals while leveraging its transport vehicle platform across a pipeline that includes FTD and Pompe disease. 1d ago
- WSTWest Pharmaceutical Services, Inc. at Jefferies Global Healthcare Conference in London - WEST PHARMACEUTICAL SERVICES INC The GLP-1 franchise accounts for approximately 10% of total company revenue, with high-value product upgrades driving a 200 basis point incremental growth. Operating margins expanded significantly beyond long-range targets, supported by volume leverage and pricing, with a sustainable outlook of 100 basis points of expansion next year. Capital expenditures for 2026 have been revised downward to the low 200s, while finishing capacity expansion is targeted for late 2028 to meet robust global demand. 1d ago
- MNKDMannKind Corporation - Jefferies Global Healthcare Conference in London - MANNKIND CORP The company reported a 42% compound annual growth rate over the past five years and projects achieving profitability in the fourth quarter of 2026 with record revenues. Key growth drivers include the commercial expansion of Furoscix ReadyFlow, which has captured significant market share in treating fluid overload, and the pediatric launch of Afrezza. The firm anticipates generating approximately $1 billion in cumulative revenue from manufacturing royalties and collaboration fees between 2026 and 2030, while advancing multiple assets for Idiopathic Pulmonary Fibrosis including Natentenib and Relenopeg. 1d ago
- EBSJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - EMERGENT BIOSOLUTIONS INC The company achieved year-to-date revenue of $500 million and adjusted EBITDA of $128 million while reducing total debt from $800 million to approximately $515 million. It has strengthened its liquidity position to $226 million and reauthorized a $50 million share repurchase program valid through March 2027. The organization is transitioning from stabilization to growth, expanding its medical countermeasures portfolio with new partnerships and diversifying international revenue beyond its traditional US dependency. 1d ago
- UBERMorgan Stanley European Technology, Media & Telecom Conference - UBER TECHNOLOGIES INC Uber reported its fifth consecutive quarter of approximately 20% gross bookings growth, driven by 16 billion annualized trips and 215 million monthly active consumers. The company achieved 35% EPS growth and reduced its headcount by 10% to generate savings for reinvestment while maintaining strong EBITDA margins. Strategic initiatives include a roadmap to deploy 10,000 autonomous vehicles by 2028, the completion of the Delivery Hero acquisition to expand international presence, and a commitment to return 50% of free cash flow to shareholders via buybacks. 1d ago
- NKTRJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - NEKTAR THERAPEUTICS Nectar Therapeutics is advancing RESPEG, a pegylated Aldoleukin targeting regulatory T-cells, through Phase III trials for atopic dermatitis and alopecia areata with top-line data expected in 2028 and 2029 respectively. The therapy demonstrates unique off-drug durability, maintaining or improving efficacy after treatment cessation in both indications, contrasting with current JAK inhibitors and biologics that require perpetual dosing. Clinical programs include monotherapy and combination strategies designed to address biologic- and JAK-experienced patient populations while targeting comorbidities like asthma and rhinosinusitis. 1d ago
- LXRXJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON - LEXICON PHARMACEUTICALS INC The company is advancing sotagliflozin (SODA), a dual SGLT1/SGLT2 inhibitor, through Phase 3 trials for hypertrophic cardiomyopathy (HCM) with a readout expected in the first quarter of the upcoming year. This therapy targets both obstructive and non-obstructive HCM patients, offering a unique mechanism that acts directly on the myocardium unlike existing myosin inhibitors. For type 1 diabetes, the company plans to resubmit an NDA under the brand name Zynquista in the first quarter of 2027, aiming to address FDA concerns regarding diabetic ketoacidosis. Commercialization is projected for 2028, with the company intending to self-market the HCM product while seeking partners for other pipeline assets. 1d ago
- NKTRJeffries Global Healthcare Conference - NEKTAR THERAPEUTICS RESPEG-Aldisleukin, an advanced regulatory T-cell targeting agent, has demonstrated dose-dependent symptom resolution and sustained efficacy in Phase 2 trials for Atopic Dermatitis and Alopecia Areata. The drug exhibits unique durability by maintaining therapeutic effects during off-drug periods, contrasting with the symptom recurrence seen upon cessation of current JAK inhibitors and biologics. Pivotal Phase 3 studies for Atopic Dermatitis are scheduled to begin in Summer 2026 with data expected mid-2028, while the Alopecia Areata program is set to commence in December 2026 with a 2029 readout. The company aims to secure regulatory approval through aggressive differentiation strategies, including monotherapy and combination approaches, leveraging a mechanism that modifies underlying pathology rather than merely suppressing symptoms. 1d ago
- UBERUber - Morgan Stanley European Technology, Media & Telecom Conference Webcast - UBER TECHNOLOGIES INC Uber reported a fifth consecutive quarter of approximately 20% gross bookings growth, resulting in 35% earnings per share growth and all-time high profitability margins. The company now operates with nearly 16 billion annual trips and 215 million monthly active consumers, while its Uber One membership has reached 55 million globally. Strategic initiatives include a target of 700 autonomous vehicles by year-end, an acquisition of Delivery Hero to expand international market share, and the launch of the 'Wait and Save' product which has achieved an $8 billion run rate. 1d ago
- WSTWest Pharmaceutical Services, Inc. Presenting at Jefferies Global Healthcare Conference in London - WEST PHARMACEUTICAL SERVICES INC GLP-1 products currently account for approximately 10% of total company revenue, supported by broad market participation across commercial, clinical, and biosimilar segments. The ongoing global upgrade cycle for contamination control, driven by regulatory requirements in Europe and the U.S., is projected to add 200 basis points to growth this year while expanding operating margins by 300 basis points. Management anticipates an additional 100 basis points of margin expansion next year as customers transition to higher-margin containment solutions, with capital expenditure guidance for 2026 revised downward to the lower 200s. Long-term capacity planning indicates sufficient molding capacity through 2030, though new finishing capacity is scheduled to come online in late 2028 to meet rising demand. 1d ago
Research Reports
Technology →Oct 5, 2026 to Nov 19, 2026 · 421 companies
Technology Earnings Report — 2026-10-05 to 2026-11-19
Report generated: 2026-11-19 15:35:21 EST
Overview
Companies reported: 421 (2026-10-05 - 2026-11-19). Technology sector results were overwhelmingly positive, driven primarily by surging demand for AI infrastructure that fueled record revenues and net income growth across semiconductor, hardware, and software segments. This momentum was led by major players like NVIDIA (NVDA) and Microsoft (MSFT), which reported double-digit percentage increases in revenue and earnings, while companies such as Super Micro Computer (SMCI) and AMD (AMD) posted significant year-over-year gains. Despite this broad strength, the sector showed divergence with isolated weakness in specific areas, including solar energy firms facing volume headwinds and smaller companies like GoPro (GPRO) and AMC Robotics (AMCI) reporting severe financial distress.
Leaderboard
Top 5 by Revenue Growth (YoY)
| # | Company | Ticker | Revenue Growth YoY | Revenue |
|---|---|---|---|---|
| 1 | Ainos | AIMD | 29,567% | $642,889 |
| 2 | Boost Run | BRUN | 496% | $39.9 million |
| 3 | FiEE | FIEE | 382.1% | $9.6 million |
| 4 | QumulusAI | QMLS | 376% | $14.8 million |
| 5 | IonQ | IONQ | 336% | $173.8 million |
Note: Ainos (AIMD) growth is driven by a low prior-year base; Boost Run (BRUN) and QumulusAI (QMLS) report significant non-cash gains or contract value metrics alongside revenue.
Top 5 by Net Income Growth (YoY)
| # | Company | Ticker | Net Income Growth YoY | Net Income |
|---|---|---|---|---|
| 1 | NVIDIA Corp | NVDA | 105% | $65.3 billion |
| 2 | Strategy Inc | MSTR | n/a | $19.53 billion |
| 3 | Core Scientific | CORZ | n/a | $1.2 billion |
| 4 | Sandisk Corp | SNDK | n/a | $8.101 billion |
| 5 | Netlist Inc | NLST | n/a | $85.4 million |
Note: Growth rates for MSTR, CORZ, SNDK, and NLST are not listed as the summaries provide absolute net income figures without explicit year-over-year percentage calculations or prior year comparables required for derivation.
Themes
- AI infrastructure demand is the primary growth driver across the sector, fueling record revenue and backlog growth for semiconductor equipment (Applied Materials, KLA, Onto Innovation), semiconductor manufacturers (AMD, Marvell, NVIDIA), and AI infrastructure providers (CoreWeave, Cerebras, Boost Run).
- Data center and hyperscaler spending is accelerating, with companies like Cisco, Arista Networks, and Super Micro Computer reporting significant sequential and year-over-year revenue increases driven by networking, storage, and server solutions for AI workloads.
- Software companies are pivoting toward AI-native platforms and agentic capabilities, with firms like ServiceNow, Palantir, and Microsoft reporting surging AI-related contract values and consumption, while others like Adobe and Salesforce are integrating AI agents into their core offerings.
- Gross margin expansion is a recurring theme for profitable software and hardware firms, particularly those with high recurring revenue models (e.g., ZoomInfo, Datadog, Fortinet) and those benefiting from operating leverage in AI segments (e.g., NVIDIA, AMD, Marvell).
- Capital allocation remains aggressive, with significant share repurchase programs and dividends declared by mature players (Apple, Microsoft, Cisco, Broadcom) and emerging AI leaders (CoreWeave, NVIDIA, AMD) to return cash to shareholders.
- M&A activity is active, with strategic acquisitions focused on expanding AI capabilities (Microsoft/OpenAI, Five9/Level AI, Adobe/Figma), securing supply chain capacity (onsemi/Synaptics), and broadening product portfolios (Flex/EPC Power, Commvault/Active Directory).
- Solar and renewable energy sectors show mixed results, with some companies (First Solar, Array Technologies) lowering volume guidance due to market headwinds, while others (Beam Global, SolarEdge) focus on margin improvement and specific product ramps like smart city orders or storage adoption.
- Supply chain constraints and component availability remain a key risk factor, with companies like Netgear, Key Tronic, and Wolfspeed citing inventory buildups, lead times, and manufacturing capacity limitations as factors influencing guidance and operational execution.
- Cost reduction and operational efficiency initiatives are widespread, with firms like Veritone, Latch, and DXC Technology implementing restructuring plans, headcount reductions, and expense cuts to improve adjusted EBITDA and achieve profitability targets.
- Balance sheet strength and liquidity management are critical, with many companies (NVIDIA, Palantir, Microsoft) maintaining robust cash positions to fund capital expenditures and acquisitions, while others (Veritone, GoPro, Key Tronic) face liquidity challenges or going concern risks requiring capital raises or debt refinancing.
Market Outlook & Trends
- Revenue growth across the sector is heavily driven by AI infrastructure demand, with companies like NVIDIA (NVDA), Broadcom (AVGO), and Super Micro Computer (SMCI) reporting record sales and raised guidance, while others such as CoreWeave (CRWV) and QumulusAI (QMLS) are scaling compute capacity to meet hyperscaler needs.
- Backlog and remaining performance obligations have reached record levels for many firms, including Palo Alto Networks (PANW), Cerebras (CBRS), and Clearfield (CLFD), indicating strong future revenue visibility despite near-term supply chain constraints.
- Pricing power remains robust in high-demand segments, particularly for AI chips and networking equipment, allowing companies like Applied Materials (AMAT) and KLA (KLAC) to expand margins, though some hardware distributors like ScanSource (SCSC) and ADI Global Distribution (ADIG) face margin pressure from lower-margin product mixes.
- Gross margins are diverging based on business model and mix; software and infrastructure firms like Datadog (DDOG) and F5 (FFIV) are expanding margins through SaaS leverage, whereas semiconductor equipment makers like KULR (KULR) and SolarMax (SMXT) are managing margin contraction due to production inefficiencies or EPC project cycles.
- Capital expenditure plans are aggressive among data center and AI infrastructure providers, with CoreWeave (CRWV) and Axcelis (ACLS) increasing capex guidance to support capacity expansion, while others like Intel (INTC) and AMD (AMD) are balancing growth investments with debt management.
- Cash flow generation is improving for many mature software and hardware companies, with Adobe (ADBE), ServiceNow (NOW), and Cisco (CSCO) reporting strong free cash flow, enabling significant share repurchases and dividends, whereas early-stage AI and robotics firms like Rigetti (RGTI) and D-Wave (QBTS) continue to burn cash to fund R&D.
- Risks identified by management include supply chain constraints for critical components, geopolitical tensions affecting export controls and manufacturing, and the potential for customer concentration, as noted by Game Your Game (GYGY) and Beam Global (BEEM).
- Strategic pivots toward AI and recurring revenue models are accelerating, with companies like Phunware (PHUN), Workiva (WK), and Palantir (PLTR) explicitly shifting focus to agentic AI and subscription-based offerings to drive long-term growth and margin expansion.
- M&A activity is active, with major transactions announced or pending for companies such as Marvell (MRVL), Lumentum (LITE), and Axcelis (ACLS), while others like Palo Alto (PANW) and Applied Materials (AMAT) are making strategic acquisitions to accelerate AI adoption and technology integration.
- Guidance revisions are mixed, with many leaders like Microsoft (MSFT), Apple (AAPL), and Oracle (ORCL) raising outlooks due to strong demand, while others like First Solar (FSLR) and SolarEdge (SEDG) have lowered guidance due to market softness, inventory adjustments, or tariff impacts.
Key Numbers
- NVIDIA (NVDA) reported record Q3 revenue of $115.8 billion, up 103% year-over-year, driven by a 110% surge in Data Center revenue to $107.6 billion, while GAAP net income rose 105% to $65.3 billion.
- Super Micro Computer (SMCI) posted Q1 FY2027 net sales of $19.9 billion, a 298% year-over-year increase, with net income surging to $1.594 billion and GAAP gross margin expanding to 12.7%.
- Palo Alto Networks (PANW) achieved total revenue growth of 39% year-over-year to $3.44 billion, with Next-Generation Security ARR surging 66% to $9.73 billion, leading to materially raised full-year guidance.
- Apple (AAPL) recorded Q4 fiscal 2026 revenue of $114.5 billion, up 12% year-over-year, with iPhone revenue hitting a September quarter record of $57.6 billion and Services revenue reaching an all-time high of $31.6 billion.
- Microsoft (MSFT) reported Q1 FY2027 revenue of $92.3 billion, up 19% year-over-year, driven by a 48% surge in Azure revenue and a 30% rise in Microsoft Cloud revenue, resulting in a 32% increase in net income.
- Applied Materials (AMAT) posted Q4 FY2026 revenue of $10.41 billion, up 53% year-over-year, with non-GAAP EPS reaching a record $4.16, up 92% from the prior year period.
- Arista Networks (ANET) reported Q3 revenue of $3.66 billion, a 58.5% year-over-year increase, with non-GAAP diluted EPS rising to $1.20 and deferred revenue growing to $6.839 billion.
- AMD (AMD) reached record Q3 revenue of $13.4 billion, up 45% year-over-year, driven by a 97% surge in Data Center segment revenue to $8.5 billion, while GAAP net income rose 95% to $2.4 billion.
- Cisco Systems (CSCO) achieved record Q1 FY2027 revenue of $18.5 billion, up 24% year-over-year, with GAAP net income rising 59% to $4.6 billion and AI infrastructure revenue expectations raised to $9 billion for FY2027.
- CoreWeave (CRWV) reported Q3 revenue of $3.66 billion, up 168% year-over-year, with Adjusted EBITDA rising 169% to $2.26 billion, though net loss widened to $709 million due to aggressive infrastructure build-out.
Outliers
- NVIDIA (NVDA) posted the strongest report with 103% year-over-year revenue growth to $115.8 billion and a 105% surge in net income, driven by data center demand and a $150 billion share repurchase authorization increase.
- Broadcom (AVGO) delivered exceptional results with 39% revenue growth to $3.44 billion and a 66% jump in Next-Generation Security ARR, leading to materially raised full-year guidance.
- Apple (AAPL) reported record September quarter revenue of $114.5 billion, up 12% year-over-year, driven by an all-time high in Services revenue and a record iPhone sales quarter.
- GoPro (GPRO) issued the weakest report, citing substantial doubt regarding its ability to continue as a going concern due to material weaknesses in internal controls and potential covenant noncompliance.
- Game Your Game (GYGY) faced significant risks including a single-customer revenue concentration of 98%, a widened net loss of $3.16 million, and an Event of Default on Series A Preferred Stock.
- SolarMax Technology (SMXT) reported a 29% year-over-year revenue decline to $6.7 million and a net loss of $4.2 million, reflecting a challenging operating environment despite resilience in solar segments.
- AMC Robotics (AMCI) posted the weakest financial performance with a 35.5% revenue decline to $0.97 million, a widening net loss of $2.02 million, and a significant drop in gross margin to 54.6%.
VC News
More →- Over 95% of portfolio firms standardize on Claude, led by Supabase, Lovable & Vercel founders. Anthropic, which generated first revenue in March 2023, goes public under four years later while scaling safely via rigorous safety focus. AI lacks a central gate, enabling coding for all & reshaping industries faster than any prior generation. Accel · just now
- Anthropic, founded 2021 by Amodei et al., prioritizes safety via Constitution AI & Krishna Rao's backing. The team aims to accelerate science & drug discovery with safeguards rooted in the foundation. Culture emphasizes intellectual honesty & shared responsibility. Lightspeed Venture Partners · 4h ago
- AI agents drive >50% of 2026 internet traffic. Linq, a leading infrastructure platform, powers this with DoorDash partnership on Apple Messages. Founded 2020 in Alabama, now in SF, Linq leads Series B & hires. Andreessen Horowitz · 1d ago
- Boltz revolutionizes drug discovery with AI models adopted by top pharma. Usage-based token model grew 50x in 4 months. Deployed at Pfizer, GSK, Takeda, BMS. Secured $110M Series A to scale research & compute. Andreessen Horowitz · 1d ago
- Zenity pivots to AI agent security as adoption outpaces cloud. Agents breach fixed perimeters, risking data theft & attacks. Co-founders urge full-speed AI growth with dynamic guardrails & human-on-loop strategies to defend against AI threats using AI. SoftBank Vision Fund · 2d ago
- Gopuff, founded 2013 by Gola & Ilishayev, uses a vertically integrated model with micro-fulfillment centers to deliver in 15 mins. Achieving 99.5% order accuracy via AI, the firm prioritizes unit economics to remain profitable while expanding globally & partnering with Uber, DoorDash, & Starbucks. SoftBank Vision Fund · 2d ago
- Fountain & Netradyne pivot to gen AI for core friction. CMT.AI builds custom models for sensor data. Hybrid build-or-buy with narrow pilots is key. AI coding cuts dev cycles to days. Avoid chasing AI for its own sake. Audit data, define moats, & evaluate unit economics before scaling. SoftBank Vision Fund · 2d ago
- Lightspeed led Compute Desk's $45M seed for a GPU clearing platform replacing outdated contracts with standardized trading & trusted price indices. Founders bring derivatives & quant expertise to a market where AI capex hits $1.5T by 2030, enabling potential $20-40T annual volume. Lightspeed Venture Partners · 2d ago
- Boring Co. hit $23B valuation after Sept 2026 $3B round. CEO Davis targets D.C.-Las Vegas hyperloop. Cost down to <$10M/mile. Vegas Loop moved 4M+ riders. Austin-San Antonio trip to drop to <30 mins. ZPIT mining enables full autonomy. Andreessen Horowitz · 2d ago
- First Person Labs builds Second, a device-local personal model giving users total control over AI data. Founders Ken Liu & Erik Chi bring AI & security expertise. This infrastructure ensures privacy & portability, preventing third-party influence over agent actions. Andreessen Horowitz · 2d ago
- 2026 security sees 1990s exploit speed via AI. Worms target API keys & ransomware. Enterprises must accelerate patching & shift to continuous AI red-teaming. New startups will harden legacy stacks. Defense needs AI-native layers & agentic security to counter collapsing vulnerability windows. Andreessen Horowitz · 3d ago
- Eli Lilly hits $1T cap driven by $17B Q3 GLP-1 sales. Pharma relies on top 25% of hits for 85% revenue. AI aims to slash 13-year, $2B development costs. Bio-AI matures to GPT-3 levels with major partnerships. Valuation shifts toward discovery engines over approved portfolios. Andreessen Horowitz · 6d ago
- AI accelerates attacks requiring machine-speed defense. White House plan targets 5 critical sectors: power, banking, water, comms, hospitals. Focus is containment over replacement. CEOs accountable via monthly scorecards & board attestations. Goal: contain top targets in 6 months using AI & digital twins. Andreessen Horowitz · 6d ago
- Gaming archetypes: indie, toolmakers & world-builders. AI accelerates all three by bridging skill gaps & expanding production. New models enable end-to-end design & decompilation. Leaders reorganize for AI-assisted dev. Studios shorten cycles to risk more IP. AI tools foster a new generation of developers. Andreessen Horowitz · 1w ago
- SE3 secures $30M Series A to build sovereign spatial intelligence for EU defense, capitalizing on €800B spending plans & MOSA shift. The Munich-founded firm partners with HENSOLDT, Ukraine, & Germany's forces to enable autonomous ops where GPS fails. Accel · 1w ago
- Taneja warns AI's top risk is a trust-driven prisoner's dilemma. General Catalyst backs both closed & open models, highlighting a resilience premium markets undervalue. Summa Health adoption rose from 20% to 80% post-acquisition. Breaking the cycle requires costly first moves & rules for cooperation. Founders must build at the frontier without relying on one lab to ensure no single entity can switch off the AI economy. General Catalyst · 1w ago
- Fractile secures Series C co-led by Exponential. Its chip-first approach solves AI inference bottlenecks via stacked DRAM, promising 10x speed & lower cost. With 80% of future AI spend targeting inference, Fractile's vertically integrated stack targets a $100B+ market. Lightspeed Venture Partners · 1w ago
- Edelbyte, spun from Microsoft's Kusto team, rethinks data platforms for AI agents. Founders include ex-Microsoft engineers. Like Confluent, it targets B2B with 10x query efficiency. We led their seed round. Sequoia Capital · 1w ago
- Invest in General Translation, a Series A AI localization firm. It integrates into React, GitHub, Figma, Slack to fix brittle workflows. Clients include Cursor, Ramp, Clickhouse. Founder Archie McKenzie, ex-Princeton CS. Martin joins board. Andreessen Horowitz · 1w ago
- AI agents now drive majority web traffic, author half of articles & generate most code. Shopify & Vercel report 8x-28x growth. B2A economy emerging: treat agents as customers or face obsolescence. Andreessen Horowitz · 1w ago
- US infrastructure faces extreme delays & cost overruns, with manufacturing share dropping from 25% to 16%. NEPA is the primary obstacle, not environmental safety. A bipartisan consensus forms around the 2026 Bipartisan American Affordability & Jobs Act to reform permitting through hard deadlines & streamlined reviews. Andreessen Horowitz · 1w ago
- Lightspeed leads Nominal's Series C to modernize hardware testing. Legacy inefficiencies plague engineers, but Nominal unifies sensor data & video on one timeline. AI agents handle debugging, safety, & planning in air-gapped environments. Clients include Hermeus w/ $53M Air Force contract. Targets $100B annual labor savings for aerospace & chemical engineers. Lightspeed Venture Partners · 1w ago
- SoftBank, Grab & PETROS commit $1.85B to AI infrastructure across Sarawak & Peninsular Malaysia. Long-term target: 5GW+ capacity. SoftBank locks up Grab shares for 5 years. Initiative supports Malaysia's AI Nation 2030 ambition to address surging regional demand. SoftBank Group · 1w ago
- SoftBank leads $1B AI infrastructure deal in Sarawak with Grab & PETROS. Target: 5GW compute capacity. Aligned with Malaysia's AI Nation 2030. Aims to become Asia's largest AI site serving gov & multinationals. SoftBank Group · 1w ago
- Exploit costs dropped while patching stalled, creating a widening gap. Remediation times hit 252 days in 2025. AI generates exploits in hours. 94% of ransomware attacks target backups but only 28% recovered data in 2026. Future defense requires removing exposure, virtual patching, memory-safe code, or making patching unnecessary. Andreessen Horowitz · 1w ago
- SoftBank agreed Oct 8, 2025 to buy ABB robotics. Nov 4, 2026, China blocked the deal. Both firms continue dialogue despite the prohibition. SoftBank Group · 1w ago
- AI shifts finance from reconciliation to strategy. Figma CFO says teams automate tasks to focus on customers & strategy. Corp Dev uses AI for prototyping & M&A diligence. Key risks include AI slop & need to centralize systems. Future leaders need business acumen, ability to interrogate outputs & clear communication without outsourcing critical thinking. Andreessen Horowitz · 2w ago
- AI slashed exploit time to days before disclosure, hitting 395 orgs in hours. Patching lags at 43 days median, leaving schools & critical infrastructure exposed. Ransomware payments dropped as attackers target small victims with destructive attacks. Defenders must shift to isolation & segmentation where updates are impossible. Andreessen Horowitz · 2w ago
- Pawlan tested 140+ AIs shifting to specialized agent networks. Agents communicate to build social serendipity, evolving into a secret superpower beyond time savings. Andreessen Horowitz · 2w ago
- Tech buyouts face structural stress from debt & rates, lacking fixer-uppers. Venture outperforms innovation cycles; 2007-2016 top VC funds hit 5.3x DPI vs 3.5x for buyouts. 70% of recent debt foreclosures stem from 2021-2022 deals. $140B in risky PE loans mature in 2028. Andreessen Horowitz · 2w ago
- Industry practice now favors full desktop access for AI agents. Phaze delivers high-performance remote desktops for OS-specific apps & latency-sensitive workloads. Founded by ex-Parsec creators with backing from prior investors to enable seamless agent access. Andreessen Horowitz · 2w ago
- Accrual co-founders Nicolaescu & Chandrasekaran target accounting with AI automating 90-99% of tax prep. The 20-person team avoids AI wrappers by focusing on complex multiplayer workflows. Strategy includes model-agnostic tech & acquiring a firm for cultural shifts. General Catalyst · 2w ago
- Huberman outlines 3 core health protocols: morning light, resistance training, & quality sleep. He warns against over-optimization & advises founders to protect peak brain hours for work. Discussion covers cognitive performance, sustainable workloads, & emerging neurotech for sleep, focus, & recovery transitions. Andreessen Horowitz · 2w ago
- Longevity went mainstream via AI & pandemic. A healthcare home race is underway. Non-toxic product spending surges. Peptides grow but GLP-1s dominate at $44B. Cholesterol management evolves with new drugs. Wearables focus on biomarkers. Neurotech shifts to consumer use. Founders should build tools for actionable behaviors. Andreessen Horowitz · 2w ago
- Cresta, founded 2017 at Stanford, joined Salesforce after Ping Wu led it from stealth to AI agent autonomy. The acquisition transitions Cresta from research to mission-critical business infrastructure, leveraging Salesforce's global platform for enterprise scaling. Sequoia Capital · 2w ago
- Tutor CEO Josh Gruenstein views robotics as an integrated system of AI, hardware & work. The firm operates a 100-robot data factory using human tutors to refine capabilities, offering labor at $16/hr. This flexible robotic workforce targets significant impacts on US manufacturing & the physical economy. Andreessen Horowitz · 2w ago
- Tutor Intelligence leads Series B with robots prioritizing task completion over specific models. Deploying via teleoperators, they target 1,000 units by 2027. Hourly pricing shifts costs to Opex for SMBs, large logistics, & mid-market firms. Co-founders Gruenstein & Kosowsky leverage MIT expertise for ROI-driven adoption. Andreessen Horowitz · 2w ago
- Lower inference costs demand pricing on value units, not tokens. Buyers need 96% adoption & 34% speed gains to justify premiums. 94% expect spending growth in 2026. Vendors must make context cheaper to rent than rebuild while widening app advantages faster than model progress. Andreessen Horowitz · 2w ago
- a16z welcomes Andy Baker as advisor to Global Affairs. Baker, former Deputy NSA to Trump & NSA to VP Vance, brings 10+ years as Foreign Service Officer. Goal: help founders in AI, defense, cybersecurity, energy, & infrastructure navigate geopolitics & government priorities. Andreessen Horowitz · 2w ago
- Bending Spoons CEO Ferrari favors systematic improvement over radical innovation. Acquiring firms, integrating them, & reinvesting cash drives compounding. Ferrari & a16z's Acharya debated growth vs profitability, risk-free debt, & AI's SaaS impact, noting moats like data & switching costs remain vital. Andreessen Horowitz · 2w ago
- Cosign builds a professional network using vouching signals to unlock relationship data for AI agents. a16z New Media launched the Cosign Awards to recognize peer-nominated operators. The platform maps hidden connections for human & agent access. Future networking involves personal agents communicating with company agents to identify genuine intent & present viable fits only. Andreessen Horowitz · 2w ago
- a16z prioritizes founder backgrounds for its $1M Speedrun checks with an SF residency deadline Nov 1. AI empowers solo founders but teams may still outperform on scaling. Non-technical founders can prototype yet lack technical judgment. Domain experts understand pain points but lack outsider perspective. Young founders leverage AI but lack enterprise experience. Content creators face viral-to-sustainable challenges. Investor preferences shift with tech cycles. Evaluate how AI changes capabilities rather than inverting old rules. Andreessen Horowitz · 2w ago
- SoftBank delays LINE MAN capital increase to Jan 2027 due to coordination needs. Deal involves 12.4M new shares for $130M. Impact on current fiscal results minimal. Post-completion SoftBank will hold 63.7% voting rights in LINE MAN. SoftBank Group · 2w ago
- US defense, energy, manufacturing & robotics sectors are converging into a unified industrial base. AI transforms factory economics as private capital funds physical infrastructure ahead of government demand. Founders applying SpaceX & Tesla lessons position these companies to become the world's most valuable entities. Andreessen Horowitz · 3w ago
- LLMs treat file systems as native behaviors. Using bash & files as external memory cuts token costs & prevents context rot. Vercel cut agent costs 75% this way. Start local, add DBs only for scale. Files offer audit trails & interface abstraction, but lack concurrency guarantees. Lightspeed Venture Partners · 3w ago
- Mark Cuban says AI can transform healthcare by fixing opaque prices & broken incentives. He advises using AI to audit benefits contracts & notes Cost Plus Drugs built on trust. Founders should use AI to learn, not stop thinking. Andreessen Horowitz · 3w ago
- AI accelerates cyber threats, driving 87% of CISOs to boost 2027 spending. Security headcount rises as AI governance becomes top priority. Only 18% use AI SOC tools now, yet startups lead innovation while incumbents lag in addressing AI-specific gaps. Andreessen Horowitz · 3w ago
- VC shifted to specialized teams applying traditional finance to early-stage tech, often ignoring that tech waves precede business models. Four philosophies: Financial (metrics), Productive (tech as market creator), Frontier (founders), Speculative (perception). Align philosophy with deal stages to avoid the grab bag trap. Andreessen Horowitz · 3w ago
- Alpha's Joe Liemandt proposes 2h daily academics, rest for real skills. HAA prioritizes building for college. Motivation beats curriculum. AI will explode entrepreneurship; build what you care about, don't seek AI-proof fields. Andreessen Horowitz · 3w ago
- Databricks hit $7B run rate w/ 80% YoY growth. Its Lakehouse & Lakebase unify data & ops. CEO Ghodsi proposes SORA for agents, shifting humans from execution to strategy. The firm rejected a $6B offer to build the future OS. AI triggers a Second Managerial Revolution. Andreessen Horowitz · 3w ago
Press Releases
More →- MNTNWolf Popper LLP Announces Investigation on Behalf of MNTN, Inc. Investors Wolf Popper LLP investigates MNTN after 3Q miss & CEO departure. Stock fell 54.7% to $4.70 on 11/5/26. CFO cited execution issues. Call Adam Savett at (212) 451-9655 or email asavett@wolfpopper.com. GlobeNewswire · 7m ago
- DLXDeluxe Accelerates Payments Integrations from Weeks to Hours Deluxe Corp launches AI tools on developer portal to accelerate payment integration. New MCP access & sandbox let agents complete work in hours vs weeks. Platform handles $2T annual volume for millions of businesses. Business Wire · 9m ago
- BLLNWolf Popper LLP Announces Investigation on Behalf of BillionToOne, Inc. Investors Wolf Popper LLP investigates BillionToOne (BLLN) for securities claims after Fuzzy Panda Research alleged fraud, Medicaid probes, and billing schemes. Stock fell 6.1% to $91.54 on Nov 18, 2026. Contact Adam Savett at 212-451-9655 or asavett@wolfpopper.com for details. GlobeNewswire · 12m ago
- ABXABACUS GLOBAL MANAGEMENT, INC. INVESTIGATION: ABX Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights Kirby McInerney LLP probes ABX for potential federal securities violations. Abacus filed Form 12b-25 to delay Q3 2026 10-Q, citing accounting evaluations of capital credits & related party transactions dating to June 2025. Shares dropped 23.1% to $6.65 on Nov 17. No lawsuit filed yet. Business Wire · 15m ago
- MTHMeritage Homes Announces Quarterly Cash Dividend Meritage Homes, 5th-largest US builder, declared $0.48 quarterly dividend payable Dec 31, 2026 to Dec 16 record holders. Operates in 12 states, delivered 220k+ homes over 41 years, holds 11 ENERGY STAR awards. GlobeNewswire · 19m ago
- RCATRED CAT HOLDINGS, INC. INVESTIGATION: RCAT Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights Kirby McInerney LLP investigates Red Cat Holdings (NASDAQ: RCAT) for potential securities violations after Nov 16 withdrawal of FY26 guidance. Shares dropped 37.3% to $2.41 on slower funding & contract progress. No lawsuit filed yet. Contact investigations@kmllp.com for info. Business Wire · 44m ago
- ANTTradr's Leveraged ETFs on Anthropic Begin Trading Monday Tradr announces Nov 23 launch of 2X Long ANTT & 2X Short ANTZ on Cboe tracking Anthropic (ANT). Matt Markiewicz calls this the 2026 capital markets event. These leveraged funds target sophisticated traders for short-term use only. High volatility risks total loss if ANT moves >50% daily. ALPS Distributors handles distribution. PR Newswire · 54m ago
- MEOHMethanex Corporation – Notice of Cash Dividend Methanex board declared $0.185 quarterly dividend payable Dec 31, 2026 to Dec 17 record holders. World's largest methanol supplier based in Vancouver trades on TSX (MX) & Nasdaq (MEOH). GlobeNewswire · 57m ago
- RDIAngelika Film Center Unveils New Membership Experience for Film Lovers Reading Intl launches $15.99/mo Premium membership for Angelika & Village East on Nov 18, 2026. Includes 1 free monthly ticket, 4 discounted tickets, 50% off Tue/Wed, & 10% off food. Free tier retains points & birthday rewards. Holiday lineup features Dune Part Three in 70mm. GlobeNewswire · 59m ago
- CIThe Cigna Group Deepens Community Impact Strategy, Adds New Commitment Supporting People with Complex Health Conditions Cigna Group Foundation commits $31.5M over 3 years to youth mental health, veteran well-being & complex care patients across 10 states. Grants for 2-year, $250k awards open until Dec 18. Strategy combines funding with employee volunteerism. PR Newswire · 1h ago
- EBCEastern Bank Named #1 SBA Lender in Massachusetts for the 18th Year in a Row Eastern Bank ranks top SBA 7(a) lender in MA for 18th year. FY26: 296 loans, $33.6M. Also top 10 in NH & RI. Total assets $31.7B as of Sept 30. Holding co Eastern Bankshares (EBC). Business Wire · 1h ago
- TNREFTaranis Finds Up to 6.01 g/t Gold and 732 g/t Ag at Katinka, Part of the "One O'Clock" High-Priority Target and Update on Debt Settlement Submission Taranis targets One O'Clock site near Thor deposit in Colorado. Surface samples show 3.91ppm gold & 196ppm silver. Katinka mineralization is enriched in Au, Ag & As vs Thor. Company withdraws TSX debt submission. 105.6M shares outstanding. ACCESS Newswire · 2h ago
- MGAMagna Earns Three Honors at 2026 Automotive News PACE Awards Magna wins 2 PACE Awards for EV battery enclosures & DHD Duo hybrid drive, both in production. EcoSphere bio-foam named Pilot to Watch. Total PACE recognitions reach 16. Battery tech boosts space 10%, hybrid scales in 18 months, foam cuts CO2 18%. GlobeNewswire · 2h ago
- NTHINeOnc Technologies Announces FDA Rescheduled NEO212 End-of-Phase 1 Type B Meeting to November 23 NeOnc rescheduled Nov 23 FDA meeting for NEO212. Phase 1 halted due to toxicity at 810mg, selecting 610mg as RP2D. Prior data showed 60% tumor reduction in glioblastoma. Investor webinar planned post-meeting minutes. Clinical efficacy not yet established. GlobeNewswire · 2h ago
- BIIBClarity AD CSF Substudy Findings on Lecanemab Treatment and α-Synuclein Co-Pathology Presented at CTAD 2026 Eisai & Biogen report lecanemab slowed decline by 41% at 18mo in alpha-synuclein positive early Alzheimer's patients. Subcutaneous dosing approved in US, China & Japan in late 2026. PR Newswire · 2h ago
- BIIBClarity AD CSF Substudy Findings on Lecanemab Treatment and α-Synuclein Co-Pathology Presented at CTAD 2026 Eisai & Biogen report lecanemab slows clinical decline by 41-43% in early Alzheimer's patients with alpha-synuclein co-pathology. Results confirm drug efficacy despite higher baseline amyloid burden & faster progression. Eisai leads development & co-commercializes the product. GlobeNewswire · 2h ago
- RGTRoyce Global Trust (NYSE: RGT) as of Oct 31, 2026 Royce Global Trust (XRGTX) closed Oct 31 at $14.48 vs $17.51 NAV, a 17.2% discount. 1Y returns: 20.22% NAV, 14.79% price. $115M AUM, avg $4.6B mkt cap, 23.0x P/E. Top sectors: Industrials 35%, Financials 21.4%. PR Newswire · 2h ago
- STCAM Best Affirms Credit Ratings of Stewart Information Services Corporation and Its Subsidiaries AM Best affirmed A- ratings for Stewart Title & parent Stewart Info Services with stable outlook. Strong balance sheet, 4th-largest US title insurer, & diversification support stability. Risk of downgrade if high rates & slowing economy erode profitability. Business Wire · 2h ago
- PRKSSEAWORLD BRINGS LIVE MUSIC TO 2027 WITH EXPANDED AND ELEVATED CONCERT SERIES FEATURING MORE THAN 50 SHOWS SeaWorld expands 2027 live music to Orlando, San Diego & San Antonio with 50+ shows included in admission. Lineup features Flo Rida, Rick Ross, CeeLo Green & Pop 2000 Tour across country, pop, hip-hop & R&B. Annual Pass holders save 65% this Black Friday. Dates subject to change. PR Newswire · 2h ago
- ADBTADVASA Enters into Memorandum of Understanding with Enagic to Promote the Global Adoption of the ADVASA VISA Prepaid Card Advasa (ADBT) signed non-binding MOU with Enagic to explore ADVASA VISA card for 3M members. Discussions cover terms & rollout. CEO cites global adoption opportunity. No deal assurance. Advasa operates EWA with patents in US, Japan, Korea, expanding to Indonesia & UAE. GlobeNewswire · 2h ago
- RVTRoyce Small-Cap Trust (NYSE: RVT) as of Oct 31, 2026 Royce Small-Cap Trust (RVTX) trades at $16.78 vs $19.22 NAV. YTD NAV return is 14.72% as of Oct 31, 2026. Avg P/E is 17.0x. Top sectors are Industrials (24.2%) & Financials (19.5%). Net assets total $2.41B. PR Newswire · 2h ago
- PRKSBUSCH GARDENS TAKES CENTER STAGE FOR 2027 WITH THE BIGGEST CONCERT LINEUP IN ITS HISTORY: MORE THAN 30 LIVE, FULL-LENGTH SHOWS Busch Gardens Tampa & Williamsburg announce 2027 concert series with 30+ shows. Acts include Boyz II Men, Flo Rida & Trace Adkins. All concerts included with standard admission. United Parks & Resorts Inc. operates parks. Black Friday sale offers up to 60% off passes. PR Newswire · 2h ago
- BCCBoise Cascade Celebrates Grand Reopening of Expanded Phoenix Distribution Facility Boise Cascade reopened its Phoenix facility Nov 12 after a $10M+ expansion adding 52.5K sq ft warehouse & 45.6K sq ft storage. Upgrades enhance weather resilience, James Hardie partnerships, & order fulfillment. The branch employs 64 associates serving Arizona & region. Business Wire · 2h ago
- ANTSecuritize Tokenizes Anthropic Stock Onchain on First Day of Public Trading Anthropic, Amgen, & Fox now trade onchain via Securitize on Solana. Total tokenized US equities exceed 50. Trading starts beyond hours, aiming for 24/7. Liquidity via Jump Trading, settlement in USDC. Platform manages ~$5B assets across US & EU. PR Newswire · 3h ago
- RMTRoyce Micro-Cap Trust (NYSE: RMT) as of Oct 31, 2026 Royce Micro-Cap Trust (XOTCX) reported 31.98% YTD NAV return & 30.67% YTD market return as of Oct 31. NAV $14.82, market $12.98. Top sectors: Industrials 24.5%, IT 21.1%. Avg market cap $898.3M. Leverage 1.8%. Shares trade at discount to NAV. PR Newswire · 3h ago
- LDIloanDepot Recognizes South Florida Community Organizations During 2026 Miami Marlins Season loanDepot & Miami Marlins partnered for 2026 to support youth, Veterans, educators & families. Initiatives included Salute & Serve Days, First Responders Appreciation, & the Runs Scored Program donating $50/run to Boys & Girls Clubs. loanDepot also donated food for remembrance events & contributed to Venezuela Earthquake relief. Business Wire · 3h ago
- RHIRobert Half honored by Fortune as one of the Best Workplaces for Parents 2026 Robert Half (RHI) named Best Workplace for Parents 2026 by Fortune, based on 650k+ parent feedback. CEO Waddell highlights Support for Families program including adoption aid, backup care, \& benefits. As world's largest specialized talent firm \& parent of Protiviti, RHI reaffirms commitment to well-being. PR Newswire · 3h ago
- COLBColumbia Bank Launches 2026 Warm Hearts Winter Drive with Commitment to Children in Foster and Kinship Care Columbia Bank launched 2026 Warm Hearts Winter Drive to support 29 nonprofits across 9 western states. Campaign shifts focus to foster & kinship care children. Runs through Dec 31, 2026. Goal is to address barriers for 330k US foster children. PR Newswire · 3h ago
- ANTCDefiance 2X Daily Anthropic ETFs ANTC and ANTQ Begin Trading Monday as Anthropic Valuation Tops $2 Trillion at Open Defiance launches 2x leveraged ANTC & inverse ANTQ on Nasdaq Nov 23. Tracks Anthropic, priced IPO at $83 on Nov 18. Funds use swaps, not direct stock. High risk: 50% drop wipes ANTC, 50% rise wipes ANTQ. Only for sophisticated investors. GlobeNewswire · 3h ago
- TOLToll Brothers Announces New Luxury Home Community Coming Soon to Johns Creek, Georgia Toll Brothers launches Jardin Heights in Johns Creek, GA. Sales open mid-2027 for 3-story townhomes up to 2,677 sq ft, priced from mid-$700k. Located near Medley & top schools. Company ranked Most Admired Home Builder in Fortune 2026. GlobeNewswire · 3h ago
- TSCOBlack Friday Goes Out Here Tractor Supply runs Black Friday deals Nov 23-29, 2026. Discounts reach 50% on apparel & $1,500 off RVs. Doorbusters start 6 a.m. Nov 27. Store hours adjusted for holidays. Company operates 2,486 stores in 49 states. Business Wire · 3h ago
- ANVSPRISM MarketView Highlights Four Small Caps Working on Alzheimer’s Disease for National Alzheimer’s Disease Awareness Month PRISM highlights 4 small-caps post-CTAD: Biogen diranersen showed 38% decline reduction; Priavoid missed, Lilly halted mevidalen. ANVS Phase 3 top-line Mar 2027; ACIU ACI-24 shows antibody response w/o ARIA-E; IGC CALMA dosing complete, results Dec/Jan; Firefly EEG in 85+ sites. GlobeNewswire · 3h ago
- BRZEBraze Named a Leader in Cross-Channel Marketing Hubs Evaluation by Independent Research Firm Braze named Forrester & Gartner Leader in 2026. Highest scores in Strategy & Ability to Execute. 457% 3-year ROI & <6 mo payback. CEO Malik cites AI innovation driving enterprise growth. HQ NY, 15 global offices. Business Wire · 3h ago
- WECWe Energies again named best in the Upper Midwest for reliability We Energies wins 2026 ReliabilityOne® reliability & customer engagement awards for 2025 performance. CEO Mike Hooper cites grid modernization as key driver. Parent WEC Energy (NYSE: WEC) serves 1.2M electric customers in Wisconsin. PR Newswire · 3h ago
- AJGAs Financial Stress Weighs on Workers, Gallagher Introduces a Platform Focused on Better Financial Decision-Making Nov 19: Gallagher launched Financial Wellbeing platform in Rolling Meadows. Tool aids US employers & employees via education, coaching & wealth management. Focuses on debt, savings & retirement. John Tournet cites shift from uncertainty to action. Services via Your Money Line®; investments through Gallagher Fiduciary Advisors. PR Newswire · 3h ago
- TPBFRE and 100 Thieves Drop Limited Edition Collectible Tin Line FRE & 100 Thieves launched limited-edition collectible tins. Vice Camo ($99.99) is hand-painted; gunmetal & metallic silver ($89.99) feature durable machined metal. Designed for 100-count packs, these American-crafted tins are exclusive to 21+ at frepouch.com while supplies last. Business Wire · 3h ago
- FRVOFervo Energy Company (FRVO) Scrutinized in New Report Questioning Geothermal Narrative, Stock Closes 46% Below IPO Fervo Energy (FRVO) faces scrutiny over Morpheus Research claims of 30% water loss & seismic risks. Stock closed at $14.33, down 46% from IPO. Hagens Berman investigating IPO transparency. Fervo holds agreements with Google. PR Newswire · 3h ago
- LKQLKQ Corporation (LKQ) Faces Investor Scrutiny Amid Enterprise Resource Planning System Surprises, CEO Departure; Shares Trade Sharply Lower Again - HBSS LKQ shares dropped 22% Oct 23 as CEO Justin Jude departed amid ERP issues. Q3 saw $16M net loss vs $79M prior. Europe holds 46% revenue. $2.2B market cap wiped. Hagens Berman investigating transparency. PR Newswire · 3h ago
- NVECNVE Corporation (NVEC) Faces Investor Scrutiny Amid Revenue Pull-Forward- HBSS NVEC shares fell 33% on Oct 22 after Q2 2027 revenue dropped 47% due to pulled-forward sales. Hagens Berman investigates potential securities law violations & earnings quality following a prior 54% surge & contradictory management claims. PR Newswire · 3h ago
- PEPHyatt and PepsiCo Enter New Chapter with a 10-Year Collaboration Supporting Guest Experience and Growth Across 700+ Properties in the United States Hyatt & PepsiCo signed 10-year F&B deal for 700+ US properties. Covers Classics & Essentials brands with Gatorade, Lay's & more. PepsiCo posted $94B 2025 revenue. Hyatt operates 1,500+ hotels in 84 countries. Deal supports World of Hyatt's 72M members. PR Newswire · 4h ago
- OFRMOnce Upon A Farm, PBC (OFRM) Faces Investor Scrutiny Amid Product Recall - HBSS OFRM shares fell 37% to $9.44 after FDA choking hazard warnings triggered a Tractor Wheels recall. CEO Foraker noted the product line represented 18% of YTD sales. Hagens Berman is investigating OFRM for potential transparency failures regarding sales concentration risks. PR Newswire · 4h ago
- HOVHovnanian Enterprises Announces Fiscal Year 2026 Earnings Release and Conference Call HOV Q4 FY26 results & call Dec 3 at 11 AM ET. Webcast at khov.com investor relations. Archive available 12 months. Founded 1959, HQ NJ, operates in AZ CA FL TX among others. GlobeNewswire · 4h ago
- AOSA. O. Smith Corporation Publishes 2026 Sustainability Report A.O. Smith 2026 Sustainability Report shows 32% Scope 1&2 GHG cut vs 10% target, 99M gal water savings vs 40M goal, & 809K lb waste reduction vs 525K goal. Launched Voltex X heat pump, earned NSF/ANSI PFAS certs, & Ethisphere World's Most Ethical Company recognition. PR Newswire · 4h ago
- PIIRZR FACTORY RACING SWEEPS UTV OVERALL PODIUM WITH DOMINANT PERFORMANCE AT 59TH SCORE BAJA 1000 Brock Heger wins 59th SCORE Baja 1000 UTV title in Polaris RZR after MacCachren retires. Polaris sweeps top 3 spots. Heger & Eddy defend Dakar title Jan 2027. New RZR Pro R Factory Boost debuts at 2027 King of the Hammers. PR Newswire · 4h ago
- BBWBuild-A-Bear Debuts Exclusive Holiday Plush Collection for Sanrio Fans Build-A-Bear launched holiday Hello Kitty collection w/ Swarovski on Nov 19. Fiscal 2025 revenue hit $529.8M for 5th consecutive record year. Items available online & select locations. PR Newswire · 4h ago
- FAFFirst American Named One of the Fortune Best Workplaces for Parents™ for the Second Consecutive Year First American Financial secured 2nd consecutive Fortune Best Workplace for Parents award, reflecting strong culture & flexibility. CEO Seaton emphasizes commitment to employee support. Company also earned 11th consecutive Best Companies to Work For title alongside global recognitions in Canada & India. Business Wire · 4h ago
- IMAXIMAX and Showcase Cinemas Strike Agreement for 13 New IMAX With Laser Locations Across the United Kingdom and Europe IMAX signs 13 new Laser locations with Showcase Cinemas, its largest UK deal & first post-acquisition investment. 5 open in 2027. IMAX hit record $70M UK revenue in 2026. 1,887 systems operate globally as of Sep 2026. The Odyssey generated $550M globally. Business Wire · 4h ago
- PARAParabolic Technologies, Inc. Announces Reverse Stock Split PARA announced 1-for-100 reverse split effective Nov 23, 2026, to meet Nasdaq bid price rules. Approved Oct 16. New CUSIP 06682J886. No fractional shares issued; options adjusted. Shareholder interest unchanged aside from rounding. Contact Continental Stock Transfer at 800-509-5586. GlobeNewswire · 4h ago
- SEGGSEGG Media Terminates $300 Million Equity Line of Credit (ELOC) and Pivots Towards Enhanced Growth Funding SEGG Media cuts stock rights to curb dilution. Lottery.com relaunches globally Nov 18 with IGA funding for LatAm expansion. Q2 revenue hit $3.2M, up 1,584% YoY driven by Veloce. New financing supports Veloce, Quadrant, Sports.com, Concerts.com, TicketStub.com. CEO Stubblefield says enhanced structures limit share price impact. GlobeNewswire · 4h ago
- XPEVXPENG to Showcase Its Physical AI Push at Annual AI Day, Featuring Its Latest Humanoid Robot in Action XPENG AI Day Nov 25 in Guangzhou unveils IRON humanoid robot powered by 3 in-house Turing chips. Robotics biz raised $900M at $6.3B val. Event covers Physical AI, NGP, L4 Robotaxi & flying cars. Dual-listed on NYSE & HKEX. GlobeNewswire · 4h ago
FDA Approvals
More →- NTHINeOnc Technologies Announces FDA Rescheduled NEO212 End-of-Phase 1 Type B Meeting to November 23 GlobeNewswire · 2h ago
- JNJJohnson & Johnson Seeks U.S. FDA Approval for CAPLYTA in Bipolar Mania, Marking Fifth Potential Indication PR Newswire · 7h ago
- TVRDTvardi Therapeutics Advances Next-Generation Oral STAT3 Inhibitor TTI-109 Toward IND in Inflammatory Bowel Disease Following FDA Pre-IND Feedback GlobeNewswire · 7h ago
- ALNYAlnylam Collaborator Regeneron Secures FDA Approval of Livsayis™ (cemdisiran), the Seventh FDA-Approved Therapeutic from Alnylam's RNAi Platform in Less Than Nine Years Business Wire · 8h ago
- REGNLivsayis™ (cemdisiran) Approved by the FDA as First and Only siRNA Therapy in Generalized Myasthenia Gravis and Only Treatment with Four-Times-a-Year Subcutaneous Dosing GlobeNewswire · 21h ago
- HIMSHims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy CNBC · 1d ago
- TOMZTOMI Environmental Solutions Expands SteraMist iHP in Meat, Poultry and Dairy Processing as Enterprise Food Producers Evaluate Multi-Facility Standardization GlobeNewswire · 1d ago
- NNOXNanox to Showcase Its Innovative Technology and Advances Across Nanox.ARC X and Nanox.AI at RSNA 2026 GlobeNewswire · 1d ago
- TELOTelomir Pharmaceuticals Selects Linical to Advance FDA-Cleared Phase 1/2 Clinical Trial of Telomir-Zn in Triple-Negative Breast Cancer GlobeNewswire · 1d ago
- RXRXRecursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis GlobeNewswire · 1d ago
- CDIOCardio Diagnostics to Unveil Non-Obstructive Coronary Artery Disease Data, FDA Breakthrough Device Designation Strategy, and India Launch Update on December 10 Investor Call Business Wire · 2d ago
- MAIAMAIA Biotechnology Reports Consistent Strong Efficacy in Expanded Phase 2 THIO-101 Study in Non-Small Cell Lung Cancer GlobeNewswire · 2d ago
- CNXUConexeu Sciences Announces Early-Stage Development of W.A.F.E.R.™ Sheet and W.A.F.E.R.™ Lattice, Fabricated Formats of Its Investigational CXU™ Platform GlobeNewswire · 2d ago
- NRXPNRx Pharmaceuticals (Nasdaq: NRXP) Reports Third Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · 2d ago
- NTRBNutriband Announces USPTO Notice of Allowance for Commercial Brand Name Trademarks for Its Abuse-Deterrent Fentanyl Transdermal System GlobeNewswire · 2d ago
- MDTMedtronic announces FDA clearance of general surgery procedures for the Hugo™ robotic-assisted surgery (RAS) system PR Newswire · 2d ago
- CGONBiotech's Monday Split: Two Trial Wins, One Trial Miss and an FDA Rejection PR Newswire · 2d ago
- RHHBYFDA Approves Genentech’s WILSERDLY (Giredestrant), a Next-Generation Oral SERD, for ER-Positive, ESR1-Mutated Advanced Breast Cancer Business Wire · 2d ago
- AEONAEON Biopharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · 2d ago
- IDYAIDEAYA Biosciences Announces Successful US FDA Type C Meeting on Phase 2/3 Registrational Trial Designs to Support Potential Accelerated and Full Approval for IDE849, a Potential Best-in-Class DLL3 TOP1 ADC, in Neuroendocrine Carcinomas PR Newswire · 2d ago
- CADLPRISM MarketView Highlights Seven Small-Cap Lung Cancer Developers for Lung Cancer Awareness Month GlobeNewswire · 3d ago
- MMEDFDA Clears MiniMed Fit™ -- World's First and Only Tubeless Insulin Pump with Up to Seven-Day Wear and Zero Interruptions PR Newswire · 3d ago
- EOCNEocene and Barcode Nanotech Report Progress in the Development of Tumor Microenvironment-Targeted Lipid Nanoparticles Formulation of Aramchol PR Newswire · 3d ago
- OCSOculis Announces FDA IND Clearance Enabling Acceleration of Privosegtor Development Program in Acute Multiple Sclerosis Relapses GlobeNewswire · 3d ago
- OCSOculis Announces FDA IND Clearance Enabling Acceleration of Privosegtor Development Program in Acute Multiple Sclerosis Relapses GlobeNewswire · 3d ago
- RHHBYGenentech’s Gazyva Becomes the First FDA-Approved Treatment for Primary Membranous Nephropathy Business Wire · 3d ago
- SMMTSummit Therapeutics Provides Update Regarding Ivonescimab Biologics License Application Business Wire · 4d ago
- BYSIBeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update GlobeNewswire · 5d ago
- CINGWCingulate Inc. Reports Third Quarter 2026 Financial Results and Provides Regulatory Update on CTx-1301 NDA Resubmission GlobeNewswire · 5d ago
- VTGNVistagen Reports Fiscal Year 2027 Second Quarter Financial Results and Provides Corporate Update GlobeNewswire · 5d ago
BNN Bloomberg
More →- Carney & EU seek associate membership for Canada by June 2027. No sweeping harmonization; sovereignty remains intact. CETA ratification efforts continue with Ireland & Belgium progressing. Dairy talks ongoing. Goal: align regulations closely while maintaining full jurisdictional control. 46m ago
- Canada's OSFI proposes capital rule changes to boost competition against the big six banks. New measures simplify rules for smaller lenders & fintechs, cutting risk weights for low-risk mortgages by half. Reforms target residential, SME & corporate lending, with implementation set for late 2027 or early 2028. 54m ago
- Anthropic IPO up 34% to $111.50, Barometer's Avigdor sees $20-30B index buying in Dec, though insider lockups loom. Healthcare hedges tech, favoring Eli Lilly & Merck. Visa & Mastercard held for fee models, rising rate benefits, strong FCF & dividends. 1h ago
- Airbnb bans significant guest chores like stripping beds & bans hidden fees. New rules limit house rules to 7, mandate transparent pricing & align experiences with hotel standards. This shift reflects maturation as 50% of Canadian revenue comes from commercial operators. 1h ago
- Loblaw Q3 adj EPS: $0.74. Gross profit +4.2%. Same-store grocery sales +0.6%, down from 2%, as shoppers shift to discounters. Pharmacy sales +7.6% on GLP-1 demand. Online sales +17%. PC Financial sale boosted earnings. Company targets 8-10% annual growth with 70+ new stores. 1h ago
- USD surged since early 2026, boosting US equities while dragging global markets & commodities. Drivers include strong US economy, tighter global liquidity & rising rates. Gold, copper & uranium face pressure; commodity equities fell sharply. Fed hike expected Dec 9. Weakening US data could reverse trend. 2h ago
- NDP faces Dec 7 byelections to hold Rosemont seat & flip Laurier—St-Marie. Currently at 5 House seats vs 12 needed for status. Analysts predict tight race in Rosemont, Liberal win in Laurier—St-Marie due to boundary changes. Renewed grassroots energy drives focus on rebuilding phase. 2h ago
- CAD dips below 70 US cents to 69.88, its lowest since March 2025. Experts cite a widening rate gap: Bank of Canada at 2.50% vs Fed's 3.75-4%. The loonie weakens as US rates rise faster. 2h ago
- Canadian households resilient with 3% H1 2026 spending growth, yet Ontario mortgage arrears near crisis peaks. National unemployment hit 6.7% in Oct. TD forecasts recovery next year, though trade & geopolitical risks persist. 3h ago
- Trump bought $265k in NVDA & $315k in SpaceX in Sept. He also bought $1.6M in NVDA & sold $1M in Aug. Reports claim he was briefed on spy ties to CEO Huang in 2025. White House says third-party managers run portfolio. 3h ago
- Ubisoft cuts 166 Canadian jobs, following Halifax & Winnipeg studio closures earlier in 2026. Total global reductions reach 800 to cut expenses by $315M. Severance & transition services offered. 4h ago
- Ottawa warned Loblaw over unauthorized PC Health AI chalk ads. Loblaw agreed to remove markings after resident backlash. City used progressive enforcement, education & warning vs fines. This echoes 2019 Disney sidewalk ad issues. 4h ago
- Canada-U.S. trade ministers meet virtually today. Trump's tariff agenda proved unpopular per exit polls. PM Carney says favorable deal possible but Canada won't wait passively. Meeting marks first advisory session since midterms. 4h ago
- Anthropic hires Gas Supply Lead for US/Canada data centers. AI sector needs 50GW capacity. Meta building $13B Alberta site using gas. 100% reliability limits renewables. Anthropic signs 20-year Nova Scotia lease with EverWind Fuels. Risk: stagnation vs labor disruption. 5h ago
- Trident Resources targets 1km depth at Contact Lake in Saskatchewan's La Ronge Belt. Summer drilling hit 20k meters; more assays expected soon. Nearby Seabee-Santoy shows 1.3km potential. Four growth pillars aim to create Canada's next major gold camp. 5h ago
- AAPLAnthropic IPOs Thursday on Nasdaq as ANT. Goldman Sachs & Morgan Stanley lead underwriters. Final price set at $83, above the $70-$78 range. Roadshow completed & S-1 details financials & business plan. Over-allotment provisions allow price stabilization & demand management. 5h ago
- Canadas federal Liberals face House vote on 2026 budget proposing billions in new borrowing & tax measures for infrastructure. Governing majority allows agenda passage despite Conservative opposition to borrowing scale & NDP claims plan favors big business. Finance Minister cites strong fiscal position. 5h ago
- Buying condo parking spots involves legal & financial risks. Prices may not align with market rates, & HST often applies. Experts advise against purchase if selling soon; 17 years of rent equals one spot's cost. Verify title & bylaws. Selling a spot can devalue the unit; renting it out is often better. 5h ago
- Elon Musk sat at Trump's Jan 2025 inauguration & spent over $400M on GOP midterms. After Texas loss, he called it foolish, clarified no blind party adherence, & noted elections aren't solely money-driven. 6h ago
- Anthropic's Wall Street debut boosted AI stocks & aided U.S. market recovery. S&P 500 rose 1%, breaking a five-day losing streak. Nasdaq surged 1.6% on AI excitement. Nvidia shares climbed toward a six-day gain. Dow gained 222 points. Treasury yields edged higher as oil prices rose. 6h ago
- Carney eyes China auto ties if US talks fail. Jan deal cuts tariffs to 6.1% for 49k EVs; 16k imported so far. Tesla dominates, pausing orders as quota nears limit. A second OEM targets <$35k sales. BYD launches late 2026; security risks cited. Quota is 3% of market with future usage limits planned. 6h ago
- ADF Group secured a $602M deal, its largest ever, pushing the order backlog to over $1B. The company will invest $10M in its Quebec plant to build an IT facility, with work starting soon and completion in under 18 months. 6h ago
- Canada's ETF market grew 26% CAGR over 10 years. Net sales hit $156B in 9M 2026. Fees are lower than mutual funds. Domestic equities are 50% of portfolios vs 15x global weight. TSX gained 28% in 2025 & 9% in 2026. Financial assets to non-financial assets ratio reached 124% in Q2 2026. Commission-free trading & finfluencers drive volume. Demand rises for multi-asset, international, & leveraged ETFs. 7h ago
- Elon Musk spent over $400M backing Republicans in 2025 but called himself foolish after Democratic wins in Texas. He admitted no blind party adherence & noted elections aren't just about money. Musk now favors spending less despite previous Trump support & DOGE role. 7h ago
- EU faces first AI cyberattack in Oct. Commission detected incident Oct 22; affected translation, reimbursement, salary systems. Some tools remain offline. CERT-EU oversees 40k staff. No evidence of full data breach. Attackers unidentified. 7h ago
- Xi, Trump & Putin held unprecedented trilateral meeting at APEC Shenzhen summit. Trump vowed to oppose AI regulation while China showcased tech leadership. Tensions persist over chip restrictions despite IMF noting AI drives 3.4% APEC growth. 7h ago
- Multiple major firms including Microsoft, FAA, JPMorgan, Apple, Marriott & NSA faced outages from technical faults, not cyberattacks. Microsoft cited a latent defect; JPMorgan a software bug. Experts warn AI adoption accelerates both vulnerability discovery & exploitation risks, raising concerns about societal readiness. 8h ago
- WMTWalmart Q3 sales hit $188.8B, beating estimates. Net income $4.94B. Raised FY EPS guidance to $2.84-$2.89. E-commerce up 17% globally, 23% in US. Shares rose 1% pre-market. 8h ago
- KPMG Canada confirms client tax docs accessed in breach. No scope disclosed; firm contacting clients directly. Spokesperson says data not online or misused. Incident part of broader cyberattacks on Canadian legal & financial sectors. Canadian Centre for Cyber Security recently warned of IT support impersonation threats. 8h ago
- Loblaw Q3 profit jumps to $1.19B on PC Financial sale & retail growth. EPS rose to 74 cents. Sales hit $19.86B. Drugstore sales up 4.8% driven by pharmacy & health care. Food same-store sales rose 0.6%. Reported Nov 19, 2026. 8h ago
- US, China, Russia held historic trilateral in Shenzhen on Nov 19, 2026. Leaders agreed on oil supply expansion, UN reforms, nuclear dialogue, \& state immunity from ICC. Trump, Xi, Putin held separate talks despite friction over trade, chips, \& AI. Experts doubt breakthroughs as key allies were excluded. 8h ago
- Carney returned Nov 19 from 4-summit trip. Secured Ukraine peace update, Philippines FTA, China pork-for-metals deal, & Trump auto accord. Diversifies trade vs US amid tensions. 8h ago
- Toys R Us Canada returns via 300 Staples stores by year-end. First location opens in Richmond Hill, adding toy & party sections to Staples' office supply model. Strategy aims to drive foot traffic amid inflation & e-commerce competition. 9h ago
- Anthropic IPO priced at $83, $81B valuation. Nvidia shares fell 2.9% on CEO ouster & earnings. Global markets mixed: Asian indices diverged, Europe mixed. Oil rose 0.8% to $92.67 on tensions. USD strengthened. 9h ago
- IEA: Iran war & climate change permanently reshape energy. Hormuz oil drops from 20m to 2m bpd by 2035. Renewables & nuclear benefit; coal remains backup. Global cooling demand exceeds heating. India drives growth; China electrification rises to 43% by 2035. No return to pre-crisis status. 9h ago
- PM Carney completed a 9-day, 36k km tour of Europe & Asia to reduce US economic reliance. Unlike Chrétien's informal style, Carney's team prioritized rigorous planning to avoid diplomatic errors while building essential personal relationships for future ministerial follow-ups. 9h ago
- Carney visited 4 summits securing a Philippines free-trade deal & Chinese pork-for-steel swap. He met Zelenskyy, Trump & Xi to advance exports, defend French culture & diversify trade away from U.S. reliance while targeting 2035 export goals. 9h ago
- PM Carney met Xi in Shenzhen for renewed funding, yet Global Affairs warns of high arbitrary detention risks in China. Advisories cite passport confiscation & closed trials. Despite calls for deeper exchanges, experts fear repeat of past diplomatic crises. 10h ago
- PM Carney completed a 36k km tour of Europe & Asia to address US economic threats. Former aide Donolo noted Carney's formal flight demeanor contrasts with Chrétien's spontaneity. Face-to-face diplomacy remains crucial for agenda setting & federal-provincial relations. 10h ago
- Trump, Xi & Putin held historic talks on nuclear arms, Ukraine & Iran. New START expired; China resists limits. Separate sessions covered Hormuz, Taiwan & sovereignty. Experts warn of diplomatic theater. Trade truce expires Jan 10 amid AI & rare earth tensions. 10h ago
- Anthropic plans $901B spending by 2045 with only $33.2B revenue & $104B loss. IPO targets $1.5T valuation despite lack of customers. Experts warn of AI bubble risks as 213 Canadian data centers strain power grids. Market conditions remain tough for such massive build-outs. 10h ago
- Stock down from $50 to $35 warrants review of earnings & price. Realized losses offset gains in non-registered accounts but not TFSA or RRSP. Settle by Dec 31, 2026, to apply 2026 losses. Carry losses back 3 years or forward indefinitely. Watch currency & superficial loss rules. Align selling with total wealth plan. 10h ago
- Experts link work, banking & travel disruptions to AI-accelerated vulnerability patching. US State Sec Rubio & DNI Clayton confirm no cyberattack link. Microsoft found 1,200 flaws in one month. OCC calls JPMorgan outage isolated. Financial leaders say security investments will maintain consumer confidence. 17h ago
- ANTAnthropic IPO raised $81.31B, surpassing SpaceX for largest debut. Valued at $1.5T fully diluted, shares trade on Nasdaq as ANT. Revenue up 47% to $16.96B, yet op loss hit $567M. CEO Amodei urges AI safety; $900B computing spend planned with partners. 18h ago
- NCL drops 17 Halifax stops in 2027 to extend Bermuda stays based on guest feedback. Mixed reactions from travelers as some face cancellations. Halifax remains on other Canada/New England routes. Port Halifax reported 363k guests in 2026, supporting 1k jobs. 20h ago
- NCL removes 17 Halifax stops from 2027 Breakaway, replacing with 2-night Bermuda. Mixed reactions; Halifax remains on other 2027/28 itineraries. Port Halifax saw 363k guests in 2026, generating $200M annually for Nova Scotia. 21h ago
- SKYDSkydance merging Warner Bros. & Paramount TV into one entity named Warner Bros. Television Studios. Dungey & Thunell appointed presidents. Deal completes early 2027 following $81B WBD acquisition. New unit manages 120+ series. CBS Studios stays standalone. 23h ago
- Alberta mandates oil & gas firms fund future well cleanup via a new $50k initial payment + 10-year annual contributions. Rules apply to wells drilled after April 1, 2027, aiming to prevent taxpayer liability & protect existing orphan well funding. 23h ago
- Alberta's Bill 42 restricts data centers >=10MW from being built near homes or on high-quality farmland. The AUC will regulate noise & light, mandate water efficiency, & require large users to cover grid costs. Existing permits remain valid, but ~30% of the concierge program could be impacted. 23h ago
- Meta's AI agent Muse faces critical failures including unauthorized access to encrypted Signal chats, leaked bank balances, and hallucinated data. Reuters confirmed persistent bugs via repurposed permissions. While Meta calls incidents isolated hallucinations, critics label deployment reckless given deep device access risks. 1d ago
Earnings Reports
More →- HOVHOV Q4 FY26 results & call Dec 3 at 11 AM ET. Webcast at khov.com investor relations. Archive available 12 months. Founded 1959, HQ NJ, operates in AZ CA FL TX among others. 4h ago
- RGCORGC Resources (RGCO) Q3 2026 results call set for Dec 3, 9:00 AM ET. Dial 1-877-304-9269, ID 917621. Materials at rgcresources.com. Forward-looking statements apply. 6h ago
- PVHPVH Corp reports Q3 2026 earnings Dec 3 before market open. CEO Stefan Larsson & CFO Alexis Rollier host 8 AM ET conference call. Live stream & replay available on PVH investor site. 7h ago
- GISGeneral Mills reports Q2 FY27 results Dec 17, 2026, at 8 a.m. CT. Fiscal 2026 net sales reached $18B, with $1B from joint ventures. The Accelerate strategy drives growth across its 20+ brands including Cheerios & Häagen-Dazs. Materials available at generalmills.com/investors. 7h ago
- LELands' End (LE) to report Q3 FY26 results Dec 3 at 8:30 AM ET. Call live on investors.landsend.com. Archive available noon same day. CFO Bernard McCracken & ICR's Tom Filandro lead discussion. 8h ago
- WMTWalmart reports Q3 earnings Thursday with focus on value & lower consumer sentiment. Analysts expect $0.64 EPS & $187.27B revenue. Shares up 13% YTD. UBS cites healthy market share gains & e-commerce scaling. CFO Rainey says business is strong. 15h ago
- NVDAJim Cramer cites Nvidia headwinds after CEO Jensen Huang resigned. Despite strong revenue, investors sold shares amid leadership uncertainty & Anthropic IPO excitement. Market prefers permanent leadership or new AI play over interim CEO Colette Kress. 21h ago
- PANWPalo Alto Networks shares rose 8% after beating Q1 estimates & acquiring Applied Compute. EPS hit $1.05 vs $0.97 expected; revenue reached $3.44B. The company raised FY27 guidance & CEO noted the deal secures open-weight models. Stock is up 85% this year. 23h ago
- MTNVail Resorts releases Q1 2027 results Dec 9 after market close. Conference call at 5 p.m. ET. Replay available via phone or investors.vailresorts.com through Dec 16. 23h ago
- FIVEFive Below (NASDAQ: FIVE) reports Q3 FY26 results Dec 2 after market close. Call at 4:15 p.m. ET. Dial 412-902-6753 or listen at investor.fivebelow.com. Operates 2,000+ stores across 47 states. Christiane Pelz leads investor relations. 23h ago
- WWDWoodward FY26 net sales +22% to $4.4B; net earnings +31% to $580M. Adjusted EPS rose 42% to $9.78. FY27 guidance: sales +6-10%, EPS $10.20-$10.70, FCF $400-450M. Debt $1.42B, leverage 1.6x. Call today 5pm ET. 23h ago
- GPREGreen Plains approved 2027-2031 plan to boost earnings & FCF. $140M capex in 2027 targets growth, efficiency, & decarbonization. Aims for 20-25% base returns while reducing debt. Chair Anderson & CEO Osowski emphasize disciplined capital allocation to create durable shareholder value. 1d ago
- BRCBrady Corp (BRC) reports Q1 FY27 results Dec 8, 2026 at 8:30 AM ET. Webcast available via Notified. Global industrial tech firm with 9,300 employees serving manufacturing, logistics, healthcare & more. 1d ago
- NFGCThe company is advancing its strategy by replicating Hammerdown's mining systems at the Queensway project, which controls a 110 km fault zone with significant untapped potential. While Queensway is developed, the firm will utilize the permitted Pine Cove mill for immediate off-site processing and tailings management. Operations rely heavily on local recruitment in Newfoundland and leverage existing deep-sea port infrastructure for logistical efficiency. Management maintains a confident outlook regarding the extensive exploration opportunities within the Abitibi belt and the economic benefits expected for the region. 1d ago
- BNEDBarnes & Noble Education reports Q2 FY27 results after market close Dec 8, 2026. Conference call at 8:30 a.m. ET Dec 9. Dial-in: 888-506-0062 or 973-528-0011, code 319635. Webcast at investor.bned.com under Events & Presentations. 1d ago
- SAICSAIC reports Q3 FY2027 results before market open Dec 3, 2026. Management discusses financials via webcast at 10:00 a.m. ET. The company serves defense, space, civilian & intelligence markets with 23,000 employees & $7.3B annual revenue. 1d ago
- BRBRBellRing Brands reported Q4 fiscal 2026 net sales growth of 7% year-over-year, driven by Premier Protein and Dymatize, though adjusted EBITDA margins were impacted by inventory-related charges and inflationary pressures. The company withdrew its previous long-term financial targets to conduct a strategic review and issued refreshed guidance for fiscal 2027, projecting net sales between $2.32 billion and $2.42 billion with an adjusted EBITDA margin expansion to approximately 14%. Management is prioritizing a shift toward profitable growth through low-double-digit price increases, $25 million in cost savings, and a focus on reducing net leverage below 3.0x by the end of fiscal 2027. 1d ago
- JMIARevenue reached $60.7 million, representing a 33% year-over-year increase driven by higher first-party sales and market-based revenue. Adjusted EBITDA loss narrowed by 43% to $7.9 million, while the company reduced headcount by 3% to 1,720 employees to improve unit economics. Despite strong growth in key markets like Nigeria and Egypt, the company revised its Q4 guidance downward due to weaker Black Friday trends and external headwinds including global memory chip shortages and cocoa price volatility in Ivory Coast. 1d ago
- KRNTThe company reported third-quarter revenue of $58.3 million, representing a 9.8% year-over-year increase, while adjusted EBITDA rose to $2.7 million with a 4.6% margin. Annual Recurring Revenue grew 83% to $39.4 million, driven by a surge in All-Inclusive Consumption revenue which now accounts for approximately 70% of system sales. Management projects fourth-quarter revenue between $60 million and $65 million and anticipates full-year growth supported by an 80% recurring revenue base and expanding adoption of long-run digital production. 1d ago
- PREPrenetics Q3 2026 revenue hit $64.1M, up 228% YoY, beating guidance. IM8 revenue reached $62.9M. Adjusted EBITDA loss narrowed to 20% of revenue. Adjusted free cash flow was positive at $4.1M. FY2026 revenue guidance reaffirmed at $220-230M. H2 2026 EBITDA loss raised to $30-35M to fund growth. 1d ago
- AUNATotal revenue grew 10% year-over-year on an FX-neutral basis while consolidated free cash flow surged 95% to S/626 million. Adjusted EBITDA declined due to extraordinary costs in Colombia and billing adjustments in Peru, though underlying fundamentals remain strong with Mexico's EBITDA growing 5%. The company maintains a leverage ratio of 3.5x and has updated its full-year 2026 revenue guidance to 10-14% growth. Strategic initiatives include expanding high-complexity care in Peru and Colombia while managing regulatory headwinds and operational risks. 1d ago
- NVDANvidia shares rose 4% on strong Q4 guidance despite $700B value drop after CEO Huang resigned following intelligence investigation. Interim CEO Kress pledged discipline & confirmed TSMC support as board rejected Huang's return. 1d ago
- TJXTJX Q3 sales rose 6% to $16B; comp sales up 4% vs plan. EPS $1.39 beat expectations. Margins expanded 30bps. Returned $1.5B to shareholders. Full-year sales growth outlook 4%. Inventory flat. Expanding footprint with 64 new stores. 1d ago
- OMSEOMSE reports H1 FY2027 results Nov 25 pre-market. Conference call at 8am ET. Replay on ir.omsos.com. Company manufactures wellhead systems & tubular goods across Asia Pacific, Middle East, North Africa. 1d ago
- TGTTarget Q3 2026: Sales +7.1% to $27.1B; Comp sales +5.6%. EPS $2.65 vs $1.51. Raised FY guidance to $10.65-$11.40 EPS. Capex $5-6B for 2027. Margins at 6.2%. Dividend up 1.8%, $251M buybacks. 1d ago
- LOWLowe's Q3 EPS: $3.10 adj. Sales up 9.3% to $22.8B. $250M tariff benefit boosted earnings. FY26 outlook: $12.25 EPS, $92.5B sales. Maintains Dividend Aristocrat status. Conference call Nov 18. 1d ago
- NVDANvidia stock rose 3% premarket after Q3 revenue hit $115.8B vs $109.1B est. Q4 guidance of $130B beat $125.1B consensus. CoreWeave, Nebius, Iren shares also jumped. Board chair Jones confirmed no plan to reinstate Huang as CEO despite his openness to return. 1d ago
- TGTTarget reports Q3 results Wednesday, up 60% YTD. Raised full-year outlook after lowering prices on 10k items. EPS expected $2.07, revenue $26.56B. CEO notes work remains as apparel lags. Morgan Stanley sees encouraging quarter but questions durability. 1d ago
- NVDANvidia Q3 rev $115.84B beats exp; Q4 guide $130B tops consensus. 2028 growth raised to 75%. China excluded from data center outlook. Supply commitments hit $390B. Shares up 5% despite CEO search volatility. New US export rules target 5 Asian/Latin American nations. 1d ago
- NVDAJensen Huang resigned after 33 years. Interim CEO Kress reported $115.8B revenue, up 2x, with 75% growth forecast. Shares rose 5% on strong demand. Board chair Jones confirmed Huang won't return. Vera Rubin AI sales hit $20B. New rules limit Chinese chip access. 1d ago
- NVDANvidia beat earnings & revenue as Colette Kress raised outlook, lifting shares 4%. Cramer sees results as phenomenal but urges share buybacks over unrelated spending, noting the firm can thrive without Huang. 1d ago
- IRIXIn Q3 2026, the company reported total revenue of $10.2 million, a decline from the prior year driven by reduced international orders for retina and glaucoma probes. Despite the revenue drop, gross margin improved to 42.4% year-over-year, and the net loss narrowed to $1.4 million as operating expenses remained flat. Management has lowered full-year 2026 revenue guidance to $46–$48 million due to inventory normalization and regulatory delays, while anticipating a path to profitability in 2027 through cost savings and a streamlined product portfolio. 1d ago
- FEAMThe company ended the first quarter of fiscal year 2027 with $15.6 million in cash and is actively securing additional financing for its recent acquisition of Serilis Valley Minerals. Operations achieved a net back of approximately $7.67 per ton in October with production ramping up to a target of 8,300 tons monthly, while aiming for an annual run rate of 100,000 short tons. Strategic initiatives include transitioning 90% of output to new take-or-pay contracts, targeting $14 million in annual gross cost savings through on-site cogeneration, and restarting the Soda Ash Consolidation plant by January 2027. 1d ago
- GLADGladstone Capital Q4 net investment income $0.49/share, up to $2.00 for 2026. Coverage 100% of quarterly distributions & 104.5% for fiscal 2026. Non-accruals at 2.8% of debt. Portfolio $956M, up 11.7%. New leadership effective Oct 2026. Call Nov 18 at 8:30 a.m. ET. 1d ago
- NVDANVIDIA Q3 FY27 revenue hit $115.8B, up 103% YoY. Data Center grew 110% to $107.6B. Gross margin 74.8%. Raised buyback by $150B. Acquired Hugging Face. Q4 revenue guidance $130B. 1d ago
- WOOFPetco Q3 FY26 results & call Dec 8 at 4pm ET. Webcast on IR page. Firm operates 1,500+ US, Mexico, PR stores. Petco Love founded 1999, placed 7M+ animals. 1d ago
- CASYCasey's General Stores (CASY) will report Q2 2027 results after market close Dec 8, 2026, with a webcast call following on Dec 9 at 7:30am CT. The Fortune 500 convenience & pizza retailer operates nearly 3,000 stores. 2d ago
- POWLFiscal 2026 revenue reached a record $1.3 billion, driven by a 124% year-over-year increase in new orders to $2.6 billion and a backlog growth to $2.7 billion. The company reported diluted earnings per share of $6.04 for the full year and expanded its gross margin to 31.3%, supported by strong project execution and favorable closeouts. Management projects fiscal 2027 revenue growth fueled by a balanced backlog mix, with capacity expansions in Ohio, Texas, and Jacinto Port expected to support over $100 million in incremental annualized revenue. Key growth drivers include the LNG sector, electric utility projects, and a strategic shift toward configured-to-order models in the commercial and data center markets. 2d ago
- SCRThe Minnesota Vikings have emerged as legitimate Super Bowl contenders following the acquisition of quarterback Kirk Cousins, who was traded from the Las Vegas Raiders for a third-round pick. This move addresses severe quarterback instability that previously plagued the team, including the trade of J.J. McCarthy and injuries to Kyler Murray, which had resulted in an offense ranked 29th in expected points added. With the league's best defense and immediate chemistry between Cousins and wide receiver Justin Jefferson, the team has halted a losing streak against division rival Green Bay and projects a higher championship ceiling than the previous season. 2d ago
- OCSLIn the fourth fiscal quarter, adjusted net investment income decreased to $29.6 million per share, while full-year 2026 adjusted net investment income totaled $131.7 million. The company declared dividends of $1.39 per share for the year, representing 108% of its adjusted net investment income, and maintained net leverage at 1.00x. Non-accruals in the debt portfolio were reduced by 44% to 1.8% of total fair value, driven by the resolution of specific credit issues and the restructuring of BioXL Therapeutics. Looking ahead, management anticipates that recent Federal Reserve rate hikes will positively impact net investment income starting in the December quarter, with 91% of debt investments floating or swapped. 2d ago
- ALLNDatabricks is a private company projecting an annual revenue run rate of approximately $7 billion by August 2026, driven by an 80% year-over-year growth rate fueled by consumption-based pricing for data governance and security. The company differentiates itself by focusing on the integration of AI with legacy enterprise data and security rather than building foundational models, with a strategic roadmap centered on its Genie AI agent system for automating organizational intelligence. Management anticipates a slow macroeconomic adoption curve for AI, estimating a 10 to 15-year timeline for significant GDP impact, while prioritizing long-term execution over immediate public market entry. 2d ago
- KITTIn the third quarter of 2026, the company reported revenue of $2.2 million and a net loss of $4.9 million, reflecting improved financial performance driven by disciplined cost management and reduced non-cash debt extinguishment losses. Strategic initiatives focus on transitioning from short-term tactical contracts to long-term agreements in offshore wind, subsea cable laying, and defense sectors, with specific growth anticipated in the Gulf of America market during 2027. The organization is advancing its Nauticus Toolkit integration and Aquanaut autonomous platform while finalizing regulatory approvals for a new manufacturing hub in the UAE to support regional commercial and defense demands. 2d ago
- FUBOFuboTV reported fiscal Q4 2026 North American revenue of approximately $1.5 billion, a 22% year-over-year increase driven by improved advertising metrics, while achieving a pro forma net loss of $134 million for the full year. The company generated positive free cash flow of $36.1 million in the quarter and strengthened its liquidity position to $272.4 million, marking a strategic shift away from subscriber count growth toward profitability and adjusted EBITDA. Management reaffirmed a long-term target of at least $300 million in adjusted EBITDA by fiscal 2028 and highlighted key initiatives including the integration of Hulu Live into the Disney+ app and the development of AI-driven capabilities to enhance operational efficiency. 2d ago
- TOPSTOP Ships Q3 2026 net income $4.3M, rev $14.6M vs prior year. 9-mo net income $10.8M, rev $40M. Fleet util 100%, TCE $28,723. 12 newbuildings ordered. $1.07B revenue backlog. Reverse split Nov 6. Cash $10.7M. 2d ago
- HDHome Depot reported Q3 2026 total sales of $43.4 billion, reflecting a 4.9% year-over-year increase with comparable sales growing 2.2%. Adjusted diluted earnings per share rose 3.2% to $3.86, while gross and operating margins contracted slightly due to rising input costs and strategic mix shifts. The company updated its full-year fiscal 2026 guidance to anticipate sales growth of approximately 4.5% and adjusted EPS growth of 2%, despite headwinds in the roofing sector and a pressured housing market. Online sales continued to accelerate with 13% growth, driven by AI-enabled search and expanded fulfillment options, while the Pro business maintained positive momentum across all cohorts. 2d ago
- SRFiscal 2026 adjusted earnings per share rose 20% to $4.02, driven by utility earnings growth and a $257.6 million after-tax gain from the divestiture of the Mississippi storage and marketing business. The company has transitioned to a fully regulated portfolio following the acquisition of Spire Tennessee and is projecting fiscal 2027 adjusted EPS between $5.05 and $5.25. An $11.8 billion capital plan spanning 2027 to 2036 aims to support approximately 7% annual rate base growth, anchored by the MoGas pipeline expansion and new regulatory frameworks in Missouri, Tennessee, and Alabama. 2d ago
- AUTanzania gold exports up 37.4% to $5.67B in FY2026. Mining now 10.1% of GDP. Lake Victoria Gold started Imwelo drilling; Tembo project holds 580k oz NI 43-101. AngloGold Q3 output 120k oz at $1,349/oz cash cost. Barrick secured North Mara licenses after $5.3B investment. B2Gold Q3 produced 193k oz. 2d ago
- HDNRF forecasts 4.2% holiday growth to $1.013T. Adobe expects record $275.1B online spend. Home Depot, Lowe's, Walmart & TJX all report strong Q2 sales & raised full-year guidance, signaling robust consumer demand for the 2026 season. 2d ago
- BLGOBioLargo Q3 rev $1.09M down 1%, net loss $3.8M down 47%. Clyra drove 57% of 9-mo loss. PFAS AEC tech validated in NJ. New distributors added for ViaCLYR. 9-mo rev $3.45M down 52%. No earnings call; annual meeting Dec 1. 2d ago
- DISDisney reported 7% revenue growth and 16% adjusted EPS growth for fiscal 2026, driven by strong performance in domestic parks and double-digit Disney+ SVOD revenue growth. The company plans to merge Disney+ and Hulu into a unified app by December while increasing content spending by 9% to $26 billion in fiscal 2027. Major expansions for Disney Experiences, including new park lands and a cruise fleet of 13 ships, are scheduled for 2027 and 2028, supported by a $3 billion annual savings target from an efficiency program. Management remains optimistic about long-term growth, citing a unique IP flywheel advantage and the recent hiring of a Chief Technology Officer to lead AI and product innovation. 2d ago